activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
Not Active	1650108	CHEMBL860651	Average Binding Constant for MKNK2; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL4204	Homo sapiens	Kd		
Not Active	1650108	CHEMBL860651	Average Binding Constant for MKNK2; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL4204	Homo sapiens	Kd		
Not Active	1650109	CHEMBL860651	Average Binding Constant for MKNK2; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707		Kd			CHEMBL4204	Homo sapiens	Kd		
Not Active	1650110	CHEMBL860651	Average Binding Constant for MKNK2; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL4204	Homo sapiens	Kd		
Not Active	1650111	CHEMBL860651	Average Binding Constant for MKNK2; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Kd			CHEMBL4204	Homo sapiens	Kd		
Not Active	1650112	CHEMBL860651	Average Binding Constant for MKNK2; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL4204	Homo sapiens	Kd		
Not Active	1650113	CHEMBL860651	Average Binding Constant for MKNK2; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL4204	Homo sapiens	Kd		
	1650114	CHEMBL860651	Average Binding Constant for MKNK2; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	250.0	CHEMBL4204	Homo sapiens	Kd	uM	0.25
Not Active	1650115	CHEMBL860651	Average Binding Constant for MKNK2; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL4204	Homo sapiens	Kd		
	1650116	CHEMBL860651	Average Binding Constant for MKNK2; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	1900.0	CHEMBL4204	Homo sapiens	Kd	uM	1.9
	1651236	CHEMBL860651	Average Binding Constant for MKNK2; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	22.0	CHEMBL4204	Homo sapiens	Kd	uM	0.022
Not Active	1651237	CHEMBL860651	Average Binding Constant for MKNK2; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL4204	Homo sapiens	Kd		
Not Active	1651238	CHEMBL860651	Average Binding Constant for MKNK2; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL4204	Homo sapiens	Kd		
Not Active	1651239	CHEMBL860651	Average Binding Constant for MKNK2; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL4204	Homo sapiens	Kd		
	1651240	CHEMBL860651	Average Binding Constant for MKNK2; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	1100.0	CHEMBL4204	Homo sapiens	Kd	uM	1.1
	1651241	CHEMBL860651	Average Binding Constant for MKNK2; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Kd	nM	1000.0	CHEMBL4204	Homo sapiens	Kd	uM	1.0
Not Active	1651242	CHEMBL860651	Average Binding Constant for MKNK2; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL4204	Homo sapiens	Kd		
	1651243	CHEMBL860651	Average Binding Constant for MKNK2; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	360.0	CHEMBL4204	Homo sapiens	Kd	uM	0.36
	1651244	CHEMBL860651	Average Binding Constant for MKNK2; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	1600.0	CHEMBL4204	Homo sapiens	Kd	uM	1.6
	1651245	CHEMBL860651	Average Binding Constant for MKNK2; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	3400.0	CHEMBL4204	Homo sapiens	Kd	uM	3.4
	1651246	CHEMBL860651	Average Binding Constant for MKNK2; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	1300.0	CHEMBL4204	Homo sapiens	Kd	uM	1.3
	1790355	CHEMBL856382	Percent residual activity, relative to control, of MNK2 at 1 uM concentration of inhibitor in presence of 50 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)NC(=O)CCCCCNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL413460	=	Activity	%	31.0	CHEMBL4204	Homo sapiens	Activity	%	31.0
	1790409	CHEMBL856382	Percent residual activity, relative to control, of MNK2 at 1 uM concentration of inhibitor in presence of 50 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL279185	=	Activity	%	99.0	CHEMBL4204	Homo sapiens	Activity	%	99.0
	2051645	CHEMBL941782	Inhibition of MNK2	B	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	>	Ki	nM	9350.0	CHEMBL4204	Homo sapiens	Ki	uM	9.35
	2147315	CHEMBL922000	Activity of human Mnk2 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	94.0	CHEMBL4204	Homo sapiens	Activity	%	94.0
Not Active	2302179	CHEMBL950848	Inhibition of MNK2alpha at 10 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL4204	Homo sapiens	INH		
	2395467	CHEMBL963595	Binding affinity to MKNK2 at 10 uM by Ambit binding assay relative to control	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Activity	%	0.0	CHEMBL4204	Homo sapiens	Activity	%	0.0
	2395470	CHEMBL963598	Inhibition of MNK2 by Ambit binding assay	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	IC50	nM	500.0	CHEMBL4204	Homo sapiens	IC50	nM	500.0
	2470274	CHEMBL987193	Inhibition of MKNK2 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL4204	Homo sapiens	INH	%	10.0
Not Evaluated	2476719	CHEMBL982747	Binding affinity to human MNK2 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL4204	Homo sapiens	Activity		
Not Evaluated	2478558	CHEMBL982747	Binding affinity to human MNK2 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL4204	Homo sapiens	Activity		
Not Evaluated	2478761	CHEMBL982747	Binding affinity to human MNK2 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL4204	Homo sapiens	Activity		
	2479558	CHEMBL988950	Binding affinity to human MNK2	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337	=	Kd	nM	1230.0	CHEMBL4204	Homo sapiens	Kd	nM	1230.0
	2479616	CHEMBL982747	Binding affinity to human MNK2 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Activity	%	1.4	CHEMBL4204	Homo sapiens	Activity	%	1.4
	2479819	CHEMBL982747	Binding affinity to human MNK2 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	24.8	CHEMBL4204	Homo sapiens	Activity	%	24.8
	2480616	CHEMBL982747	Binding affinity to human MNK2 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	2.1	CHEMBL4204	Homo sapiens	Activity	%	2.1
Not Evaluated	2480818	CHEMBL982747	Binding affinity to human MNK2 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL4204	Homo sapiens	Activity		
	2577237	CHEMBL982747	Binding affinity to human MNK2 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901	=	Activity	%	2.1	CHEMBL4204	Homo sapiens	Activity	%	2.1
	2577440	CHEMBL982747	Binding affinity to human MNK2 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337	=	Activity	%	2.5	CHEMBL4204	Homo sapiens	Activity	%	2.5
	2593645	CHEMBL982747	Binding affinity to human MNK2 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Activity	%	16.1	CHEMBL4204	Homo sapiens	Activity	%	16.1
	2593911	CHEMBL982747	Binding affinity to human MNK2 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Activity	%	19.4	CHEMBL4204	Homo sapiens	Activity	%	19.4
Not Evaluated	2594114	CHEMBL982747	Binding affinity to human MNK2 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL4204	Homo sapiens	Activity		
Not Evaluated	2594854	CHEMBL982747	Binding affinity to human MNK2 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL4204	Homo sapiens	Activity		
Not Evaluated	2595057	CHEMBL982747	Binding affinity to human MNK2 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL4204	Homo sapiens	Activity		
	2596254	CHEMBL982747	Binding affinity to human MNK2 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342	=	Activity	%	8.5	CHEMBL4204	Homo sapiens	Activity	%	8.5
Not Evaluated	2596457	CHEMBL982747	Binding affinity to human MNK2 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL4204	Homo sapiens	Activity		
	2596886	CHEMBL1017900	Inhibition of MKNK2 assessed as enzyme activity relative to control	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Activity	%	19.0	CHEMBL4204	Homo sapiens	Activity	%	19.0
Not Evaluated	2597726	CHEMBL982747	Binding affinity to human MNK2 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL4204	Homo sapiens	Activity		
	2635917	CHEMBL1004129	Inhibition of MNK2 at 1 uM relative to control	B	CSc1cc(Oc2ccnc3[nH]c(=O)[nH]c23)ccc1NC(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL496009	=	Residual_activity	%	100.0	CHEMBL4204	Homo sapiens	Residual_activity	%	100.0
	2635985	CHEMBL1004129	Inhibition of MNK2 at 1 uM relative to control	B	O=C(Nc1cc(C(F)(F)F)ccc1F)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)c2ccccc12		CHEMBL498112	=	Residual_activity	%	100.0	CHEMBL4204	Homo sapiens	Residual_activity	%	100.0
	2636053	CHEMBL1004129	Inhibition of MNK2 at 1 uM relative to control	B	CC(C)(C)c1cccc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)c1		CHEMBL496073	=	Residual_activity	%	100.0	CHEMBL4204	Homo sapiens	Residual_activity	%	100.0
	2721655	CHEMBL1057484	Inhibition of Mnk2 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
Antagonist	2897319	CHEMBL1062886	Inhibition of MNK2 in the presence of 50uM ATP	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	IC50	nM	1600.0	CHEMBL4204	Homo sapiens	IC50	uM	1.6
	2900646	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	270.0	CHEMBL4204	Homo sapiens	Kd	nM	270.0
	2900647	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	2900648	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	3.0	CHEMBL4204	Homo sapiens	Kd	nM	3.0
	2900649	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	2900650	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	1600.0	CHEMBL4204	Homo sapiens	Kd	nM	1600.0
	2900651	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	2900652	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	2900653	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	2900654	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	1800.0	CHEMBL4204	Homo sapiens	Kd	nM	1800.0
	2900655	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	2900656	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	=	Kd	nM	840.0	CHEMBL4204	Homo sapiens	Kd	nM	840.0
	2900657	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	2900658	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	2901442	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	2901443	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	3200.0	CHEMBL4204	Homo sapiens	Kd	nM	3200.0
	2901444	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	1200.0	CHEMBL4204	Homo sapiens	Kd	nM	1200.0
	2901445	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	2901446	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	2901447	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	2901448	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	2901449	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	2901450	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	2901451	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	2901452	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	2901453	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	2901454	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	950.0	CHEMBL4204	Homo sapiens	Kd	nM	950.0
	2901455	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	2901456	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	2901457	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	2901458	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	2901459	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	2901460	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	130.0	CHEMBL4204	Homo sapiens	Kd	nM	130.0
	2901461	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	17.0	CHEMBL4204	Homo sapiens	Kd	nM	17.0
	2901462	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	5500.0	CHEMBL4204	Homo sapiens	Kd	nM	5500.0
	2901463	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	2901464	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	2901465	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	2901466	CHEMBL1050830	Binding constant for MKNK2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	1700.0	CHEMBL4204	Homo sapiens	Kd	nM	1700.0
Antagonist	2907013	CHEMBL1062764	Percentage MNK2 activity remaining in the presence of 0.01uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	47.0	CHEMBL4204	Homo sapiens	Activity	%	47.0
	2907014	CHEMBL1062764	Percentage MNK2 activity remaining in the presence of 0.01uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	97.0	CHEMBL4204	Homo sapiens	Activity	%	97.0
	2907015	CHEMBL1062764	Percentage MNK2 activity remaining in the presence of 0.01uM inhibitor	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Activity	%	103.0	CHEMBL4204	Homo sapiens	Activity	%	103.0
	2907016	CHEMBL1061971	Percentage MNK2 activity remaining in the presence of 0.1uM inhibitor	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	Activity	%	96.0	CHEMBL4204	Homo sapiens	Activity	%	96.0
Antagonist	2907017	CHEMBL1061971	Percentage MNK2 activity remaining in the presence of 0.1uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	19.0	CHEMBL4204	Homo sapiens	Activity	%	19.0
	2907018	CHEMBL1061971	Percentage MNK2 activity remaining in the presence of 0.1uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	80.0	CHEMBL4204	Homo sapiens	Activity	%	80.0
	2907019	CHEMBL1061971	Percentage MNK2 activity remaining in the presence of 0.1uM inhibitor	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Activity	%	98.0	CHEMBL4204	Homo sapiens	Activity	%	98.0
	2907020	CHEMBL1061971	Percentage MNK2 activity remaining in the presence of 0.1uM inhibitor	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Activity	%	103.0	CHEMBL4204	Homo sapiens	Activity	%	103.0
Antagonist	2907021	CHEMBL1061971	Percentage MNK2 activity remaining in the presence of 0.1uM inhibitor	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Activity	%	30.0	CHEMBL4204	Homo sapiens	Activity	%	30.0
	2907022	CHEMBL1061971	Percentage MNK2 activity remaining in the presence of 0.1uM inhibitor	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Activity	%	101.0	CHEMBL4204	Homo sapiens	Activity	%	101.0
	2907023	CHEMBL1060207	Percentage MNK2 activity remaining in the presence of 10uM inhibitor	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Activity	%	99.0	CHEMBL4204	Homo sapiens	Activity	%	99.0
	2907024	CHEMBL1060207	Percentage MNK2 activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Activity	%	104.0	CHEMBL4204	Homo sapiens	Activity	%	104.0
	2907025	CHEMBL1060207	Percentage MNK2 activity remaining in the presence of 10uM inhibitor	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Activity	%	95.0	CHEMBL4204	Homo sapiens	Activity	%	95.0
Antagonist	2907026	CHEMBL1060207	Percentage MNK2 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	31.0	CHEMBL4204	Homo sapiens	Activity	%	31.0
	2907027	CHEMBL1060207	Percentage MNK2 activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	88.0	CHEMBL4204	Homo sapiens	Activity	%	88.0
	2907028	CHEMBL1060207	Percentage MNK2 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Activity	%	92.0	CHEMBL4204	Homo sapiens	Activity	%	92.0
	2907029	CHEMBL1060207	Percentage MNK2 activity remaining in the presence of 10uM inhibitor	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Activity	%	95.0	CHEMBL4204	Homo sapiens	Activity	%	95.0
Antagonist	2907030	CHEMBL1060207	Percentage MNK2 activity remaining in the presence of 10uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	39.0	CHEMBL4204	Homo sapiens	Activity	%	39.0
	2907031	CHEMBL1060207	Percentage MNK2 activity remaining in the presence of 10uM inhibitor	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Activity	%	90.0	CHEMBL4204	Homo sapiens	Activity	%	90.0
	2907032	CHEMBL1060207	Percentage MNK2 activity remaining in the presence of 10uM inhibitor	B	C[C@H]1CNCCN1S(=O)(=O)c1cccc2cnccc12		CHEMBL1233654	=	Activity	%	80.0	CHEMBL4204	Homo sapiens	Activity	%	80.0
	2907033	CHEMBL1060207	Percentage MNK2 activity remaining in the presence of 10uM inhibitor	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Activity	%	91.0	CHEMBL4204	Homo sapiens	Activity	%	91.0
	2907034	CHEMBL1060207	Percentage MNK2 activity remaining in the presence of 10uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	98.0	CHEMBL4204	Homo sapiens	Activity	%	98.0
Antagonist	2907035	CHEMBL1060207	Percentage MNK2 activity remaining in the presence of 10uM inhibitor	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Activity	%	46.0	CHEMBL4204	Homo sapiens	Activity	%	46.0
	2907036	CHEMBL1060207	Percentage MNK2 activity remaining in the presence of 10uM inhibitor	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Activity	%	55.0	CHEMBL4204	Homo sapiens	Activity	%	55.0
	2907037	CHEMBL1060207	Percentage MNK2 activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1sc(-c2ccsc2)cc1N		CHEMBL193093	=	Activity	%	91.0	CHEMBL4204	Homo sapiens	Activity	%	91.0
	2907038	CHEMBL1060207	Percentage MNK2 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	85.0	CHEMBL4204	Homo sapiens	Activity	%	85.0
	2907039	CHEMBL1060207	Percentage MNK2 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	98.0	CHEMBL4204	Homo sapiens	Activity	%	98.0
	2907040	CHEMBL1060207	Percentage MNK2 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Activity	%	102.0	CHEMBL4204	Homo sapiens	Activity	%	102.0
Antagonist	2907041	CHEMBL1060207	Percentage MNK2 activity remaining in the presence of 10uM inhibitor	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	40.0	CHEMBL4204	Homo sapiens	Activity	%	40.0
	2907042	CHEMBL1060207	Percentage MNK2 activity remaining in the presence of 10uM inhibitor	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	Activity	%	97.0	CHEMBL4204	Homo sapiens	Activity	%	97.0
	2907043	CHEMBL1060207	Percentage MNK2 activity remaining in the presence of 10uM inhibitor	B	O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1		CHEMBL79004	=	Activity	%	70.0	CHEMBL4204	Homo sapiens	Activity	%	70.0
	2907044	CHEMBL1060207	Percentage MNK2 activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl.O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL540501	=	Activity	%	106.0	CHEMBL4204	Homo sapiens	Activity	%	106.0
	2907045	CHEMBL1060207	Percentage MNK2 activity remaining in the presence of 10uM inhibitor	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Activity	%	85.0	CHEMBL4204	Homo sapiens	Activity	%	85.0
	2907046	CHEMBL1060207	Percentage MNK2 activity remaining in the presence of 10uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	80.0	CHEMBL4204	Homo sapiens	Activity	%	80.0
	2907047	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Activity	%	91.0	CHEMBL4204	Homo sapiens	Activity	%	91.0
	2907048	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Activity	%	85.0	CHEMBL4204	Homo sapiens	Activity	%	85.0
	2907049	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Activity	%	104.0	CHEMBL4204	Homo sapiens	Activity	%	104.0
	2907050	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	72.0	CHEMBL4204	Homo sapiens	Activity	%	72.0
	2907051	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	96.0	CHEMBL4204	Homo sapiens	Activity	%	96.0
	2907052	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Activity	%	89.0	CHEMBL4204	Homo sapiens	Activity	%	89.0
	2907053	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Activity	%	56.0	CHEMBL4204	Homo sapiens	Activity	%	56.0
	2907054	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Activity	%	107.0	CHEMBL4204	Homo sapiens	Activity	%	107.0
	2907055	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Activity	%	103.0	CHEMBL4204	Homo sapiens	Activity	%	103.0
	2907056	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Activity	%	97.0	CHEMBL4204	Homo sapiens	Activity	%	97.0
	2907057	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Activity	%	97.0	CHEMBL4204	Homo sapiens	Activity	%	97.0
	2907058	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Activity	%	90.0	CHEMBL4204	Homo sapiens	Activity	%	90.0
	2907059	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Activity	%	102.0	CHEMBL4204	Homo sapiens	Activity	%	102.0
Antagonist	2907060	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL265470	=	Activity	%	50.0	CHEMBL4204	Homo sapiens	Activity	%	50.0
	2907061	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Activity	%	59.0	CHEMBL4204	Homo sapiens	Activity	%	59.0
	2907062	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	70.0	CHEMBL4204	Homo sapiens	Activity	%	70.0
	2907063	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	80.0	CHEMBL4204	Homo sapiens	Activity	%	80.0
	2907064	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	CC1=NCCc2c1[nH]c1cc(O)ccc21		CHEMBL129177	=	Activity	%	106.0	CHEMBL4204	Homo sapiens	Activity	%	106.0
	2907065	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	Cc1nccc2c1[nH]c1ccccc12		CHEMBL12014	=	Activity	%	112.0	CHEMBL4204	Homo sapiens	Activity	%	112.0
	2907066	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c3c([nH]c2c1)C(C)=NCC3		CHEMBL340807	=	Activity	%	92.0	CHEMBL4204	Homo sapiens	Activity	%	92.0
	2907923	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	107.0	CHEMBL4204	Homo sapiens	Activity	%	107.0
	2907924	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	115.0	CHEMBL4204	Homo sapiens	Activity	%	115.0
	2907925	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Activity	%	102.0	CHEMBL4204	Homo sapiens	Activity	%	102.0
	2907926	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Activity	%	102.0	CHEMBL4204	Homo sapiens	Activity	%	102.0
Antagonist	2907927	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Activity	%	38.0	CHEMBL4204	Homo sapiens	Activity	%	38.0
	2907928	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Activity	%	61.0	CHEMBL4204	Homo sapiens	Activity	%	61.0
	2907929	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	99.0	CHEMBL4204	Homo sapiens	Activity	%	99.0
	2907930	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Activity	%	97.0	CHEMBL4204	Homo sapiens	Activity	%	97.0
	2907931	CHEMBL1061972	Percentage MNK2 activity remaining in the presence of 25uM inhibitor	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	97.0	CHEMBL4204	Homo sapiens	Activity	%	97.0
	2907932	CHEMBL1061972	Percentage MNK2 activity remaining in the presence of 25uM inhibitor	B	NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12		CHEMBL489157	=	Activity	%	76.0	CHEMBL4204	Homo sapiens	Activity	%	76.0
	2907933	CHEMBL1061973	Percentage MNK2 activity remaining in the presence of 2uM inhibitor	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Activity	%	94.0	CHEMBL4204	Homo sapiens	Activity	%	94.0
	2907934	CHEMBL1062765	Percentage MNK2 activity remaining in the presence of 3uM inhibitor	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	Activity	%	65.0	CHEMBL4204	Homo sapiens	Activity	%	65.0
	2908271	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br		CHEMBL1794051	=	Activity	%	91.0	CHEMBL4204	Homo sapiens	Activity	%	91.0
	2908272	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	97.0	CHEMBL4204	Homo sapiens	Activity	%	97.0
	2908273	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Activity	%	68.0	CHEMBL4204	Homo sapiens	Activity	%	68.0
	2908274	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Activity	%	64.0	CHEMBL4204	Homo sapiens	Activity	%	64.0
	2908275	CHEMBL1060126	Percentage MNK2 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	106.0	CHEMBL4204	Homo sapiens	Activity	%	106.0
	2921263	CHEMBL1047453	Inhibition of MKNK2 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL4204	Homo sapiens	Activity	%	100.0
	2924765	CHEMBL1056864	Inhibition of MNK2 assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c3cc[nH]c3ccc21		CHEMBL567173	=	Activity	%	103.0	CHEMBL4204	Homo sapiens	Activity	%	103.0
	2924766	CHEMBL1056864	Inhibition of MNK2 assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c2ccc2cc[nH]c21		CHEMBL584980	=	Activity	%	95.0	CHEMBL4204	Homo sapiens	Activity	%	95.0
	2924767	CHEMBL1056864	Inhibition of MNK2 assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2ccc3c4ccccc4[nH]c3c12		CHEMBL575754	=	Activity	%	109.0	CHEMBL4204	Homo sapiens	Activity	%	109.0
	2924768	CHEMBL1056864	Inhibition of MNK2 assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12		CHEMBL583972	=	Activity	%	55.0	CHEMBL4204	Homo sapiens	Activity	%	55.0
	2926212	CHEMBL1050224	Inhibition of MNK2 assessed as remaining enzyme activity at 3 uM relative to DMSO	B	COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL574236	=	Activity	%	85.0	CHEMBL4204	Homo sapiens	Activity	%	85.0
	2928398	CHEMBL1060296	Inhibition of MNK2 assessed as remaining enzyme activity at 1 uM relative to DMSO	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	74.0	CHEMBL4204	Homo sapiens	Activity	%	74.0
	2999004	CHEMBL1041976	Inhibition of MNK2 assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 50 uM ATP	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	110.0	CHEMBL4204	Homo sapiens	Activity	%	110.0
	2999794	CHEMBL1041976	Inhibition of MNK2 assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 50 uM ATP	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	101.0	CHEMBL4204	Homo sapiens	Activity	%	101.0
	2999871	CHEMBL1049873	Inhibition of MNK2 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 50 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	Activity	%	85.0	CHEMBL4204	Homo sapiens	Activity	%	85.0
	2999947	CHEMBL1049873	Inhibition of MNK2 assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 50 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	Activity	%	88.0	CHEMBL4204	Homo sapiens	Activity	%	88.0
	3062488	CHEMBL1037975	Binding affinity to human MKNK2 at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	57.0	CHEMBL4204	Homo sapiens	Activity	%	57.0
	3063623	CHEMBL1074889	Binding affinity to human MKNK2 at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	39.0	CHEMBL4204	Homo sapiens	Activity	%	39.0
	3063713	CHEMBL1042475	Binding affinity to human MKNK2 at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	100.0	CHEMBL4204	Homo sapiens	Activity	%	100.0
	3066868	CHEMBL1066074	Inhibition of MKNK2 at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	0.0	CHEMBL4204	Homo sapiens	INH	%	0.0
	3066958	CHEMBL1066074	Inhibition of MKNK2 at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	0.0	CHEMBL4204	Homo sapiens	INH	%	0.0
	3117937	CHEMBL1072213	Inhibition of MNK2	B	CC(=O)N1CCC(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)CC1		CHEMBL599224	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	3117990	CHEMBL1072213	Inhibition of MNK2	B	Cn1nc(C(N)=O)c2c1-c1nc(NC3CCN(C(=O)c4ccccc4)CC3)ncc1CC2		CHEMBL599428	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	3118043	CHEMBL1072213	Inhibition of MNK2	B	CNC(=O)c1nn(C)c2c1CCc1cnc(NC3CCN(C(=O)C4CCN(S(C)(=O)=O)CC4)CC3)nc1-2		CHEMBL597754	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	3130798	CHEMBL1065095	Inhibition of MNK2 at 3 to 6 uM relative to control	B	COc1ccc(C(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1OC		CHEMBL604087	>	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	3131766	CHEMBL1065770	Inhibition of MNK2 at 3 uM relative to control	B	NC(=O)c1ccc(NC(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1		CHEMBL600852	>	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	3213971	CHEMBL1116719	Inhibition of MNK2 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	7.0	CHEMBL4204	Homo sapiens	INH	%	7.0
	3261344	CHEMBL1108063	Inhibition of MNK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	21.0	CHEMBL4204	Homo sapiens	Activity	%	21.0
	3261368	CHEMBL1108063	Inhibition of MNK2 at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	14.0	CHEMBL4204	Homo sapiens	Activity	%	14.0
	3306945	CHEMBL1118069	Inhibition of MNK2alpha at 3 uM	B	O=C(Nc1cc2cc[nH]c(=O)c2cc1Cl)C(NC1CC1)c1ccccc1		CHEMBL1084106	=	Inhibition	%	90.0	CHEMBL4204	Homo sapiens	INH	%	90.0
	3332033	CHEMBL1166571	Inhibition of MKNK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	3333448	CHEMBL1166571	Inhibition of MKNK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	3334853	CHEMBL1166571	Inhibition of MKNK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	3336273	CHEMBL1166571	Inhibition of MKNK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	3337584	CHEMBL1166571	Inhibition of MKNK2 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	3338915	CHEMBL1166571	Inhibition of MKNK2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	3339168	CHEMBL1166571	Inhibition of MKNK2 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	3340472	CHEMBL1166571	Inhibition of MKNK2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	3341815	CHEMBL1166571	Inhibition of MKNK2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	3343262	CHEMBL1166571	Inhibition of MKNK2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	3358676	CHEMBL1174918	Inhibition of MKNK2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.0	CHEMBL4204	Homo sapiens	INH	%	0.0
	3359118	CHEMBL1174918	Inhibition of MKNK2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.6	CHEMBL4204	Homo sapiens	INH	%	0.6
	3434676	CHEMBL1246545	Inhibition of MNK2	B	c1cc(-c2cc(C3CCNCC3)n[nH]2)ccn1		CHEMBL1241462	=	IC50	nM	575.0	CHEMBL4204	Homo sapiens	IC50	nM	575.0
	3434728	CHEMBL1246545	Inhibition of MNK2	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	IC50	nM	1600.0	CHEMBL4204	Homo sapiens	IC50	uM	1.6
	3434730	CHEMBL1246545	Inhibition of MNK2	B	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	=	IC50	nM	171.0	CHEMBL4204	Homo sapiens	IC50	nM	171.0
	3434732	CHEMBL1246572	Inhibition of MNK2 at 5 uM	B	CCNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)s1		CHEMBL1242995	=	Inhibition	%	80.0	CHEMBL4204	Homo sapiens	INH	%	80.0
	3444999	CHEMBL1244517	Binding affinity to MKNK2	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	2600.0	CHEMBL4204	Homo sapiens	Kd	nM	2600.0
	3445205	CHEMBL1244517	Binding affinity to MKNK2	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	1.4	CHEMBL4204	Homo sapiens	Kd	nM	1.4
	3448509	CHEMBL1244517	Binding affinity to MKNK2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	3448992	CHEMBL1244517	Binding affinity to MKNK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	950.0	CHEMBL4204	Homo sapiens	Kd	nM	950.0
	3449274	CHEMBL1244517	Binding affinity to MKNK2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	130.0	CHEMBL4204	Homo sapiens	Kd	nM	130.0
	3450363	CHEMBL1244517	Binding affinity to MKNK2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	3451061	CHEMBL1244517	Binding affinity to MKNK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
Not Active	3499136	CHEMBL1259880	Inhibition of MNK2 at 10 uM relative to control	B	CCNC(=O)NCc1ccccc1-c1cc(-c2cnc(NC(C)C)s2)nc(NCCN(C)C)n1		CHEMBL1230171		Inhibition	%		CHEMBL4204	Homo sapiens	INH		
	5121123	CHEMBL1646202	Inhibition of human Mnk2 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	112.0	CHEMBL4204	Homo sapiens	INH	%	112.0
	5132588	CHEMBL1645822	Inhibition of MNK2 assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	92.0	CHEMBL4204	Homo sapiens	Activity	%	92.0
	5133731	CHEMBL1645822	Inhibition of MNK2 assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	100.0	CHEMBL4204	Homo sapiens	Activity	%	100.0
	5133940	CHEMBL1645822	Inhibition of MNK2 assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	85.0	CHEMBL4204	Homo sapiens	Activity	%	85.0
Not Determined	5152426	CHEMBL1656378	Inhibition of MNK2 by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL2012519		IC50			CHEMBL4204	Homo sapiens	IC50		
	5152438	CHEMBL1656378	Inhibition of MNK2 by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)CC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1651521	=	IC50	nM	150.0	CHEMBL4204	Homo sapiens	IC50	nM	150.0
Not Determined	5152450	CHEMBL1656378	Inhibition of MNK2 by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)CC(=O)/C=C/C[C@H](C)OC2=O		CHEMBL1651522		IC50			CHEMBL4204	Homo sapiens	IC50		
	5152462	CHEMBL1656378	Inhibition of MNK2 by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCCCCC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1651523	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	nM	10000.0
	5191377	CHEMBL1664045	Inhibition of MNK2 at 1 uM	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1236782	=	Inhibition	%	10.0	CHEMBL4204	Homo sapiens	INH	%	10.0
	5191378	CHEMBL1664045	Inhibition of MNK2 at 1 uM	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12		CHEMBL1650131	=	Inhibition	%	62.0	CHEMBL4204	Homo sapiens	INH	%	62.0
	5223297	CHEMBL1679287	Binding affinity to MNK2 at 10 uM by immobilized ligand displacement assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673039	>	Inhibition	%	90.0	CHEMBL4204	Homo sapiens	INH	%	90.0
	5243740	CHEMBL1685703	Inhibition of Mnk2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	101.0	CHEMBL4204	Homo sapiens	INH	%	101.0
	5243848	CHEMBL1686060	Inhibition of Mnk2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	44.0	CHEMBL4204	Homo sapiens	INH	%	44.0
	5243961	CHEMBL1685703	Inhibition of Mnk2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	52.0	CHEMBL4204	Homo sapiens	INH	%	52.0
	5244069	CHEMBL1686060	Inhibition of Mnk2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	14.0	CHEMBL4204	Homo sapiens	INH	%	14.0
	5244942	CHEMBL1685703	Inhibition of Mnk2 at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	87.0	CHEMBL4204	Homo sapiens	INH	%	87.0
	5245050	CHEMBL1686060	Inhibition of Mnk2 at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	5245201	CHEMBL1685703	Inhibition of Mnk2 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	115.0	CHEMBL4204	Homo sapiens	INH	%	115.0
	5246031	CHEMBL1686060	Inhibition of Mnk2 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	111.0	CHEMBL4204	Homo sapiens	INH	%	111.0
	6167349	CHEMBL1768567	Binding affinity to MKNK2 at 1 uM relative to control	B	Nc1ccc(-c2ccc3ncc4ccc(=O)n(-c5cccc(C(F)(F)F)c5)c4c3c2)cn1		CHEMBL1765602	=	Activity	%	0.9	CHEMBL4204	Homo sapiens	Activity	%	0.9
	6198132	CHEMBL1776223	Inhibition of MNK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1		CHEMBL1738758	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	6274431	CHEMBL1806024	Inhibition of MNK2 assessed as residual enzyme activity at 10 uM	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833	=	Activity	%	136.0	CHEMBL4204	Homo sapiens	Activity	%	136.0
	6341092	CHEMBL1828405	Activity of MKNK2 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL4204	Homo sapiens	Activity	%	100.0
	6352243	CHEMBL1825891	Inhibition of MNK2alpha assessed as residual activity at 10 uM by radioactivity assay in presence of 50 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	39.0	CHEMBL4204	Homo sapiens	Activity	%	39.0
	6386361	CHEMBL1839854	Inhibition of recombinant MNK2	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	7567525	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7567996	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7568464	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7568896	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	5500.0	CHEMBL4204	Homo sapiens	Kd	nM	5500.0
	7569039	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7569499	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Kd	nM	1600.0	CHEMBL4204	Homo sapiens	Kd	nM	1600.0
	7569971	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7570434	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7570861	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	5700.0	CHEMBL4204	Homo sapiens	Kd	nM	5700.0
	7571015	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7571472	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7571948	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	200.0	CHEMBL4204	Homo sapiens	Kd	nM	200.0
	7572411	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7572827	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	44.0	CHEMBL4204	Homo sapiens	Kd	nM	44.0
	7572996	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7573453	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7573929	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7574974	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7575435	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	1000.0	CHEMBL4204	Homo sapiens	Kd	nM	1000.0
	7575906	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7575929	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	950.0	CHEMBL4204	Homo sapiens	Kd	nM	950.0
	7576337	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	=	Kd	nM	720.0	CHEMBL4204	Homo sapiens	Kd	nM	720.0
	7576948	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	=	Kd	nM	1600.0	CHEMBL4204	Homo sapiens	Kd	nM	1600.0
	7577407	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	3.7	CHEMBL4204	Homo sapiens	Kd	nM	3.7
	7577913	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7578318	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	380.0	CHEMBL4204	Homo sapiens	Kd	nM	380.0
	7578956	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	3400.0	CHEMBL4204	Homo sapiens	Kd	nM	3400.0
	7579330	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	1600.0	CHEMBL4204	Homo sapiens	Kd	nM	1600.0
	7579812	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	1200.0	CHEMBL4204	Homo sapiens	Kd	nM	1200.0
	7580281	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	820.0	CHEMBL4204	Homo sapiens	Kd	nM	820.0
	7580684	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	1700.0	CHEMBL4204	Homo sapiens	Kd	nM	1700.0
	7581702	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	3200.0	CHEMBL4204	Homo sapiens	Kd	nM	3200.0
	7582173	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7582637	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7583037	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	5200.0	CHEMBL4204	Homo sapiens	Kd	nM	5200.0
	7583218	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7583615	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7584060	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7584531	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7584993	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	130.0	CHEMBL4204	Homo sapiens	Kd	nM	130.0
	7585397	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7585548	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	270.0	CHEMBL4204	Homo sapiens	Kd	nM	270.0
	7585956	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	4300.0	CHEMBL4204	Homo sapiens	Kd	nM	4300.0
	7586402	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7586873	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7587327	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7587509	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	2600.0	CHEMBL4204	Homo sapiens	Kd	nM	2600.0
	7587928	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7588381	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	1200.0	CHEMBL4204	Homo sapiens	Kd	nM	1200.0
	7588852	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7589303	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7589474	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7589898	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	1.4	CHEMBL4204	Homo sapiens	Kd	nM	1.4
	7590365	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7590839	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7591447	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7591869	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7592341	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7592825	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7593414	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	3.0	CHEMBL4204	Homo sapiens	Kd	nM	3.0
	7593849	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7594352	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7594804	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7595382	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7595826	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	1800.0	CHEMBL4204	Homo sapiens	Kd	nM	1800.0
	7595858	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7596329	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7596776	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	130.0	CHEMBL4204	Homo sapiens	Kd	nM	130.0
	7597354	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	1200.0	CHEMBL4204	Homo sapiens	Kd	nM	1200.0
	7597838	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7598308	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	nM	10000.0
	7598750	CHEMBL1908805	Binding constant for MKNK2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	17.0	CHEMBL4204	Homo sapiens	Kd	nM	17.0
	7922683	CHEMBL1918463	Inhibition of human recombinant Mnk2 at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	46.0	CHEMBL4204	Homo sapiens	INH	%	46.0
	7939654	CHEMBL1919614	Inhibition of human Mnk2	B	[O-][n+]1ccc2c(-c3ccc(F)cc3Cl)ccnc2c1-c1c(Cl)cccc1Cl		CHEMBL1916359	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	7969758	CHEMBL1931457	Inhibition of MNK2 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	93.0	CHEMBL4204	Homo sapiens	Activity	%	93.0
	7982599	CHEMBL1936982	Inhibition of MKNK2 at 10 uM after 1 hr by competitive binding assay	B	CNC(=O)NC[C@H]1O[C@@H](n2cnc3c(NC(=O)Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL1079596	=	Inhibition	%	37.0	CHEMBL4204	Homo sapiens	INH	%	37.0
	8047140	CHEMBL1958969	Inhibition of MKNK2 at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	8061272	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	1.14	CHEMBL4204	Homo sapiens	Inhibition	%	1.14
	8061449	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	1.29	CHEMBL4204	Homo sapiens	Inhibition	%	1.29
	8061780	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	4.18	CHEMBL4204	Homo sapiens	Inhibition	%	4.18
	8061971	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	1.53	CHEMBL4204	Homo sapiens	Inhibition	%	1.53
	8062195	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	15.34	CHEMBL4204	Homo sapiens	Inhibition	%	15.34
	8062311	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.67	CHEMBL4204	Homo sapiens	Inhibition	%	2.67
	8062697	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	2.4	CHEMBL4204	Homo sapiens	Inhibition	%	2.4
	8062795	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	3.51	CHEMBL4204	Homo sapiens	Inhibition	%	3.51
	8063019	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.4	CHEMBL4204	Homo sapiens	Inhibition	%	0.4
	8063151	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	4.8	CHEMBL4204	Homo sapiens	Inhibition	%	4.8
	8063318	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.9	CHEMBL4204	Homo sapiens	Inhibition	%	1.9
	8063542	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.43	CHEMBL4204	Homo sapiens	Inhibition	%	2.43
	8063650	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.27	CHEMBL4204	Homo sapiens	Inhibition	%	1.27
	8064056	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	0.83	CHEMBL4204	Homo sapiens	Inhibition	%	0.83
	8064171	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	16.9	CHEMBL4204	Homo sapiens	Inhibition	%	16.9
	8064605	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	5.87	CHEMBL4204	Homo sapiens	Inhibition	%	5.87
	8064743	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	4.65	CHEMBL4204	Homo sapiens	Inhibition	%	4.65
	8065133	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.32	CHEMBL4204	Homo sapiens	Inhibition	%	1.32
	8065249	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	3.13	CHEMBL4204	Homo sapiens	Inhibition	%	3.13
	8065473	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.96	CHEMBL4204	Homo sapiens	Inhibition	%	1.96
	8065648	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.61	CHEMBL4204	Homo sapiens	Inhibition	%	1.61
	8065763	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	3.41	CHEMBL4204	Homo sapiens	Inhibition	%	3.41
	8065987	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	27.81	CHEMBL4204	Homo sapiens	Inhibition	%	27.81
	8066197	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-0.46	CHEMBL4204	Homo sapiens	Inhibition	%	-0.46
	8066333	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	26.1	CHEMBL4204	Homo sapiens	Inhibition	%	26.1
	8066557	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	3.13	CHEMBL4204	Homo sapiens	Inhibition	%	3.13
	8066723	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	5.48	CHEMBL4204	Homo sapiens	Inhibition	%	5.48
	8067071	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	4.55	CHEMBL4204	Homo sapiens	Inhibition	%	4.55
	8067246	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	1.0	CHEMBL4204	Homo sapiens	Inhibition	%	1.0
	8067591	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	-0.39	CHEMBL4204	Homo sapiens	Inhibition	%	-0.39
	8067801	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	4.5	CHEMBL4204	Homo sapiens	Inhibition	%	4.5
	8068160	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	17.19	CHEMBL4204	Homo sapiens	Inhibition	%	17.19
	8068324	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.19	CHEMBL4204	Homo sapiens	Inhibition	%	2.19
	8068673	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.57	CHEMBL4204	Homo sapiens	Inhibition	%	0.57
	8068847	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.01	CHEMBL4204	Homo sapiens	Inhibition	%	0.01
	8069196	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	3.58	CHEMBL4204	Homo sapiens	Inhibition	%	3.58
	8069491	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	4.12	CHEMBL4204	Homo sapiens	Inhibition	%	4.12
	8069652	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	8.7	CHEMBL4204	Homo sapiens	Inhibition	%	8.7
	8069876	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.41	CHEMBL4204	Homo sapiens	Inhibition	%	1.41
	8070002	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.1	CHEMBL4204	Homo sapiens	Inhibition	%	1.1
	8070174	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	0.53	CHEMBL4204	Homo sapiens	Inhibition	%	0.53
	8070398	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	0.5	CHEMBL4204	Homo sapiens	Inhibition	%	0.5
	8070523	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.97	CHEMBL4204	Homo sapiens	Inhibition	%	0.97
	8070821	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	24.54	CHEMBL4204	Homo sapiens	Inhibition	%	24.54
	8071202	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	4.45	CHEMBL4204	Homo sapiens	Inhibition	%	4.45
	8071328	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.2	CHEMBL4204	Homo sapiens	Inhibition	%	0.2
	8071725	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	1.26	CHEMBL4204	Homo sapiens	Inhibition	%	1.26
	8071850	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	2.83	CHEMBL4204	Homo sapiens	Inhibition	%	2.83
	8072074	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	2.41	CHEMBL4204	Homo sapiens	Inhibition	%	2.41
	8072164	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	3.02	CHEMBL4204	Homo sapiens	Inhibition	%	3.02
	8072388	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-0.05	CHEMBL4204	Homo sapiens	Inhibition	%	-0.05
	8072545	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.92	CHEMBL4204	Homo sapiens	Inhibition	%	1.92
	8072670	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	3.14	CHEMBL4204	Homo sapiens	Inhibition	%	3.14
	8072894	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.13	CHEMBL4204	Homo sapiens	Inhibition	%	-0.13
	8073061	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	1.34	CHEMBL4204	Homo sapiens	Inhibition	%	1.34
	8073410	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	7.88	CHEMBL4204	Homo sapiens	Inhibition	%	7.88
	8073529	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-0.44	CHEMBL4204	Homo sapiens	Inhibition	%	-0.44
	8073753	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.0	CHEMBL4204	Homo sapiens	Inhibition	%	0.0
	8073986	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-0.06	CHEMBL4204	Homo sapiens	Inhibition	%	-0.06
	8074138	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	4.02	CHEMBL4204	Homo sapiens	Inhibition	%	4.02
	8074492	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	2.71	CHEMBL4204	Homo sapiens	Inhibition	%	2.71
	8074649	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.62	CHEMBL4204	Homo sapiens	Inhibition	%	0.62
	8075000	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-0.09	CHEMBL4204	Homo sapiens	Inhibition	%	-0.09
	8075335	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-1.39	CHEMBL4204	Homo sapiens	Inhibition	%	-1.39
	8075572	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	1.84	CHEMBL4204	Homo sapiens	Inhibition	%	1.84
	8075713	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	2.61	CHEMBL4204	Homo sapiens	Inhibition	%	2.61
	8075937	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	4.0	CHEMBL4204	Homo sapiens	Inhibition	%	4.0
	8076079	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.74	CHEMBL4204	Homo sapiens	Inhibition	%	0.74
	8076227	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.77	CHEMBL4204	Homo sapiens	Inhibition	%	0.77
	8076451	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	0.86	CHEMBL4204	Homo sapiens	Inhibition	%	0.86
	8076585	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	1.91	CHEMBL4204	Homo sapiens	Inhibition	%	1.91
	8076911	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.24	CHEMBL4204	Homo sapiens	Inhibition	%	-0.24
	8077158	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	5.3	CHEMBL4204	Homo sapiens	Inhibition	%	5.3
	8077510	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	0.9	CHEMBL4204	Homo sapiens	Inhibition	%	0.9
	8077661	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	4.03	CHEMBL4204	Homo sapiens	Inhibition	%	4.03
	8078028	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	12.82	CHEMBL4204	Homo sapiens	Inhibition	%	12.82
	8078167	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	0.26	CHEMBL4204	Homo sapiens	Inhibition	%	0.26
	8078493	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.66	CHEMBL4204	Homo sapiens	Inhibition	%	0.66
	8078743	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	33.12	CHEMBL4204	Homo sapiens	Inhibition	%	33.12
	8079083	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	3.32	CHEMBL4204	Homo sapiens	Inhibition	%	3.32
	8079241	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.15	CHEMBL4204	Homo sapiens	Inhibition	%	0.15
	8079607	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	1.32	CHEMBL4204	Homo sapiens	Inhibition	%	1.32
	8079746	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	7.33	CHEMBL4204	Homo sapiens	Inhibition	%	7.33
	8079970	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	3.26	CHEMBL4204	Homo sapiens	Inhibition	%	3.26
	8080075	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.78	CHEMBL4204	Homo sapiens	Inhibition	%	0.78
	8080327	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	1.73	CHEMBL4204	Homo sapiens	Inhibition	%	1.73
	8080666	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.39	CHEMBL4204	Homo sapiens	Inhibition	%	1.39
	8080830	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	2.94	CHEMBL4204	Homo sapiens	Inhibition	%	2.94
	8081054	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.4	CHEMBL4204	Homo sapiens	Inhibition	%	0.4
	8081189	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	9.37	CHEMBL4204	Homo sapiens	Inhibition	%	9.37
	8081557	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	7.76	CHEMBL4204	Homo sapiens	Inhibition	%	7.76
	8081660	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.54	CHEMBL4204	Homo sapiens	Inhibition	%	0.54
	8081884	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.96	CHEMBL4204	Homo sapiens	Inhibition	%	1.96
	8081912	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	13.9	CHEMBL4204	Homo sapiens	Inhibition	%	13.9
	8082136	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	0.19	CHEMBL4204	Homo sapiens	Inhibition	%	0.19
	8082249	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	11.31	CHEMBL4204	Homo sapiens	Inhibition	%	11.31
	8082646	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	4.75	CHEMBL4204	Homo sapiens	Inhibition	%	4.75
	8082769	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.84	CHEMBL4204	Homo sapiens	Inhibition	%	0.84
	8082993	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.97	CHEMBL4204	Homo sapiens	Inhibition	%	1.97
	8083149	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	3.98	CHEMBL4204	Homo sapiens	Inhibition	%	3.98
	8083472	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.41	CHEMBL4204	Homo sapiens	Inhibition	%	0.41
	8083726	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	8.42	CHEMBL4204	Homo sapiens	Inhibition	%	8.42
	8083836	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	3.66	CHEMBL4204	Homo sapiens	Inhibition	%	3.66
	8084060	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	16.93	CHEMBL4204	Homo sapiens	Inhibition	%	16.93
	8084245	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	2.52	CHEMBL4204	Homo sapiens	Inhibition	%	2.52
	8084587	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	3.73	CHEMBL4204	Homo sapiens	Inhibition	%	3.73
	8084748	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	14.18	CHEMBL4204	Homo sapiens	Inhibition	%	14.18
	8085070	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	3.39	CHEMBL4204	Homo sapiens	Inhibition	%	3.39
	8085326	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-0.35	CHEMBL4204	Homo sapiens	Inhibition	%	-0.35
	8085658	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	1.79	CHEMBL4204	Homo sapiens	Inhibition	%	1.79
	8085847	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	20.41	CHEMBL4204	Homo sapiens	Inhibition	%	20.41
	8086186	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	22.97	CHEMBL4204	Homo sapiens	Inhibition	%	22.97
	8086348	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	6.5	CHEMBL4204	Homo sapiens	Inhibition	%	6.5
	8086572	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	36.89	CHEMBL4204	Homo sapiens	Inhibition	%	36.89
	8086671	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.41	CHEMBL4204	Homo sapiens	Inhibition	%	0.41
	8086882	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	3.42	CHEMBL4204	Homo sapiens	Inhibition	%	3.42
	8087106	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	16.29	CHEMBL4204	Homo sapiens	Inhibition	%	16.29
	8087264	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.52	CHEMBL4204	Homo sapiens	Inhibition	%	0.52
	8087602	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	1.93	CHEMBL4204	Homo sapiens	Inhibition	%	1.93
	8087740	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	9.13	CHEMBL4204	Homo sapiens	Inhibition	%	9.13
	8088106	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	0.78	CHEMBL4204	Homo sapiens	Inhibition	%	0.78
	8088254	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-0.47	CHEMBL4204	Homo sapiens	Inhibition	%	-0.47
	8088478	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	3.27	CHEMBL4204	Homo sapiens	Inhibition	%	3.27
	8088606	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	-0.9	CHEMBL4204	Homo sapiens	Inhibition	%	-0.9
	8088923	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	14.66	CHEMBL4204	Homo sapiens	Inhibition	%	14.66
	8089051	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.85	CHEMBL4204	Homo sapiens	Inhibition	%	0.85
	8089275	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.99	CHEMBL4204	Homo sapiens	Inhibition	%	0.99
	8089423	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	1.9	CHEMBL4204	Homo sapiens	Inhibition	%	1.9
	8089767	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.17	CHEMBL4204	Homo sapiens	Inhibition	%	0.17
	8089947	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	2.23	CHEMBL4204	Homo sapiens	Inhibition	%	2.23
	8090336	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	4.51	CHEMBL4204	Homo sapiens	Inhibition	%	4.51
	8090503	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	1.85	CHEMBL4204	Homo sapiens	Inhibition	%	1.85
	8090866	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	20.52	CHEMBL4204	Homo sapiens	Inhibition	%	20.52
	8091071	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.2	CHEMBL4204	Homo sapiens	Inhibition	%	3.2
	8091432	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	1.78	CHEMBL4204	Homo sapiens	Inhibition	%	1.78
	8091587	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	1.17	CHEMBL4204	Homo sapiens	Inhibition	%	1.17
	8091927	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	7.25	CHEMBL4204	Homo sapiens	Inhibition	%	7.25
	8092064	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.12	CHEMBL4204	Homo sapiens	Inhibition	%	1.12
	8092288	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	0.76	CHEMBL4204	Homo sapiens	Inhibition	%	0.76
	8092439	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	1.16	CHEMBL4204	Homo sapiens	Inhibition	%	1.16
	8092811	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.36	CHEMBL4204	Homo sapiens	Inhibition	%	1.36
	8092940	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	7.84	CHEMBL4204	Homo sapiens	Inhibition	%	7.84
	8093252	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	2.75	CHEMBL4204	Homo sapiens	Inhibition	%	2.75
	8093616	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	0.08	CHEMBL4204	Homo sapiens	Inhibition	%	0.08
	8093755	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	4.65	CHEMBL4204	Homo sapiens	Inhibition	%	4.65
	8094099	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	7.7	CHEMBL4204	Homo sapiens	Inhibition	%	7.7
	8094279	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	4.58	CHEMBL4204	Homo sapiens	Inhibition	%	4.58
	8094503	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	35.17	CHEMBL4204	Homo sapiens	Inhibition	%	35.17
	8094678	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	1.81	CHEMBL4204	Homo sapiens	Inhibition	%	1.81
	8094834	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	3.34	CHEMBL4204	Homo sapiens	Inhibition	%	3.34
	8095058	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.42	CHEMBL4204	Homo sapiens	Inhibition	%	3.42
	8095198	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	67.35	CHEMBL4204	Homo sapiens	Inhibition	%	67.35
	8095401	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	15.69	CHEMBL4204	Homo sapiens	Inhibition	%	15.69
	8095766	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	7.47	CHEMBL4204	Homo sapiens	Inhibition	%	7.47
	8095914	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	0.99	CHEMBL4204	Homo sapiens	Inhibition	%	0.99
	8096138	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	17.13	CHEMBL4204	Homo sapiens	Inhibition	%	17.13
	8096255	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	0.48	CHEMBL4204	Homo sapiens	Inhibition	%	0.48
	8096618	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.13	CHEMBL4204	Homo sapiens	Inhibition	%	0.13
	8096774	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	7.96	CHEMBL4204	Homo sapiens	Inhibition	%	7.96
	8097145	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	5.08	CHEMBL4204	Homo sapiens	Inhibition	%	5.08
	8097452	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	3.6	CHEMBL4204	Homo sapiens	Inhibition	%	3.6
	8097676	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	11.76	CHEMBL4204	Homo sapiens	Inhibition	%	11.76
	8097826	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	3.19	CHEMBL4204	Homo sapiens	Inhibition	%	3.19
	8097959	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.28	CHEMBL4204	Homo sapiens	Inhibition	%	0.28
	8098183	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	3.85	CHEMBL4204	Homo sapiens	Inhibition	%	3.85
	8098303	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.04	CHEMBL4204	Homo sapiens	Inhibition	%	-0.04
	8098707	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.49	CHEMBL4204	Homo sapiens	Inhibition	%	2.49
	8098892	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	8.99	CHEMBL4204	Homo sapiens	Inhibition	%	8.99
	8099260	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	14.05	CHEMBL4204	Homo sapiens	Inhibition	%	14.05
	8099402	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.92	CHEMBL4204	Homo sapiens	Inhibition	%	1.92
	8099596	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-0.74	CHEMBL4204	Homo sapiens	Inhibition	%	-0.74
	8099820	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.03	CHEMBL4204	Homo sapiens	Inhibition	%	1.03
	8099967	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	3.79	CHEMBL4204	Homo sapiens	Inhibition	%	3.79
	8100337	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	2.14	CHEMBL4204	Homo sapiens	Inhibition	%	2.14
	8100453	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	0.21	CHEMBL4204	Homo sapiens	Inhibition	%	0.21
	8100677	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	-0.25	CHEMBL4204	Homo sapiens	Inhibition	%	-0.25
	8100817	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	8.54	CHEMBL4204	Homo sapiens	Inhibition	%	8.54
	8100977	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	0.23	CHEMBL4204	Homo sapiens	Inhibition	%	0.23
	8101201	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	6.75	CHEMBL4204	Homo sapiens	Inhibition	%	6.75
	8101343	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	1.26	CHEMBL4204	Homo sapiens	Inhibition	%	1.26
	8101528	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	0.29	CHEMBL4204	Homo sapiens	Inhibition	%	0.29
	8101752	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	2.7	CHEMBL4204	Homo sapiens	Inhibition	%	2.7
	8102005	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	51.07	CHEMBL4204	Homo sapiens	Inhibition	%	51.07
	8102160	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	0.64	CHEMBL4204	Homo sapiens	Inhibition	%	0.64
	8102515	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	1.51	CHEMBL4204	Homo sapiens	Inhibition	%	1.51
	8102635	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	6.31	CHEMBL4204	Homo sapiens	Inhibition	%	6.31
	8102859	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-1.1	CHEMBL4204	Homo sapiens	Inhibition	%	-1.1
	8103037	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	8.27	CHEMBL4204	Homo sapiens	Inhibition	%	8.27
	8103233	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	3.54	CHEMBL4204	Homo sapiens	Inhibition	%	3.54
	8103595	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.26	CHEMBL4204	Homo sapiens	Inhibition	%	0.26
	8103745	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	4.93	CHEMBL4204	Homo sapiens	Inhibition	%	4.93
	8103969	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	0.55	CHEMBL4204	Homo sapiens	Inhibition	%	0.55
	8104154	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-1.23	CHEMBL4204	Homo sapiens	Inhibition	%	-1.23
	8104302	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	11.23	CHEMBL4204	Homo sapiens	Inhibition	%	11.23
	8104672	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	8.88	CHEMBL4204	Homo sapiens	Inhibition	%	8.88
	8105010	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	-0.69	CHEMBL4204	Homo sapiens	Inhibition	%	-0.69
	8105150	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.24	CHEMBL4204	Homo sapiens	Inhibition	%	1.24
	8105540	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	3.77	CHEMBL4204	Homo sapiens	Inhibition	%	3.77
	8105678	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	24.2	CHEMBL4204	Homo sapiens	Inhibition	%	24.2
	8105958	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.16	CHEMBL4204	Homo sapiens	Inhibition	%	1.16
	8106347	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.89	CHEMBL4204	Homo sapiens	Inhibition	%	0.89
	8106503	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	23.72	CHEMBL4204	Homo sapiens	Inhibition	%	23.72
	8106856	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	2.53	CHEMBL4204	Homo sapiens	Inhibition	%	2.53
	8107201	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.1	CHEMBL4204	Homo sapiens	Inhibition	%	-0.1
	8107373	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.3	CHEMBL4204	Homo sapiens	Inhibition	%	1.3
	8107574	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	2.92	CHEMBL4204	Homo sapiens	Inhibition	%	2.92
	8107798	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	3.35	CHEMBL4204	Homo sapiens	Inhibition	%	3.35
	8107933	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	8.7	CHEMBL4204	Homo sapiens	Inhibition	%	8.7
	8108315	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	2.13	CHEMBL4204	Homo sapiens	Inhibition	%	2.13
	8108490	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.19	CHEMBL4204	Homo sapiens	Inhibition	%	0.19
	8108637	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	1.96	CHEMBL4204	Homo sapiens	Inhibition	%	1.96
	8108861	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	5.86	CHEMBL4204	Homo sapiens	Inhibition	%	5.86
	8109003	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-0.55	CHEMBL4204	Homo sapiens	Inhibition	%	-0.55
	8109341	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	-1.52	CHEMBL4204	Homo sapiens	Inhibition	%	-1.52
	8109471	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	2.75	CHEMBL4204	Homo sapiens	Inhibition	%	2.75
	8109695	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.56	CHEMBL4204	Homo sapiens	Inhibition	%	-1.56
	8109866	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	20.98	CHEMBL4204	Homo sapiens	Inhibition	%	20.98
	8109998	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	1.3	CHEMBL4204	Homo sapiens	Inhibition	%	1.3
	8110222	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	12.41	CHEMBL4204	Homo sapiens	Inhibition	%	12.41
	8110277	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	6.2	CHEMBL4204	Homo sapiens	Inhibition	%	6.2
	8110501	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	0.32	CHEMBL4204	Homo sapiens	Inhibition	%	0.32
	8110667	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	6.51	CHEMBL4204	Homo sapiens	Inhibition	%	6.51
	8110825	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	5.13	CHEMBL4204	Homo sapiens	Inhibition	%	5.13
	8111049	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	10.19	CHEMBL4204	Homo sapiens	Inhibition	%	10.19
	8111172	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	4.24	CHEMBL4204	Homo sapiens	Inhibition	%	4.24
	8111523	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.48	CHEMBL4204	Homo sapiens	Inhibition	%	0.48
	8111689	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.88	CHEMBL4204	Homo sapiens	Inhibition	%	2.88
	8111913	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-0.26	CHEMBL4204	Homo sapiens	Inhibition	%	-0.26
	8112118	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	8.3	CHEMBL4204	Homo sapiens	Inhibition	%	8.3
	8112255	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.51	CHEMBL4204	Homo sapiens	Inhibition	%	-0.51
	8112647	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	1.7	CHEMBL4204	Homo sapiens	Inhibition	%	1.7
	8112819	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.34	CHEMBL4204	Homo sapiens	Inhibition	%	0.34
	8113195	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	0.5	CHEMBL4204	Homo sapiens	Inhibition	%	0.5
	8113331	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	4.88	CHEMBL4204	Homo sapiens	Inhibition	%	4.88
	8113555	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	1.96	CHEMBL4204	Homo sapiens	Inhibition	%	1.96
	8113679	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	-1.94	CHEMBL4204	Homo sapiens	Inhibition	%	-1.94
	8114019	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.03	CHEMBL4204	Homo sapiens	Inhibition	%	-1.03
	8114195	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	0.53	CHEMBL4204	Homo sapiens	Inhibition	%	0.53
	8114551	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	-0.22	CHEMBL4204	Homo sapiens	Inhibition	%	-0.22
	8114827	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	-0.44	CHEMBL4204	Homo sapiens	Inhibition	%	-0.44
	8114993	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	7.71	CHEMBL4204	Homo sapiens	Inhibition	%	7.71
	8115382	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	3.48	CHEMBL4204	Homo sapiens	Inhibition	%	3.48
	8115502	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	12.21	CHEMBL4204	Homo sapiens	Inhibition	%	12.21
	8115726	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	13.45	CHEMBL4204	Homo sapiens	Inhibition	%	13.45
	8115859	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-0.07	CHEMBL4204	Homo sapiens	Inhibition	%	-0.07
	8116242	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	9.44	CHEMBL4204	Homo sapiens	Inhibition	%	9.44
	8116445	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	2.54	CHEMBL4204	Homo sapiens	Inhibition	%	2.54
	8116579	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.76	CHEMBL4204	Homo sapiens	Inhibition	%	0.76
	8116803	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.22	CHEMBL4204	Homo sapiens	Inhibition	%	0.22
	8116975	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	6.22	CHEMBL4204	Homo sapiens	Inhibition	%	6.22
	8117146	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	5.82	CHEMBL4204	Homo sapiens	Inhibition	%	5.82
	8117370	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.14	CHEMBL4204	Homo sapiens	Inhibition	%	0.14
	8117528	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	1.12	CHEMBL4204	Homo sapiens	Inhibition	%	1.12
	8117882	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	9.71	CHEMBL4204	Homo sapiens	Inhibition	%	9.71
	8118020	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	1.28	CHEMBL4204	Homo sapiens	Inhibition	%	1.28
	8118360	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.02	CHEMBL4204	Homo sapiens	Inhibition	%	2.02
	8118532	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	5.47	CHEMBL4204	Homo sapiens	Inhibition	%	5.47
	8118756	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	2.53	CHEMBL4204	Homo sapiens	Inhibition	%	2.53
	8118892	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	15.08	CHEMBL4204	Homo sapiens	Inhibition	%	15.08
	8119163	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	0.92	CHEMBL4204	Homo sapiens	Inhibition	%	0.92
	8119322	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	40.29	CHEMBL4204	Homo sapiens	Inhibition	%	40.29
	8119546	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	13.66	CHEMBL4204	Homo sapiens	Inhibition	%	13.66
	8119713	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	14.26	CHEMBL4204	Homo sapiens	Inhibition	%	14.26
	8120056	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	55.69	CHEMBL4204	Homo sapiens	Inhibition	%	55.69
	8120195	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.66	CHEMBL4204	Homo sapiens	Inhibition	%	0.66
	8120579	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.04	CHEMBL4204	Homo sapiens	Inhibition	%	0.04
	8120780	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	2.87	CHEMBL4204	Homo sapiens	Inhibition	%	2.87
	8121132	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	2.57	CHEMBL4204	Homo sapiens	Inhibition	%	2.57
	8121304	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	9.26	CHEMBL4204	Homo sapiens	Inhibition	%	9.26
	8121695	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	1.83	CHEMBL4204	Homo sapiens	Inhibition	%	1.83
	8121858	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	0.25	CHEMBL4204	Homo sapiens	Inhibition	%	0.25
	8122203	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	2.55	CHEMBL4204	Homo sapiens	Inhibition	%	2.55
	8122341	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	1.04	CHEMBL4204	Homo sapiens	Inhibition	%	1.04
	8122565	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	0.94	CHEMBL4204	Homo sapiens	Inhibition	%	0.94
	8122685	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	5.44	CHEMBL4204	Homo sapiens	Inhibition	%	5.44
	8123076	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	6.08	CHEMBL4204	Homo sapiens	Inhibition	%	6.08
	8123218	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	2.21	CHEMBL4204	Homo sapiens	Inhibition	%	2.21
	8123496	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.25	CHEMBL4204	Homo sapiens	Inhibition	%	1.25
	8123870	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	51.98	CHEMBL4204	Homo sapiens	Inhibition	%	51.98
	8124037	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	3.13	CHEMBL4204	Homo sapiens	Inhibition	%	3.13
	8124380	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	3.27	CHEMBL4204	Homo sapiens	Inhibition	%	3.27
	8124519	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.73	CHEMBL4204	Homo sapiens	Inhibition	%	1.73
	8124743	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.49	CHEMBL4204	Homo sapiens	Inhibition	%	1.49
	8124908	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	11.5	CHEMBL4204	Homo sapiens	Inhibition	%	11.5
	8125109	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.36	CHEMBL4204	Homo sapiens	Inhibition	%	3.36
	8125463	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.77	CHEMBL4204	Homo sapiens	Inhibition	%	0.77
	8125631	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	48.15	CHEMBL4204	Homo sapiens	Inhibition	%	48.15
	8125855	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.55	CHEMBL4204	Homo sapiens	Inhibition	%	2.55
	8126019	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.51	CHEMBL4204	Homo sapiens	Inhibition	%	0.51
	8126183	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	4.3	CHEMBL4204	Homo sapiens	Inhibition	%	4.3
	8126407	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	2.76	CHEMBL4204	Homo sapiens	Inhibition	%	2.76
	8126522	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	28.75	CHEMBL4204	Homo sapiens	Inhibition	%	28.75
	8126882	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	10.53	CHEMBL4204	Homo sapiens	Inhibition	%	10.53
	8127004	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	0.72	CHEMBL4204	Homo sapiens	Inhibition	%	0.72
	8127228	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	1.76	CHEMBL4204	Homo sapiens	Inhibition	%	1.76
	8127395	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	1.15	CHEMBL4204	Homo sapiens	Inhibition	%	1.15
	8127537	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	7.89	CHEMBL4204	Homo sapiens	Inhibition	%	7.89
	8127761	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	9.53	CHEMBL4204	Homo sapiens	Inhibition	%	9.53
	8127825	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.07	CHEMBL4204	Homo sapiens	Inhibition	%	0.07
	8128049	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.2	CHEMBL4204	Homo sapiens	Inhibition	%	1.2
	8128201	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	2.2	CHEMBL4204	Homo sapiens	Inhibition	%	2.2
	8128368	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	13.69	CHEMBL4204	Homo sapiens	Inhibition	%	13.69
	8128592	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	6.83	CHEMBL4204	Homo sapiens	Inhibition	%	6.83
	8128711	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	22.74	CHEMBL4204	Homo sapiens	Inhibition	%	22.74
	8129072	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	2.79	CHEMBL4204	Homo sapiens	Inhibition	%	2.79
	8129243	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.16	CHEMBL4204	Homo sapiens	Inhibition	%	0.16
	8129432	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.52	CHEMBL4204	Homo sapiens	Inhibition	%	3.52
	8129656	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	5.75	CHEMBL4204	Homo sapiens	Inhibition	%	5.75
	8129795	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	2.11	CHEMBL4204	Homo sapiens	Inhibition	%	2.11
	8130180	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	26.39	CHEMBL4204	Homo sapiens	Inhibition	%	26.39
	8130352	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	1.47	CHEMBL4204	Homo sapiens	Inhibition	%	1.47
	8130736	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	8.84	CHEMBL4204	Homo sapiens	Inhibition	%	8.84
	8130852	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	-0.37	CHEMBL4204	Homo sapiens	Inhibition	%	-0.37
	8131215	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.3	CHEMBL4204	Homo sapiens	Inhibition	%	4.3
	8131559	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	2.38	CHEMBL4204	Homo sapiens	Inhibition	%	2.38
	8131726	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	12.22	CHEMBL4204	Homo sapiens	Inhibition	%	12.22
	8132091	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	53.91	CHEMBL4204	Homo sapiens	Inhibition	%	53.91
	8132377	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-1.19	CHEMBL4204	Homo sapiens	Inhibition	%	-1.19
	8132524	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	9.99	CHEMBL4204	Homo sapiens	Inhibition	%	9.99
	8132916	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	17.61	CHEMBL4204	Homo sapiens	Inhibition	%	17.61
	8133037	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.92	CHEMBL4204	Homo sapiens	Inhibition	%	1.92
	8133261	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	10.68	CHEMBL4204	Homo sapiens	Inhibition	%	10.68
	8133399	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.98	CHEMBL4204	Homo sapiens	Inhibition	%	1.98
	8133571	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	2.71	CHEMBL4204	Homo sapiens	Inhibition	%	2.71
	8133795	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.06	CHEMBL4204	Homo sapiens	Inhibition	%	-0.06
	8133975	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	33.78	CHEMBL4204	Homo sapiens	Inhibition	%	33.78
	8134123	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.74	CHEMBL4204	Homo sapiens	Inhibition	%	0.74
	8134347	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	4.21	CHEMBL4204	Homo sapiens	Inhibition	%	4.21
	8134507	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-0.05	CHEMBL4204	Homo sapiens	Inhibition	%	-0.05
	8134691	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	0.01	CHEMBL4204	Homo sapiens	Inhibition	%	0.01
	8135075	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	0.76	CHEMBL4204	Homo sapiens	Inhibition	%	0.76
	8135190	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	-2.48	CHEMBL4204	Homo sapiens	Inhibition	%	-2.48
	8135414	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	-0.02	CHEMBL4204	Homo sapiens	Inhibition	%	-0.02
	8135555	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.83	CHEMBL4204	Homo sapiens	Inhibition	%	3.83
	8135900	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	2.64	CHEMBL4204	Homo sapiens	Inhibition	%	2.64
	8136068	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	-0.25	CHEMBL4204	Homo sapiens	Inhibition	%	-0.25
	8136436	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	1.84	CHEMBL4204	Homo sapiens	Inhibition	%	1.84
	8136726	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-0.74	CHEMBL4204	Homo sapiens	Inhibition	%	-0.74
	8136861	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	0.25	CHEMBL4204	Homo sapiens	Inhibition	%	0.25
	8137085	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	1.48	CHEMBL4204	Homo sapiens	Inhibition	%	1.48
	8137248	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	37.57	CHEMBL4204	Homo sapiens	Inhibition	%	37.57
	8137592	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	0.57	CHEMBL4204	Homo sapiens	Inhibition	%	0.57
	8137740	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.98	CHEMBL4204	Homo sapiens	Inhibition	%	2.98
	8138130	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	2.26	CHEMBL4204	Homo sapiens	Inhibition	%	2.26
	8138309	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.84	CHEMBL4204	Homo sapiens	Inhibition	%	0.84
	8138681	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-0.04	CHEMBL4204	Homo sapiens	Inhibition	%	-0.04
	8138839	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	2.22	CHEMBL4204	Homo sapiens	Inhibition	%	2.22
	8139024	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	5.59	CHEMBL4204	Homo sapiens	Inhibition	%	5.59
	8139248	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	2.51	CHEMBL4204	Homo sapiens	Inhibition	%	2.51
	8139407	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	2.73	CHEMBL4204	Homo sapiens	Inhibition	%	2.73
	8139745	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	4.64	CHEMBL4204	Homo sapiens	Inhibition	%	4.64
	8139886	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	1.46	CHEMBL4204	Homo sapiens	Inhibition	%	1.46
	8140110	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	6.51	CHEMBL4204	Homo sapiens	Inhibition	%	6.51
	8140233	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	1.37	CHEMBL4204	Homo sapiens	Inhibition	%	1.37
	8140392	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.4	CHEMBL4204	Homo sapiens	Inhibition	%	2.4
	8140616	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	-0.84	CHEMBL4204	Homo sapiens	Inhibition	%	-0.84
	8140759	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	6.88	CHEMBL4204	Homo sapiens	Inhibition	%	6.88
	8141061	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.08	CHEMBL4204	Homo sapiens	Inhibition	%	0.08
	8141415	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.06	CHEMBL4204	Homo sapiens	Inhibition	%	0.06
	8141575	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	72.19	CHEMBL4204	Homo sapiens	Inhibition	%	72.19
	8141918	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	5.36	CHEMBL4204	Homo sapiens	Inhibition	%	5.36
	8142079	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-0.13	CHEMBL4204	Homo sapiens	Inhibition	%	-0.13
	8142303	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	1.25	CHEMBL4204	Homo sapiens	Inhibition	%	1.25
	8142471	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	1.1	CHEMBL4204	Homo sapiens	Inhibition	%	1.1
	8142647	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	6.94	CHEMBL4204	Homo sapiens	Inhibition	%	6.94
	8143020	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	1.12	CHEMBL4204	Homo sapiens	Inhibition	%	1.12
	8143175	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.63	CHEMBL4204	Homo sapiens	Inhibition	%	0.63
	8143399	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	7.26	CHEMBL4204	Homo sapiens	Inhibition	%	7.26
	8143586	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	17.65	CHEMBL4204	Homo sapiens	Inhibition	%	17.65
	8143745	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	2.04	CHEMBL4204	Homo sapiens	Inhibition	%	2.04
	8144083	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	2.36	CHEMBL4204	Homo sapiens	Inhibition	%	2.36
	8144446	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	0.17	CHEMBL4204	Homo sapiens	Inhibition	%	0.17
	8144576	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	2.78	CHEMBL4204	Homo sapiens	Inhibition	%	2.78
	8144953	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	-0.59	CHEMBL4204	Homo sapiens	Inhibition	%	-0.59
	8145090	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	0.8	CHEMBL4204	Homo sapiens	Inhibition	%	0.8
	8145314	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	4.95	CHEMBL4204	Homo sapiens	Inhibition	%	4.95
	8145403	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	7.67	CHEMBL4204	Homo sapiens	Inhibition	%	7.67
	8145751	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	4.01	CHEMBL4204	Homo sapiens	Inhibition	%	4.01
	8145912	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	20.35	CHEMBL4204	Homo sapiens	Inhibition	%	20.35
	8146136	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	45.59	CHEMBL4204	Homo sapiens	Inhibition	%	45.59
	8146256	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.6	CHEMBL4204	Homo sapiens	Inhibition	%	0.6
	8146640	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-0.68	CHEMBL4204	Homo sapiens	Inhibition	%	-0.68
	8146807	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	4.25	CHEMBL4204	Homo sapiens	Inhibition	%	4.25
	8146976	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	5.49	CHEMBL4204	Homo sapiens	Inhibition	%	5.49
	8147200	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	34.66	CHEMBL4204	Homo sapiens	Inhibition	%	34.66
	8147342	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	0.22	CHEMBL4204	Homo sapiens	Inhibition	%	0.22
	8147719	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	0.77	CHEMBL4204	Homo sapiens	Inhibition	%	0.77
	8147906	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	2.35	CHEMBL4204	Homo sapiens	Inhibition	%	2.35
	8148064	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	3.52	CHEMBL4204	Homo sapiens	Inhibition	%	3.52
	8148288	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	0.51	CHEMBL4204	Homo sapiens	Inhibition	%	0.51
	8148402	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	7.73	CHEMBL4204	Homo sapiens	Inhibition	%	7.73
	8148765	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	1.27	CHEMBL4204	Homo sapiens	Inhibition	%	1.27
	8148903	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	3.56	CHEMBL4204	Homo sapiens	Inhibition	%	3.56
	8149127	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.79	CHEMBL4204	Homo sapiens	Inhibition	%	4.79
	8149286	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	2.33	CHEMBL4204	Homo sapiens	Inhibition	%	2.33
	8149644	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	0.78	CHEMBL4204	Homo sapiens	Inhibition	%	0.78
	8149742	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	3.17	CHEMBL4204	Homo sapiens	Inhibition	%	3.17
	8149966	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	25.06	CHEMBL4204	Homo sapiens	Inhibition	%	25.06
	8150091	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	2.04	CHEMBL4204	Homo sapiens	Inhibition	%	2.04
	8150475	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.92	CHEMBL4204	Homo sapiens	Inhibition	%	1.92
	8150595	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	1.48	CHEMBL4204	Homo sapiens	Inhibition	%	1.48
	8150984	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	0.28	CHEMBL4204	Homo sapiens	Inhibition	%	0.28
	8151147	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	0.44	CHEMBL4204	Homo sapiens	Inhibition	%	0.44
	8151548	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	2.69	CHEMBL4204	Homo sapiens	Inhibition	%	2.69
	8151686	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	4.37	CHEMBL4204	Homo sapiens	Inhibition	%	4.37
	8152064	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.76	CHEMBL4204	Homo sapiens	Inhibition	%	1.76
	8152252	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	18.96	CHEMBL4204	Homo sapiens	Inhibition	%	18.96
	8152634	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	4.71	CHEMBL4204	Homo sapiens	Inhibition	%	4.71
	8152748	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	0.35	CHEMBL4204	Homo sapiens	Inhibition	%	0.35
	8152972	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	3.48	CHEMBL4204	Homo sapiens	Inhibition	%	3.48
	8153111	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	-0.2	CHEMBL4204	Homo sapiens	Inhibition	%	-0.2
	8153472	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	1.78	CHEMBL4204	Homo sapiens	Inhibition	%	1.78
	8153629	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	11.48	CHEMBL4204	Homo sapiens	Inhibition	%	11.48
	8153986	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	13.45	CHEMBL4204	Homo sapiens	Inhibition	%	13.45
	8154307	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	0.78	CHEMBL4204	Homo sapiens	Inhibition	%	0.78
	8154433	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	37.29	CHEMBL4204	Homo sapiens	Inhibition	%	37.29
	8154816	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	13.09	CHEMBL4204	Homo sapiens	Inhibition	%	13.09
	8154936	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.78	CHEMBL4204	Homo sapiens	Inhibition	%	0.78
	8155160	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	3.28	CHEMBL4204	Homo sapiens	Inhibition	%	3.28
	8155336	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.49	CHEMBL4204	Homo sapiens	Inhibition	%	0.49
	8155497	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	1.35	CHEMBL4204	Homo sapiens	Inhibition	%	1.35
	8155721	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.33	CHEMBL4204	Homo sapiens	Inhibition	%	1.33
	8155899	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	8.83	CHEMBL4204	Homo sapiens	Inhibition	%	8.83
	8156037	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	-0.81	CHEMBL4204	Homo sapiens	Inhibition	%	-0.81
	8156261	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	3.49	CHEMBL4204	Homo sapiens	Inhibition	%	3.49
	8156473	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	1.94	CHEMBL4204	Homo sapiens	Inhibition	%	1.94
	8156623	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	6.18	CHEMBL4204	Homo sapiens	Inhibition	%	6.18
	8156847	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.32	CHEMBL4204	Homo sapiens	Inhibition	%	2.32
	8156990	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	18.85	CHEMBL4204	Homo sapiens	Inhibition	%	18.85
	8157334	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	4.23	CHEMBL4204	Homo sapiens	Inhibition	%	4.23
	8157475	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	2.94	CHEMBL4204	Homo sapiens	Inhibition	%	2.94
	8157829	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	1.34	CHEMBL4204	Homo sapiens	Inhibition	%	1.34
	8157990	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.25	CHEMBL4204	Homo sapiens	Inhibition	%	0.25
	8158214	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	0.67	CHEMBL4204	Homo sapiens	Inhibition	%	0.67
	8158240	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	3.34	CHEMBL4204	Homo sapiens	Inhibition	%	3.34
	8158464	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	2.07	CHEMBL4204	Homo sapiens	Inhibition	%	2.07
	8158622	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	1.11	CHEMBL4204	Homo sapiens	Inhibition	%	1.11
	8158791	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	1.25	CHEMBL4204	Homo sapiens	Inhibition	%	1.25
	8159015	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.16	CHEMBL4204	Homo sapiens	Inhibition	%	2.16
	8159150	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	5.13	CHEMBL4204	Homo sapiens	Inhibition	%	5.13
	8159494	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	0.34	CHEMBL4204	Homo sapiens	Inhibition	%	0.34
	8159625	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	5.79	CHEMBL4204	Homo sapiens	Inhibition	%	5.79
	8159849	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	1.87	CHEMBL4204	Homo sapiens	Inhibition	%	1.87
	8159990	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	-0.19	CHEMBL4204	Homo sapiens	Inhibition	%	-0.19
	8160351	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	6.58	CHEMBL4204	Homo sapiens	Inhibition	%	6.58
	8160501	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	0.18	CHEMBL4204	Homo sapiens	Inhibition	%	0.18
	8160795	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	5.77	CHEMBL4204	Homo sapiens	Inhibition	%	5.77
	8161169	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	9.63	CHEMBL4204	Homo sapiens	Inhibition	%	9.63
	8161312	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	4.36	CHEMBL4204	Homo sapiens	Inhibition	%	4.36
	8161661	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	0.71	CHEMBL4204	Homo sapiens	Inhibition	%	0.71
	8161799	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	6.0	CHEMBL4204	Homo sapiens	Inhibition	%	6.0
	8162023	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	3.32	CHEMBL4204	Homo sapiens	Inhibition	%	3.32
	8162153	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	5.14	CHEMBL4204	Homo sapiens	Inhibition	%	5.14
	8162537	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	9.51	CHEMBL4204	Homo sapiens	Inhibition	%	9.51
	8162790	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	10.85	CHEMBL4204	Homo sapiens	Inhibition	%	10.85
	8162938	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	3.84	CHEMBL4204	Homo sapiens	Inhibition	%	3.84
	8163331	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.09	CHEMBL4204	Homo sapiens	Inhibition	%	1.09
	8163465	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	13.18	CHEMBL4204	Homo sapiens	Inhibition	%	13.18
	8163689	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	2.9	CHEMBL4204	Homo sapiens	Inhibition	%	2.9
	8163812	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	6.79	CHEMBL4204	Homo sapiens	Inhibition	%	6.79
	8164170	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	2.51	CHEMBL4204	Homo sapiens	Inhibition	%	2.51
	8164310	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.35	CHEMBL4204	Homo sapiens	Inhibition	%	0.35
	8164689	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	5.65	CHEMBL4204	Homo sapiens	Inhibition	%	5.65
	8164833	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	0.46	CHEMBL4204	Homo sapiens	Inhibition	%	0.46
	8165127	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	1.22	CHEMBL4204	Homo sapiens	Inhibition	%	1.22
	8165492	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	2.01	CHEMBL4204	Homo sapiens	Inhibition	%	2.01
	8165635	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	25.88	CHEMBL4204	Homo sapiens	Inhibition	%	25.88
	8165859	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	0.38	CHEMBL4204	Homo sapiens	Inhibition	%	0.38
	8165985	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	0.58	CHEMBL4204	Homo sapiens	Inhibition	%	0.58
	8166347	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	12.97	CHEMBL4204	Homo sapiens	Inhibition	%	12.97
	8166477	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	1.57	CHEMBL4204	Homo sapiens	Inhibition	%	1.57
	8166802	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	19.23	CHEMBL4204	Homo sapiens	Inhibition	%	19.23
	8167114	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	3.73	CHEMBL4204	Homo sapiens	Inhibition	%	3.73
	8167255	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	18.06	CHEMBL4204	Homo sapiens	Inhibition	%	18.06
	8167479	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	1.36	CHEMBL4204	Homo sapiens	Inhibition	%	1.36
	8167643	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.55	CHEMBL4204	Homo sapiens	Inhibition	%	1.55
	8168000	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	9.38	CHEMBL4204	Homo sapiens	Inhibition	%	9.38
	8168124	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.85	CHEMBL4204	Homo sapiens	Inhibition	%	3.85
	8168489	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	3.16	CHEMBL4204	Homo sapiens	Inhibition	%	3.16
	8168625	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.79	CHEMBL4204	Homo sapiens	Inhibition	%	0.79
	8168849	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-1.27	CHEMBL4204	Homo sapiens	Inhibition	%	-1.27
	8169013	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	33.05	CHEMBL4204	Homo sapiens	Inhibition	%	33.05
	8169155	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.69	CHEMBL4204	Homo sapiens	Inhibition	%	1.69
	8169379	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.32	CHEMBL4204	Homo sapiens	Inhibition	%	1.32
	8169459	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	1.54	CHEMBL4204	Homo sapiens	Inhibition	%	1.54
	8169683	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	1.48	CHEMBL4204	Homo sapiens	Inhibition	%	1.48
	8169817	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	4.98	CHEMBL4204	Homo sapiens	Inhibition	%	4.98
	8170186	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	7.49	CHEMBL4204	Homo sapiens	Inhibition	%	7.49
	8170311	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	0.84	CHEMBL4204	Homo sapiens	Inhibition	%	0.84
	8170675	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	0.56	CHEMBL4204	Homo sapiens	Inhibition	%	0.56
	8170810	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	14.75	CHEMBL4204	Homo sapiens	Inhibition	%	14.75
	8171034	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	2.64	CHEMBL4204	Homo sapiens	Inhibition	%	2.64
	8171231	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	2.68	CHEMBL4204	Homo sapiens	Inhibition	%	2.68
	8171448	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	21.01	CHEMBL4204	Homo sapiens	Inhibition	%	21.01
	8171813	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	3.03	CHEMBL4204	Homo sapiens	Inhibition	%	3.03
	8171966	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	1.92	CHEMBL4204	Homo sapiens	Inhibition	%	1.92
	8172322	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	2.62	CHEMBL4204	Homo sapiens	Inhibition	%	2.62
	8172450	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	65.29	CHEMBL4204	Homo sapiens	Inhibition	%	65.29
	8172674	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.5	CHEMBL4204	Homo sapiens	Inhibition	%	0.5
	8172816	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	7.35	CHEMBL4204	Homo sapiens	Inhibition	%	7.35
	8173176	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	1.02	CHEMBL4204	Homo sapiens	Inhibition	%	1.02
	8173341	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	15.22	CHEMBL4204	Homo sapiens	Inhibition	%	15.22
	8173706	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	6.02	CHEMBL4204	Homo sapiens	Inhibition	%	6.02
	8174017	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	4.85	CHEMBL4204	Homo sapiens	Inhibition	%	4.85
	8174149	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	3.34	CHEMBL4204	Homo sapiens	Inhibition	%	3.34
	8174521	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	-1.06	CHEMBL4204	Homo sapiens	Inhibition	%	-1.06
	8174643	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.26	CHEMBL4204	Homo sapiens	Inhibition	%	1.26
	8174867	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	0.73	CHEMBL4204	Homo sapiens	Inhibition	%	0.73
	8175010	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	4.38	CHEMBL4204	Homo sapiens	Inhibition	%	4.38
	8175370	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	15.16	CHEMBL4204	Homo sapiens	Inhibition	%	15.16
	8175626	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	8.07	CHEMBL4204	Homo sapiens	Inhibition	%	8.07
	8175789	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	2.38	CHEMBL4204	Homo sapiens	Inhibition	%	2.38
	8176166	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	1.06	CHEMBL4204	Homo sapiens	Inhibition	%	1.06
	8176315	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	6.42	CHEMBL4204	Homo sapiens	Inhibition	%	6.42
	8176539	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	1.66	CHEMBL4204	Homo sapiens	Inhibition	%	1.66
	8176671	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	10.95	CHEMBL4204	Homo sapiens	Inhibition	%	10.95
	8177025	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	7.2	CHEMBL4204	Homo sapiens	Inhibition	%	7.2
	8177167	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	22.63	CHEMBL4204	Homo sapiens	Inhibition	%	22.63
	8177529	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	8.34	CHEMBL4204	Homo sapiens	Inhibition	%	8.34
	8177693	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	59.25	CHEMBL4204	Homo sapiens	Inhibition	%	59.25
	8177917	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	1.91	CHEMBL4204	Homo sapiens	Inhibition	%	1.91
	8178057	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	35.97	CHEMBL4204	Homo sapiens	Inhibition	%	35.97
	8178369	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.15	CHEMBL4204	Homo sapiens	Inhibition	%	1.15
	8178496	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	16.05	CHEMBL4204	Homo sapiens	Inhibition	%	16.05
	8178720	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	4.13	CHEMBL4204	Homo sapiens	Inhibition	%	4.13
	8178869	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	0.04	CHEMBL4204	Homo sapiens	Inhibition	%	0.04
	8179216	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	5.72	CHEMBL4204	Homo sapiens	Inhibition	%	5.72
	8179360	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	1.66	CHEMBL4204	Homo sapiens	Inhibition	%	1.66
	8179584	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	6.27	CHEMBL4204	Homo sapiens	Inhibition	%	6.27
	8179721	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	2.98	CHEMBL4204	Homo sapiens	Inhibition	%	2.98
	8179978	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	2.9	CHEMBL4204	Homo sapiens	Inhibition	%	2.9
	8180132	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	7.27	CHEMBL4204	Homo sapiens	Inhibition	%	7.27
	8180356	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	0.75	CHEMBL4204	Homo sapiens	Inhibition	%	0.75
	8180512	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	10.08	CHEMBL4204	Homo sapiens	Inhibition	%	10.08
	8180884	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	3.67	CHEMBL4204	Homo sapiens	Inhibition	%	3.67
	8181017	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	1.97	CHEMBL4204	Homo sapiens	Inhibition	%	1.97
	8181372	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-1.74	CHEMBL4204	Homo sapiens	Inhibition	%	-1.74
	8181512	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	63.77	CHEMBL4204	Homo sapiens	Inhibition	%	63.77
	8181736	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	3.14	CHEMBL4204	Homo sapiens	Inhibition	%	3.14
	8181875	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	18.12	CHEMBL4204	Homo sapiens	Inhibition	%	18.12
	8182262	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	5.26	CHEMBL4204	Homo sapiens	Inhibition	%	5.26
	8182402	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	0.89	CHEMBL4204	Homo sapiens	Inhibition	%	0.89
	8182718	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	6.67	CHEMBL4204	Homo sapiens	Inhibition	%	6.67
	8183064	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	13.35	CHEMBL4204	Homo sapiens	Inhibition	%	13.35
	8183213	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	1.44	CHEMBL4204	Homo sapiens	Inhibition	%	1.44
	8183566	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	6.24	CHEMBL4204	Homo sapiens	Inhibition	%	6.24
	8183932	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	1.59	CHEMBL4204	Homo sapiens	Inhibition	%	1.59
	8184068	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	10.92	CHEMBL4204	Homo sapiens	Inhibition	%	10.92
	8184334	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	8.1	CHEMBL4204	Homo sapiens	Inhibition	%	8.1
	8184705	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	3.83	CHEMBL4204	Homo sapiens	Inhibition	%	3.83
	8184862	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	0.58	CHEMBL4204	Homo sapiens	Inhibition	%	0.58
	8185235	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	2.64	CHEMBL4204	Homo sapiens	Inhibition	%	2.64
	8185366	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	9.18	CHEMBL4204	Homo sapiens	Inhibition	%	9.18
	8185590	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	4.73	CHEMBL4204	Homo sapiens	Inhibition	%	4.73
	8185721	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	3.41	CHEMBL4204	Homo sapiens	Inhibition	%	3.41
	8186084	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	10.18	CHEMBL4204	Homo sapiens	Inhibition	%	10.18
	8186225	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	2.16	CHEMBL4204	Homo sapiens	Inhibition	%	2.16
	8186449	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	6.26	CHEMBL4204	Homo sapiens	Inhibition	%	6.26
	8186613	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	1.85	CHEMBL4204	Homo sapiens	Inhibition	%	1.85
	8186752	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	2.32	CHEMBL4204	Homo sapiens	Inhibition	%	2.32
	8186976	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	0.95	CHEMBL4204	Homo sapiens	Inhibition	%	0.95
	8187074	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	4.98	CHEMBL4204	Homo sapiens	Inhibition	%	4.98
	8187422	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	2.32	CHEMBL4204	Homo sapiens	Inhibition	%	2.32
	8187570	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	10.55	CHEMBL4204	Homo sapiens	Inhibition	%	10.55
	8187794	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	0.49	CHEMBL4204	Homo sapiens	Inhibition	%	0.49
	8187923	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	9.7	CHEMBL4204	Homo sapiens	Inhibition	%	9.7
	8188290	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	5.65	CHEMBL4204	Homo sapiens	Inhibition	%	5.65
	8188425	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	16.71	CHEMBL4204	Homo sapiens	Inhibition	%	16.71
	8188649	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	23.95	CHEMBL4204	Homo sapiens	Inhibition	%	23.95
	8188699	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.49	CHEMBL4204	Homo sapiens	Inhibition	%	3.49
	8188923	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	14.25	CHEMBL4204	Homo sapiens	Inhibition	%	14.25
	8189071	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.33	CHEMBL4204	Homo sapiens	Inhibition	%	1.33
	8189227	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	-0.01	CHEMBL4204	Homo sapiens	Inhibition	%	-0.01
	8189451	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	1.04	CHEMBL4204	Homo sapiens	Inhibition	%	1.04
	8189600	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	11.8	CHEMBL4204	Homo sapiens	Inhibition	%	11.8
	8189956	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	31.77	CHEMBL4204	Homo sapiens	Inhibition	%	31.77
	8190088	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	7.61	CHEMBL4204	Homo sapiens	Inhibition	%	7.61
	8190312	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	40.12	CHEMBL4204	Homo sapiens	Inhibition	%	40.12
	8190452	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	2.09	CHEMBL4204	Homo sapiens	Inhibition	%	2.09
	8190813	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	2.63	CHEMBL4204	Homo sapiens	Inhibition	%	2.63
	8190977	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	4.28	CHEMBL4204	Homo sapiens	Inhibition	%	4.28
	8191339	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	5.14	CHEMBL4204	Homo sapiens	Inhibition	%	5.14
	8191435	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	37.75	CHEMBL4204	Homo sapiens	Inhibition	%	37.75
	8191659	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	0.9	CHEMBL4204	Homo sapiens	Inhibition	%	0.9
	8191781	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	8.78	CHEMBL4204	Homo sapiens	Inhibition	%	8.78
	8192154	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.79	CHEMBL4204	Homo sapiens	Inhibition	%	1.79
	8192283	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	4.37	CHEMBL4204	Homo sapiens	Inhibition	%	4.37
	8192507	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	8.59	CHEMBL4204	Homo sapiens	Inhibition	%	8.59
	8192651	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	2.12	CHEMBL4204	Homo sapiens	Inhibition	%	2.12
	8193011	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	2.3	CHEMBL4204	Homo sapiens	Inhibition	%	2.3
	8193283	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	1.44	CHEMBL4204	Homo sapiens	Inhibition	%	1.44
	8193428	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	2.77	CHEMBL4204	Homo sapiens	Inhibition	%	2.77
	8193809	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	2.05	CHEMBL4204	Homo sapiens	Inhibition	%	2.05
	8193958	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-1.08	CHEMBL4204	Homo sapiens	Inhibition	%	-1.08
	8194182	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	1.33	CHEMBL4204	Homo sapiens	Inhibition	%	1.33
	8194313	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	3.13	CHEMBL4204	Homo sapiens	Inhibition	%	3.13
	8194668	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	1.0	CHEMBL4204	Homo sapiens	Inhibition	%	1.0
	8194811	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	6.55	CHEMBL4204	Homo sapiens	Inhibition	%	6.55
	8195168	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	8.42	CHEMBL4204	Homo sapiens	Inhibition	%	8.42
	8195332	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	6.52	CHEMBL4204	Homo sapiens	Inhibition	%	6.52
	8195556	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	34.71	CHEMBL4204	Homo sapiens	Inhibition	%	34.71
	8195695	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	0.41	CHEMBL4204	Homo sapiens	Inhibition	%	0.41
	8196017	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	3.32	CHEMBL4204	Homo sapiens	Inhibition	%	3.32
	8196134	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	1.25	CHEMBL4204	Homo sapiens	Inhibition	%	1.25
	8196358	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	5.19	CHEMBL4204	Homo sapiens	Inhibition	%	5.19
	8196508	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	0.04	CHEMBL4204	Homo sapiens	Inhibition	%	0.04
	8196860	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	3.17	CHEMBL4204	Homo sapiens	Inhibition	%	3.17
	8197001	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	14.95	CHEMBL4204	Homo sapiens	Inhibition	%	14.95
	8197362	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	4.37	CHEMBL4204	Homo sapiens	Inhibition	%	4.37
	8197637	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	3.34	CHEMBL4204	Homo sapiens	Inhibition	%	3.34
	8197777	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	1.58	CHEMBL4204	Homo sapiens	Inhibition	%	1.58
	8198001	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	7.9	CHEMBL4204	Homo sapiens	Inhibition	%	7.9
	8198158	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-2.37	CHEMBL4204	Homo sapiens	Inhibition	%	-2.37
	8198520	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	2.83	CHEMBL4204	Homo sapiens	Inhibition	%	2.83
	8198650	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	15.84	CHEMBL4204	Homo sapiens	Inhibition	%	15.84
	8199005	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	3.38	CHEMBL4204	Homo sapiens	Inhibition	%	3.38
	8199153	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	0.92	CHEMBL4204	Homo sapiens	Inhibition	%	0.92
	8199377	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	4.05	CHEMBL4204	Homo sapiens	Inhibition	%	4.05
	8199511	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	2.53	CHEMBL4204	Homo sapiens	Inhibition	%	2.53
	8199898	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.84	CHEMBL4204	Homo sapiens	Inhibition	%	1.84
	8200036	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	0.09	CHEMBL4204	Homo sapiens	Inhibition	%	0.09
	8200364	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.53	CHEMBL4204	Homo sapiens	Inhibition	%	0.53
	8200703	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	3.33	CHEMBL4204	Homo sapiens	Inhibition	%	3.33
	8200853	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	0.75	CHEMBL4204	Homo sapiens	Inhibition	%	0.75
	8201207	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	12.97	CHEMBL4204	Homo sapiens	Inhibition	%	12.97
	8201342	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	4.29	CHEMBL4204	Homo sapiens	Inhibition	%	4.29
	8201566	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	26.43	CHEMBL4204	Homo sapiens	Inhibition	%	26.43
	8201699	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.98	CHEMBL4204	Homo sapiens	Inhibition	%	0.98
	8201978	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	3.07	CHEMBL4204	Homo sapiens	Inhibition	%	3.07
	8202342	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.49	CHEMBL4204	Homo sapiens	Inhibition	%	0.49
	8202509	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	0.35	CHEMBL4204	Homo sapiens	Inhibition	%	0.35
	8202858	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	6.06	CHEMBL4204	Homo sapiens	Inhibition	%	6.06
	8202988	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	2.31	CHEMBL4204	Homo sapiens	Inhibition	%	2.31
	8203212	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	8.75	CHEMBL4204	Homo sapiens	Inhibition	%	8.75
	8203343	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	-0.12	CHEMBL4204	Homo sapiens	Inhibition	%	-0.12
	8203713	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.64	CHEMBL4204	Homo sapiens	Inhibition	%	1.64
	8203847	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	6.84	CHEMBL4204	Homo sapiens	Inhibition	%	6.84
	8204237	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	9.67	CHEMBL4204	Homo sapiens	Inhibition	%	9.67
	8204374	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	1.72	CHEMBL4204	Homo sapiens	Inhibition	%	1.72
	8204598	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	4.94	CHEMBL4204	Homo sapiens	Inhibition	%	4.94
	8204703	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.38	CHEMBL4204	Homo sapiens	Inhibition	%	1.38
	8205042	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	25.72	CHEMBL4204	Homo sapiens	Inhibition	%	25.72
	8205191	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	7.65	CHEMBL4204	Homo sapiens	Inhibition	%	7.65
	8205415	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	42.5	CHEMBL4204	Homo sapiens	Inhibition	%	42.5
	8205551	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	3.06	CHEMBL4204	Homo sapiens	Inhibition	%	3.06
	8205914	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	1.63	CHEMBL4204	Homo sapiens	Inhibition	%	1.63
	8206046	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	3.96	CHEMBL4204	Homo sapiens	Inhibition	%	3.96
	8206270	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	2.95	CHEMBL4204	Homo sapiens	Inhibition	%	2.95
	8206322	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	10.41	CHEMBL4204	Homo sapiens	Inhibition	%	10.41
	8206546	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	0.86	CHEMBL4204	Homo sapiens	Inhibition	%	0.86
	8206689	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	10.6	CHEMBL4204	Homo sapiens	Inhibition	%	10.6
	8206869	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	0.54	CHEMBL4204	Homo sapiens	Inhibition	%	0.54
	8207093	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	-0.09	CHEMBL4204	Homo sapiens	Inhibition	%	-0.09
	8207219	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	2.72	CHEMBL4204	Homo sapiens	Inhibition	%	2.72
	8207573	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	5.42	CHEMBL4204	Homo sapiens	Inhibition	%	5.42
	8207705	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	3.7	CHEMBL4204	Homo sapiens	Inhibition	%	3.7
	8208074	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	7.83	CHEMBL4204	Homo sapiens	Inhibition	%	7.83
	8208206	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	2.0	CHEMBL4204	Homo sapiens	Inhibition	%	2.0
	8208430	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	6.65	CHEMBL4204	Homo sapiens	Inhibition	%	6.65
	8208596	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	1.21	CHEMBL4204	Homo sapiens	Inhibition	%	1.21
	8208953	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	4.37	CHEMBL4204	Homo sapiens	Inhibition	%	4.37
	8209058	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.34	CHEMBL4204	Homo sapiens	Inhibition	%	0.34
	8209282	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	3.99	CHEMBL4204	Homo sapiens	Inhibition	%	3.99
	8209398	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.0	CHEMBL4204	Homo sapiens	Inhibition	%	1.0
	8209772	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	0.71	CHEMBL4204	Homo sapiens	Inhibition	%	0.71
	8209908	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	6.16	CHEMBL4204	Homo sapiens	Inhibition	%	6.16
	8210132	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	3.53	CHEMBL4204	Homo sapiens	Inhibition	%	3.53
	8210273	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	5.54	CHEMBL4204	Homo sapiens	Inhibition	%	5.54
	8210633	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	28.17	CHEMBL4204	Homo sapiens	Inhibition	%	28.17
	8210892	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	1.57	CHEMBL4204	Homo sapiens	Inhibition	%	1.57
	8211036	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	0.22	CHEMBL4204	Homo sapiens	Inhibition	%	0.22
	8211430	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.3	CHEMBL4204	Homo sapiens	Inhibition	%	1.3
	8211553	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	7.56	CHEMBL4204	Homo sapiens	Inhibition	%	7.56
	8211906	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	35.13	CHEMBL4204	Homo sapiens	Inhibition	%	35.13
	8212038	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	3.83	CHEMBL4204	Homo sapiens	Inhibition	%	3.83
	8212262	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	25.1	CHEMBL4204	Homo sapiens	Inhibition	%	25.1
	8212403	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	1.37	CHEMBL4204	Homo sapiens	Inhibition	%	1.37
	8212760	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	2.35	CHEMBL4204	Homo sapiens	Inhibition	%	2.35
	8212930	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	3.81	CHEMBL4204	Homo sapiens	Inhibition	%	3.81
	8213283	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	18.18	CHEMBL4204	Homo sapiens	Inhibition	%	18.18
	8213611	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.57	CHEMBL4204	Homo sapiens	Inhibition	%	-0.57
	8213724	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	5.53	CHEMBL4204	Homo sapiens	Inhibition	%	5.53
	8213948	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	1.42	CHEMBL4204	Homo sapiens	Inhibition	%	1.42
	8214095	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	6.29	CHEMBL4204	Homo sapiens	Inhibition	%	6.29
	8214456	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	11.76	CHEMBL4204	Homo sapiens	Inhibition	%	11.76
	8214590	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	2.08	CHEMBL4204	Homo sapiens	Inhibition	%	2.08
	8214966	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	3.62	CHEMBL4204	Homo sapiens	Inhibition	%	3.62
	8215217	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	1.53	CHEMBL4204	Homo sapiens	Inhibition	%	1.53
	8215370	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	-0.04	CHEMBL4204	Homo sapiens	Inhibition	%	-0.04
	8215758	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.83	CHEMBL4204	Homo sapiens	Inhibition	%	1.83
	8215877	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	1.03	CHEMBL4204	Homo sapiens	Inhibition	%	1.03
	8216101	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	5.28	CHEMBL4204	Homo sapiens	Inhibition	%	5.28
	8216220	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	1.04	CHEMBL4204	Homo sapiens	Inhibition	%	1.04
	8216580	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	2.73	CHEMBL4204	Homo sapiens	Inhibition	%	2.73
	8216718	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	7.23	CHEMBL4204	Homo sapiens	Inhibition	%	7.23
	8216942	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.55	CHEMBL4204	Homo sapiens	Inhibition	%	1.55
	8217076	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	6.05	CHEMBL4204	Homo sapiens	Inhibition	%	6.05
	8217250	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.86	CHEMBL4204	Homo sapiens	Inhibition	%	0.86
	8217474	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	2.44	CHEMBL4204	Homo sapiens	Inhibition	%	2.44
	8217605	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	41.75	CHEMBL4204	Homo sapiens	Inhibition	%	41.75
	8217930	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	0.11	CHEMBL4204	Homo sapiens	Inhibition	%	0.11
	8218269	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	5.3	CHEMBL4204	Homo sapiens	Inhibition	%	5.3
	8218396	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	28.73	CHEMBL4204	Homo sapiens	Inhibition	%	28.73
	8218763	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	9.42	CHEMBL4204	Homo sapiens	Inhibition	%	9.42
	8218894	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	16.74	CHEMBL4204	Homo sapiens	Inhibition	%	16.74
	8219118	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	2.44	CHEMBL4204	Homo sapiens	Inhibition	%	2.44
	8219278	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	2.02	CHEMBL4204	Homo sapiens	Inhibition	%	2.02
	8219528	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	0.94	CHEMBL4204	Homo sapiens	Inhibition	%	0.94
	8219689	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	0.67	CHEMBL4204	Homo sapiens	Inhibition	%	0.67
	8219913	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	0.83	CHEMBL4204	Homo sapiens	Inhibition	%	0.83
	8220082	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	0.45	CHEMBL4204	Homo sapiens	Inhibition	%	0.45
	8220435	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	2.52	CHEMBL4204	Homo sapiens	Inhibition	%	2.52
	8220549	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	3.71	CHEMBL4204	Homo sapiens	Inhibition	%	3.71
	8220773	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	2.19	CHEMBL4204	Homo sapiens	Inhibition	%	2.19
	8220911	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	15.87	CHEMBL4204	Homo sapiens	Inhibition	%	15.87
	8221271	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	15.05	CHEMBL4204	Homo sapiens	Inhibition	%	15.05
	8221404	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	1.57	CHEMBL4204	Homo sapiens	Inhibition	%	1.57
	8221793	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.49	CHEMBL4204	Homo sapiens	Inhibition	%	0.49
	8221924	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	76.83	CHEMBL4204	Homo sapiens	Inhibition	%	76.83
	8222246	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	2.96	CHEMBL4204	Homo sapiens	Inhibition	%	2.96
	8222604	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	3.92	CHEMBL4204	Homo sapiens	Inhibition	%	3.92
	8222722	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	67.54	CHEMBL4204	Homo sapiens	Inhibition	%	67.54
	8222946	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	1.45	CHEMBL4204	Homo sapiens	Inhibition	%	1.45
	8223090	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	56.29	CHEMBL4204	Homo sapiens	Inhibition	%	56.29
	8223443	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	22.05	CHEMBL4204	Homo sapiens	Inhibition	%	22.05
	8223604	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	3.14	CHEMBL4204	Homo sapiens	Inhibition	%	3.14
	8223854	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	1.75	CHEMBL4204	Homo sapiens	Inhibition	%	1.75
	8224240	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	-0.01	CHEMBL4204	Homo sapiens	Inhibition	%	-0.01
	8224410	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	-0.24	CHEMBL4204	Homo sapiens	Inhibition	%	-0.24
	8224769	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	4.47	CHEMBL4204	Homo sapiens	Inhibition	%	4.47
	8225107	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	5.02	CHEMBL4204	Homo sapiens	Inhibition	%	5.02
	8225241	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	0.45	CHEMBL4204	Homo sapiens	Inhibition	%	0.45
	8225603	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.98	CHEMBL4204	Homo sapiens	Inhibition	%	0.98
	8225738	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	5.1	CHEMBL4204	Homo sapiens	Inhibition	%	5.1
	8225962	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	1.2	CHEMBL4204	Homo sapiens	Inhibition	%	1.2
	8226120	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.44	CHEMBL4204	Homo sapiens	Inhibition	%	1.44
	8226245	CHEMBL1961982	GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	2.98	CHEMBL4204	Homo sapiens	Inhibition	%	2.98
	8226469	CHEMBL1961983	GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	8.39	CHEMBL4204	Homo sapiens	Inhibition	%	8.39
active	9611006	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	=	Ki	nM	199.53	CHEMBL4204	Homo sapiens	pKi		6.7
inactive	9611007	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)c(OC)c1		CHEMBL2003768	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611008	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	=	Ki	nM	630.96	CHEMBL4204	Homo sapiens	pKi		6.2
active	9611009	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	100.0	CHEMBL4204	Homo sapiens	pKi		7.0
active	9611010	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	=	Ki	nM	1995.26	CHEMBL4204	Homo sapiens	pKi		5.7
inactive	9611011	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611012	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611013	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	=	Ki	nM	7943.28	CHEMBL4204	Homo sapiens	pKi		5.1
active	9611014	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	=	Ki	nM	3981.07	CHEMBL4204	Homo sapiens	pKi		5.4
inactive	9611015	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611016	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	=	Ki	nM	1584.89	CHEMBL4204	Homo sapiens	pKi		5.8
active	9611017	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	=	Ki	nM	1258.93	CHEMBL4204	Homo sapiens	pKi		5.9
active	9611018	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	=	Ki	nM	251.19	CHEMBL4204	Homo sapiens	pKi		6.6
inactive	9611019	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611020	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	=	Ki	nM	125.89	CHEMBL4204	Homo sapiens	pKi		6.9
active	9611021	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	=	Ki	nM	1258.93	CHEMBL4204	Homo sapiens	pKi		5.9
active	9611022	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	125.89	CHEMBL4204	Homo sapiens	pKi		6.9
inactive	9611023	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611024	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611025	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	39.81	CHEMBL4204	Homo sapiens	pKi		7.4
active	9611026	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	=	Ki	nM	3981.07	CHEMBL4204	Homo sapiens	pKi		5.4
active	9611027	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	=	Ki	nM	316.23	CHEMBL4204	Homo sapiens	pKi		6.5
active	9611028	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	=	Ki	nM	398.11	CHEMBL4204	Homo sapiens	pKi		6.4
inactive	9611029	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611030	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611031	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611032	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611033	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611034	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	=	Ki	nM	3981.07	CHEMBL4204	Homo sapiens	pKi		5.4
active	9611035	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	=	Ki	nM	1258.93	CHEMBL4204	Homo sapiens	pKi		5.9
active	9611036	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	=	Ki	nM	7943.28	CHEMBL4204	Homo sapiens	pKi		5.1
active	9611037	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	=	Ki	nM	1258.93	CHEMBL4204	Homo sapiens	pKi		5.9
active	9611038	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Ki	nM	794.33	CHEMBL4204	Homo sapiens	pKi		6.1
inactive	9611039	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611040	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Clc1cc2nn[nH]c2cc1Cl		CHEMBL1996923	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611041	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611042	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611043	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611044	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	=	Ki	nM	6309.57	CHEMBL4204	Homo sapiens	pKi		5.2
inactive	9611045	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611046	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	=	Ki	nM	251.19	CHEMBL4204	Homo sapiens	pKi		6.6
active	9611047	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	=	Ki	nM	15.85	CHEMBL4204	Homo sapiens	pKi		7.8
active	9611048	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(=O)c1cc(Cl)cc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1984788	=	Ki	nM	5011.87	CHEMBL4204	Homo sapiens	pKi		5.3
active	9611049	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1OC		CHEMBL1996604	=	Ki	nM	6309.57	CHEMBL4204	Homo sapiens	pKi		5.2
inactive	9611050	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611051	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611052	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611053	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611054	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611055	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Ki	nM	1258.93	CHEMBL4204	Homo sapiens	pKi		5.9
inactive	9611056	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611057	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	=	Ki	nM	501.19	CHEMBL4204	Homo sapiens	pKi		6.3
active	9611058	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	=	Ki	nM	630.96	CHEMBL4204	Homo sapiens	pKi		6.2
active	9611059	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	=	Ki	nM	1000.0	CHEMBL4204	Homo sapiens	pKi		6.0
inactive	9611060	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=c1[nH]cc(I)c2nc(-c3ccccc3)cn12		CHEMBL2001668	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611061	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611062	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	=	Ki	nM	7943.28	CHEMBL4204	Homo sapiens	pKi		5.1
active	9611063	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	=	Ki	nM	398.11	CHEMBL4204	Homo sapiens	pKi		6.4
inactive	9611064	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611065	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611066	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611067	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)Oc1ccc(-c2noc(-c3ccc(NC4CCC(C(=O)O)C4)cc3)n2)cc1C(F)(F)F		CHEMBL1981947	=	Ki	nM	3981.07	CHEMBL4204	Homo sapiens	pKi		5.4
active	9611068	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCCCNc1cc(-c2c[nH]c3ncccc23)ncn1		CHEMBL1968459	=	Ki	nM	63.1	CHEMBL4204	Homo sapiens	pKi		7.2
active	9611069	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	158.49	CHEMBL4204	Homo sapiens	pKi		6.8
inactive	9611070	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(=O)C1CCCN(C(=O)c2cc(-c3ccc4[nH]ncc4c3)on2)C1		CHEMBL1970369	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611071	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	=	Ki	nM	251.19	CHEMBL4204	Homo sapiens	pKi		6.6
inactive	9611072	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611073	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	=	Ki	nM	6309.57	CHEMBL4204	Homo sapiens	pKi		5.2
active	9611074	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	=	Ki	nM	630.96	CHEMBL4204	Homo sapiens	pKi		6.2
active	9611075	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	1000.0	CHEMBL4204	Homo sapiens	pKi		6.0
active	9611076	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	=	Ki	nM	5011.87	CHEMBL4204	Homo sapiens	pKi		5.3
active	9611077	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	=	Ki	nM	79.43	CHEMBL4204	Homo sapiens	pKi		7.1
inactive	9611078	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611079	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	=	Ki	nM	630.96	CHEMBL4204	Homo sapiens	pKi		6.2
inactive	9611080	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611081	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	=	Ki	nM	3981.07	CHEMBL4204	Homo sapiens	pKi		5.4
inactive	9611082	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	7943.28	CHEMBL4204	Homo sapiens	pKi		5.1
active	9611083	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	=	Ki	nM	158.49	CHEMBL4204	Homo sapiens	pKi		6.8
active	9611084	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	251.19	CHEMBL4204	Homo sapiens	pKi		6.6
inactive	9611085	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611086	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=c1[nH]c2cc(Cl)cc(Cl)c2c(-c2cc(Cl)ccc2O)c1O		CHEMBL1974803	=	Ki	nM	1584.89	CHEMBL4204	Homo sapiens	pKi		5.8
active	9611087	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	=	Ki	nM	3162.28	CHEMBL4204	Homo sapiens	pKi		5.5
active	9611088	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	=	Ki	nM	6309.57	CHEMBL4204	Homo sapiens	pKi		5.2
active	9611089	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC1=NN(c2cccc(Br)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2005112	=	Ki	nM	5011.87	CHEMBL4204	Homo sapiens	pKi		5.3
active	9611090	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	=	Ki	nM	2511.89	CHEMBL4204	Homo sapiens	pKi		5.6
inactive	9611091	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCN(CC)CCOc1ccc(-c2nc3c(C(N)=O)cccc3[nH]2)cc1		CHEMBL1984044	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611092	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	=	Ki	nM	398.11	CHEMBL4204	Homo sapiens	pKi		6.4
inactive	9611093	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611094	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611095	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	=	Ki	nM	1995.26	CHEMBL4204	Homo sapiens	pKi		5.7
active	9611096	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	=	Ki	nM	398.11	CHEMBL4204	Homo sapiens	pKi		6.4
inactive	9611097	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCCOn1c2ccc(Cl)cc2c(=O)c2c(C)nn(C)c21		CHEMBL207253	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611098	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	=	Ki	nM	501.19	CHEMBL4204	Homo sapiens	pKi		6.3
inactive	9611099	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611100	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611101	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	=	Ki	nM	1000.0	CHEMBL4204	Homo sapiens	pKi		6.0
inactive	9611102	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611103	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611104	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611105	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(Nc1ccc2[nH]ncc2c1)c1cccc(F)c1		CHEMBL1461728	=	Ki	nM	7943.28	CHEMBL4204	Homo sapiens	pKi		5.1
inactive	9611106	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611107	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	=	Ki	nM	251.19	CHEMBL4204	Homo sapiens	pKi		6.6
active	9611108	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	=	Ki	nM	2511.89	CHEMBL4204	Homo sapiens	pKi		5.6
active	9611109	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)(Nc1nccc(-c2c[nH]c3ncccc23)n1)c1ccccc1		CHEMBL1999279	=	Ki	nM	25.12	CHEMBL4204	Homo sapiens	pKi		7.6
active	9611110	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	=	Ki	nM	251.19	CHEMBL4204	Homo sapiens	pKi		6.6
active	9611111	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	=	Ki	nM	50.12	CHEMBL4204	Homo sapiens	pKi		7.3
active	9611112	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Oc1ccc(Nc2ncnc3scc(Cl)c23)cc1		CHEMBL2006580	=	Ki	nM	316.23	CHEMBL4204	Homo sapiens	pKi		6.5
inactive	9611113	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCCC1		CHEMBL2006481	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611114	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611115	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	=	Ki	nM	1000.0	CHEMBL4204	Homo sapiens	pKi		6.0
inactive	9611116	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611117	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCNc1nc2cc(Cl)c(OC)cc2nc1NCC		CHEMBL1995927	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611118	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	=	Ki	nM	5011.87	CHEMBL4204	Homo sapiens	pKi		5.3
inactive	9611119	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611120	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccc(Nc2nccc(Nc3ccccc3C(=O)O)n2)cc1F		CHEMBL243518	=	Ki	nM	251.19	CHEMBL4204	Homo sapiens	pKi		6.6
active	9611121	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	=	Ki	nM	5011.87	CHEMBL4204	Homo sapiens	pKi		5.3
inactive	9611122	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611123	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	=	Ki	nM	316.23	CHEMBL4204	Homo sapiens	pKi		6.5
inactive	9611124	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611125	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	=	Ki	nM	5011.87	CHEMBL4204	Homo sapiens	pKi		5.3
inactive	9611126	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611127	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611128	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	=	Ki	nM	316.23	CHEMBL4204	Homo sapiens	pKi		6.5
inactive	9611129	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccc3ccccc3c2)n1		CHEMBL2002240	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611130	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611131	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccc(-n2nc(C)c3c(=O)c4cc(Cl)ccc4n(O)c32)cc1		CHEMBL1991143	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611132	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Ki	nM	316.23	CHEMBL4204	Homo sapiens	pKi		6.5
inactive	9611133	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611134	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	=	Ki	nM	501.19	CHEMBL4204	Homo sapiens	pKi		6.3
active	9611135	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	=	Ki	nM	398.11	CHEMBL4204	Homo sapiens	pKi		6.4
inactive	9611136	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611137	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	=	Ki	nM	2511.89	CHEMBL4204	Homo sapiens	pKi		5.6
active	9611138	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cc(-c2ccc3c(c2)Nc2ccccc2NC3=O)ccn1		CHEMBL1981511	=	Ki	nM	316.23	CHEMBL4204	Homo sapiens	pKi		6.5
inactive	9611139	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611140	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	=	Ki	nM	794.33	CHEMBL4204	Homo sapiens	pKi		6.1
inactive	9611141	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1997025	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611142	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	=	Ki	nM	125.89	CHEMBL4204	Homo sapiens	pKi		6.9
active	9611143	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C1C(=NNc2cccc3c(=O)[nH][nH]c(=O)c23)C(c2ccccc2)=NN1c1ccccc1		CHEMBL1984274	=	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611144	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611145	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611146	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)c(Cl)ccc12		CHEMBL2006010	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611147	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611148	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611149	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	=	Ki	nM	3981.07	CHEMBL4204	Homo sapiens	pKi		5.4
active	9611150	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	=	Ki	nM	316.23	CHEMBL4204	Homo sapiens	pKi		6.5
inactive	9611151	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL1966035	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611152	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611153	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611154	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611155	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	=	Ki	nM	63.1	CHEMBL4204	Homo sapiens	pKi		7.2
active	9611156	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCN(CC)CCCNc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)n1		CHEMBL1972276	=	Ki	nM	2511.89	CHEMBL4204	Homo sapiens	pKi		5.6
active	9611157	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	=	Ki	nM	2511.89	CHEMBL4204	Homo sapiens	pKi		5.6
active	9611158	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	=	Ki	nM	100.0	CHEMBL4204	Homo sapiens	pKi		7.0
active	9611159	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	=	Ki	nM	630.96	CHEMBL4204	Homo sapiens	pKi		6.2
inactive	9611160	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1nc2ccccn2c1-c1csc(Nc2ccc(O)cc2)n1		CHEMBL513846	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611161	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611162	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	79.43	CHEMBL4204	Homo sapiens	pKi		7.1
active	9611163	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(=O)c1cccc2[nH]c(-c3cccc(NCCN4CCCC4)n3)nc12		CHEMBL1985309	=	Ki	nM	2511.89	CHEMBL4204	Homo sapiens	pKi		5.6
inactive	9611164	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611165	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611166	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	=	Ki	nM	3981.07	CHEMBL4204	Homo sapiens	pKi		5.4
inactive	9611167	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(=O)NC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2F)C1		CHEMBL1975208	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611168	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	3162.28	CHEMBL4204	Homo sapiens	pKi		5.5
active	9611169	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(=O)c1cc2c(Oc3cccc(F)c3)cncc2s1		CHEMBL1964777	=	Ki	nM	3981.07	CHEMBL4204	Homo sapiens	pKi		5.4
active	9611170	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	=	Ki	nM	6309.57	CHEMBL4204	Homo sapiens	pKi		5.2
inactive	9611171	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611172	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611173	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611174	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	=	Ki	nM	6309.57	CHEMBL4204	Homo sapiens	pKi		5.2
inactive	9611175	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611176	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611177	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	=	Ki	nM	125.89	CHEMBL4204	Homo sapiens	pKi		6.9
inactive	9611178	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611179	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611180	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611181	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611182	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611183	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1nsc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL2002553	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611184	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	=	Ki	nM	100.0	CHEMBL4204	Homo sapiens	pKi		7.0
active	9611185	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	=	Ki	nM	630.96	CHEMBL4204	Homo sapiens	pKi		6.2
active	9611186	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	=	Ki	nM	2511.89	CHEMBL4204	Homo sapiens	pKi		5.6
active	9611187	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	=	Ki	nM	5011.87	CHEMBL4204	Homo sapiens	pKi		5.3
inactive	9611188	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611189	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	=	Ki	nM	3981.07	CHEMBL4204	Homo sapiens	pKi		5.4
active	9611190	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	=	Ki	nM	1258.93	CHEMBL4204	Homo sapiens	pKi		5.9
inactive	9611191	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611192	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611193	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611194	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	=	Ki	nM	1000.0	CHEMBL4204	Homo sapiens	pKi		6.0
active	9611195	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	=	Ki	nM	3981.07	CHEMBL4204	Homo sapiens	pKi		5.4
inactive	9611196	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1ccc(C(=O)Nc2nc3ccc(Cl)cc3s2)c(OC)c1		CHEMBL1983309	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611197	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611198	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC1=NN(c2ccccc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1999126	=	Ki	nM	3162.28	CHEMBL4204	Homo sapiens	pKi		5.5
inactive	9611199	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)Oc1ccc(-c2noc(-c3ccc(NC4CCC(C(=O)O)C4)cc3)n2)cc1Cl		CHEMBL1997503	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611200	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611201	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1		CHEMBL1990821	=	Ki	nM	3162.28	CHEMBL4204	Homo sapiens	pKi		5.5
active	9611202	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	=	Ki	nM	630.96	CHEMBL4204	Homo sapiens	pKi		6.2
inactive	9611203	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611204	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611205	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611206	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611207	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(CNc2cc(-c3c[nH]c4ncccc34)ncn2)c1		CHEMBL1995932	=	Ki	nM	158.49	CHEMBL4204	Homo sapiens	pKi		6.8
active	9611208	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	=	Ki	nM	1000.0	CHEMBL4204	Homo sapiens	pKi		6.0
active	9611209	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	=	Ki	nM	794.33	CHEMBL4204	Homo sapiens	pKi		6.1
active	9611210	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	=	Ki	nM	794.33	CHEMBL4204	Homo sapiens	pKi		6.1
inactive	9611211	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611212	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611213	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	=	Ki	nM	501.19	CHEMBL4204	Homo sapiens	pKi		6.3
active	9611214	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	=	Ki	nM	1258.93	CHEMBL4204	Homo sapiens	pKi		5.9
inactive	9611215	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611216	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	=	Ki	nM	25.12	CHEMBL4204	Homo sapiens	pKi		7.6
active	9611217	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	=	Ki	nM	630.96	CHEMBL4204	Homo sapiens	pKi		6.2
active	9611218	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	=	Ki	nM	5011.87	CHEMBL4204	Homo sapiens	pKi		5.3
active	9611219	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	=	Ki	nM	630.96	CHEMBL4204	Homo sapiens	pKi		6.2
active	9611220	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	=	Ki	nM	398.11	CHEMBL4204	Homo sapiens	pKi		6.4
inactive	9611221	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611222	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611223	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CN(C)S(=O)(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL2006631	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611224	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	=	Ki	nM	1584.89	CHEMBL4204	Homo sapiens	pKi		5.8
inactive	9611225	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(Nc1n[nH]c2nc3ccccc3cc12)c1ccncc1		CHEMBL1990415	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9611226	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9611227	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	=	Ki	nM	316.23	CHEMBL4204	Homo sapiens	pKi		6.5
inactive	9611228	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614790	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614791	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614792	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL1970735	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614793	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	=	Ki	nM	7943.28	CHEMBL4204	Homo sapiens	pKi		5.1
active	9614794	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCOC(=O)C1=C(N)n2c(sc(=Cc3cccs3)c2=O)=C(C(N)=O)C1c1cccs1		CHEMBL2004365	=	Ki	nM	3162.28	CHEMBL4204	Homo sapiens	pKi		5.5
inactive	9614795	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614796	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	199.53	CHEMBL4204	Homo sapiens	pKi		6.7
inactive	9614797	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614798	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614799	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	Ki	nM	1258.93	CHEMBL4204	Homo sapiens	pKi		5.9
active	9614800	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	=	Ki	nM	2511.89	CHEMBL4204	Homo sapiens	pKi		5.6
inactive	9614801	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614802	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	=	Ki	nM	6309.57	CHEMBL4204	Homo sapiens	pKi		5.2
active	9614803	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	=	Ki	nM	1000.0	CHEMBL4204	Homo sapiens	pKi		6.0
inactive	9614804	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614805	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	=	Ki	nM	158.49	CHEMBL4204	Homo sapiens	pKi		6.8
inactive	9614806	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614807	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Ki	nM	316.23	CHEMBL4204	Homo sapiens	pKi		6.5
inactive	9614808	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614809	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614810	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614811	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614812	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC1CCCCC1Nc1nccc(Nc2ccccc2C(=O)O)n1		CHEMBL1985153	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614813	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614814	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	=	Ki	nM	1258.93	CHEMBL4204	Homo sapiens	pKi		5.9
inactive	9614815	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614816	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614817	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	199.53	CHEMBL4204	Homo sapiens	pKi		6.7
active	9614818	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	=	Ki	nM	3981.07	CHEMBL4204	Homo sapiens	pKi		5.4
inactive	9614819	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(NCc1ccc(Cl)cc1)Nc1cccc2[nH]ncc12		CHEMBL1977713	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614820	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614821	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	=	Ki	nM	630.96	CHEMBL4204	Homo sapiens	pKi		6.2
inactive	9614822	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=S(=O)(O)c1ccc(NCc2ccc3c(c2)OCO3)c2c(O)cccc12		CHEMBL2004544	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614823	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614824	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	FC(F)(F)c1cccc(CNc2cc(-c3c[nH]c4ncccc34)ncn2)c1		CHEMBL1966040	=	Ki	nM	1000.0	CHEMBL4204	Homo sapiens	pKi		6.0
active	9614825	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CN(C)CCOc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)c1		CHEMBL1989569	=	Ki	nM	1995.26	CHEMBL4204	Homo sapiens	pKi		5.7
inactive	9614826	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614827	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	=	Ki	nM	251.19	CHEMBL4204	Homo sapiens	pKi		6.6
active	9614828	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	3162.28	CHEMBL4204	Homo sapiens	pKi		5.5
inactive	9614829	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614830	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614831	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)cc3n21		CHEMBL1989265	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614832	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	79.43	CHEMBL4204	Homo sapiens	pKi		7.1
inactive	9614833	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CNC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2Br)C1		CHEMBL2004647	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614834	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	=	Ki	nM	1000.0	CHEMBL4204	Homo sapiens	pKi		6.0
inactive	9614835	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614836	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614837	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	=	Ki	nM	1995.26	CHEMBL4204	Homo sapiens	pKi		5.7
active	9614838	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	=	Ki	nM	251.19	CHEMBL4204	Homo sapiens	pKi		6.6
active	9614839	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	=	Ki	nM	1258.93	CHEMBL4204	Homo sapiens	pKi		5.9
inactive	9614840	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614841	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	=	Ki	nM	630.96	CHEMBL4204	Homo sapiens	pKi		6.2
inactive	9614842	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614843	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614844	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614845	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614846	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	=	Ki	nM	6309.57	CHEMBL4204	Homo sapiens	pKi		5.2
inactive	9614847	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614848	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	=	Ki	nM	630.96	CHEMBL4204	Homo sapiens	pKi		6.2
active	9614849	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	=	Ki	nM	7943.28	CHEMBL4204	Homo sapiens	pKi		5.1
active	9614850	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	=	Ki	nM	125.89	CHEMBL4204	Homo sapiens	pKi		6.9
active	9614851	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	=	Ki	nM	63.1	CHEMBL4204	Homo sapiens	pKi		7.2
inactive	9614852	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614853	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614854	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	=	Ki	nM	25.12	CHEMBL4204	Homo sapiens	pKi		7.6
active	9614855	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	=	Ki	nM	1584.89	CHEMBL4204	Homo sapiens	pKi		5.8
active	9614856	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	=	Ki	nM	3162.28	CHEMBL4204	Homo sapiens	pKi		5.5
inactive	9614857	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614858	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614859	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614860	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614861	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCN(CC)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1983195	=	Ki	nM	6309.57	CHEMBL4204	Homo sapiens	pKi		5.2
inactive	9614862	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614863	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614864	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	OCCNc1cc2cc(-c3ccccc3)ccc2cn1		CHEMBL1989957	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614865	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	=	Ki	nM	1000.0	CHEMBL4204	Homo sapiens	pKi		6.0
inactive	9614866	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614867	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CN(C)c1cc(-c2ccncc2)cc2[nH]nc(N)c12		CHEMBL2003229	=	Ki	nM	125.89	CHEMBL4204	Homo sapiens	pKi		6.9
active	9614868	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	Ki	nM	398.11	CHEMBL4204	Homo sapiens	pKi		6.4
inactive	9614869	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614870	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	=	Ki	nM	3162.28	CHEMBL4204	Homo sapiens	pKi		5.5
active	9614871	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	=	Ki	nM	501.19	CHEMBL4204	Homo sapiens	pKi		6.3
inactive	9614872	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614873	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	=	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614874	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	=	Ki	nM	158.49	CHEMBL4204	Homo sapiens	pKi		6.8
inactive	9614875	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614876	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	3162.28	CHEMBL4204	Homo sapiens	pKi		5.5
inactive	9614877	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614878	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	c1cnc2[nH]cc(-c3ccnc(NCC4CCCCC4)n3)c2c1		CHEMBL213207	=	Ki	nM	79.43	CHEMBL4204	Homo sapiens	pKi		7.1
active	9614879	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	Ki	nM	630.96	CHEMBL4204	Homo sapiens	pKi		6.2
active	9614880	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	=	Ki	nM	1000.0	CHEMBL4204	Homo sapiens	pKi		6.0
active	9614881	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	=	Ki	nM	7943.28	CHEMBL4204	Homo sapiens	pKi		5.1
active	9614882	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	=	Ki	nM	1584.89	CHEMBL4204	Homo sapiens	pKi		5.8
active	9614883	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	=	Ki	nM	1584.89	CHEMBL4204	Homo sapiens	pKi		5.8
inactive	9614884	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614885	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	=	Ki	nM	1584.89	CHEMBL4204	Homo sapiens	pKi		5.8
active	9614886	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	=	Ki	nM	79.43	CHEMBL4204	Homo sapiens	pKi		7.1
inactive	9614887	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)c(F)c3n21		CHEMBL1977604	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614888	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614889	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	=	Ki	nM	6309.57	CHEMBL4204	Homo sapiens	pKi		5.2
active	9614890	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	398.11	CHEMBL4204	Homo sapiens	pKi		6.4
active	9614891	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	1000.0	CHEMBL4204	Homo sapiens	pKi		6.0
inactive	9614892	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614893	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614894	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614895	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	=	Ki	nM	19.95	CHEMBL4204	Homo sapiens	pKi		7.7
active	9614896	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	3981.07	CHEMBL4204	Homo sapiens	pKi		5.4
inactive	9614897	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(NN=Cc1ccc(Sc2nc3ccccc3[nH]2)o1)c1cccc([N+](=O)[O-])c1		CHEMBL1992555	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614898	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	=	Ki	nM	3162.28	CHEMBL4204	Homo sapiens	pKi		5.5
active	9614899	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=c1cc(-c2ccncc2)nc(NCc2cc(F)cc(F)c2)[nH]1		CHEMBL2003682	=	Ki	nM	398.11	CHEMBL4204	Homo sapiens	pKi		6.4
active	9614900	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	=	Ki	nM	199.53	CHEMBL4204	Homo sapiens	pKi		6.7
inactive	9614901	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	C(=NNc1nc2ccccc2[nH]1)c1c[nH]c2ccccc12		CHEMBL535331	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614902	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614903	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	=	Ki	nM	3981.07	CHEMBL4204	Homo sapiens	pKi		5.4
active	9614904	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	=	Ki	nM	1584.89	CHEMBL4204	Homo sapiens	pKi		5.8
active	9614905	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	=	Ki	nM	3162.28	CHEMBL4204	Homo sapiens	pKi		5.5
active	9614906	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	FC(F)(F)c1ccccc1CNc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1999153	=	Ki	nM	10.0	CHEMBL4204	Homo sapiens	pKi		8.0
active	9614907	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2-c2ccccc2)cc1		CHEMBL1969473	=	Ki	nM	39.81	CHEMBL4204	Homo sapiens	pKi		7.4
inactive	9614908	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614909	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	=	Ki	nM	794.33	CHEMBL4204	Homo sapiens	pKi		6.1
inactive	9614910	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614911	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	=	Ki	nM	794.33	CHEMBL4204	Homo sapiens	pKi		6.1
inactive	9614912	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COC(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL2004513	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614913	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NCCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1972258	=	Ki	nM	7943.28	CHEMBL4204	Homo sapiens	pKi		5.1
active	9614914	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	=	Ki	nM	2511.89	CHEMBL4204	Homo sapiens	pKi		5.6
inactive	9614915	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614916	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccccc1-c1c(C(=O)O)n(CCCOc2cccc3ccccc23)c2ccccc12		CHEMBL1987793	=	Ki	nM	1995.26	CHEMBL4204	Homo sapiens	pKi		5.7
inactive	9614917	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614918	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614919	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614920	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614921	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	=	Ki	nM	316.23	CHEMBL4204	Homo sapiens	pKi		6.5
inactive	9614922	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614923	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614924	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3C3CC3)cc12		CHEMBL2004631	=	Ki	nM	398.11	CHEMBL4204	Homo sapiens	pKi		6.4
inactive	9614925	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCOC(=O)c1cccc2[nH]c(-c3ccc(N4CCC(N)C4)cc3)nc12		CHEMBL1995736	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614926	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614927	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614928	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614929	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	=	Ki	nM	100.0	CHEMBL4204	Homo sapiens	pKi		7.0
inactive	9614930	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)(O)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1998551	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614931	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1977374	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614932	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	125.89	CHEMBL4204	Homo sapiens	pKi		6.9
inactive	9614933	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614934	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccccc1-c1c(-c2ccc3[nH]nc(C)c3c2)nnn1Cc1ccccc1		CHEMBL1983315	=	Ki	nM	158.49	CHEMBL4204	Homo sapiens	pKi		6.8
inactive	9614935	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614936	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	=	Ki	nM	7943.28	CHEMBL4204	Homo sapiens	pKi		5.1
active	9614937	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	=	Ki	nM	6309.57	CHEMBL4204	Homo sapiens	pKi		5.2
active	9614938	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	=	Ki	nM	630.96	CHEMBL4204	Homo sapiens	pKi		6.2
active	9614939	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	=	Ki	nM	1584.89	CHEMBL4204	Homo sapiens	pKi		5.8
inactive	9614940	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614941	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614942	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	125.89	CHEMBL4204	Homo sapiens	pKi		6.9
inactive	9614943	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614944	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614945	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614946	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	OCCNc1cc2cc(-c3ccncc3)ccc2cn1		CHEMBL1998435	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614947	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	=	Ki	nM	79.43	CHEMBL4204	Homo sapiens	pKi		7.1
active	9614948	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)N(C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1)C(C)C		CHEMBL2006156	=	Ki	nM	2511.89	CHEMBL4204	Homo sapiens	pKi		5.6
active	9614949	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	=	Ki	nM	1258.93	CHEMBL4204	Homo sapiens	pKi		5.9
active	9614950	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	=	Ki	nM	3162.28	CHEMBL4204	Homo sapiens	pKi		5.5
active	9614951	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Ki	nM	63.1	CHEMBL4204	Homo sapiens	pKi		7.2
active	9614952	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	=	Ki	nM	630.96	CHEMBL4204	Homo sapiens	pKi		6.2
active	9614953	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	100.0	CHEMBL4204	Homo sapiens	pKi		7.0
inactive	9614954	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	FC(F)(F)Oc1ccc(-c2ccc3[nH]cc(C4=CCNCC4)c3c2)cc1		CHEMBL1987982	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614955	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614956	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	=	Ki	nM	2511.89	CHEMBL4204	Homo sapiens	pKi		5.6
inactive	9614957	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614958	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	=	Ki	nM	1995.26	CHEMBL4204	Homo sapiens	pKi		5.7
inactive	9614959	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614960	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	1000.0	CHEMBL4204	Homo sapiens	pKi		6.0
active	9614961	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	=	Ki	nM	5011.87	CHEMBL4204	Homo sapiens	pKi		5.3
inactive	9614962	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614963	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	c1ccc(CSc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL1968926	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614964	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614965	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	=	Ki	nM	501.19	CHEMBL4204	Homo sapiens	pKi		6.3
active	9614966	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	=	Ki	nM	6309.57	CHEMBL4204	Homo sapiens	pKi		5.2
inactive	9614967	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614968	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	=	Ki	nM	3162.28	CHEMBL4204	Homo sapiens	pKi		5.5
inactive	9614969	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614970	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	c1ccc(Cn2cc(-c3ccc4[nH]nc(-c5ccccc5)c4c3)nn2)cc1		CHEMBL1982400	=	Ki	nM	199.53	CHEMBL4204	Homo sapiens	pKi		6.7
inactive	9614971	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614972	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Ki	nM	398.11	CHEMBL4204	Homo sapiens	pKi		6.4
inactive	9614973	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CNc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2007372	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614974	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	=	Ki	nM	630.96	CHEMBL4204	Homo sapiens	pKi		6.2
active	9614975	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	=	Ki	nM	5011.87	CHEMBL4204	Homo sapiens	pKi		5.3
active	9614976	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	=	Ki	nM	158.49	CHEMBL4204	Homo sapiens	pKi		6.8
inactive	9614977	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614978	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	=	Ki	nM	316.23	CHEMBL4204	Homo sapiens	pKi		6.5
active	9614979	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	1995.26	CHEMBL4204	Homo sapiens	pKi		5.7
inactive	9614980	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614981	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1997349	=	Ki	nM	3162.28	CHEMBL4204	Homo sapiens	pKi		5.5
active	9614982	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	=	Ki	nM	1995.26	CHEMBL4204	Homo sapiens	pKi		5.7
active	9614983	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	=	Ki	nM	794.33	CHEMBL4204	Homo sapiens	pKi		6.1
active	9614984	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	=	Ki	nM	1258.93	CHEMBL4204	Homo sapiens	pKi		5.9
inactive	9614985	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614986	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614987	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(=O)c1ccc(-c2ccncc2)cc1NCc1cccc(F)c1		CHEMBL1982982	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9614988	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614989	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	=	Ki	nM	1995.26	CHEMBL4204	Homo sapiens	pKi		5.7
inactive	9614990	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614991	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	=	Ki	nM	3981.07	CHEMBL4204	Homo sapiens	pKi		5.4
active	9614992	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	=	Ki	nM	501.19	CHEMBL4204	Homo sapiens	pKi		6.3
inactive	9614993	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614994	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cncc(C=Cc2ccncc2)c1		CHEMBL1972568	=	Ki	nM	1995.26	CHEMBL4204	Homo sapiens	pKi		5.7
active	9614995	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C1Nc2ccccc2Nc2cc(-c3ccncc3Cl)ccc21		CHEMBL1987745	=	Ki	nM	199.53	CHEMBL4204	Homo sapiens	pKi		6.7
active	9614996	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	316.23	CHEMBL4204	Homo sapiens	pKi		6.5
inactive	9614997	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9614998	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	=	Ki	nM	3981.07	CHEMBL4204	Homo sapiens	pKi		5.4
active	9614999	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	=	Ki	nM	25.12	CHEMBL4204	Homo sapiens	pKi		7.6
inactive	9615000	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1988995	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9615001	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9615002	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	=	Ki	nM	3981.07	CHEMBL4204	Homo sapiens	pKi		5.4
inactive	9615003	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9615004	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9615005	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	=	Ki	nM	2511.89	CHEMBL4204	Homo sapiens	pKi		5.6
inactive	9615006	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9615007	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9615008	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	=	Ki	nM	6309.57	CHEMBL4204	Homo sapiens	pKi		5.2
active	9615009	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1n[nH]c2ccc(-c3cc(Cc4ccccc4)no3)cc12		CHEMBL1682358	=	Ki	nM	1000.0	CHEMBL4204	Homo sapiens	pKi		6.0
active	9615010	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	=	Ki	nM	1000.0	CHEMBL4204	Homo sapiens	pKi		6.0
active	9615011	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	=	Ki	nM	316.23	CHEMBL4204	Homo sapiens	pKi		6.5
inactive	9615012	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9615013	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	=	Ki	nM	316.23	CHEMBL4204	Homo sapiens	pKi		6.5
inactive	9615014	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9615015	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	=	Ki	nM	1584.89	CHEMBL4204	Homo sapiens	pKi		5.8
inactive	9615016	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9615017	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9615018	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	=	Ki	nM	501.19	CHEMBL4204	Homo sapiens	pKi		6.3
inactive	9615019	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9615020	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	=	Ki	nM	50.12	CHEMBL4204	Homo sapiens	pKi		7.3
inactive	9615021	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9615022	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9615023	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	=	Ki	nM	158.49	CHEMBL4204	Homo sapiens	pKi		6.8
active	9615024	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	158.49	CHEMBL4204	Homo sapiens	pKi		6.8
active	9615025	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	=	Ki	nM	6309.57	CHEMBL4204	Homo sapiens	pKi		5.2
active	9615026	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	3981.07	CHEMBL4204	Homo sapiens	pKi		5.4
inactive	9615027	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9615028	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	=	Ki	nM	630.96	CHEMBL4204	Homo sapiens	pKi		6.2
active	9615029	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	=	Ki	nM	398.11	CHEMBL4204	Homo sapiens	pKi		6.4
active	9618584	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	=	Ki	nM	7943.28	CHEMBL4204	Homo sapiens	pKi		5.1
inactive	9618585	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618586	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	=	Ki	nM	501.19	CHEMBL4204	Homo sapiens	pKi		6.3
active	9618587	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(=O)c1ccc(-c2ccncc2)cc1NCc1ccccc1		CHEMBL2001477	=	Ki	nM	6309.57	CHEMBL4204	Homo sapiens	pKi		5.2
active	9618588	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	=	Ki	nM	1258.93	CHEMBL4204	Homo sapiens	pKi		5.9
active	9618589	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	=	Ki	nM	501.19	CHEMBL4204	Homo sapiens	pKi		6.3
active	9618590	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	=	Ki	nM	79.43	CHEMBL4204	Homo sapiens	pKi		7.1
active	9618591	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	N#CC(=Cc1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL1974157	=	Ki	nM	3162.28	CHEMBL4204	Homo sapiens	pKi		5.5
active	9618592	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	=	Ki	nM	5011.87	CHEMBL4204	Homo sapiens	pKi		5.3
inactive	9618593	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618594	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618595	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618596	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	=	Ki	nM	25.12	CHEMBL4204	Homo sapiens	pKi		7.6
inactive	9618597	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618598	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618599	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	=	Ki	nM	1000.0	CHEMBL4204	Homo sapiens	pKi		6.0
inactive	9618600	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618601	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618602	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618603	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	=	Ki	nM	199.53	CHEMBL4204	Homo sapiens	pKi		6.7
inactive	9618604	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618605	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618606	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	199.53	CHEMBL4204	Homo sapiens	pKi		6.7
inactive	9618607	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618608	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	=	Ki	nM	100.0	CHEMBL4204	Homo sapiens	pKi		7.0
inactive	9618609	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618610	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(C=NNc2cc(N3CCOCC3)nc(OCCc3ccccn3)n2)c1		CHEMBL1965351	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618611	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618612	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	c1cnc2[nH]cc(-c3ccnc(NC4CCCCC4)n3)c2c1		CHEMBL385478	=	Ki	nM	25.12	CHEMBL4204	Homo sapiens	pKi		7.6
inactive	9618613	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618614	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(=O)c1cccc(-c2cnc3ccccc3c2)c1		CHEMBL2007336	=	Ki	nM	6309.57	CHEMBL4204	Homo sapiens	pKi		5.2
inactive	9618615	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618616	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618617	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CN1CCCC1COc1cncc(CCc2ccccc2)c1		CHEMBL1972183	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618618	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	398.11	CHEMBL4204	Homo sapiens	pKi		6.4
active	9618619	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	=	Ki	nM	1258.93	CHEMBL4204	Homo sapiens	pKi		5.9
inactive	9618620	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1sc2[nH]c(=O)n3nc(-c4ccncc4)nc3c2c1C		CHEMBL1980592	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618621	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	=	Ki	nM	1584.89	CHEMBL4204	Homo sapiens	pKi		5.8
active	9618622	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	=	Ki	nM	5011.87	CHEMBL4204	Homo sapiens	pKi		5.3
inactive	9618623	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618624	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	7943.28	CHEMBL4204	Homo sapiens	pKi		5.1
inactive	9618625	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618626	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618627	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618628	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618629	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618630	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	=	Ki	nM	6309.57	CHEMBL4204	Homo sapiens	pKi		5.2
active	9618631	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	=	Ki	nM	630.96	CHEMBL4204	Homo sapiens	pKi		6.2
active	9618632	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	=	Ki	nM	794.33	CHEMBL4204	Homo sapiens	pKi		6.1
inactive	9618633	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618634	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618635	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618636	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618637	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	=	Ki	nM	794.33	CHEMBL4204	Homo sapiens	pKi		6.1
active	9618638	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2ccncc2)c1-c1ccccc1		CHEMBL1419458	=	Ki	nM	5011.87	CHEMBL4204	Homo sapiens	pKi		5.3
inactive	9618639	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618640	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618641	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618642	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618643	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618644	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CN(c1ccccc1CNc1nc(N)nc2[nH]ccc12)S(C)(=O)=O		CHEMBL1970006	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618645	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618646	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618647	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	=	Ki	nM	630.96	CHEMBL4204	Homo sapiens	pKi		6.2
active	9618648	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	=	Ki	nM	501.19	CHEMBL4204	Homo sapiens	pKi		6.3
inactive	9618649	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618650	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	=	Ki	nM	1258.93	CHEMBL4204	Homo sapiens	pKi		5.9
inactive	9618651	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618652	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	39.81	CHEMBL4204	Homo sapiens	pKi		7.4
inactive	9618653	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618654	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618655	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1n[nH]c2sc(C(=O)NCCc3ccc(Cl)cc3)cc12		CHEMBL1998414	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618656	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	=	Ki	nM	3162.28	CHEMBL4204	Homo sapiens	pKi		5.5
active	9618657	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	=	Ki	nM	1258.93	CHEMBL4204	Homo sapiens	pKi		5.9
active	9618658	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	1584.89	CHEMBL4204	Homo sapiens	pKi		5.8
inactive	9618659	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618660	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618661	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	=	Ki	nM	251.19	CHEMBL4204	Homo sapiens	pKi		6.6
inactive	9618662	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618663	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	=	Ki	nM	501.19	CHEMBL4204	Homo sapiens	pKi		6.3
inactive	9618664	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618665	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	=	Ki	nM	1258.93	CHEMBL4204	Homo sapiens	pKi		5.9
active	9618666	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	=	Ki	nM	1258.93	CHEMBL4204	Homo sapiens	pKi		5.9
inactive	9618667	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618668	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618669	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	=	Ki	nM	1000.0	CHEMBL4204	Homo sapiens	pKi		6.0
active	9618670	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	=	Ki	nM	398.11	CHEMBL4204	Homo sapiens	pKi		6.4
active	9618671	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	=	Ki	nM	3162.28	CHEMBL4204	Homo sapiens	pKi		5.5
inactive	9618672	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618673	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618674	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618675	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618676	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	=	Ki	nM	1258.93	CHEMBL4204	Homo sapiens	pKi		5.9
active	9618677	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	=	Ki	nM	7943.28	CHEMBL4204	Homo sapiens	pKi		5.1
inactive	9618678	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618679	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	=	Ki	nM	501.19	CHEMBL4204	Homo sapiens	pKi		6.3
active	9618680	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	=	Ki	nM	6309.57	CHEMBL4204	Homo sapiens	pKi		5.2
inactive	9618681	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618682	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618683	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	=	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618684	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	=	Ki	nM	630.96	CHEMBL4204	Homo sapiens	pKi		6.2
inactive	9618685	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618686	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	=	Ki	nM	501.19	CHEMBL4204	Homo sapiens	pKi		6.3
inactive	9618687	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(O)c1ccccc1Nc1ccnc(NCc2cccc(O)c2)n1		CHEMBL1970950	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618688	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	=	Ki	nM	2511.89	CHEMBL4204	Homo sapiens	pKi		5.6
active	9618689	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Ki	nM	398.11	CHEMBL4204	Homo sapiens	pKi		6.4
active	9618690	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	=	Ki	nM	6309.57	CHEMBL4204	Homo sapiens	pKi		5.2
inactive	9618691	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618692	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	=	Ki	nM	6309.57	CHEMBL4204	Homo sapiens	pKi		5.2
active	9618693	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	=	Ki	nM	1995.26	CHEMBL4204	Homo sapiens	pKi		5.7
inactive	9618694	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618695	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618696	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	=	Ki	nM	158.49	CHEMBL4204	Homo sapiens	pKi		6.8
active	9618697	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	=	Ki	nM	1995.26	CHEMBL4204	Homo sapiens	pKi		5.7
active	9618698	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	=	Ki	nM	3981.07	CHEMBL4204	Homo sapiens	pKi		5.4
active	9618699	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	=	Ki	nM	2511.89	CHEMBL4204	Homo sapiens	pKi		5.6
inactive	9618700	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=c1c2c([nH]c3cc(-c4ccco4)nn13)CSC2		CHEMBL1972152	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618701	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	=	Ki	nM	6309.57	CHEMBL4204	Homo sapiens	pKi		5.2
inactive	9618702	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618703	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	=	Ki	nM	1995.26	CHEMBL4204	Homo sapiens	pKi		5.7
inactive	9618704	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618705	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618706	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	=	Ki	nM	6309.57	CHEMBL4204	Homo sapiens	pKi		5.2
active	9618707	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	=	Ki	nM	1258.93	CHEMBL4204	Homo sapiens	pKi		5.9
inactive	9618708	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618709	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	=	Ki	nM	6309.57	CHEMBL4204	Homo sapiens	pKi		5.2
inactive	9618710	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618711	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	<	Ki	nM	7943.28	CHEMBL4204	Homo sapiens	pKi		5.1
inactive	9618712	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618713	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(O)c1ccc(N2C(=O)c3ccccc3C2=O)cc1O		CHEMBL1972820	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618714	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	NNc1cc(N2CCOCC2)nc(OCCc2ccccn2)n1		CHEMBL1996208	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618715	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	=	Ki	nM	3162.28	CHEMBL4204	Homo sapiens	pKi		5.5
inactive	9618716	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618717	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618718	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	=	Ki	nM	251.19	CHEMBL4204	Homo sapiens	pKi		6.6
inactive	9618719	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618720	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618721	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618722	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	=	Ki	nM	1995.26	CHEMBL4204	Homo sapiens	pKi		5.7
inactive	9618723	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)(C)OC(=O)n1cc(-c2cncn2C2CCCCC2)c2ccccc21		CHEMBL1975357	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618724	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	=	Ki	nM	630.96	CHEMBL4204	Homo sapiens	pKi		6.2
inactive	9618725	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618726	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	=	Ki	nM	2511.89	CHEMBL4204	Homo sapiens	pKi		5.6
inactive	9618727	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618728	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618729	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618730	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618731	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618732	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	199.53	CHEMBL4204	Homo sapiens	pKi		6.7
inactive	9618733	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618734	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	=	Ki	nM	3981.07	CHEMBL4204	Homo sapiens	pKi		5.4
inactive	9618735	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
inactive	9618736	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
active	9618737	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	794.33	CHEMBL4204	Homo sapiens	pKi		6.1
active	9618738	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	251.19	CHEMBL4204	Homo sapiens	pKi		6.6
active	9618739	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	=	Ki	nM	1584.89	CHEMBL4204	Homo sapiens	pKi		5.8
active	9618740	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	CSc1nn(-c2ccccn2)c(N)c1C(N)=O		CHEMBL2004615	=	Ki	nM	2511.89	CHEMBL4204	Homo sapiens	pKi		5.6
active	9618741	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	Cc1nn(C)c(C)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)[nH]c12		CHEMBL1984039	=	Ki	nM	7943.28	CHEMBL4204	Homo sapiens	pKi		5.1
active	9618742	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	Ki	nM	7943.28	CHEMBL4204	Homo sapiens	pKi		5.1
inactive	9618743	CHEMBL1963786	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	<	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	pKi		5.0
	10838123	CHEMBL2015897	Inhibition of MNK2 using 5-FAM-TATKSGSTTKNRFVV-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 2 hrs by IMAP assay	B	C[C@H]1CCC[C@@H](O)[C@@H](O)CCC(=O)Cc2cc(O)cc(O)c2C(=O)O1		CHEMBL2012386	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	10838124	CHEMBL2015897	Inhibition of MNK2 using 5-FAM-TATKSGSTTKNRFVV-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 2 hrs by IMAP assay	B	C[C@H]1C/C=C/[C@@H](O)[C@@H](O)CCC(O)Cc2cc(O)cc(O)c2C(=O)O1		CHEMBL2012387	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	10838125	CHEMBL2015897	Inhibition of MNK2 using 5-FAM-TATKSGSTTKNRFVV-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 2 hrs by IMAP assay	B	C[C@H]1CCC[C@@H](O)[C@@H](O)CCC(O)Cc2cc(O)cc(O)c2C(=O)O1		CHEMBL2012388	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	10838126	CHEMBL2015897	Inhibition of MNK2 using 5-FAM-TATKSGSTTKNRFVV-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 2 hrs by IMAP assay	B	C[C@H]1CCC[C@@H](O)[C@@H](O)CC/C=C/c2cc(O)cc(O)c2C(=O)O1		CHEMBL2012390	=	IC50	nM	1350.0	CHEMBL4204	Homo sapiens	IC50	uM	1.35
	10838127	CHEMBL2015897	Inhibition of MNK2 using 5-FAM-TATKSGSTTKNRFVV-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 2 hrs by IMAP assay	B	C[C@H]1C/C=C/[C@@H](O)[C@@H](O)CCC(=NO)Cc2cc(O)cc(O)c2C(=O)O1		CHEMBL2012389	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	10838128	CHEMBL2015897	Inhibition of MNK2 using 5-FAM-TATKSGSTTKNRFVV-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 2 hrs by IMAP assay	B	C[C@H]1C/C=C/[C@H]2OC(C)(C)O[C@H]2CC/C=C/c2cc(O)cc(O)c2C(=O)O1		CHEMBL2012392	=	IC50	nM	580.0	CHEMBL4204	Homo sapiens	IC50	uM	0.58
	10838129	CHEMBL2015897	Inhibition of MNK2 using 5-FAM-TATKSGSTTKNRFVV-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 2 hrs by IMAP assay	B	C[C@H]1CCC[C@@H](O)[C@@H](O)CCCCc2cc(O)cc(O)c2C(=O)O1		CHEMBL2012391	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	10838130	CHEMBL2015897	Inhibition of MNK2 using 5-FAM-TATKSGSTTKNRFVV-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 2 hrs by IMAP assay	B	COc1cc2c(c(OC)c1)C(=O)O[C@@H](C)C/C=C/[C@@H](O)[C@@H](O)CC/C=C/2		CHEMBL2012393	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	10838131	CHEMBL2015897	Inhibition of MNK2 using 5-FAM-TATKSGSTTKNRFVV-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 2 hrs by IMAP assay	B	COc1cc(O)c2c(c1)/C=C/CC[C@H](O)[C@H](O)/C=C/C[C@H](C)OC2=O		CHEMBL2012394	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	10838132	CHEMBL2015897	Inhibition of MNK2 using 5-FAM-TATKSGSTTKNRFVV-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 2 hrs by IMAP assay	B	COc1cc(O)cc2c1C(=O)O[C@@H](C)C/C=C/[C@@H](O)[C@@H](O)CC/C=C/2		CHEMBL2012395	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	10838133	CHEMBL2015897	Inhibition of MNK2 using 5-FAM-TATKSGSTTKNRFVV-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 2 hrs by IMAP assay	B	COc1cc(O)cc2c1C(=O)O[C@@H](C)CCC[C@@H](O)[C@@H](O)CC/C=C/2		CHEMBL2012396	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	10838138	CHEMBL2015892	Inhibition of MNK2	B	C[C@H]1C/C=C/[C@@H](O)[C@@H](O)CC/C=C/c2cc(O)cc(O)c2C(=O)O1		CHEMBL1173442	=	Kd	nM	160.0	CHEMBL4204	Homo sapiens	Kd	uM	0.16
	10838139	CHEMBL2015891	Inhibition of MNK2 assessed as enzyme activity at 10 uM relative to control	B	C[C@H]1C/C=C/[C@@H](O)[C@@H](O)CC/C=C/c2cc(O)cc(O)c2C(=O)O1		CHEMBL1173442	=	Activity	%	0.15	CHEMBL4204	Homo sapiens	Activity	%	0.15
	10838183	CHEMBL2015897	Inhibition of MNK2 using 5-FAM-TATKSGSTTKNRFVV-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 2 hrs by IMAP assay	B	C[C@H]1C/C=C/[C@@H](O)[C@@H](O)CCC(=O)Cc2cc(O)cc(O)c2C(=O)O1		CHEMBL2012385	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	10838184	CHEMBL2015897	Inhibition of MNK2 using 5-FAM-TATKSGSTTKNRFVV-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 2 hrs by IMAP assay	B	C[C@H]1C/C=C/CCCC/C=C/c2cc(O)cc(O)c2C(=O)O1		CHEMBL2012384	=	IC50	nM	1610.0	CHEMBL4204	Homo sapiens	IC50	uM	1.61
	10838185	CHEMBL2015897	Inhibition of MNK2 using 5-FAM-TATKSGSTTKNRFVV-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 2 hrs by IMAP assay	B	O=C1OCC/C=C/[C@@H](O)[C@@H](O)CC/C=C/c2cc(O)cc(O)c21		CHEMBL2012383	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	10838186	CHEMBL2015897	Inhibition of MNK2 using 5-FAM-TATKSGSTTKNRFVV-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 2 hrs by IMAP assay	B	C[C@@H]1C/C=C/[C@@H](O)[C@@H](O)CC/C=C/c2cc(O)cc(O)c2C(=O)O1		CHEMBL2012382	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	10838187	CHEMBL2015897	Inhibition of MNK2 using 5-FAM-TATKSGSTTKNRFVV-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 2 hrs by IMAP assay	B	C[C@H]1C/C=C/[C@@H](O)[C@@H](O)CC/C=C/c2cc(O)cc(O)c2C(=O)O1		CHEMBL1173442	=	IC50	nM	450.0	CHEMBL4204	Homo sapiens	IC50	uM	0.45
	10839407	CHEMBL2015069	Inhibition of MNK2 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	34.0	CHEMBL4204	Homo sapiens	INH	%	34.0
	10839576	CHEMBL2015164	Inhibition of MNK2 assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	60.0	CHEMBL4204	Homo sapiens	Activity	%	60.0
	10840434	CHEMBL2016296	Inhibition of MNK2 assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	101.0	CHEMBL4204	Homo sapiens	Activity	%	101.0
	10926112	CHEMBL2046205	Inhibition of human Mnk2 assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	CC(C)Nc1cc(-c2oc3ccccc3c(=O)c2-c2ccc(F)cc2)ccn1		CHEMBL2041958	=	Activity	%	96.0	CHEMBL4204	Homo sapiens	Activity	%	96.0
	10926113	CHEMBL2046205	Inhibition of human Mnk2 assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)oc2ccccc12		CHEMBL2041962	=	Activity	%	103.0	CHEMBL4204	Homo sapiens	Activity	%	103.0
	10978455	CHEMBL2066252	Inhibition of human recombinant MNK2 using CREBtide as substrate assessed as residual activity at 1 uM after 90 mins by Cerep assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2064515	>	Activity	%	80.0	CHEMBL4204	Homo sapiens	Activity	%	80.0
	12103774	CHEMBL2173943	Inhibition of MNK2 by radiometric assay	B	CNc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)ncc1Cl		CHEMBL2170016	=	IC50	nM	600.0	CHEMBL4204	Homo sapiens	IC50	uM	0.6
	12103776	CHEMBL2173941	Inhibition of MNK2 at 10 uM by radiometric assay	B	CNc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)ncc1Cl		CHEMBL2170016	>	Inhibition	%	80.0	CHEMBL4204	Homo sapiens	INH	%	80.0
	12150583	CHEMBL2188518	Inhibition of human recombinant MNK2 by radiometric kinase assay	B	CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n(C5CCCC5)c4n3)cc2)CC1		CHEMBL2178352	=	IC50	nM	3200.0	CHEMBL4204	Homo sapiens	IC50	uM	3.2
	12170774	CHEMBL2209901	Inhibition of MNK2 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	93.0	CHEMBL4204	Homo sapiens	Activity	%	93.0
	12170905	CHEMBL2213464	Inhibition of MNK2 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	98.0	CHEMBL4204	Homo sapiens	Activity	%	98.0
	12172341	CHEMBL2215904	Inhibition of MKNK2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	52.0	CHEMBL4204	Homo sapiens	Activity	%	52.0
	12195599	CHEMBL2212378	Inhibition of human recombinant MNK2 expressed in Sf21 cells using CKRREILSRRPSYRK as substrate assessed as residual activity at 1 uM after 90 mins relative to staurosporine	B	CCN(CC)CCOc1ccc(/C=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL2206008	=	Activity	%	107.4	CHEMBL4204	Homo sapiens	Activity	%	107.4
	12229359	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	94.0	CHEMBL4204	Homo sapiens	Residual Activity	%	94.0
	12229360	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	96.0	CHEMBL4204	Homo sapiens	Residual Activity	%	96.0
	12229361	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	39.0	CHEMBL4204	Homo sapiens	Residual Activity	%	39.0
	12229362	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	107.0	CHEMBL4204	Homo sapiens	Residual Activity	%	107.0
	12229363	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	21.0	CHEMBL4204	Homo sapiens	Residual Activity	%	21.0
	12229364	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	56.0	CHEMBL4204	Homo sapiens	Residual Activity	%	56.0
	12229365	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	80.0	CHEMBL4204	Homo sapiens	Residual Activity	%	80.0
	12229366	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	33.0	CHEMBL4204	Homo sapiens	Residual Activity	%	33.0
	12229367	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	84.0	CHEMBL4204	Homo sapiens	Residual Activity	%	84.0
	12229368	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	26.0	CHEMBL4204	Homo sapiens	Residual Activity	%	26.0
	12229369	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	101.0	CHEMBL4204	Homo sapiens	Residual Activity	%	101.0
	12229370	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	108.0	CHEMBL4204	Homo sapiens	Residual Activity	%	108.0
	12229371	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	30.0	CHEMBL4204	Homo sapiens	Residual Activity	%	30.0
	12229372	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	113.0	CHEMBL4204	Homo sapiens	Residual Activity	%	113.0
	12229373	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	88.0	CHEMBL4204	Homo sapiens	Residual Activity	%	88.0
	12229374	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	109.0	CHEMBL4204	Homo sapiens	Residual Activity	%	109.0
	12229375	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	104.0	CHEMBL4204	Homo sapiens	Residual Activity	%	104.0
	12229376	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	101.0	CHEMBL4204	Homo sapiens	Residual Activity	%	101.0
	12229377	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	99.0	CHEMBL4204	Homo sapiens	Residual Activity	%	99.0
	12229378	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	66.0	CHEMBL4204	Homo sapiens	Residual Activity	%	66.0
	12229379	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	99.0	CHEMBL4204	Homo sapiens	Residual Activity	%	99.0
	12229380	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	106.0	CHEMBL4204	Homo sapiens	Residual Activity	%	106.0
	12229381	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	116.0	CHEMBL4204	Homo sapiens	Residual Activity	%	116.0
	12229382	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	112.0	CHEMBL4204	Homo sapiens	Residual Activity	%	112.0
	12229383	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	103.0	CHEMBL4204	Homo sapiens	Residual Activity	%	103.0
	12229384	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	21.0	CHEMBL4204	Homo sapiens	Residual Activity	%	21.0
	12229385	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	33.0	CHEMBL4204	Homo sapiens	Residual Activity	%	33.0
	12229386	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	10.0	CHEMBL4204	Homo sapiens	Residual Activity	%	10.0
	12229387	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	92.0	CHEMBL4204	Homo sapiens	Residual Activity	%	92.0
	12229388	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	103.0	CHEMBL4204	Homo sapiens	Residual Activity	%	103.0
	12229389	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	109.0	CHEMBL4204	Homo sapiens	Residual Activity	%	109.0
	12229390	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	105.0	CHEMBL4204	Homo sapiens	Residual Activity	%	105.0
	12229391	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	97.0	CHEMBL4204	Homo sapiens	Residual Activity	%	97.0
	12229392	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	100.0	CHEMBL4204	Homo sapiens	Residual Activity	%	100.0
	12229393	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	108.0	CHEMBL4204	Homo sapiens	Residual Activity	%	108.0
	12229394	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	101.0	CHEMBL4204	Homo sapiens	Residual Activity	%	101.0
	12229395	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	73.0	CHEMBL4204	Homo sapiens	Residual Activity	%	73.0
	12229396	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	105.0	CHEMBL4204	Homo sapiens	Residual Activity	%	105.0
	12229397	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	114.0	CHEMBL4204	Homo sapiens	Residual Activity	%	114.0
	12229398	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	108.0	CHEMBL4204	Homo sapiens	Residual Activity	%	108.0
	12229399	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	107.0	CHEMBL4204	Homo sapiens	Residual Activity	%	107.0
	12229400	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	105.0	CHEMBL4204	Homo sapiens	Residual Activity	%	105.0
	12229401	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	10.0	CHEMBL4204	Homo sapiens	Residual Activity	%	10.0
	12229402	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	47.0	CHEMBL4204	Homo sapiens	Residual Activity	%	47.0
	12229403	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	91.0	CHEMBL4204	Homo sapiens	Residual Activity	%	91.0
	12229404	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	35.0	CHEMBL4204	Homo sapiens	Residual Activity	%	35.0
	12229405	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	111.0	CHEMBL4204	Homo sapiens	Residual Activity	%	111.0
	12229406	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	100.0	CHEMBL4204	Homo sapiens	Residual Activity	%	100.0
	12229407	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	100.0	CHEMBL4204	Homo sapiens	Residual Activity	%	100.0
	12229408	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	109.0	CHEMBL4204	Homo sapiens	Residual Activity	%	109.0
	12229409	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	105.0	CHEMBL4204	Homo sapiens	Residual Activity	%	105.0
	12229410	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	75.0	CHEMBL4204	Homo sapiens	Residual Activity	%	75.0
	12229411	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	9.0	CHEMBL4204	Homo sapiens	Residual Activity	%	9.0
	12229412	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	107.0	CHEMBL4204	Homo sapiens	Residual Activity	%	107.0
	12229413	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	114.0	CHEMBL4204	Homo sapiens	Residual Activity	%	114.0
	12229414	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	95.0	CHEMBL4204	Homo sapiens	Residual Activity	%	95.0
	12229415	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	98.0	CHEMBL4204	Homo sapiens	Residual Activity	%	98.0
	12229416	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	112.0	CHEMBL4204	Homo sapiens	Residual Activity	%	112.0
	12229417	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	80.0	CHEMBL4204	Homo sapiens	Residual Activity	%	80.0
	12229418	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	105.0	CHEMBL4204	Homo sapiens	Residual Activity	%	105.0
	12229419	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	90.0	CHEMBL4204	Homo sapiens	Residual Activity	%	90.0
	12229420	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	44.0	CHEMBL4204	Homo sapiens	Residual Activity	%	44.0
	12229421	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	99.0	CHEMBL4204	Homo sapiens	Residual Activity	%	99.0
	12229422	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	106.0	CHEMBL4204	Homo sapiens	Residual Activity	%	106.0
	12229423	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	91.0	CHEMBL4204	Homo sapiens	Residual Activity	%	91.0
	12229424	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	107.0	CHEMBL4204	Homo sapiens	Residual Activity	%	107.0
	12229425	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	104.0	CHEMBL4204	Homo sapiens	Residual Activity	%	104.0
	12229426	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	108.0	CHEMBL4204	Homo sapiens	Residual Activity	%	108.0
	12229427	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	76.0	CHEMBL4204	Homo sapiens	Residual Activity	%	76.0
	12229428	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	52.0	CHEMBL4204	Homo sapiens	Residual Activity	%	52.0
	12229429	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	112.0	CHEMBL4204	Homo sapiens	Residual Activity	%	112.0
	12229430	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	70.0	CHEMBL4204	Homo sapiens	Residual Activity	%	70.0
	12229431	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	93.0	CHEMBL4204	Homo sapiens	Residual Activity	%	93.0
	12229432	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	90.0	CHEMBL4204	Homo sapiens	Residual Activity	%	90.0
	12229433	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	21.0	CHEMBL4204	Homo sapiens	Residual Activity	%	21.0
	12229434	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	105.0	CHEMBL4204	Homo sapiens	Residual Activity	%	105.0
	12229435	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	109.0	CHEMBL4204	Homo sapiens	Residual Activity	%	109.0
	12229436	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	99.0	CHEMBL4204	Homo sapiens	Residual Activity	%	99.0
	12229437	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	111.0	CHEMBL4204	Homo sapiens	Residual Activity	%	111.0
	12229438	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	8.0	CHEMBL4204	Homo sapiens	Residual Activity	%	8.0
	12229439	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	103.0	CHEMBL4204	Homo sapiens	Residual Activity	%	103.0
	12229440	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	95.0	CHEMBL4204	Homo sapiens	Residual Activity	%	95.0
	12229441	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	48.0	CHEMBL4204	Homo sapiens	Residual Activity	%	48.0
	12229442	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	106.0	CHEMBL4204	Homo sapiens	Residual Activity	%	106.0
	12229443	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	96.0	CHEMBL4204	Homo sapiens	Residual Activity	%	96.0
	12229444	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	105.0	CHEMBL4204	Homo sapiens	Residual Activity	%	105.0
	12229445	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	108.0	CHEMBL4204	Homo sapiens	Residual Activity	%	108.0
	12229446	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	103.0	CHEMBL4204	Homo sapiens	Residual Activity	%	103.0
	12229447	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	100.0	CHEMBL4204	Homo sapiens	Residual Activity	%	100.0
	12229448	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	62.0	CHEMBL4204	Homo sapiens	Residual Activity	%	62.0
	12229449	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	97.0	CHEMBL4204	Homo sapiens	Residual Activity	%	97.0
	12229450	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	96.0	CHEMBL4204	Homo sapiens	Residual Activity	%	96.0
	12229451	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	90.0	CHEMBL4204	Homo sapiens	Residual Activity	%	90.0
	12229452	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	100.0	CHEMBL4204	Homo sapiens	Residual Activity	%	100.0
	12229453	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	111.0	CHEMBL4204	Homo sapiens	Residual Activity	%	111.0
	12229454	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	99.0	CHEMBL4204	Homo sapiens	Residual Activity	%	99.0
	12229455	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	106.0	CHEMBL4204	Homo sapiens	Residual Activity	%	106.0
	12229456	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	98.0	CHEMBL4204	Homo sapiens	Residual Activity	%	98.0
	12229457	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	98.0	CHEMBL4204	Homo sapiens	Residual Activity	%	98.0
	12229458	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	107.0	CHEMBL4204	Homo sapiens	Residual Activity	%	107.0
	12229459	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	32.0	CHEMBL4204	Homo sapiens	Residual Activity	%	32.0
	12229460	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL4204	Homo sapiens	Residual Activity	%	0.0
	12229461	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	107.0	CHEMBL4204	Homo sapiens	Residual Activity	%	107.0
	12229462	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	97.0	CHEMBL4204	Homo sapiens	Residual Activity	%	97.0
	12229463	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	84.0	CHEMBL4204	Homo sapiens	Residual Activity	%	84.0
	12229464	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	90.0	CHEMBL4204	Homo sapiens	Residual Activity	%	90.0
	12229465	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	91.0	CHEMBL4204	Homo sapiens	Residual Activity	%	91.0
	12229466	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	55.0	CHEMBL4204	Homo sapiens	Residual Activity	%	55.0
	12229467	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	99.0	CHEMBL4204	Homo sapiens	Residual Activity	%	99.0
	12229468	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	90.0	CHEMBL4204	Homo sapiens	Residual Activity	%	90.0
	12229469	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	109.0	CHEMBL4204	Homo sapiens	Residual Activity	%	109.0
	12229470	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	106.0	CHEMBL4204	Homo sapiens	Residual Activity	%	106.0
	12229471	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	72.0	CHEMBL4204	Homo sapiens	Residual Activity	%	72.0
	12229472	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	98.0	CHEMBL4204	Homo sapiens	Residual Activity	%	98.0
	12229473	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	61.0	CHEMBL4204	Homo sapiens	Residual Activity	%	61.0
	12229474	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	97.0	CHEMBL4204	Homo sapiens	Residual Activity	%	97.0
	12229475	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	72.0	CHEMBL4204	Homo sapiens	Residual Activity	%	72.0
	12229476	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	106.0	CHEMBL4204	Homo sapiens	Residual Activity	%	106.0
	12229477	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	101.0	CHEMBL4204	Homo sapiens	Residual Activity	%	101.0
	12229478	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	110.0	CHEMBL4204	Homo sapiens	Residual Activity	%	110.0
	12229479	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	86.0	CHEMBL4204	Homo sapiens	Residual Activity	%	86.0
	12229480	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	97.0	CHEMBL4204	Homo sapiens	Residual Activity	%	97.0
	12229481	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	95.0	CHEMBL4204	Homo sapiens	Residual Activity	%	95.0
	12229482	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	91.0	CHEMBL4204	Homo sapiens	Residual Activity	%	91.0
	12229483	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	66.0	CHEMBL4204	Homo sapiens	Residual Activity	%	66.0
	12229484	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	104.0	CHEMBL4204	Homo sapiens	Residual Activity	%	104.0
	12229485	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	111.0	CHEMBL4204	Homo sapiens	Residual Activity	%	111.0
	12229486	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	96.0	CHEMBL4204	Homo sapiens	Residual Activity	%	96.0
	12229487	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	99.0	CHEMBL4204	Homo sapiens	Residual Activity	%	99.0
	12229488	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	6.0	CHEMBL4204	Homo sapiens	Residual Activity	%	6.0
	12229489	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	99.0	CHEMBL4204	Homo sapiens	Residual Activity	%	99.0
	12229490	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	94.0	CHEMBL4204	Homo sapiens	Residual Activity	%	94.0
	12229491	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	43.0	CHEMBL4204	Homo sapiens	Residual Activity	%	43.0
	12229492	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	102.0	CHEMBL4204	Homo sapiens	Residual Activity	%	102.0
	12229493	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	68.0	CHEMBL4204	Homo sapiens	Residual Activity	%	68.0
	12229494	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	94.0	CHEMBL4204	Homo sapiens	Residual Activity	%	94.0
	12229495	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	101.0	CHEMBL4204	Homo sapiens	Residual Activity	%	101.0
	12229496	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	85.0	CHEMBL4204	Homo sapiens	Residual Activity	%	85.0
	12229497	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	62.0	CHEMBL4204	Homo sapiens	Residual Activity	%	62.0
	12229498	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	81.0	CHEMBL4204	Homo sapiens	Residual Activity	%	81.0
	12229499	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	102.0	CHEMBL4204	Homo sapiens	Residual Activity	%	102.0
	12229500	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	105.0	CHEMBL4204	Homo sapiens	Residual Activity	%	105.0
	12229501	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	67.0	CHEMBL4204	Homo sapiens	Residual Activity	%	67.0
	12229502	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	56.0	CHEMBL4204	Homo sapiens	Residual Activity	%	56.0
	12229503	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	108.0	CHEMBL4204	Homo sapiens	Residual Activity	%	108.0
	12229504	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	103.0	CHEMBL4204	Homo sapiens	Residual Activity	%	103.0
	12229505	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	101.0	CHEMBL4204	Homo sapiens	Residual Activity	%	101.0
	12229506	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	36.0	CHEMBL4204	Homo sapiens	Residual Activity	%	36.0
	12229507	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	60.0	CHEMBL4204	Homo sapiens	Residual Activity	%	60.0
	12229508	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	105.0	CHEMBL4204	Homo sapiens	Residual Activity	%	105.0
	12229509	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	94.0	CHEMBL4204	Homo sapiens	Residual Activity	%	94.0
	12229510	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	74.0	CHEMBL4204	Homo sapiens	Residual Activity	%	74.0
	12229511	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	112.0	CHEMBL4204	Homo sapiens	Residual Activity	%	112.0
	12229512	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	76.0	CHEMBL4204	Homo sapiens	Residual Activity	%	76.0
	12229513	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	107.0	CHEMBL4204	Homo sapiens	Residual Activity	%	107.0
	12229514	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	105.0	CHEMBL4204	Homo sapiens	Residual Activity	%	105.0
	12229515	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	117.0	CHEMBL4204	Homo sapiens	Residual Activity	%	117.0
	12229516	CHEMBL2219295	Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	98.0	CHEMBL4204	Homo sapiens	Residual Activity	%	98.0
	12229517	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	89.0	CHEMBL4204	Homo sapiens	Residual Activity	%	89.0
	12229518	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	55.0	CHEMBL4204	Homo sapiens	Residual Activity	%	55.0
	12229519	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	9.0	CHEMBL4204	Homo sapiens	Residual Activity	%	9.0
	12229520	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	81.0	CHEMBL4204	Homo sapiens	Residual Activity	%	81.0
	12229521	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	12.0	CHEMBL4204	Homo sapiens	Residual Activity	%	12.0
	12229522	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	22.0	CHEMBL4204	Homo sapiens	Residual Activity	%	22.0
	12229523	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	72.0	CHEMBL4204	Homo sapiens	Residual Activity	%	72.0
	12229524	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	10.0	CHEMBL4204	Homo sapiens	Residual Activity	%	10.0
	12229525	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	37.0	CHEMBL4204	Homo sapiens	Residual Activity	%	37.0
	12229526	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	13.0	CHEMBL4204	Homo sapiens	Residual Activity	%	13.0
	12229527	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	90.0	CHEMBL4204	Homo sapiens	Residual Activity	%	90.0
	12229528	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	94.0	CHEMBL4204	Homo sapiens	Residual Activity	%	94.0
	12229529	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	9.0	CHEMBL4204	Homo sapiens	Residual Activity	%	9.0
	12229530	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	98.0	CHEMBL4204	Homo sapiens	Residual Activity	%	98.0
	12229531	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	32.0	CHEMBL4204	Homo sapiens	Residual Activity	%	32.0
	12229532	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	91.0	CHEMBL4204	Homo sapiens	Residual Activity	%	91.0
	12229533	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	63.0	CHEMBL4204	Homo sapiens	Residual Activity	%	63.0
	12229534	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	82.0	CHEMBL4204	Homo sapiens	Residual Activity	%	82.0
	12229535	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	82.0	CHEMBL4204	Homo sapiens	Residual Activity	%	82.0
	12229536	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	65.0	CHEMBL4204	Homo sapiens	Residual Activity	%	65.0
	12229537	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	100.0	CHEMBL4204	Homo sapiens	Residual Activity	%	100.0
	12229538	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	86.0	CHEMBL4204	Homo sapiens	Residual Activity	%	86.0
	12229539	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	105.0	CHEMBL4204	Homo sapiens	Residual Activity	%	105.0
	12229540	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	96.0	CHEMBL4204	Homo sapiens	Residual Activity	%	96.0
	12229541	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	94.0	CHEMBL4204	Homo sapiens	Residual Activity	%	94.0
	12229542	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	7.0	CHEMBL4204	Homo sapiens	Residual Activity	%	7.0
	12229543	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	8.0	CHEMBL4204	Homo sapiens	Residual Activity	%	8.0
	12229544	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	6.0	CHEMBL4204	Homo sapiens	Residual Activity	%	6.0
	12229545	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	64.0	CHEMBL4204	Homo sapiens	Residual Activity	%	64.0
	12229546	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	91.0	CHEMBL4204	Homo sapiens	Residual Activity	%	91.0
	12229547	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	98.0	CHEMBL4204	Homo sapiens	Residual Activity	%	98.0
	12229548	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	64.0	CHEMBL4204	Homo sapiens	Residual Activity	%	64.0
	12229549	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	67.0	CHEMBL4204	Homo sapiens	Residual Activity	%	67.0
	12229550	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	93.0	CHEMBL4204	Homo sapiens	Residual Activity	%	93.0
	12229551	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	100.0	CHEMBL4204	Homo sapiens	Residual Activity	%	100.0
	12229552	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	87.0	CHEMBL4204	Homo sapiens	Residual Activity	%	87.0
	12229553	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	30.0	CHEMBL4204	Homo sapiens	Residual Activity	%	30.0
	12229554	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	88.0	CHEMBL4204	Homo sapiens	Residual Activity	%	88.0
	12229555	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	109.0	CHEMBL4204	Homo sapiens	Residual Activity	%	109.0
	12229556	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	102.0	CHEMBL4204	Homo sapiens	Residual Activity	%	102.0
	12229557	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	84.0	CHEMBL4204	Homo sapiens	Residual Activity	%	84.0
	12229558	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	96.0	CHEMBL4204	Homo sapiens	Residual Activity	%	96.0
	12229559	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	10.0	CHEMBL4204	Homo sapiens	Residual Activity	%	10.0
	12229560	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	14.0	CHEMBL4204	Homo sapiens	Residual Activity	%	14.0
	12229561	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	93.0	CHEMBL4204	Homo sapiens	Residual Activity	%	93.0
	12229562	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	9.0	CHEMBL4204	Homo sapiens	Residual Activity	%	9.0
	12229563	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	109.0	CHEMBL4204	Homo sapiens	Residual Activity	%	109.0
	12229564	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	83.0	CHEMBL4204	Homo sapiens	Residual Activity	%	83.0
	12229565	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	75.0	CHEMBL4204	Homo sapiens	Residual Activity	%	75.0
	12229566	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	106.0	CHEMBL4204	Homo sapiens	Residual Activity	%	106.0
	12229567	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	82.0	CHEMBL4204	Homo sapiens	Residual Activity	%	82.0
	12229568	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	24.0	CHEMBL4204	Homo sapiens	Residual Activity	%	24.0
	12229569	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	4.0	CHEMBL4204	Homo sapiens	Residual Activity	%	4.0
	12229570	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	72.0	CHEMBL4204	Homo sapiens	Residual Activity	%	72.0
	12229571	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	83.0	CHEMBL4204	Homo sapiens	Residual Activity	%	83.0
	12229572	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	87.0	CHEMBL4204	Homo sapiens	Residual Activity	%	87.0
	12229573	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	57.0	CHEMBL4204	Homo sapiens	Residual Activity	%	57.0
	12229574	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	103.0	CHEMBL4204	Homo sapiens	Residual Activity	%	103.0
	12229575	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	24.0	CHEMBL4204	Homo sapiens	Residual Activity	%	24.0
	12229576	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	97.0	CHEMBL4204	Homo sapiens	Residual Activity	%	97.0
	12232182	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	61.0	CHEMBL4204	Homo sapiens	Residual Activity	%	61.0
	12232183	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	27.0	CHEMBL4204	Homo sapiens	Residual Activity	%	27.0
	12232184	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	50.0	CHEMBL4204	Homo sapiens	Residual Activity	%	50.0
	12232185	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	80.0	CHEMBL4204	Homo sapiens	Residual Activity	%	80.0
	12232186	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	54.0	CHEMBL4204	Homo sapiens	Residual Activity	%	54.0
	12232187	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	95.0	CHEMBL4204	Homo sapiens	Residual Activity	%	95.0
	12232188	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	107.0	CHEMBL4204	Homo sapiens	Residual Activity	%	107.0
	12232189	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	101.0	CHEMBL4204	Homo sapiens	Residual Activity	%	101.0
	12232190	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	28.0	CHEMBL4204	Homo sapiens	Residual Activity	%	28.0
	12232191	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	16.0	CHEMBL4204	Homo sapiens	Residual Activity	%	16.0
	12232192	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	110.0	CHEMBL4204	Homo sapiens	Residual Activity	%	110.0
	12232193	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	77.0	CHEMBL4204	Homo sapiens	Residual Activity	%	77.0
	12232194	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	52.0	CHEMBL4204	Homo sapiens	Residual Activity	%	52.0
	12232195	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	68.0	CHEMBL4204	Homo sapiens	Residual Activity	%	68.0
	12232196	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	7.0	CHEMBL4204	Homo sapiens	Residual Activity	%	7.0
	12232197	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	90.0	CHEMBL4204	Homo sapiens	Residual Activity	%	90.0
	12232198	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	96.0	CHEMBL4204	Homo sapiens	Residual Activity	%	96.0
	12232199	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	45.0	CHEMBL4204	Homo sapiens	Residual Activity	%	45.0
	12232200	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	77.0	CHEMBL4204	Homo sapiens	Residual Activity	%	77.0
	12232201	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	4.0	CHEMBL4204	Homo sapiens	Residual Activity	%	4.0
	12232202	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	102.0	CHEMBL4204	Homo sapiens	Residual Activity	%	102.0
	12232203	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	66.0	CHEMBL4204	Homo sapiens	Residual Activity	%	66.0
	12232204	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	41.0	CHEMBL4204	Homo sapiens	Residual Activity	%	41.0
	12232205	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	77.0	CHEMBL4204	Homo sapiens	Residual Activity	%	77.0
	12232206	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	89.0	CHEMBL4204	Homo sapiens	Residual Activity	%	89.0
	12232207	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	85.0	CHEMBL4204	Homo sapiens	Residual Activity	%	85.0
	12232208	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	95.0	CHEMBL4204	Homo sapiens	Residual Activity	%	95.0
	12232209	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	87.0	CHEMBL4204	Homo sapiens	Residual Activity	%	87.0
	12232210	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	94.0	CHEMBL4204	Homo sapiens	Residual Activity	%	94.0
	12232211	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	18.0	CHEMBL4204	Homo sapiens	Residual Activity	%	18.0
	12232212	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	77.0	CHEMBL4204	Homo sapiens	Residual Activity	%	77.0
	12232213	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	101.0	CHEMBL4204	Homo sapiens	Residual Activity	%	101.0
	12232214	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	61.0	CHEMBL4204	Homo sapiens	Residual Activity	%	61.0
	12232215	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	102.0	CHEMBL4204	Homo sapiens	Residual Activity	%	102.0
	12232216	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	111.0	CHEMBL4204	Homo sapiens	Residual Activity	%	111.0
	12232217	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	64.0	CHEMBL4204	Homo sapiens	Residual Activity	%	64.0
	12232218	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	98.0	CHEMBL4204	Homo sapiens	Residual Activity	%	98.0
	12232219	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	101.0	CHEMBL4204	Homo sapiens	Residual Activity	%	101.0
	12232220	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	110.0	CHEMBL4204	Homo sapiens	Residual Activity	%	110.0
	12232221	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	99.0	CHEMBL4204	Homo sapiens	Residual Activity	%	99.0
	12232222	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	21.0	CHEMBL4204	Homo sapiens	Residual Activity	%	21.0
	12232223	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL4204	Homo sapiens	Residual Activity	%	0.0
	12232224	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	113.0	CHEMBL4204	Homo sapiens	Residual Activity	%	113.0
	12232225	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	95.0	CHEMBL4204	Homo sapiens	Residual Activity	%	95.0
	12232226	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	91.0	CHEMBL4204	Homo sapiens	Residual Activity	%	91.0
	12232227	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	80.0	CHEMBL4204	Homo sapiens	Residual Activity	%	80.0
	12232228	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	76.0	CHEMBL4204	Homo sapiens	Residual Activity	%	76.0
	12232229	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	42.0	CHEMBL4204	Homo sapiens	Residual Activity	%	42.0
	12232230	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	96.0	CHEMBL4204	Homo sapiens	Residual Activity	%	96.0
	12232231	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	39.0	CHEMBL4204	Homo sapiens	Residual Activity	%	39.0
	12232232	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	106.0	CHEMBL4204	Homo sapiens	Residual Activity	%	106.0
	12232233	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	77.0	CHEMBL4204	Homo sapiens	Residual Activity	%	77.0
	12232234	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	42.0	CHEMBL4204	Homo sapiens	Residual Activity	%	42.0
	12232235	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	70.0	CHEMBL4204	Homo sapiens	Residual Activity	%	70.0
	12232236	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	19.0	CHEMBL4204	Homo sapiens	Residual Activity	%	19.0
	12232237	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	89.0	CHEMBL4204	Homo sapiens	Residual Activity	%	89.0
	12232238	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	24.0	CHEMBL4204	Homo sapiens	Residual Activity	%	24.0
	12232239	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	96.0	CHEMBL4204	Homo sapiens	Residual Activity	%	96.0
	12232240	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	82.0	CHEMBL4204	Homo sapiens	Residual Activity	%	82.0
	12232241	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	92.0	CHEMBL4204	Homo sapiens	Residual Activity	%	92.0
	12232242	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	76.0	CHEMBL4204	Homo sapiens	Residual Activity	%	76.0
	12232243	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	70.0	CHEMBL4204	Homo sapiens	Residual Activity	%	70.0
	12232244	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	77.0	CHEMBL4204	Homo sapiens	Residual Activity	%	77.0
	12232245	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	89.0	CHEMBL4204	Homo sapiens	Residual Activity	%	89.0
	12232246	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	44.0	CHEMBL4204	Homo sapiens	Residual Activity	%	44.0
	12232247	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	89.0	CHEMBL4204	Homo sapiens	Residual Activity	%	89.0
	12232248	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	98.0	CHEMBL4204	Homo sapiens	Residual Activity	%	98.0
	12232249	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	80.0	CHEMBL4204	Homo sapiens	Residual Activity	%	80.0
	12232250	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	94.0	CHEMBL4204	Homo sapiens	Residual Activity	%	94.0
	12232251	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	14.0	CHEMBL4204	Homo sapiens	Residual Activity	%	14.0
	12232252	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	100.0	CHEMBL4204	Homo sapiens	Residual Activity	%	100.0
	12232253	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	101.0	CHEMBL4204	Homo sapiens	Residual Activity	%	101.0
	12232254	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	10.0	CHEMBL4204	Homo sapiens	Residual Activity	%	10.0
	12232255	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	94.0	CHEMBL4204	Homo sapiens	Residual Activity	%	94.0
	12232256	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	20.0	CHEMBL4204	Homo sapiens	Residual Activity	%	20.0
	12232257	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	75.0	CHEMBL4204	Homo sapiens	Residual Activity	%	75.0
	12232258	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	71.0	CHEMBL4204	Homo sapiens	Residual Activity	%	71.0
	12232259	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	44.0	CHEMBL4204	Homo sapiens	Residual Activity	%	44.0
	12232260	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	77.0	CHEMBL4204	Homo sapiens	Residual Activity	%	77.0
	12232261	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	72.0	CHEMBL4204	Homo sapiens	Residual Activity	%	72.0
	12232262	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	106.0	CHEMBL4204	Homo sapiens	Residual Activity	%	106.0
	12232263	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	78.0	CHEMBL4204	Homo sapiens	Residual Activity	%	78.0
	12232264	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	23.0	CHEMBL4204	Homo sapiens	Residual Activity	%	23.0
	12232265	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	24.0	CHEMBL4204	Homo sapiens	Residual Activity	%	24.0
	12232266	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	96.0	CHEMBL4204	Homo sapiens	Residual Activity	%	96.0
	12232267	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	102.0	CHEMBL4204	Homo sapiens	Residual Activity	%	102.0
	12232268	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	92.0	CHEMBL4204	Homo sapiens	Residual Activity	%	92.0
	12232269	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	8.0	CHEMBL4204	Homo sapiens	Residual Activity	%	8.0
	12232270	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	13.0	CHEMBL4204	Homo sapiens	Residual Activity	%	13.0
	12232271	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	59.0	CHEMBL4204	Homo sapiens	Residual Activity	%	59.0
	12232272	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	40.0	CHEMBL4204	Homo sapiens	Residual Activity	%	40.0
	12232273	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	14.0	CHEMBL4204	Homo sapiens	Residual Activity	%	14.0
	12232274	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	103.0	CHEMBL4204	Homo sapiens	Residual Activity	%	103.0
	12232275	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	67.0	CHEMBL4204	Homo sapiens	Residual Activity	%	67.0
	12232276	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	104.0	CHEMBL4204	Homo sapiens	Residual Activity	%	104.0
	12232277	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	74.0	CHEMBL4204	Homo sapiens	Residual Activity	%	74.0
	12232278	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	94.0	CHEMBL4204	Homo sapiens	Residual Activity	%	94.0
	12232279	CHEMBL2219296	Millipore: Percentage of residual kinase activity of MKNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	79.0	CHEMBL4204	Homo sapiens	Residual Activity	%	79.0
	12672971	CHEMBL2339712	Inhibition of recombinant MNK2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	122.0	CHEMBL4204	Homo sapiens	Activity	%	122.0
	12672972	CHEMBL2339712	Inhibition of recombinant MNK2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	119.0	CHEMBL4204	Homo sapiens	Activity	%	119.0
	12693206	CHEMBL2343891	Inhibition of MNK2 (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	nM	10000.0
	12729900	CHEMBL2349804	Inhibition of MNK2 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	89.0	CHEMBL4204	Homo sapiens	Activity	%	89.0
	13367200	CHEMBL2406328	Inhibition of MKNK2 (unknown origin) after 60 mins	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	2240.0	CHEMBL4204	Homo sapiens	IC50	uM	2.24
	13374433	CHEMBL2404170	Inhibition of MNK2 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	-7.0	CHEMBL4204	Homo sapiens	INH	%	-7.0
	13440849	CHEMBL2429593	Inhibition of MNK-2-a (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc4c(N)ncnc43)cc2)cc1	Outside typical range	CHEMBL2425144	=	Inhibition	%	-85.0	CHEMBL4204	Homo sapiens	INH	%	-85.0
	13442333	CHEMBL2429501	Competitive binding affinity to MKNK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	13445468	CHEMBL2429501	Competitive binding affinity to MKNK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	87.0	CHEMBL4204	Homo sapiens	INH	%	87.0
	13448523	CHEMBL2429501	Competitive binding affinity to MKNK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	=	Inhibition	%	75.0	CHEMBL4204	Homo sapiens	INH	%	75.0
	13448659	CHEMBL2429501	Competitive binding affinity to MKNK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	=	Inhibition	%	97.0	CHEMBL4204	Homo sapiens	INH	%	97.0
	13451454	CHEMBL2429501	Competitive binding affinity to MKNK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	=	Inhibition	%	100.0	CHEMBL4204	Homo sapiens	INH	%	100.0
	13453027	CHEMBL2429593	Inhibition of MNK-2-a (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3cccnc3)cc2)cc1	Outside typical range	CHEMBL2425156	=	Inhibition	%	-26.0	CHEMBL4204	Homo sapiens	INH	%	-26.0
	13453075	CHEMBL2429593	Inhibition of MNK-2-a (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc(C)c3)cc2)cc1	Outside typical range	CHEMBL2425145	=	Inhibition	%	-25.0	CHEMBL4204	Homo sapiens	INH	%	-25.0
	13454639	CHEMBL2429501	Competitive binding affinity to MKNK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	86.0	CHEMBL4204	Homo sapiens	INH	%	86.0
Active	13488398	CHEMBL2439416	Inhibition of human MNK2 at 1 uM	B	CN1CCC(Nc2ccc3ncc(-c4cnn(-c5ccc(C#N)cc5)c4)n3n2)CC1		CHEMBL2436446		Inhibition	%		CHEMBL4204	Homo sapiens	INH		
	13872092	CHEMBL3101277	Inhibition of human Mnk2 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	99.0	CHEMBL4204	Homo sapiens	Activity	%	99.0
	13954591	CHEMBL3132508	Inhibition of human MNK2 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	5.0	CHEMBL4204	Homo sapiens	Activity	%	5.0
	13954610	CHEMBL3132508	Inhibition of human MNK2 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	1.0	CHEMBL4204	Homo sapiens	Activity	%	1.0
	13954820	CHEMBL3132508	Inhibition of human MNK2 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	4.0	CHEMBL4204	Homo sapiens	Activity	%	4.0
	14582554	CHEMBL3242555	Inhibition of human MKNK2 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	105.5	CHEMBL4204	Homo sapiens	Activity	%	105.5
	14648084	CHEMBL3266643	Inhibition of human MNK2 at 1 uM relative to control	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)CC4)nn23)cn1		CHEMBL2380687	<	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	14648085	CHEMBL3266643	Inhibition of human MNK2 at 1 uM relative to control	B	N[C@H]1CC[C@H](Nc2ccc3ncc(-c4cnc(Nc5ncccc5F)nc4)n3n2)CC1		CHEMBL3264059	<	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	14751789	CHEMBL3300952	Inhibition of MNK2 (unknown origin)	B	CC(C)(C)CNC(=O)CC1CNC(=O)c2cc(-c3ccsc3)cn21		CHEMBL3298400	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	14751790	CHEMBL3300952	Inhibition of MNK2 (unknown origin)	B	CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(Cl)c4)cn32)C2CCCCC2)CC1		CHEMBL3297762	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	14979202	CHEMBL3379063	Inhibition of Mnk2 (unknown origin) by Millipore kinase analysis	B	COc1cc(-c2cn[nH]c2)ccc1C(=O)Nc1ccc2c(c1)CCNCC2	Outside typical range	CHEMBL3355059	=	IC50	nM	760000.0	CHEMBL4204	Homo sapiens	IC50	uM	760.0
	14979203	CHEMBL3379062	Inhibition of Mnk2 (unknown origin) at 1 uM by Millipore kinase analysis	B	COc1cc(-c2cn[nH]c2)ccc1C(=O)Nc1ccc2c(c1)CCNCC2		CHEMBL3355059	=	Inhibition	%	59.0	CHEMBL4204	Homo sapiens	INH	%	59.0
	14986255	CHEMBL3387277	Inhibition of MNK2 (unknown origin) at 10 uM	B	C=CC(=O)NC/C=C/c1cc(OCCc2ccc(F)cc2)cc(O)c1C(=O)OC(C)C		CHEMBL3357176	=	Inhibition	%	1.1	CHEMBL4204	Homo sapiens	INH	%	1.1
	14986256	CHEMBL3387277	Inhibition of MNK2 (unknown origin) at 10 uM	B	C=CC(=O)NC/C=C/c1cc(OCCCN2CCOCC2)cc(O)c1C(=O)OC(C)C		CHEMBL3357177	=	Inhibition	%	6.5	CHEMBL4204	Homo sapiens	INH	%	6.5
	14986257	CHEMBL3387277	Inhibition of MNK2 (unknown origin) at 10 uM	B	C/C=C/C(=O)NC/C=C/c1cc(OCCCN2CCOCC2)cc(O)c1C(=O)OC(C)C		CHEMBL3357178	=	Inhibition	%	12.9	CHEMBL4204	Homo sapiens	INH	%	12.9
	14986258	CHEMBL3387277	Inhibition of MNK2 (unknown origin) at 10 uM	B	CCN(CC)C/C=C/C(=O)NC/C=C/c1cc(OC)cc(O)c1C(=O)OC(C)C		CHEMBL3357179	=	Inhibition	%	5.2	CHEMBL4204	Homo sapiens	INH	%	5.2
	14986259	CHEMBL3387277	Inhibition of MNK2 (unknown origin) at 10 uM	B	CCN(CC)C/C=C/C(=O)NC/C=C/c1cc(OCCc2ccc(F)cc2)cc(O)c1C(=O)OC(C)C		CHEMBL3357180	=	Inhibition	%	0.8	CHEMBL4204	Homo sapiens	INH	%	0.8
	14986260	CHEMBL3387277	Inhibition of MNK2 (unknown origin) at 10 uM	B	C=CS(=O)(=O)NC/C=C/c1cc(OC)cc(O)c1C(=O)OC(C)C		CHEMBL3357181	=	Inhibition	%	13.9	CHEMBL4204	Homo sapiens	INH	%	13.9
	14986261	CHEMBL3387277	Inhibition of MNK2 (unknown origin) at 10 uM	B	COc1cc(/C=C/CN2C(=O)C=CC2=O)c(C(=O)OC(C)C)c(OC(C)=O)c1		CHEMBL3357187	=	Inhibition	%	5.0	CHEMBL4204	Homo sapiens	INH	%	5.0
	14986262	CHEMBL3387277	Inhibition of MNK2 (unknown origin) at 10 uM	B	COc1cc(O)c(C(=O)OC(C)C)c(/C=C/CN2C(=O)C=CC2=O)c1		CHEMBL3357188	=	Inhibition	%	4.1	CHEMBL4204	Homo sapiens	INH	%	4.1
	14986263	CHEMBL3387277	Inhibition of MNK2 (unknown origin) at 10 uM	B	COc1cc(O)c(C(=O)OC(C)C)c(CCCN2C(=O)C=CC2=O)c1		CHEMBL3357189	=	Inhibition	%	2.4	CHEMBL4204	Homo sapiens	INH	%	2.4
	14986264	CHEMBL3387277	Inhibition of MNK2 (unknown origin) at 10 uM	B	CC(C)OC(=O)c1c(O)cc(OCCCN2CCOCC2)cc1/C=C/CN1C(=O)C=CC1=O		CHEMBL3357190	=	Inhibition	%	3.1	CHEMBL4204	Homo sapiens	INH	%	3.1
	14986265	CHEMBL3387277	Inhibition of MNK2 (unknown origin) at 10 uM	B	CC(C)OC(=O)c1c(O)cc(OCCN2CCOCC2)cc1CCCN1C(=O)C=CC1=O		CHEMBL3357191	=	Inhibition	%	1.8	CHEMBL4204	Homo sapiens	INH	%	1.8
	14986266	CHEMBL3387277	Inhibition of MNK2 (unknown origin) at 10 uM	B	COc1cc(O)c(C(=O)OCc2ccc(Br)cc2)c(/C=C/CN2C(=O)C=CC2=O)c1		CHEMBL3357192	=	Inhibition	%	0.0	CHEMBL4204	Homo sapiens	INH	%	0.0
	14986267	CHEMBL3387277	Inhibition of MNK2 (unknown origin) at 10 uM	B	COc1cc(O)c(C(=O)OCc2ccc(F)cc2)c(/C=C/CN2C(=O)C=CC2=O)c1		CHEMBL3357193	=	Inhibition	%	0.0	CHEMBL4204	Homo sapiens	INH	%	0.0
	14986268	CHEMBL3387277	Inhibition of MNK2 (unknown origin) at 10 uM	B	COc1cc(O)c(C(=O)OCC2CCCCC2)c(/C=C/CN2C(=O)C=CC2=O)c1		CHEMBL3357194	=	Inhibition	%	0.0	CHEMBL4204	Homo sapiens	INH	%	0.0
	14986269	CHEMBL3387277	Inhibition of MNK2 (unknown origin) at 10 uM	B	COc1cc(O)c(C(=O)OCC(C)c2ccccc2)c(/C=C/CN2C(=O)C=CC2=O)c1		CHEMBL3357195	=	Inhibition	%	0.0	CHEMBL4204	Homo sapiens	INH	%	0.0
	15036868	CHEMBL3381089	Inhibition of MNK2 (unknown origin)	B	Nc1nc2c3c(F)cccc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309990	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	15036869	CHEMBL3381089	Inhibition of MNK2 (unknown origin)	B	Nc1ccc2c(c1)nc(Cc1ccc3c(c1)OCO3)n1nc(N)nc21		CHEMBL3309995	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	15036870	CHEMBL3381089	Inhibition of MNK2 (unknown origin)	B	OCCCNc1ccc2c(c1)nc(-c1ccc3c(c1)OCO3)n1ncnc21		CHEMBL3309997	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	15036871	CHEMBL3381089	Inhibition of MNK2 (unknown origin)	B	Nc1nc2c3ccc(NCCO)cc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309998	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	15036872	CHEMBL3381089	Inhibition of MNK2 (unknown origin)	B	CN1CCN(c2cc(F)c3c(c2)nc(Cc2ccc4c(c2)OCO4)n2nc(N)nc32)CC1		CHEMBL3310151	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	15072466	CHEMBL3380108	Inhibition of MNK2 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	109.0	CHEMBL4204	Homo sapiens	Activity	%	109.0
	15091081	CHEMBL3381548	Inhibition of human recombinant MNK2 expressed Sf21 cells using CREBtide (CKRREILSRRPSYRK) substrate assessed as remaining enzyme activity at 1 uM after 90 mins relative to control	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Br)c(O)c(Br)c1		CHEMBL2206014	=	Activity	%	89.0	CHEMBL4204	Homo sapiens	Activity	%	89.0
	15109397	CHEMBL3373407	Inhibition of MKNK2 (unknown origin) assessed as residual enzyme activity at 10 uM	B	COc1cccc(C(=O)Nc2nc3cc4c(cc3[nH]2)OC(F)(F)O4)c1		CHEMBL3337846	=	Activity	%	33.0	CHEMBL4204	Homo sapiens	Activity	%	33.0
	15141954	CHEMBL3396746	Inhibition of MKNK2 (unknown origin) by KINOMEScan assay	B	O/N=C1/c2ccccc2-c2nc3ccccc3nc21		CHEMBL3393601	=	Kd	nM	920.0	CHEMBL4204	Homo sapiens	Kd	uM	0.92
	15141955	CHEMBL3396746	Inhibition of MKNK2 (unknown origin) by KINOMEScan assay	B	O=C(O/N=C1/c2ccccc2-c2nc3ccccc3nc21)c1ccco1		CHEMBL3393602	=	Kd	nM	1200.0	CHEMBL4204	Homo sapiens	Kd	uM	1.2
	15141956	CHEMBL3396746	Inhibition of MKNK2 (unknown origin) by KINOMEScan assay	B	COc1ccc(C(=O)O/N=C2/c3ccccc3-c3nc4ccccc4nc32)cc1OC		CHEMBL3393603	=	Kd	nM	10000.0	CHEMBL4204	Homo sapiens	Kd	uM	10.0
	15217672	CHEMBL3419829	Inhibition of Mnk2 (unknown origin) pre-incubated for 10 mins before eIF4E peptide substrate addition by ADP-Glo kinase assay	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Ki	nM	880.0	CHEMBL4204	Homo sapiens	Ki	uM	0.88
	15217673	CHEMBL3419829	Inhibition of Mnk2 (unknown origin) pre-incubated for 10 mins before eIF4E peptide substrate addition by ADP-Glo kinase assay	B	Cc1c(C(N)=O)sc2ncnc(Nc3ccc(=O)n(C)c3)c12		CHEMBL3417208	=	Ki	nM	1600.0	CHEMBL4204	Homo sapiens	Ki	uM	1.6
	15217674	CHEMBL3419829	Inhibition of Mnk2 (unknown origin) pre-incubated for 10 mins before eIF4E peptide substrate addition by ADP-Glo kinase assay	B	Cc1c(C(=O)O)sc2ncnc(Nc3ccc(=O)n(C)c3)c12		CHEMBL3417207	=	Ki	nM	900.0	CHEMBL4204	Homo sapiens	Ki	uM	0.9
	15217675	CHEMBL3419829	Inhibition of Mnk2 (unknown origin) pre-incubated for 10 mins before eIF4E peptide substrate addition by ADP-Glo kinase assay	B	COC(=O)c1sc2ncnc(Nc3ccc(=O)n(C)c3)c2c1C		CHEMBL3417206	>	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	Ki	uM	10.0
	15217676	CHEMBL3419829	Inhibition of Mnk2 (unknown origin) pre-incubated for 10 mins before eIF4E peptide substrate addition by ADP-Glo kinase assay	B	COCCn1cc(C)cc(Nc2ncnc3sc(C(N)=O)c(C)c23)c1=O		CHEMBL3417205	=	Ki	nM	340.0	CHEMBL4204	Homo sapiens	Ki	uM	0.34
	15217677	CHEMBL3419829	Inhibition of Mnk2 (unknown origin) pre-incubated for 10 mins before eIF4E peptide substrate addition by ADP-Glo kinase assay	B	COCCCNC(=O)c1sc2ncnc(Nc3cc(C)cn(C)c3=O)c2c1C		CHEMBL3417204	=	Ki	nM	2630.0	CHEMBL4204	Homo sapiens	Ki	uM	2.63
	15217678	CHEMBL3419829	Inhibition of Mnk2 (unknown origin) pre-incubated for 10 mins before eIF4E peptide substrate addition by ADP-Glo kinase assay	B	COCCNC(=O)c1sc2ncnc(Nc3cc(C)cn(C)c3=O)c2c1C		CHEMBL3417203	=	Ki	nM	3170.0	CHEMBL4204	Homo sapiens	Ki	uM	3.17
	15217679	CHEMBL3419829	Inhibition of Mnk2 (unknown origin) pre-incubated for 10 mins before eIF4E peptide substrate addition by ADP-Glo kinase assay	B	CCNC(=O)c1sc2ncnc(Nc3cc(C)cn(C)c3=O)c2c1C		CHEMBL3417202	=	Ki	nM	5990.0	CHEMBL4204	Homo sapiens	Ki	uM	5.99
	15217680	CHEMBL3419829	Inhibition of Mnk2 (unknown origin) pre-incubated for 10 mins before eIF4E peptide substrate addition by ADP-Glo kinase assay	B	CNC(=O)c1sc2ncnc(Nc3cc(C)cn(C)c3=O)c2c1C		CHEMBL3417201	=	Ki	nM	9050.0	CHEMBL4204	Homo sapiens	Ki	uM	9.05
	15217681	CHEMBL3419829	Inhibition of Mnk2 (unknown origin) pre-incubated for 10 mins before eIF4E peptide substrate addition by ADP-Glo kinase assay	B	Cc1cc(Nc2ncnc3sc(C(N)=O)c(C)c23)c(=O)n(C)c1		CHEMBL3417200	>	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	Ki	uM	10.0
	15217682	CHEMBL3419829	Inhibition of Mnk2 (unknown origin) pre-incubated for 10 mins before eIF4E peptide substrate addition by ADP-Glo kinase assay	B	COCCn1cc(C)cc(Nc2ncnc3sc(C(=O)O)c(C)c23)c1=O		CHEMBL3417199	=	Ki	nM	240.0	CHEMBL4204	Homo sapiens	Ki	uM	0.24
	15217683	CHEMBL3419829	Inhibition of Mnk2 (unknown origin) pre-incubated for 10 mins before eIF4E peptide substrate addition by ADP-Glo kinase assay	B	Cc1cc(Nc2ncnc3sc(C(=O)O)c(C)c23)c(=O)n(C)c1		CHEMBL3417198	=	Ki	nM	350.0	CHEMBL4204	Homo sapiens	Ki	uM	0.35
	15218853	CHEMBL3419829	Inhibition of Mnk2 (unknown origin) pre-incubated for 10 mins before eIF4E peptide substrate addition by ADP-Glo kinase assay	B	COCCn1cc(C)cc(Nc2ncnc3sc(C(=O)OC)c(C)c23)c1=O		CHEMBL3417197	>	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	Ki	uM	10.0
	15218854	CHEMBL3419829	Inhibition of Mnk2 (unknown origin) pre-incubated for 10 mins before eIF4E peptide substrate addition by ADP-Glo kinase assay	B	COC(=O)c1sc2ncnc(Nc3cc(C)cn(C)c3=O)c2c1C		CHEMBL3417196	>	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	Ki	uM	10.0
	15247453	CHEMBL3427930	Inhibition of human MKNK2 at 10 uM after 1 hr by qPCR analysis relative to control	B	C#CCCCn1c(Sc2ccc(Cl)cc2Cl)nc2c(N)ncnc21		CHEMBL365118	=	Inhibition	%	34.0	CHEMBL4204	Homo sapiens	INH	%	34.0
	15251795	CHEMBL3427805	Inhibition of MNK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	52.0	CHEMBL4204	Homo sapiens	Activity	%	52.0
	15251897	CHEMBL3427805	Inhibition of MNK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	17.0	CHEMBL4204	Homo sapiens	Activity	%	17.0
	15252002	CHEMBL3427805	Inhibition of MNK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	59.0	CHEMBL4204	Homo sapiens	Activity	%	59.0
	15252647	CHEMBL3427805	Inhibition of MNK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	58.0	CHEMBL4204	Homo sapiens	Activity	%	58.0
	15252749	CHEMBL3427805	Inhibition of MNK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	83.0	CHEMBL4204	Homo sapiens	Activity	%	83.0
	15252851	CHEMBL3427805	Inhibition of MNK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	88.0	CHEMBL4204	Homo sapiens	Activity	%	88.0
	15253525	CHEMBL3427805	Inhibition of MNK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	64.0	CHEMBL4204	Homo sapiens	Activity	%	64.0
	15253627	CHEMBL3427805	Inhibition of MNK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	66.0	CHEMBL4204	Homo sapiens	Activity	%	66.0
	15253729	CHEMBL3427805	Inhibition of MNK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	30.0	CHEMBL4204	Homo sapiens	Activity	%	30.0
	15254395	CHEMBL3427805	Inhibition of MNK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	30.0	CHEMBL4204	Homo sapiens	Activity	%	30.0
	15254497	CHEMBL3427805	Inhibition of MNK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	34.0	CHEMBL4204	Homo sapiens	Activity	%	34.0
	15254599	CHEMBL3427805	Inhibition of MNK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	24.0	CHEMBL4204	Homo sapiens	Activity	%	24.0
	15255290	CHEMBL3427805	Inhibition of MNK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	26.0	CHEMBL4204	Homo sapiens	Activity	%	26.0
	15255392	CHEMBL3427805	Inhibition of MNK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	36.0	CHEMBL4204	Homo sapiens	Activity	%	36.0
	15255495	CHEMBL3427805	Inhibition of MNK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	24.0	CHEMBL4204	Homo sapiens	Activity	%	24.0
	15256226	CHEMBL3427805	Inhibition of MNK2 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	13.0	CHEMBL4204	Homo sapiens	Activity	%	13.0
	15685901	CHEMBL3607977	Inhibition of human MNK2	B	NC(=O)c1cc(F)cc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2		CHEMBL3606021	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	15755904	CHEMBL3630847	Inhibition of MKNK2 (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	59.0	CHEMBL4204	Homo sapiens	Activity	%	59.0
	15756906	CHEMBL3631450	Inhibition of MNK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	99.16	CHEMBL4204	Homo sapiens	INH	%	99.16
	15757817	CHEMBL3631450	Inhibition of MNK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	81.49	CHEMBL4204	Homo sapiens	INH	%	81.49
	15758796	CHEMBL3631450	Inhibition of MNK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	2.19	CHEMBL4204	Homo sapiens	INH	%	2.19
	15774205	CHEMBL3637759	Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis	B	C[C@H]1CCc2c(sc3ncnc(Nc4ccc(F)c(Cl)c4)c23)C1		CHEMBL3632735	>	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	15774206	CHEMBL3637759	Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis	B	Ic1ccc(Nc2ncnc3[nH]ncc23)cc1		CHEMBL3632736	>	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	15774207	CHEMBL3637759	Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis	B	CCOC(=O)c1sc2ncnc(Nc3ccc(F)cc3)c2c1C		CHEMBL3237084	>	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	15774208	CHEMBL3637759	Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Ki	nM	340.0	CHEMBL4204	Homo sapiens	Ki	uM	0.34
	15774209	CHEMBL3637759	Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis	B	CC(=O)C1=C(O)C=C2Oc3c(C(N)=O)c(O)cc(O)c3[C@@]2(C)C1=O		CHEMBL3416305	=	Ki	nM	79.0	CHEMBL4204	Homo sapiens	Ki	uM	0.079
	15774210	CHEMBL3637759	Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis	B	COC(=O)c1sc2ncnc(Nc3ccc(F)cc3)c2c1C		CHEMBL3632737	>	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	Ki	uM	10.0
	15774211	CHEMBL3637759	Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis	B	COC(=O)c1sc2ncnc(Nc3ccc(F)cc3C)c2c1C		CHEMBL3632738	>	Ki	nM	10000.0	CHEMBL4204	Homo sapiens	Ki	uM	10.0
	15774212	CHEMBL3637759	Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis	B	COC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(C)C)c2c1C		CHEMBL3632739	=	Ki	nM	4050.0	CHEMBL4204	Homo sapiens	Ki	uM	4.05
	15774213	CHEMBL3637759	Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis	B	Cc1c(C(=O)O)sc2ncnc(Nc3ccc(F)cc3)c12		CHEMBL3632740	=	Ki	nM	164.0	CHEMBL4204	Homo sapiens	Ki	uM	0.164
	15774214	CHEMBL3637759	Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis	B	Cc1cc(F)ccc1Nc1ncnc2sc(C(=O)O)c(C)c12		CHEMBL3632741	=	Ki	nM	500.0	CHEMBL4204	Homo sapiens	Ki	uM	0.5
	15774215	CHEMBL3637759	Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis	B	Cc1c(C(=O)O)sc2ncnc(Nc3ccc(F)cc3OC(C)C)c12		CHEMBL3632742	=	Ki	nM	68.0	CHEMBL4204	Homo sapiens	Ki	uM	0.068
	15774216	CHEMBL3637759	Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis	B	Cc1c(C(N)=O)sc2ncnc(Nc3ccc(F)cc3OC(C)C)c12		CHEMBL3632743	=	Ki	nM	110.0	CHEMBL4204	Homo sapiens	Ki	uM	0.11
	15774217	CHEMBL3637759	Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis	B	CNC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(C)C)c2c1C		CHEMBL3632744	=	Ki	nM	18.0	CHEMBL4204	Homo sapiens	Ki	uM	0.018
	15774218	CHEMBL3637759	Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis	B	CCNC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(C)C)c2c1C		CHEMBL3632745	=	Ki	nM	18.0	CHEMBL4204	Homo sapiens	Ki	uM	0.018
	15774219	CHEMBL3637759	Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis	B	COCCNC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(C)C)c2c1C		CHEMBL3632746	=	Ki	nM	31.0	CHEMBL4204	Homo sapiens	Ki	uM	0.031
	15774220	CHEMBL3637759	Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis	B	COCCCNC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(C)C)c2c1C		CHEMBL3632747	=	Ki	nM	164.0	CHEMBL4204	Homo sapiens	Ki	uM	0.164
	15774221	CHEMBL3637759	Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis	B	Cc1cccc(Nc2ncnc3ccc(Br)cc23)c1C		CHEMBL3632748	<	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	15774222	CHEMBL3637759	Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis	B	Cc1ccc(Nc2ncnc3ccc(Br)cc23)c(C)c1		CHEMBL3632624	<	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	15774223	CHEMBL3637759	Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis	B	COc1ccc(Nc2ncnc3sc4c(c23)CC[C@H](C)C4)cc1		CHEMBL3632749	<	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	15774224	CHEMBL3637759	Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis	B	CCOC(=O)c1ccc(Nc2ncnc3ccc(C)cc23)cc1		CHEMBL1344639	<	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	15774225	CHEMBL3637759	Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis	B	COCCNC(=O)c1sc2ncnc(NCCc3ccc(OC)cc3)c2c1C		CHEMBL3632915	<	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	15774226	CHEMBL3637759	Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis	B	O=C1Nc2ccc(Br)cc2/C1=N\c1cccc(F)c1		CHEMBL3632916	<	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	15774227	CHEMBL3637759	Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis	B	N#C/C(=C\c1ccc(O)c(O)c1)c1nc(-c2ccc(Cl)cc2Cl)cs1		CHEMBL3632917	<	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	15774228	CHEMBL3637759	Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis	B	O=c1[nH]nc(CCNC2CCN(c3cccc(-c4cccc(F)c4)c3)CC2)[nH]1		CHEMBL3632918	<	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	15774229	CHEMBL3637759	Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis	B	COc1cc([C@@H]2N[C@H](C(=O)O)CS2)cc(I)c1O		CHEMBL3632919	<	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	15774230	CHEMBL3637759	Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis	B	Cc1ccc(NC(=O)c2c(O)[nH]c3ccccc3c2=O)c(C)c1		CHEMBL3632920	<	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	15774869	CHEMBL3637764	Inhibition of human Mnk2a using TAMRA-labeled eIF4E peptide as substrate incubated for 10 mins followed by addition of ATP measured after 45 mins by ADP-Glo kinase assay	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	IC50	nM	1600.0	CHEMBL4204	Homo sapiens	IC50	uM	1.6
	15774883	CHEMBL3637766	Inhibition of human Mnk2a assessed as remaining enzyme activity using TAMRA-labeled eIF4E peptide as substrate at 1 uM incubated for 10 mins followed by addition of ATP measured after 90 mins by IMAP TR-FRET analysis	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Activity	%	56.0	CHEMBL4204	Homo sapiens	Activity	%	56.0
	15774884	CHEMBL3637769	Inhibition of human Mnk2	B	CC(=O)C1=C(O)C=C2Oc3c(C(N)=O)c(O)cc(O)c3[C@@]2(C)C1=O		CHEMBL3416305	=	IC50	nM	11.0	CHEMBL4204	Homo sapiens	IC50	uM	0.011
214017	16278076	CHEMBL3707986	In Vitro Kinase Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 M substrate peptide, 20 M ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 M antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949). After 1 h equilibration time at room temperature, samples are subjected to fluorescence polarization measurement. The fluorescence polarization readout was generated on an Analyst AD multimode reader (Molecular Devices, Sunnyvale, Calif., USA) equipped with a DLRP650 dichroic mirror (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF2035), a 630AF50 band pass filter (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF1069) on the excitation and a 695AF55 band pass filter on the emission side (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF3076).	B	Fc1ccc(Nc2ncnc3sc4c(c23)CCNC4)c(OC2CCOCC2)c1		CHEMBL3659489	=	IC50	nM	110.0	CHEMBL4204	Homo sapiens	IC50	nM	110.0
214016	16289089	CHEMBL3707986	In Vitro Kinase Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 M substrate peptide, 20 M ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 M antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949). After 1 h equilibration time at room temperature, samples are subjected to fluorescence polarization measurement. The fluorescence polarization readout was generated on an Analyst AD multimode reader (Molecular Devices, Sunnyvale, Calif., USA) equipped with a DLRP650 dichroic mirror (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF2035), a 630AF50 band pass filter (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF1069) on the excitation and a 695AF55 band pass filter on the emission side (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF3076).	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3ccc(C(F)(F)F)nc3OC3CCOCC3)c12		CHEMBL3659488	=	IC50	nM	560.0	CHEMBL4204	Homo sapiens	IC50	nM	560.0
214013	16303628	CHEMBL3707986	In Vitro Kinase Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 M substrate peptide, 20 M ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 M antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949). After 1 h equilibration time at room temperature, samples are subjected to fluorescence polarization measurement. The fluorescence polarization readout was generated on an Analyst AD multimode reader (Molecular Devices, Sunnyvale, Calif., USA) equipped with a DLRP650 dichroic mirror (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF2035), a 630AF50 band pass filter (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF1069) on the excitation and a 695AF55 band pass filter on the emission side (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF3076).	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3ccc(F)cc3OC3CCOCC3)c12		CHEMBL3659486	=	IC50	nM	27.0	CHEMBL4204	Homo sapiens	IC50	nM	27.0
214020	16313251	CHEMBL3707986	In Vitro Kinase Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 M substrate peptide, 20 M ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 M antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949). After 1 h equilibration time at room temperature, samples are subjected to fluorescence polarization measurement. The fluorescence polarization readout was generated on an Analyst AD multimode reader (Molecular Devices, Sunnyvale, Calif., USA) equipped with a DLRP650 dichroic mirror (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF2035), a 630AF50 band pass filter (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF1069) on the excitation and a 695AF55 band pass filter on the emission side (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF3076).	B	Cc1c(C(N)=O)sc2ncnc(Nc3ccc(F)cc3OC3CCN(CC(=O)N4CCOCC4)CC3)c12		CHEMBL3659492	=	IC50	nM	160.0	CHEMBL4204	Homo sapiens	IC50	nM	160.0
214015	16323943	CHEMBL3707986	In Vitro Kinase Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 M substrate peptide, 20 M ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 M antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949). After 1 h equilibration time at room temperature, samples are subjected to fluorescence polarization measurement. The fluorescence polarization readout was generated on an Analyst AD multimode reader (Molecular Devices, Sunnyvale, Calif., USA) equipped with a DLRP650 dichroic mirror (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF2035), a 630AF50 band pass filter (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF1069) on the excitation and a 695AF55 band pass filter on the emission side (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF3076).	B	COC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(C)C)c2c1C		CHEMBL3632739	=	IC50	nM	60.0	CHEMBL4204	Homo sapiens	IC50	nM	60.0
214014	16329722	CHEMBL3707986	In Vitro Kinase Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 M substrate peptide, 20 M ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 M antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949). After 1 h equilibration time at room temperature, samples are subjected to fluorescence polarization measurement. The fluorescence polarization readout was generated on an Analyst AD multimode reader (Molecular Devices, Sunnyvale, Calif., USA) equipped with a DLRP650 dichroic mirror (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF2035), a 630AF50 band pass filter (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF1069) on the excitation and a 695AF55 band pass filter on the emission side (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF3076).	B	Cc1c(C(=O)NCCN2CCOCC2)sc2ncnc(Nc3ccc(F)cc3OC3CCOCC3)c12		CHEMBL3659487	=	IC50	nM	34.0	CHEMBL4204	Homo sapiens	IC50	nM	34.0
214018	16330285	CHEMBL3707986	In Vitro Kinase Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 M substrate peptide, 20 M ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 M antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949). After 1 h equilibration time at room temperature, samples are subjected to fluorescence polarization measurement. The fluorescence polarization readout was generated on an Analyst AD multimode reader (Molecular Devices, Sunnyvale, Calif., USA) equipped with a DLRP650 dichroic mirror (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF2035), a 630AF50 band pass filter (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF1069) on the excitation and a 695AF55 band pass filter on the emission side (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF3076).	B	Cc1c(C(N)=O)sc2ncnc(Nc3ccc(F)cc3OC3CCN(Cc4ncon4)CC3)c12		CHEMBL3659490	=	IC50	nM	92.0	CHEMBL4204	Homo sapiens	IC50	nM	92.0
214019	16333626	CHEMBL3707986	In Vitro Kinase Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 M substrate peptide, 20 M ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 M antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949). After 1 h equilibration time at room temperature, samples are subjected to fluorescence polarization measurement. The fluorescence polarization readout was generated on an Analyst AD multimode reader (Molecular Devices, Sunnyvale, Calif., USA) equipped with a DLRP650 dichroic mirror (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF2035), a 630AF50 band pass filter (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF1069) on the excitation and a 695AF55 band pass filter on the emission side (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF3076).	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3ccc(F)cc3OC(C)C)c12		CHEMBL3659491	=	IC50	nM	6.0	CHEMBL4204	Homo sapiens	IC50	nM	6.0
214012	16335196	CHEMBL3707986	In Vitro Kinase Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 M substrate peptide, 20 M ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 M antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949). After 1 h equilibration time at room temperature, samples are subjected to fluorescence polarization measurement. The fluorescence polarization readout was generated on an Analyst AD multimode reader (Molecular Devices, Sunnyvale, Calif., USA) equipped with a DLRP650 dichroic mirror (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF2035), a 630AF50 band pass filter (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF1069) on the excitation and a 695AF55 band pass filter on the emission side (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF3076).	B	COCCNC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC3CCOCC3)c2c1C		CHEMBL3659485	=	IC50	nM	35.0	CHEMBL4204	Homo sapiens	IC50	nM	35.0
214011	16337260	CHEMBL3707986	In Vitro Kinase Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 M substrate peptide, 20 M ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 M antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949). After 1 h equilibration time at room temperature, samples are subjected to fluorescence polarization measurement. The fluorescence polarization readout was generated on an Analyst AD multimode reader (Molecular Devices, Sunnyvale, Calif., USA) equipped with a DLRP650 dichroic mirror (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF2035), a 630AF50 band pass filter (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF1069) on the excitation and a 695AF55 band pass filter on the emission side (Omega Opticals, Brattleboro, Vt., USA, cat. no. XF3076).	B	CCOc1cc(C(N)=O)ccc1Nc1ncnc2sc(C(N)=O)c(C)c12		CHEMBL3659484	=	IC50	nM	28.0	CHEMBL4204	Homo sapiens	IC50	nM	28.0
	16413477	CHEMBL3742703	Inhibition of MNK2 (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	16421934	CHEMBL3750416	Inhibition of MNK2 (unknown origin)	B	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1		CHEMBL3651966	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	16425280	CHEMBL3751104	Inhibition of MKNK2 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	-0.2	CHEMBL4204	Homo sapiens	INH	%	-0.2
	16431912	CHEMBL3748005	Inhibition of human MNK2 using MBP as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	16451516	CHEMBL3760639	Inhibition of MKNK2 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	-2.3	CHEMBL4204	Homo sapiens	INH	%	-2.3
	16474700	CHEMBL3767320	Inhibition of MNK2 (unknown origin) at 10 uM	B	CN1CCN(CCCOc2ccc(N3C(=O)/C(=C/c4ccc(Oc5ccc(F)cc5)cc4)SC3=S)cc2)CC1		CHEMBL3765499	=	Inhibition	%	33.1	CHEMBL4204	Homo sapiens	INH	%	33.1
	16486363	CHEMBL3771596	Inhibition of human recombinant MKNK2 assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	91.0	CHEMBL4204	Homo sapiens	Activity	%	91.0
	16495135	CHEMBL3777498	Inhibition of N-terminal His6-tagged recombinant human MNK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-5.0	CHEMBL4204	Homo sapiens	Activity	%	-5.0
	16496054	CHEMBL3777498	Inhibition of N-terminal His6-tagged recombinant human MNK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-14.0	CHEMBL4204	Homo sapiens	Activity	%	-14.0
	16506508	CHEMBL3776502	Inhibition of full length recombinant human N-terminal GST-tagged MKNK2 expressed in insect cells at 1 uM by lantha screen kinase binding assay relative to control	B	O=C1NC(=S)S/C1=C\c1ccc2ncccc2c1		CHEMBL3774448	=	Inhibition	%	34.0	CHEMBL4204	Homo sapiens	INH	%	34.0
	16508241	CHEMBL3777498	Inhibition of N-terminal His6-tagged recombinant human MNK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	0.0	CHEMBL4204	Homo sapiens	Activity	%	0.0
Not Active	16514148	CHEMBL3782339	Inhibition of partial length human MKNK2 expressed in mammalian system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL4204	Homo sapiens	INH		
	16540888	CHEMBL3790006	Inhibition of MKNK2 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787112	=	IC50	nM	1100.0	CHEMBL4204	Homo sapiens	IC50	uM	1.1
	16540889	CHEMBL3790006	Inhibition of MKNK2 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCC34CCC(CC3)O4)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3785500	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	16540890	CHEMBL3790006	Inhibition of MKNK2 (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cccc(OC[C@@H]5CCCO5)c4F)c4c(N)ncnc43)C2)CC1		CHEMBL3786167	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	16540891	CHEMBL3790006	Inhibition of MKNK2 (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	16566127	CHEMBL3803164	Inhibition of N-terminal 6His-tagged recombinant human full length wild type MNK2b using biotin-SGSGKRREILSRRPSYR-NH2 as substrate after 1 hr by HTRF assay	B	Nc1ncccc1-c1nc2ccccc2[nH]1		CHEMBL3797559	=	IC50	nM	900.0	CHEMBL4204	Homo sapiens	IC50	uM	0.9
	16566128	CHEMBL3803164	Inhibition of N-terminal 6His-tagged recombinant human full length wild type MNK2b using biotin-SGSGKRREILSRRPSYR-NH2 as substrate after 1 hr by HTRF assay	B	Nc1ncc(-c2ccccc2)cc1-c1nc2ccccc2[nH]1		CHEMBL3799935	=	IC50	nM	720.0	CHEMBL4204	Homo sapiens	IC50	uM	0.72
	16566129	CHEMBL3803164	Inhibition of N-terminal 6His-tagged recombinant human full length wild type MNK2b using biotin-SGSGKRREILSRRPSYR-NH2 as substrate after 1 hr by HTRF assay	B	CN(C)C(=O)c1cccc(-c2cnc(N)c(-c3nc4ccccc4[nH]3)c2)c1		CHEMBL3797574	=	IC50	nM	34.0	CHEMBL4204	Homo sapiens	IC50	uM	0.034
	16566130	CHEMBL3803164	Inhibition of N-terminal 6His-tagged recombinant human full length wild type MNK2b using biotin-SGSGKRREILSRRPSYR-NH2 as substrate after 1 hr by HTRF assay	B	CN(C)C(=O)c1cccc(-c2cnc(N)c(-c3nc4cccc(N5CCNCC5)c4[nH]3)c2)c1		CHEMBL3797828	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	uM	0.002
	16566131	CHEMBL3803164	Inhibition of N-terminal 6His-tagged recombinant human full length wild type MNK2b using biotin-SGSGKRREILSRRPSYR-NH2 as substrate after 1 hr by HTRF assay	B	CN(C)C(=O)c1cccc(-c2cnc(N)c(-c3nc4cccc(N5CCNCC5)c4[nH]3)n2)c1		CHEMBL3798066	=	IC50	nM	20.0	CHEMBL4204	Homo sapiens	IC50	uM	0.02
	16566132	CHEMBL3803164	Inhibition of N-terminal 6His-tagged recombinant human full length wild type MNK2b using biotin-SGSGKRREILSRRPSYR-NH2 as substrate after 1 hr by HTRF assay	B	CN(C)C(=O)c1cccc(-c2cnc(N)c(-c3nc4cccc(N5CCNCC5)c4n3C)n2)c1		CHEMBL3798762	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	uM	0.001
	16566133	CHEMBL3803164	Inhibition of N-terminal 6His-tagged recombinant human full length wild type MNK2b using biotin-SGSGKRREILSRRPSYR-NH2 as substrate after 1 hr by HTRF assay	B	C[C@H]1CN(c2cccc3nc(-c4nc(-c5cccc(C(=O)N(C)C)c5)cnc4N)n(C)c23)CCN1		CHEMBL3797873	=	IC50	nM	0.7	CHEMBL4204	Homo sapiens	IC50	uM	0.0007
	16566134	CHEMBL3803164	Inhibition of N-terminal 6His-tagged recombinant human full length wild type MNK2b using biotin-SGSGKRREILSRRPSYR-NH2 as substrate after 1 hr by HTRF assay	B	C[C@H]1CN(c2cccc3nc(-c4nc(-c5cc(C(=O)N(C)C)ccn5)cnc4N)n(C)c23)CCN1		CHEMBL3800585	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	uM	0.003
	16588145	CHEMBL3806739	Inhibition of N-terminal GST-tagged MNK2 kinase domain (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) cells using JH3 peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by mobility shift assay	B	CN1CCN(Cc2ccc(NC(=O)CNc3ccc(-c4ccc(NC(=O)C5CC5)nc4)cc3F)cc2C(F)(F)F)CC1		CHEMBL3806189	=	IC50	nM	10.0	CHEMBL4204	Homo sapiens	IC50	uM	0.01
	16588146	CHEMBL3806739	Inhibition of N-terminal GST-tagged MNK2 kinase domain (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) cells using JH3 peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by mobility shift assay	B	CCN1CCN(Cc2ccc(NC(=O)CNc3ccc(-c4ccc(NC(=O)C5CC5)nc4)cc3)cc2C(F)(F)F)CC1		CHEMBL3805771	=	IC50	nM	16.0	CHEMBL4204	Homo sapiens	IC50	uM	0.016
	16588147	CHEMBL3806739	Inhibition of N-terminal GST-tagged MNK2 kinase domain (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) cells using JH3 peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by mobility shift assay	B	O=C(CNc1ccc(-c2ccc(NC(=O)C3CC3)nc2)cc1)Nc1ccc(CN2CCNCC2)c(C(F)(F)F)c1		CHEMBL3805330	=	IC50	nM	8.0	CHEMBL4204	Homo sapiens	IC50	uM	0.008
	16588148	CHEMBL3806739	Inhibition of N-terminal GST-tagged MNK2 kinase domain (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) cells using JH3 peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by mobility shift assay	B	CC(C)C(=O)Nc1ccc(-c2ccc(NCC(=O)Nc3ccc(CN4CCNCC4)c(C(F)(F)F)c3)cc2)cn1		CHEMBL3804972	=	IC50	nM	130.0	CHEMBL4204	Homo sapiens	IC50	uM	0.13
	16588149	CHEMBL3806739	Inhibition of N-terminal GST-tagged MNK2 kinase domain (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) cells using JH3 peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by mobility shift assay	B	CC(=O)Nc1ccc(-c2ccc(NCC(=O)Nc3ccc(CN4CCNCC4)c(C(F)(F)F)c3)cc2)cn1		CHEMBL3804921	=	IC50	nM	32.0	CHEMBL4204	Homo sapiens	IC50	uM	0.032
	16588150	CHEMBL3806739	Inhibition of N-terminal GST-tagged MNK2 kinase domain (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) cells using JH3 peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by mobility shift assay	B	CCN1CCN(Cc2ccc(NC(=O)CNc3ccc(-c4ccc(NC(C)=O)nc4)cc3)cc2C(F)(F)F)CC1		CHEMBL3805891	=	IC50	nM	44.0	CHEMBL4204	Homo sapiens	IC50	uM	0.044
	16588151	CHEMBL3806739	Inhibition of N-terminal GST-tagged MNK2 kinase domain (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) cells using JH3 peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by mobility shift assay	B	CCN1CCN(Cc2ccc(NC(=O)COc3ccc(-c4ccc(NC(C)=O)nc4)cc3)cc2C(F)(F)F)CC1		CHEMBL3805865	=	IC50	nM	33.0	CHEMBL4204	Homo sapiens	IC50	uM	0.033
	16588152	CHEMBL3806739	Inhibition of N-terminal GST-tagged MNK2 kinase domain (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) cells using JH3 peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by mobility shift assay	B	CCN1CCN(Cc2ccc(NC(=O)COc3ccc(-c4ccc(C(=O)NC)nc4)cc3)cc2C(F)(F)F)CC1		CHEMBL3806302	=	IC50	nM	6860.0	CHEMBL4204	Homo sapiens	IC50	uM	6.86
	16588153	CHEMBL3806739	Inhibition of N-terminal GST-tagged MNK2 kinase domain (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) cells using JH3 peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by mobility shift assay	B	CCN1CCN(Cc2ccc(NC(=O)C(C)Oc3ccc(-c4cccnc4)cc3)cc2C(F)(F)F)CC1		CHEMBL3806022	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	16588154	CHEMBL3806739	Inhibition of N-terminal GST-tagged MNK2 kinase domain (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) cells using JH3 peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by mobility shift assay	B	O=C(COc1ccc(-c2cccnc2)cc1)Nc1ccc(CN2CCNCC2)c(C(F)(F)F)c1		CHEMBL3805029	=	IC50	nM	12.0	CHEMBL4204	Homo sapiens	IC50	uM	0.012
	16588155	CHEMBL3806739	Inhibition of N-terminal GST-tagged MNK2 kinase domain (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) cells using JH3 peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by mobility shift assay	B	CCN1CCN(Cc2ccc(NC(=O)COc3ccc(-c4cccnc4)cc3)cc2C2CC2)CC1		CHEMBL3806240	=	IC50	nM	130.0	CHEMBL4204	Homo sapiens	IC50	uM	0.13
	16588156	CHEMBL3806739	Inhibition of N-terminal GST-tagged MNK2 kinase domain (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) cells using JH3 peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by mobility shift assay	B	CCN1CCC(Cc2ccc(NC(=O)COc3ccc(-c4cccnc4)cc3)cc2C(F)(F)F)CC1		CHEMBL3805647	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	16588157	CHEMBL3806739	Inhibition of N-terminal GST-tagged MNK2 kinase domain (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) cells using JH3 peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by mobility shift assay	B	CCC1CCN(Cc2ccc(NC(=O)COc3ccc(-c4cccnc4)cc3)cc2C(F)(F)F)CC1		CHEMBL3804941	=	IC50	nM	82.0	CHEMBL4204	Homo sapiens	IC50	uM	0.082
	16588158	CHEMBL3806739	Inhibition of N-terminal GST-tagged MNK2 kinase domain (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) cells using JH3 peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by mobility shift assay	B	CCN1CCN(Cc2ccc(NC(=O)COc3ccc(-c4ccncc4)cc3)cc2C(F)(F)F)CC1		CHEMBL3806141	=	IC50	nM	1910.0	CHEMBL4204	Homo sapiens	IC50	uM	1.91
	16588159	CHEMBL3806739	Inhibition of N-terminal GST-tagged MNK2 kinase domain (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) cells using JH3 peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by mobility shift assay	B	CCN1CCN(Cc2ccc(NC(=O)COc3ccc(-c4ccccn4)cc3)cc2C(F)(F)F)CC1		CHEMBL3805624	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	16588160	CHEMBL3806739	Inhibition of N-terminal GST-tagged MNK2 kinase domain (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) cells using JH3 peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by mobility shift assay	B	CCN1CCN(Cc2ccc(NC(=O)CNc3ccc(-c4cccnc4)cc3)cc2C(F)(F)F)CC1		CHEMBL3806261	=	IC50	nM	11.0	CHEMBL4204	Homo sapiens	IC50	uM	0.011
	16588161	CHEMBL3806739	Inhibition of N-terminal GST-tagged MNK2 kinase domain (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) cells using JH3 peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by mobility shift assay	B	CCN1CCN(Cc2ccc(NC(=O)COc3ccc(-c4cccnc4)cc3)cc2C(F)(F)F)CC1		CHEMBL3805956	=	IC50	nM	14.0	CHEMBL4204	Homo sapiens	IC50	uM	0.014
	16588162	CHEMBL3806739	Inhibition of N-terminal GST-tagged MNK2 kinase domain (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) cells using JH3 peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by mobility shift assay	B	CCN1CCN(Cc2ccc(NC(=O)Cc3ccc(Oc4ccncc4)cc3)cc2C(F)(F)F)CC1		CHEMBL3805114	=	IC50	nM	10.0	CHEMBL4204	Homo sapiens	IC50	uM	0.01
	16588163	CHEMBL3806739	Inhibition of N-terminal GST-tagged MNK2 kinase domain (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) cells using JH3 peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by mobility shift assay	B	CCN1CCN(Cc2ccc(NC(=O)Cc3ccc(Oc4ccnc(NC)c4)cc3)cc2C(F)(F)F)CC1		CHEMBL3804952	=	IC50	nM	8.0	CHEMBL4204	Homo sapiens	IC50	uM	0.008
	16588164	CHEMBL3806739	Inhibition of N-terminal GST-tagged MNK2 kinase domain (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) cells using JH3 peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by mobility shift assay	B	CCN1CCN(Cc2ccc(NC(=O)Cc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL3805074	=	IC50	nM	22.0	CHEMBL4204	Homo sapiens	IC50	uM	0.022
	16588165	CHEMBL3806739	Inhibition of N-terminal GST-tagged MNK2 kinase domain (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) cells using JH3 peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by mobility shift assay	B	CCN1CCN(Cc2ccc(CC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL3805094	=	IC50	nM	760.0	CHEMBL4204	Homo sapiens	IC50	uM	0.76
	16588166	CHEMBL3806739	Inhibition of N-terminal GST-tagged MNK2 kinase domain (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) cells using JH3 peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by mobility shift assay	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	IC50	nM	20.0	CHEMBL4204	Homo sapiens	IC50	uM	0.02
	16594866	CHEMBL3812871	Inhibition of human MKNK2 (63 to 388 amino acid residues) assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	98.0	CHEMBL4204	Homo sapiens	Activity	%	98.0
	16612000	CHEMBL3815485	Inhibition of human MNK2alpha (2 to 465 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-35.0	CHEMBL4204	Homo sapiens	Activity	%	-35.0
	16612597	CHEMBL3815485	Inhibition of human MNK2alpha (2 to 465 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	=	Activity	%	-15.0	CHEMBL4204	Homo sapiens	Activity	%	-15.0
	16612598	CHEMBL3815485	Inhibition of human MNK2alpha (2 to 465 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3814140	=	Activity	%	-49.0	CHEMBL4204	Homo sapiens	Activity	%	-49.0
	16612599	CHEMBL3815485	Inhibition of human MNK2alpha (2 to 465 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	=	Activity	%	-42.0	CHEMBL4204	Homo sapiens	Activity	%	-42.0
	16614546	CHEMBL3817577	Inhibition of human MNK2 at 1 uM using MBP as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	2.0	CHEMBL4204	Homo sapiens	INH	%	2.0
	16654159	CHEMBL3829165	Inhibition of human MNK2 assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	49.0	CHEMBL4204	Homo sapiens	Activity	%	49.0
	16668729	CHEMBL3854937	Inhibition of MKNK2 (unknown origin) after 60 mins in presence of ATP by caliper microfluidic mobility shift assay	B	c1cnc2ccc(-n3cnc4cnc5cnc(-c6ccsc6)cc5c43)cc2c1		CHEMBL3910848	<	IC50	nM	1400.0	CHEMBL4204	Homo sapiens	IC50	uM	1.4
187089	17601858	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCO)sc2ncnc(Nc3ccc(F)cc3OCC3(CC#N)CC3)c12		CHEMBL3702330	=	IC50	nM	65.0	CHEMBL4204	Homo sapiens	IC50	nM	65.0
187090	17601859	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3ccc(F)cc3OCC3(CC#N)CC3)c12		CHEMBL3702331	=	IC50	nM	78.0	CHEMBL4204	Homo sapiens	IC50	nM	78.0
187091	17601860	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3ccc(F)cc3OCC(F)(F)F)c12		CHEMBL3702332	=	IC50	nM	66.0	CHEMBL4204	Homo sapiens	IC50	nM	66.0
187092	17601861	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(N)=O)sc2ncnc(Nc3ccc(F)cc3OCC(F)F)c12		CHEMBL3702333	=	IC50	nM	16.0	CHEMBL4204	Homo sapiens	IC50	nM	16.0
187093	17601862	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCO)sc2ncnc(Nc3ccc(F)cc3OCC(F)F)c12		CHEMBL3702334	=	IC50	nM	30.0	CHEMBL4204	Homo sapiens	IC50	nM	30.0
187094	17601863	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3ccc(F)cc3OCC(F)F)c12		CHEMBL3702335	=	IC50	nM	23.0	CHEMBL4204	Homo sapiens	IC50	nM	23.0
187095	17601864	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCO)sc2ncnc(Nc3ccc(F)cc3OCC3CC3(F)F)c12		CHEMBL3702336	=	IC50	nM	19.0	CHEMBL4204	Homo sapiens	IC50	nM	19.0
187096	17601865	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(N)=O)sc2ncnc(Nc3ccc(F)cc3OCC3CC3(F)F)c12		CHEMBL3702337	=	IC50	nM	8.0	CHEMBL4204	Homo sapiens	IC50	nM	8.0
187097	17601866	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3ccc(F)cc3OCC3CC3(F)F)c12		CHEMBL3702338	=	IC50	nM	36.0	CHEMBL4204	Homo sapiens	IC50	nM	36.0
187098	17601867	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COCC(CF)Oc1cc(F)ccc1Nc1ncnc2sc(C(=O)NCCO)c(C)c12		CHEMBL3702339	=	IC50	nM	26.0	CHEMBL4204	Homo sapiens	IC50	nM	26.0
187099	17601868	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COCC(CF)Oc1cc(F)ccc1Nc1ncnc2sc(C(=O)NCCCN(C)C)c(C)c12		CHEMBL3702340	=	IC50	nM	25.0	CHEMBL4204	Homo sapiens	IC50	nM	25.0
187116	17601869	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COCC(CF)Oc1cc(F)ccc1Nc1ncnc2sc(C(=O)NCCO)c(C)c12		CHEMBL3702339	=	IC50	nM	13.0	CHEMBL4204	Homo sapiens	IC50	nM	13.0
187117	17601870	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3ccc(F)cc3OC(C)CF)c12		CHEMBL3702341	=	IC50	nM	7.0	CHEMBL4204	Homo sapiens	IC50	nM	7.0
187118	17601871	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCO)sc2ncnc(Nc3ccc(F)cc3OC(C)CF)c12		CHEMBL3702342	=	IC50	nM	7.0	CHEMBL4204	Homo sapiens	IC50	nM	7.0
187119	17601872	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(N)=O)sc2ncnc(Nc3ccc(F)cc3OC(C)CF)c12		CHEMBL3702343	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
187120	17601873	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCO)sc2ncnc(Nc3ccc(F)cc3OC(CO)CO)c12		CHEMBL3702344	=	IC50	nM	170.0	CHEMBL4204	Homo sapiens	IC50	nM	170.0
187121	17601874	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(N)=O)sc2ncnc(Nc3ccc(F)cc3OC(CO)CO)c12		CHEMBL3702345	=	IC50	nM	56.0	CHEMBL4204	Homo sapiens	IC50	nM	56.0
187122	17601875	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3ccc(F)cc3OC(CO)CO)c12		CHEMBL3702346	=	IC50	nM	146.0	CHEMBL4204	Homo sapiens	IC50	nM	146.0
187123	17601876	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(N)=O)sc2ncnc(Nc3ccc(F)cc3OCCO)c12		CHEMBL3702347	=	IC50	nM	27.0	CHEMBL4204	Homo sapiens	IC50	nM	27.0
187124	17601877	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCO)sc2ncnc(Nc3ccc(F)cc3OCCO)c12		CHEMBL3702348	=	IC50	nM	65.0	CHEMBL4204	Homo sapiens	IC50	nM	65.0
187125	17601878	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3ccc(F)cc3OCCO)c12		CHEMBL3702349	=	IC50	nM	69.0	CHEMBL4204	Homo sapiens	IC50	nM	69.0
187126	17601879	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COCC(C)Oc1cc(F)ccc1Nc1ncnc2sc(C(=O)NCCCN(C)C)c(C)c12		CHEMBL3702350	=	IC50	nM	35.0	CHEMBL4204	Homo sapiens	IC50	nM	35.0
187127	17601880	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COCC(C)Oc1cc(F)ccc1Nc1ncnc2sc(C(=O)NCCO)c(C)c12		CHEMBL3702351	=	IC50	nM	25.0	CHEMBL4204	Homo sapiens	IC50	nM	25.0
187128	17601881	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COCC(C)Oc1cc(F)ccc1Nc1ncnc2sc(C(N)=O)c(C)c12		CHEMBL3702352	=	IC50	nM	8.0	CHEMBL4204	Homo sapiens	IC50	nM	8.0
187129	17601882	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3ccc(F)cc3OCCC(F)(F)F)c12		CHEMBL3702353	=	IC50	nM	26.0	CHEMBL4204	Homo sapiens	IC50	nM	26.0
187130	17601883	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3ccc(F)cc3OCC(C)F)c12		CHEMBL3702354	=	IC50	nM	35.0	CHEMBL4204	Homo sapiens	IC50	nM	35.0
187131	17601884	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	IC50	nM	13.0	CHEMBL4204	Homo sapiens	IC50	nM	13.0
187132	17601885	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NC2CCN(C)CC2)sc2ncnc(Nc3ccc(F)cc3OC(C)CC(F)(F)F)c12		CHEMBL3702355	=	IC50	nM	25.0	CHEMBL4204	Homo sapiens	IC50	nM	25.0
187133	17601886	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN2CCCC2)sc2ncnc(Nc3ccc(F)cc3OC(C)CC(F)(F)F)c12		CHEMBL3702356	=	IC50	nM	12.0	CHEMBL4204	Homo sapiens	IC50	nM	12.0
269910	17652229	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)O)sc2ncnc(Nc3ccc(F)cc3OC(C)CNC(=O)OC(C)(C)C)c12		CHEMBL3698909	=	IC50	nM	52.0	CHEMBL4204	Homo sapiens	IC50	nM	52.0
269911	17652230	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	CNC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(C)CNC(=O)OC(C)(C)C)c2c1C		CHEMBL3698910	=	IC50	nM	342.0	CHEMBL4204	Homo sapiens	IC50	nM	342.0
269912	17652231	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3ccc(F)cc3OC(C)CNC(=O)OC(C)(C)C)c12		CHEMBL3698911	=	IC50	nM	294.0	CHEMBL4204	Homo sapiens	IC50	nM	294.0
269913	17652232	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCO)sc2ncnc(Nc3ccc(F)cc3OC(C)CNC(=O)OC(C)(C)C)c12		CHEMBL3639977	=	IC50	nM	459.0	CHEMBL4204	Homo sapiens	IC50	nM	459.0
269914	17652233	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(C)CN)c2c1C		CHEMBL3698912	=	IC50	nM	70.0	CHEMBL4204	Homo sapiens	IC50	nM	70.0
269915	17652234	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3ccc(F)cc3OC(C)CN)c12		CHEMBL3698913	=	IC50	nM	41.0	CHEMBL4204	Homo sapiens	IC50	nM	41.0
269916	17652235	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCO)sc2ncnc(Nc3ccc(F)cc3OC(C)CN)c12		CHEMBL3698914	=	IC50	nM	50.0	CHEMBL4204	Homo sapiens	IC50	nM	50.0
269917	17652236	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	CNC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(C)CN)c2c1C		CHEMBL3698915	=	IC50	nM	23.0	CHEMBL4204	Homo sapiens	IC50	nM	23.0
269918	17652237	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(C)CNS(C)(=O)=O)c2c1C		CHEMBL3698916	=	IC50	nM	41.0	CHEMBL4204	Homo sapiens	IC50	nM	41.0
269919	17652238	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(C)CNS(=O)(=O)C(C)C)c2c1C		CHEMBL3698917	=	IC50	nM	204.0	CHEMBL4204	Homo sapiens	IC50	nM	204.0
269920	17652239	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3ccc(F)cc3OC(C)CNS(C)(=O)=O)c12		CHEMBL3698918	=	IC50	nM	18.0	CHEMBL4204	Homo sapiens	IC50	nM	18.0
269921	17652240	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(C)CNC(C)=O)c2c1C		CHEMBL3698919	=	IC50	nM	261.0	CHEMBL4204	Homo sapiens	IC50	nM	261.0
269922	17652241	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(C)CNC(=O)C(C)C)c2c1C		CHEMBL3698920	=	IC50	nM	443.0	CHEMBL4204	Homo sapiens	IC50	nM	443.0
269923	17652242	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(C)CN(C)C)c2c1C		CHEMBL3698921	=	IC50	nM	3144.0	CHEMBL4204	Homo sapiens	IC50	nM	3144.0
269924	17652243	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(N)=O)sc2ncnc(Nc3ccc(F)cc3OC(C)CNC(=O)OC(C)(C)C)c12		CHEMBL3698922	=	IC50	nM	230.0	CHEMBL4204	Homo sapiens	IC50	nM	230.0
269925	17652244	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(N)=O)sc2ncnc(Nc3ccc(F)cc3O[C@@H](C)CNC(=O)OC(C)(C)C)c12		CHEMBL3698923	=	IC50	nM	164.0	CHEMBL4204	Homo sapiens	IC50	nM	164.0
269926	17652245	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(N)=O)sc2ncnc(Nc3ccc(F)cc3O[C@@H](C)CN)c12		CHEMBL3698924	=	IC50	nM	90.0	CHEMBL4204	Homo sapiens	IC50	nM	90.0
269927	17652246	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)O)sc2ncnc(Nc3ccc(F)cc3OC(C)CN)c12		CHEMBL3698925	=	IC50	nM	14.0	CHEMBL4204	Homo sapiens	IC50	nM	14.0
269928	17652247	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(N)=O)sc2ncnc(Nc3ccc(F)cc3OC(C)CNCCC(F)(F)F)c12		CHEMBL3698926	=	IC50	nM	64.0	CHEMBL4204	Homo sapiens	IC50	nM	64.0
269929	17652248	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3ccc(F)cc3OCCN)c2c1C		CHEMBL3698927	=	IC50	nM	577.0	CHEMBL4204	Homo sapiens	IC50	nM	577.0
269930	17652249	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	CCC(CN)Oc1cc(F)ccc1Nc1ncnc2sc(C(=O)OC)c(C)c12		CHEMBL3698928	=	IC50	nM	229.0	CHEMBL4204	Homo sapiens	IC50	nM	229.0
269931	17652250	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3cccnc3OC(C)CN)c2c1C		CHEMBL3698929	=	IC50	nM	418.0	CHEMBL4204	Homo sapiens	IC50	nM	418.0
269932	17652251	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(C)CCN)c2c1C		CHEMBL3698930	=	IC50	nM	52.0	CHEMBL4204	Homo sapiens	IC50	nM	52.0
269933	17652252	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(C)CCNS(C)(=O)=O)c2c1C		CHEMBL3698931	=	IC50	nM	90.0	CHEMBL4204	Homo sapiens	IC50	nM	90.0
269934	17652253	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(C)CCNC(C)=O)c2c1C		CHEMBL3698932	=	IC50	nM	471.0	CHEMBL4204	Homo sapiens	IC50	nM	471.0
269935	17652254	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(C)CCNC(=O)C(C)C)c2c1C		CHEMBL3698933	=	IC50	nM	677.0	CHEMBL4204	Homo sapiens	IC50	nM	677.0
269936	17652255	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	CCCCNC(=O)NCCC(C)Oc1cc(F)ccc1Nc1ncnc2sc(C(=O)OC)c(C)c12		CHEMBL3698934	=	IC50	nM	898.0	CHEMBL4204	Homo sapiens	IC50	nM	898.0
269937	17652256	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(C)CCN(C)C)c2c1C		CHEMBL3698935	=	IC50	nM	1017.0	CHEMBL4204	Homo sapiens	IC50	nM	1017.0
269938	17652257	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3cccnc3OC(C)CCN)c2c1C		CHEMBL3698936	=	IC50	nM	174.0	CHEMBL4204	Homo sapiens	IC50	nM	174.0
269939	17652258	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)O)sc2ncnc(Nc3cccnc3OC(C)CCN)c12		CHEMBL3698937	=	IC50	nM	8.0	CHEMBL4204	Homo sapiens	IC50	nM	8.0
269940	17652259	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3cccnc3OC(C)CCN)c12		CHEMBL3698938	=	IC50	nM	74.0	CHEMBL4204	Homo sapiens	IC50	nM	74.0
269941	17652260	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(N)=O)sc2ncnc(Nc3cccnc3OC(C)CCN)c12		CHEMBL3698939	=	IC50	nM	44.0	CHEMBL4204	Homo sapiens	IC50	nM	44.0
269942	17652261	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(CN)CN)c2c1C		CHEMBL3698940	=	IC50	nM	691.0	CHEMBL4204	Homo sapiens	IC50	nM	691.0
269943	17652262	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(CN)CNC(C)=O)c2c1C		CHEMBL3698941	=	IC50	nM	1526.0	CHEMBL4204	Homo sapiens	IC50	nM	1526.0
269944	17652263	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(CN)CNS(C)(=O)=O)c2c1C		CHEMBL3698942	=	IC50	nM	1166.0	CHEMBL4204	Homo sapiens	IC50	nM	1166.0
269945	17652264	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(C)CC(C)(C)O)c2c1C		CHEMBL3698943	=	IC50	nM	142.0	CHEMBL4204	Homo sapiens	IC50	nM	142.0
269946	17652265	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)O)sc2ncnc(Nc3ccc(F)cc3OC(C)CC(C)(C)O)c12		CHEMBL3698944	=	IC50	nM	25.0	CHEMBL4204	Homo sapiens	IC50	nM	25.0
269947	17652266	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3ccc(F)cc3OC(C)CC(C)(C)O)c12		CHEMBL3698945	=	IC50	nM	59.0	CHEMBL4204	Homo sapiens	IC50	nM	59.0
269948	17652267	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)O)sc2ncnc(Nc3cccnc3OC(C)C(F)(F)F)c12		CHEMBL3698946	=	IC50	nM	15.0	CHEMBL4204	Homo sapiens	IC50	nM	15.0
269949	17652268	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(N)=O)sc2ncnc(Nc3cccnc3OC(C)C(F)(F)F)c12		CHEMBL3698947	=	IC50	nM	11.0	CHEMBL4204	Homo sapiens	IC50	nM	11.0
269950	17652269	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NC2CCN(C)CC2)sc2ncnc(Nc3cccnc3OC(C)C(F)(F)F)c12		CHEMBL3698948	=	IC50	nM	54.0	CHEMBL4204	Homo sapiens	IC50	nM	54.0
269951	17652270	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3cccnc3OC(C)C(F)(F)F)c12		CHEMBL3698949	=	IC50	nM	42.0	CHEMBL4204	Homo sapiens	IC50	nM	42.0
269952	17652271	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	CNC(=O)c1sc2ncnc(Nc3cccnc3OC(C)C(F)(F)F)c2c1C		CHEMBL3698950	=	IC50	nM	12.0	CHEMBL4204	Homo sapiens	IC50	nM	12.0
269953	17652272	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCC#CCN(C)C)sc2ncnc(Nc3cccnc3OC(C)C(F)(F)F)c12		CHEMBL3698951	=	IC50	nM	24.0	CHEMBL4204	Homo sapiens	IC50	nM	24.0
269954	17652273	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCO)sc2ncnc(Nc3cccnc3OC(C)C(F)(F)F)c12		CHEMBL3698952	=	IC50	nM	20.0	CHEMBL4204	Homo sapiens	IC50	nM	20.0
269955	17652274	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	CCOCC(COCC)Oc1cc(F)ccc1Nc1ncnc2sc(C(N)=O)c(C)c12		CHEMBL3698953	=	IC50	nM	296.0	CHEMBL4204	Homo sapiens	IC50	nM	296.0
269956	17652275	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(CF)CF)c2c1C		CHEMBL3698954	=	IC50	nM	78.0	CHEMBL4204	Homo sapiens	IC50	nM	78.0
269957	17652276	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)O)sc2ncnc(Nc3ccc(F)cc3OC(CF)CF)c12		CHEMBL3698955	=	IC50	nM	6.0	CHEMBL4204	Homo sapiens	IC50	nM	6.0
269958	17652277	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(N)=O)sc2ncnc(Nc3ccc(F)cc3OC(CF)CF)c12		CHEMBL3698956	=	IC50	nM	4.0	CHEMBL4204	Homo sapiens	IC50	nM	4.0
269959	17652278	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	CNC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(CF)CF)c2c1C		CHEMBL3698957	=	IC50	nM	8.0	CHEMBL4204	Homo sapiens	IC50	nM	8.0
269960	17652279	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)N[C@@H]2C[C@H]2NC(=O)OC(C)(C)C)sc2ncnc(Nc3ccc(F)cc3OC(CF)CF)c12		CHEMBL3698958	=	IC50	nM	13.0	CHEMBL4204	Homo sapiens	IC50	nM	13.0
269961	17652280	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3ccc(F)cc3OC(CF)CF)c12		CHEMBL3698959	=	IC50	nM	10.0	CHEMBL4204	Homo sapiens	IC50	nM	10.0
269962	17652281	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCN(C)C)sc2ncnc(Nc3ccc(F)cc3OC(CF)CF)c12		CHEMBL3698960	=	IC50	nM	17.0	CHEMBL4204	Homo sapiens	IC50	nM	17.0
269963	17652282	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCO)sc2ncnc(Nc3ccc(F)cc3OC(CF)CF)c12		CHEMBL3702249	=	IC50	nM	8.0	CHEMBL4204	Homo sapiens	IC50	nM	8.0
269964	17652283	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCC#CCN(C)C)sc2ncnc(Nc3ccc(F)cc3OC(CF)CF)c12		CHEMBL3702250	=	IC50	nM	7.0	CHEMBL4204	Homo sapiens	IC50	nM	7.0
269965	17652284	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN2CCCC2)sc2ncnc(Nc3ccc(F)cc3OC(CF)CF)c12		CHEMBL3702251	=	IC50	nM	7.0	CHEMBL4204	Homo sapiens	IC50	nM	7.0
269966	17652285	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NS(C)(=O)=O)sc2ncnc(Nc3ccc(F)cc3OC(CF)CF)c12		CHEMBL3702252	=	IC50	nM	7.0	CHEMBL4204	Homo sapiens	IC50	nM	7.0
269967	17652286	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)N[C@@H]2C[C@H]2N)sc2ncnc(Nc3ccc(F)cc3OC(CF)CF)c12		CHEMBL3702253	=	IC50	nM	12.0	CHEMBL4204	Homo sapiens	IC50	nM	12.0
269968	17652287	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3ccc(F)cc3OCC3CCOCC3)c12		CHEMBL3702254	=	IC50	nM	790.0	CHEMBL4204	Homo sapiens	IC50	nM	790.0
269969	17652288	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)O)sc2ncnc(Nc3cccnc3OCC(C)F)c12		CHEMBL3702255	=	IC50	nM	33.0	CHEMBL4204	Homo sapiens	IC50	nM	33.0
269970	17652289	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCO)sc2ncnc(Nc3cccnc3OCC(C)F)c12		CHEMBL3702256	=	IC50	nM	58.0	CHEMBL4204	Homo sapiens	IC50	nM	58.0
269971	17652290	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3cccnc3OCC(C)F)c12		CHEMBL3702257	=	IC50	nM	73.0	CHEMBL4204	Homo sapiens	IC50	nM	73.0
269972	17652291	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COCC(C)Oc1ncccc1Nc1ncnc2sc(C(N)=O)c(C)c12		CHEMBL3702258	=	IC50	nM	26.0	CHEMBL4204	Homo sapiens	IC50	nM	26.0
269973	17652292	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COCC(C)Oc1ncccc1Nc1ncnc2sc(C(=O)NCCO)c(C)c12		CHEMBL3702259	=	IC50	nM	78.0	CHEMBL4204	Homo sapiens	IC50	nM	78.0
269974	17652293	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COCC(C)Oc1ncccc1Nc1ncnc2sc(C(=O)NCCCN(C)C)c(C)c12		CHEMBL3702260	=	IC50	nM	93.0	CHEMBL4204	Homo sapiens	IC50	nM	93.0
269975	17652294	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(N)=O)sc2ncnc(Nc3cccnc3OCCO)c12		CHEMBL3702261	=	IC50	nM	86.0	CHEMBL4204	Homo sapiens	IC50	nM	86.0
269976	17652295	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3cccnc3OCCO)c12		CHEMBL3702262	=	IC50	nM	288.0	CHEMBL4204	Homo sapiens	IC50	nM	288.0
269977	17652296	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)O)sc2ncnc(Nc3cccnc3OCC(F)F)c12		CHEMBL3702263	=	IC50	nM	20.0	CHEMBL4204	Homo sapiens	IC50	nM	20.0
269978	17652297	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(N)=O)sc2ncnc(Nc3cccnc3OCC(F)F)c12		CHEMBL3702264	=	IC50	nM	18.0	CHEMBL4204	Homo sapiens	IC50	nM	18.0
269979	17652298	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCO)sc2ncnc(Nc3cccnc3OCC(F)F)c12		CHEMBL3702265	=	IC50	nM	48.0	CHEMBL4204	Homo sapiens	IC50	nM	48.0
269980	17652299	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3cccnc3OCC(F)F)c12		CHEMBL3702266	=	IC50	nM	57.0	CHEMBL4204	Homo sapiens	IC50	nM	57.0
269981	17652300	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	CCNC(=O)C(C)Oc1cc(F)ccc1Nc1ncnc2sc(C(=O)OC)c(C)c12		CHEMBL3702267	=	IC50	nM	77.0	CHEMBL4204	Homo sapiens	IC50	nM	77.0
269982	17652301	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	CCNC(=O)C(C)Oc1cc(F)ccc1Nc1ncnc2sc(C(=O)O)c(C)c12		CHEMBL3702268	=	IC50	nM	19.0	CHEMBL4204	Homo sapiens	IC50	nM	19.0
269983	17652302	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	CCNC(=O)C(C)Oc1cc(F)ccc1Nc1ncnc2sc(C(N)=O)c(C)c12		CHEMBL3702269	=	IC50	nM	11.0	CHEMBL4204	Homo sapiens	IC50	nM	11.0
269984	17652303	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	CCNC(=O)C(C)Oc1cc(F)ccc1Nc1ncnc2sc(C(=O)NC)c(C)c12		CHEMBL3702270	=	IC50	nM	13.0	CHEMBL4204	Homo sapiens	IC50	nM	13.0
269985	17652304	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	CCNC(=O)C(C)Oc1cc(F)ccc1Nc1ncnc2sc(C(=O)NCCCN(C)C)c(C)c12		CHEMBL3702271	=	IC50	nM	20.0	CHEMBL4204	Homo sapiens	IC50	nM	20.0
269986	17652305	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(C)C(=O)NCCN(C)C)c2c1C		CHEMBL3702272	=	IC50	nM	267.0	CHEMBL4204	Homo sapiens	IC50	nM	267.0
269987	17652306	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)O)sc2ncnc(Nc3ccc(F)cc3OCC3(CC#N)CC3)c12		CHEMBL3702318	=	IC50	nM	19.0	CHEMBL4204	Homo sapiens	IC50	nM	19.0
269988	17652307	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)O)sc2ncnc(Nc3ccc(F)cc3OCC(F)F)c12		CHEMBL3702319	=	IC50	nM	13.0	CHEMBL4204	Homo sapiens	IC50	nM	13.0
269989	17652308	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)O)sc2ncnc(Nc3ccc(F)cc3OCC3CC3(F)F)c12		CHEMBL3702320	=	IC50	nM	8.0	CHEMBL4204	Homo sapiens	IC50	nM	8.0
269990	17652309	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COCC(CF)Oc1cc(F)ccc1Nc1ncnc2sc(C(=O)O)c(C)c12		CHEMBL3702321	=	IC50	nM	23.0	CHEMBL4204	Homo sapiens	IC50	nM	23.0
269991	17652310	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)O)sc2ncnc(Nc3ccc(F)cc3OC(C)CF)c12		CHEMBL3702322	=	IC50	nM	5.0	CHEMBL4204	Homo sapiens	IC50	nM	5.0
269992	17652311	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)O)sc2ncnc(Nc3ccc(F)cc3OCCO)c12		CHEMBL3702323	=	IC50	nM	13.0	CHEMBL4204	Homo sapiens	IC50	nM	13.0
269993	17652312	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COCC(C)Oc1cc(F)ccc1Nc1ncnc2sc(C(=O)O)c(C)c12		CHEMBL3702324	=	IC50	nM	18.0	CHEMBL4204	Homo sapiens	IC50	nM	18.0
269994	17652313	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)O)sc2ncnc(Nc3ccc(F)cc3OCCC(F)(F)F)c12		CHEMBL3702325	=	IC50	nM	14.0	CHEMBL4204	Homo sapiens	IC50	nM	14.0
269995	17652314	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)O)sc2ncnc(Nc3ccc(F)cc3OCC(C)F)c12		CHEMBL3702326	=	IC50	nM	12.0	CHEMBL4204	Homo sapiens	IC50	nM	12.0
269996	17652315	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCC2CCN(C)C2)sc2ncnc(Nc3ccc(F)cc3OC(C)CF)c12		CHEMBL3702327	=	IC50	nM	12.0	CHEMBL4204	Homo sapiens	IC50	nM	12.0
269997	17652316	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN2CCCC2)sc2ncnc(Nc3ccc(F)cc3OC(C)CF)c12		CHEMBL3702328	=	IC50	nM	6.0	CHEMBL4204	Homo sapiens	IC50	nM	6.0
269998	17652317	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NC2CCN(C)CC2)sc2ncnc(Nc3ccc(F)cc3OC(C)CF)c12		CHEMBL3702329	=	IC50	nM	11.0	CHEMBL4204	Homo sapiens	IC50	nM	11.0
269999	17652318	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3cccnc3OCC3(CC#N)CC3)c2c1C		CHEMBL3702273	=	IC50	nM	47.0	CHEMBL4204	Homo sapiens	IC50	nM	47.0
270000	17652319	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(N)=O)sc2ncnc(Nc3cccnc3OCC3(CC#N)CC3)c12		CHEMBL3702274	=	IC50	nM	16.0	CHEMBL4204	Homo sapiens	IC50	nM	16.0
270001	17652320	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3cccnc3OCC3CC3(F)F)c2c1C		CHEMBL3702275	=	IC50	nM	54.0	CHEMBL4204	Homo sapiens	IC50	nM	54.0
270002	17652321	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(N)=O)sc2ncnc(Nc3cccnc3OCC3CC3(F)F)c12		CHEMBL3702276	=	IC50	nM	15.0	CHEMBL4204	Homo sapiens	IC50	nM	15.0
270003	17652322	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3cccnc3OC(C)C)c2c1C		CHEMBL3702277	=	IC50	nM	12.0	CHEMBL4204	Homo sapiens	IC50	nM	12.0
270004	17652323	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3cccnc3OC(C)C)c12		CHEMBL3640011	=	IC50	nM	29.0	CHEMBL4204	Homo sapiens	IC50	nM	29.0
270005	17652324	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN2CCCC2)sc2ncnc(Nc3cccnc3OC(C)C)c12		CHEMBL3702278	=	IC50	nM	35.0	CHEMBL4204	Homo sapiens	IC50	nM	35.0
270006	17652325	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCCO)sc2ncnc(Nc3cccnc3OC(C)C)c12		CHEMBL3702279	=	IC50	nM	42.0	CHEMBL4204	Homo sapiens	IC50	nM	42.0
270007	17652326	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	CCNC(=O)c1sc2ncnc(Nc3cccnc3OC(C)C)c2c1C		CHEMBL3702280	=	IC50	nM	26.0	CHEMBL4204	Homo sapiens	IC50	nM	26.0
270008	17652327	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN2CCOCC2)sc2ncnc(Nc3cccnc3OC(C)C)c12		CHEMBL3702281	=	IC50	nM	44.0	CHEMBL4204	Homo sapiens	IC50	nM	44.0
270009	17652328	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCC2CNCCO2)sc2ncnc(Nc3cccnc3OC(C)C)c12		CHEMBL3702282	=	IC50	nM	25.0	CHEMBL4204	Homo sapiens	IC50	nM	25.0
270010	17652329	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)N[C@H]2C[C@@H]2N)sc2ncnc(Nc3cccnc3OC(C)C)c12		CHEMBL3702283	=	IC50	nM	55.0	CHEMBL4204	Homo sapiens	IC50	nM	55.0
270011	17652330	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	CNC(=O)CNC(=O)c1sc2ncnc(Nc3cccnc3OC(C)C)c2c1C		CHEMBL3702284	=	IC50	nM	27.0	CHEMBL4204	Homo sapiens	IC50	nM	27.0
270012	17652331	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCc2cnco2)sc2ncnc(Nc3cccnc3OC(C)C)c12		CHEMBL3702285	=	IC50	nM	19.0	CHEMBL4204	Homo sapiens	IC50	nM	19.0
270013	17652332	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCN2CCCCC2)sc2ncnc(Nc3cccnc3OC(C)C)c12		CHEMBL3702286	=	IC50	nM	63.0	CHEMBL4204	Homo sapiens	IC50	nM	63.0
270014	17652333	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NC2CCN(C)CC2)sc2ncnc(Nc3cccnc3OC(C)C)c12		CHEMBL3702287	=	IC50	nM	32.0	CHEMBL4204	Homo sapiens	IC50	nM	32.0
270015	17652334	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCO)sc2ncnc(Nc3cccnc3OC(C)C)c12		CHEMBL3702288	=	IC50	nM	45.0	CHEMBL4204	Homo sapiens	IC50	nM	45.0
270016	17652335	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCO)sc2ncnc(Nc3cccnc3OC(C)C)c12		CHEMBL3702289	=	IC50	nM	31.0	CHEMBL4204	Homo sapiens	IC50	nM	31.0
270017	17652336	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCC(C)O)sc2ncnc(Nc3cccnc3OC(C)C)c12		CHEMBL3702290	=	IC50	nM	54.0	CHEMBL4204	Homo sapiens	IC50	nM	54.0
270018	17652337	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCC2COCCN2)sc2ncnc(Nc3cccnc3OC(C)C)c12		CHEMBL3702291	=	IC50	nM	64.0	CHEMBL4204	Homo sapiens	IC50	nM	64.0
270019	17652338	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCc2cn(C)cn2)sc2ncnc(Nc3cccnc3OC(C)C)c12		CHEMBL3702292	=	IC50	nM	24.0	CHEMBL4204	Homo sapiens	IC50	nM	24.0
270020	17652339	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCC#CCN(C)C)sc2ncnc(Nc3cccnc3OC(C)C)c12		CHEMBL3702293	=	IC50	nM	22.0	CHEMBL4204	Homo sapiens	IC50	nM	22.0
270021	17652340	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)N[C@H]2CC[C@H](O)CC2)sc2ncnc(Nc3cccnc3OC(C)C)c12		CHEMBL3702294	=	IC50	nM	46.0	CHEMBL4204	Homo sapiens	IC50	nM	46.0
270022	17652341	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCC#N)sc2ncnc(Nc3cccnc3OC(C)C)c12		CHEMBL3702295	=	IC50	nM	26.0	CHEMBL4204	Homo sapiens	IC50	nM	26.0
270023	17652342	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCC#CCN)sc2ncnc(Nc3cccnc3OC(C)C)c12		CHEMBL3702296	=	IC50	nM	14.0	CHEMBL4204	Homo sapiens	IC50	nM	14.0
270024	17652343	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(C)C)c2c1C		CHEMBL3632739	=	IC50	nM	4.0	CHEMBL4204	Homo sapiens	IC50	nM	4.0
270025	17652344	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3ccc(F)cc3OC(C)C)c12		CHEMBL3659491	=	IC50	nM	6.0	CHEMBL4204	Homo sapiens	IC50	nM	6.0
270026	17652345	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	CCNC(=O)C(C)Oc1cc(F)ccc1Nc1ncnc2sc(C(=O)O)c(C)c12		CHEMBL3702268	=	IC50	nM	19.0	CHEMBL4204	Homo sapiens	IC50	nM	19.0
270027	17652346	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	CCNC(=O)C(C)Oc1cc(F)ccc1Nc1ncnc2sc(C(=O)NCCCN(C)C)c(C)c12		CHEMBL3702271	=	IC50	nM	20.0	CHEMBL4204	Homo sapiens	IC50	nM	20.0
270028	17652347	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	CCNC(=O)C(C)Oc1cc(F)ccc1Nc1ncnc2sc(C(=O)NCCO)c(C)c12		CHEMBL3702297	=	IC50	nM	31.0	CHEMBL4204	Homo sapiens	IC50	nM	31.0
270029	17652348	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCO)sc2ncnc(Nc3cccnc3OC(C)CCN)c12		CHEMBL3702298	=	IC50	nM	70.0	CHEMBL4204	Homo sapiens	IC50	nM	70.0
270030	17652349	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCO)sc2ncnc(Nc3cccnc3OC(C)CCNS(C)(=O)=O)c12		CHEMBL3702299	=	IC50	nM	62.0	CHEMBL4204	Homo sapiens	IC50	nM	62.0
270031	17652350	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)O)sc2ncnc(Nc3cccnc3OC(C)CCNS(C)(=O)=O)c12		CHEMBL3702300	=	IC50	nM	24.0	CHEMBL4204	Homo sapiens	IC50	nM	24.0
270032	17652351	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(N)=O)sc2ncnc(Nc3cccnc3OC(C)CCNS(C)(=O)=O)c12		CHEMBL3702301	=	IC50	nM	20.0	CHEMBL4204	Homo sapiens	IC50	nM	20.0
270033	17652352	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3cccnc3OC(C)CCNS(C)(=O)=O)c12		CHEMBL3702302	=	IC50	nM	84.0	CHEMBL4204	Homo sapiens	IC50	nM	84.0
270034	17652353	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3ccc(C#N)cc3OC(CF)CF)c2c1C		CHEMBL3702303	=	IC50	nM	125.0	CHEMBL4204	Homo sapiens	IC50	nM	125.0
270035	17652354	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN2CCCC2)sc2ncnc(Nc3ccc(C#N)cc3OC(CF)CF)c12		CHEMBL3702304	=	IC50	nM	12.0	CHEMBL4204	Homo sapiens	IC50	nM	12.0
270036	17652355	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3ccc(C#N)cc3OC(CF)CF)c12		CHEMBL3702305	=	IC50	nM	8.0	CHEMBL4204	Homo sapiens	IC50	nM	8.0
270037	17652356	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NC2CCN(C)CC2)sc2ncnc(Nc3ccc(C#N)cc3OC(CF)CF)c12		CHEMBL3702306	=	IC50	nM	13.0	CHEMBL4204	Homo sapiens	IC50	nM	13.0
270038	17652357	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCO)sc2ncnc(Nc3ccc(C#N)cc3OC(CF)CF)c12		CHEMBL3702307	=	IC50	nM	10.0	CHEMBL4204	Homo sapiens	IC50	nM	10.0
270039	17652358	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCC#CCN(C)C)sc2ncnc(Nc3ccc(C#N)cc3OC(CF)CF)c12		CHEMBL3702308	=	IC50	nM	25.0	CHEMBL4204	Homo sapiens	IC50	nM	25.0
270040	17652359	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCC#N)sc2ncnc(Nc3ccc(C#N)cc3OC(CF)CF)c12		CHEMBL3702309	=	IC50	nM	7.0	CHEMBL4204	Homo sapiens	IC50	nM	7.0
270041	17652360	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(N)=O)sc2ncnc(Nc3ccc(F)cc3OC(C)C#N)c12		CHEMBL3702310	=	IC50	nM	11.0	CHEMBL4204	Homo sapiens	IC50	nM	11.0
270042	17652361	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(C)C(=O)O)c2c1C		CHEMBL3702311	=	IC50	nM	5403.0	CHEMBL4204	Homo sapiens	IC50	nM	5403.0
270043	17652362	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(C)C(=O)NCCCN)c2c1C		CHEMBL3702312	=	IC50	nM	314.0	CHEMBL4204	Homo sapiens	IC50	nM	314.0
270044	17652363	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCO)sc2ncnc(Nc3ccc(F)cc3OC(C)C(=O)NCCCN)c12		CHEMBL3702313	=	IC50	nM	110.0	CHEMBL4204	Homo sapiens	IC50	nM	110.0
270045	17652364	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(C)C(=O)NCCN)c2c1C		CHEMBL3702314	=	IC50	nM	119.0	CHEMBL4204	Homo sapiens	IC50	nM	119.0
270046	17652365	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCO)sc2ncnc(Nc3ccc(F)cc3OC(C)C(=O)NCCN)c12		CHEMBL3702315	=	IC50	nM	29.0	CHEMBL4204	Homo sapiens	IC50	nM	29.0
270047	17652366	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(N)=O)sc2ncnc(Nc3ccc(F)cc3OC(C)C(C)(C)O)c12		CHEMBL3702316	=	IC50	nM	37.0	CHEMBL4204	Homo sapiens	IC50	nM	37.0
270048	17652367	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	CCNC(=O)C(C)Oc1cc(F)ccc1Nc1ncnc2sc(C(=O)OC)c(C)c12		CHEMBL3702267	=	IC50	nM	77.0	CHEMBL4204	Homo sapiens	IC50	nM	77.0
270049	17652368	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	COC(=O)c1sc2ncnc(Nc3ccc(F)cc3OC(C)C(=O)NCCN(C)C)c2c1C		CHEMBL3702272	=	IC50	nM	267.0	CHEMBL4204	Homo sapiens	IC50	nM	267.0
270050	17652369	CHEMBL3706271	Inhibition Assay: Inhibition of kinase activity of Mnk1 and Mnk2a was assessed with the same assay system, using pre-activated GST-Mnk1 or GST-Mnk2a, respectively. The kinase reaction contains 30 uM substrate peptide, 20 uM ATP, 60 nM ligand and one of either 25 nM pre-activated Mnk1 or 2.5 nM pre-activated Mnk2a. The reaction buffer conditions are 16 mM HEPES/KOH pH 7.4, 8 mM MgCl2, 0.4 mM DTT, 0.08% (w/v) bovine serum albumin (BSA, Sigma, Germany, cat. no. A3059), 0.008% (w/v) Pluronic F127 (Sigma, Germany, cat. no. P2443), 3% (v/v) DMSO (Applichem, Germany, cat. no. A3006). The kinase reaction is at 30 C. for 40 min. The kinase reaction is terminated by addition of 0.67 reaction volumes of 1 uM antibody in 20 mM HEPES/KOH pH 7.4, 50 mM ethylenediaminetetraacetic acid, disodium salt (EDTA, Sigma, Germany, cat. no. E5134), 0.5 mM DTT, 0.05% (w/v) polyoxyethylene-sorbitan monolaureate (Tween 20, Sigma, Germany, cat. no. P7949).	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3ccc(F)cc3OC(C)C#N)c12		CHEMBL3702317	=	IC50	nM	17.0	CHEMBL4204	Homo sapiens	IC50	nM	17.0
328371	17706961	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(C#N)cc3OC(C)C(F)(F)F)c12		CHEMBL3906775	=	IC50	nM	17.0	CHEMBL4204	Homo sapiens	IC50	nM	17.0
328372	17706962	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CS(C)(=O)=Nc1cc(C(F)(F)F)c2c(Nc3ccc(F)cc3OC(CF)CF)ncnc2c1		CHEMBL3977414	=	IC50	nM	6.0	CHEMBL4204	Homo sapiens	IC50	nM	6.0
328373	17706963	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(Cl)c12)C(F)(F)F		CHEMBL4111493	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328374	17706964	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	O=S1(=Nc2cc(C(F)(F)F)c3c(Nc4ccc(F)cc4OC(CF)CF)ncnc3c2)CCCC1		CHEMBL3982214	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328375	17706965	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CCS(C)(=O)=Nc1cc(Cl)c2c(Nc3cccnc3O[C@H](C)c3cc(C)no3)ncnc2c1		CHEMBL4111558	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328376	17706966	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CC(CF)Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(F)c12		CHEMBL3893219	=	IC50	nM	5.0	CHEMBL4204	Homo sapiens	IC50	nM	5.0
328377	17706967	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CC(Oc1ncccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(F)c12)C(F)(F)F		CHEMBL3957816	=	IC50	nM	8.0	CHEMBL4204	Homo sapiens	IC50	nM	8.0
328378	17706968	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CCOC(Oc1ncccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(C)c12)C(F)(F)F		CHEMBL3933795	=	IC50	nM	8.0	CHEMBL4204	Homo sapiens	IC50	nM	8.0
328379	17706969	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	O=S1(=Nc2cc(C(F)(F)F)c3c(Nc4ccc(F)cc4OC(CF)CF)ncnc3c2)CCNCC1		CHEMBL3972374	=	IC50	nM	26.0	CHEMBL4204	Homo sapiens	IC50	nM	26.0
328380	17706970	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(C(Oc2cc(F)ccc2Nc2ncnc3cc(N=S(C)(C)=O)cc(C)c23)C(F)(F)F)on1		CHEMBL3942764	=	IC50	nM	17.0	CHEMBL4204	Homo sapiens	IC50	nM	17.0
328381	17706971	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3OC(CF)CF)c12		CHEMBL3982761	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328382	17706972	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(C(C)Oc2cc(C(N)=O)ccc2Nc2ncnc3cc(N=S(C)(C)=O)cc(C)c23)on1		CHEMBL3932256	=	IC50	nM	6.0	CHEMBL4204	Homo sapiens	IC50	nM	6.0
328383	17706973	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OC(C)C(F)(F)F)c12		CHEMBL3890297	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328384	17706974	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(C(N)=O)cc3OC(C)C)c12		CHEMBL3921876	=	IC50	nM	5.0	CHEMBL4204	Homo sapiens	IC50	nM	5.0
328385	17706975	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OC(C)CF)c12		CHEMBL3899248	=	IC50	nM	54.0	CHEMBL4204	Homo sapiens	IC50	nM	54.0
328386	17706976	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc([C@@H](C)Oc2ncccc2Nc2ncnc3cc(N=S(C)(C)=O)cc(Cl)c23)on1		CHEMBL4113944	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328387	17706977	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3cccnc3OC(C)C(F)(F)F)c12		CHEMBL3911848	=	IC50	nM	12.0	CHEMBL4204	Homo sapiens	IC50	nM	12.0
328388	17706978	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CS(C)(=O)=Nc1cc(F)c2c(Nc3ccc(F)cc3OC(CF)CF)ncnc2c1		CHEMBL3936235	=	IC50	nM	6.0	CHEMBL4204	Homo sapiens	IC50	nM	6.0
328389	17706979	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc([C@@H](C)Oc2cc(F)ccc2Nc2ncnc3cc(N=S(C)(C)=O)cc(Cl)c23)on1		CHEMBL4109804	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328390	17706980	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CC(Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(F)c12)C(F)(F)F		CHEMBL3905069	=	IC50	nM	7.0	CHEMBL4204	Homo sapiens	IC50	nM	7.0
328391	17706981	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	O=S1(=Nc2cc(C(F)(F)F)c3c(Nc4ccc(F)cc4OC(CF)CF)ncnc3c2)CCOCC1		CHEMBL3969508	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328392	17706982	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CS(C)(=O)=Nc1cc(C2CC2)c2c(Nc3ccc(F)cc3OC(CF)CF)ncnc2c1		CHEMBL3943394	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328393	17706983	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CCOC(Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(C)c12)C(F)(F)F		CHEMBL3958457	=	IC50	nM	8.0	CHEMBL4204	Homo sapiens	IC50	nM	8.0
328394	17706984	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3OC(C)C(C)(C)O)c12		CHEMBL3930942	=	IC50	nM	5.0	CHEMBL4204	Homo sapiens	IC50	nM	5.0
328395	17706985	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(C(C)Oc2cc(F)ccc2Nc2ncnc3cc(N=S(C)(C)=O)cc(F)c23)on1		CHEMBL3953178	=	IC50	nM	6.0	CHEMBL4204	Homo sapiens	IC50	nM	6.0
328396	17706986	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OC(C)C(C)(C)O)c12		CHEMBL3922022	=	IC50	nM	13.0	CHEMBL4204	Homo sapiens	IC50	nM	13.0
328397	17706987	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3OCc3ccccc3)c12		CHEMBL3944472	=	IC50	nM	6.0	CHEMBL4204	Homo sapiens	IC50	nM	6.0
328398	17706988	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3cccnc3OCC3CCOC3)c12		CHEMBL3916533	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328399	17706989	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(F)(F)F)c12		CHEMBL4108118	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328400	17706990	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3OC(C)C(C)(C)C#N)c12		CHEMBL3907569	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328401	17706991	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc([C@@H](C)Oc2cc(F)ccc2Nc2ncnc3cc(N=S(C)(C)=O)cc(C)c23)on1		CHEMBL4112682	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328402	17706992	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc([C@@H](C)Oc2ncccc2Nc2ncnc3cc(N=S4(=O)CCCC4)cc(C)c23)on1		CHEMBL4112720	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328403	17706993	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OC(C)C(C)(C)C#N)c12		CHEMBL3947467	=	IC50	nM	11.0	CHEMBL4204	Homo sapiens	IC50	nM	11.0
328404	17706994	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OC(C)C)c12		CHEMBL3919671	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328405	17706995	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc([C@@H](C)Oc2cc(F)ccc2Nc2ncnc3cc(N=S4(=O)CCCC4)cc(C)c23)on1		CHEMBL4111425	=	IC50	nM	28.0	CHEMBL4204	Homo sapiens	IC50	nM	28.0
328406	17706996	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3cccnc3O[C@H](C)C(=O)NCC(F)(F)F)c12		CHEMBL4110633	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328407	17706997	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc([C@@H](C)Oc2cc(F)ccc2Nc2ncnc3cc(N=S4(=O)CCCC4)cc(Cl)c23)on1		CHEMBL4114535	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328408	17706998	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CC(C)Oc1ncccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(F)c12		CHEMBL3905165	=	IC50	nM	190.0	CHEMBL4204	Homo sapiens	IC50	nM	190.0
328409	17706999	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc([C@@H](C)Oc2cc(F)ccc2Nc2ncnc3cc(N=S4(=O)CCNCC4)cc(C)c23)on1		CHEMBL4106829	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328410	17707000	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3cccnc3OC(C)C)c12		CHEMBL3896211	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328411	17707001	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc([C@@H](C)Oc2ncccc2Nc2ncnc3cc(N=S(C)(C)=O)cc(C)c23)on1		CHEMBL4111586	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328412	17707002	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CC[C@H](N)C2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC(F)(F)F)c12		CHEMBL4110377	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328413	17707003	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CC[C@@H](N)C2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC(F)(F)F)c12		CHEMBL4113160	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328414	17707004	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3cccnc3O[C@H](C)C(=O)NCC(F)F)c12		CHEMBL4111326	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328415	17707005	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3cccnc3O[C@H](C)C(=O)NCC(F)(F)F)c12		CHEMBL4107072	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328416	17707006	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC(O)C2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC(F)(F)F)c12		CHEMBL4110871	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328417	17707007	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CC4(COC4)C3)cc(Cl)c12)C(=O)NCC(F)(F)F		CHEMBL4112916	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328418	17707008	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(=O)C3CCOCC3)cc(F)c12)C(=O)NCC(F)(F)F		CHEMBL4106897	=	IC50	nM	7.0	CHEMBL4204	Homo sapiens	IC50	nM	7.0
328419	17707009	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CC(C)(C)C3)cc(F)c12)C(=O)NCC#N		CHEMBL4114582	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328420	17707010	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(=O)C2CCNC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC(F)(F)F)c12		CHEMBL4111599	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328421	17707011	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(=O)C2CCOCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC(F)(F)F)c12		CHEMBL4112566	=	IC50	nM	4.0	CHEMBL4204	Homo sapiens	IC50	nM	4.0
328422	17707012	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	COc1cc(N=S(C)(=O)C2CC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC(F)(F)F)c12		CHEMBL4107133	=	IC50	nM	4.0	CHEMBL4204	Homo sapiens	IC50	nM	4.0
328423	17707013	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1ncccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(F)c12)C(=O)NCC(F)(F)F		CHEMBL4112410	=	IC50	nM	10.0	CHEMBL4204	Homo sapiens	IC50	nM	10.0
328424	17707014	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	COC(=O)N1CC2(C1)CS(=O)(=Nc1cc(C)c3c(Nc4ccc(F)cc4O[C@H](C)C(=O)NCC(F)(F)F)ncnc3c1)C2		CHEMBL4107908	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328425	17707015	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCCC3)cc(F)c12)C(=O)NCC#N		CHEMBL4112361	=	IC50	nM	4.0	CHEMBL4204	Homo sapiens	IC50	nM	4.0
328426	17707016	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CC(C)(C)C2)cc2ncnc(Nc3ccc(Cl)cc3O[C@H](C)C(=O)N[C@@H](C)C(F)(F)F)c12		CHEMBL4111078	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328427	17707017	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC(C)C2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC(F)(F)F)c12		CHEMBL4111680	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328428	17707018	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](CO)CF)c12		CHEMBL3956958	=	IC50	nM	4.0	CHEMBL4204	Homo sapiens	IC50	nM	4.0
328429	17707019	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CC(C)(C)C3)cc(Cl)c12)C(=O)NCC(F)(F)F		CHEMBL4111260	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328430	17707020	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CC3(COC3)C2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC(F)(F)F)c12		CHEMBL4112352	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328431	17707021	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3cccnc3O[C@H](C)C(=O)NCC(F)(F)F)c12		CHEMBL4109407	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328432	17707022	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(=O)C(C)(C)C)cc(F)c12)C(=O)NCC(F)(F)F		CHEMBL4113239	=	IC50	nM	18.0	CHEMBL4204	Homo sapiens	IC50	nM	18.0
328433	17707023	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NC(C(F)(F)F)C(F)(F)F)c12		CHEMBL4108347	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328434	17707024	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(=O)C2CC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC(F)(F)F)c12		CHEMBL4113168	=	IC50	nM	5.0	CHEMBL4204	Homo sapiens	IC50	nM	5.0
328435	17707025	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](CO)C(F)(F)F)c12		CHEMBL4109919	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328436	17707026	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CC(C)(C)C2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC(F)(F)F)c12		CHEMBL4110758	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328437	17707027	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CC3(COC3)C2)cc2ncnc(Nc3ccc(Cl)cc3O[C@H](C)C(=O)N[C@@H](C)C(F)(F)F)c12		CHEMBL4108416	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328438	17707028	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(=O)C(C)C)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC(F)(F)F)c12		CHEMBL4112086	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328439	17707029	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	COc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC(F)(F)F)c12		CHEMBL4110142	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328440	17707030	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(F)(F)F)c12		CHEMBL4106460	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328441	17707031	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OC(CF)CF)c12		CHEMBL3966399	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328442	17707032	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OC(C)c3ncco3)c12		CHEMBL3933086	=	IC50	nM	8.0	CHEMBL4204	Homo sapiens	IC50	nM	8.0
328443	17707033	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OC[C@H]3CNC(=O)O3)c12		CHEMBL4112877	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328444	17707034	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OC(C)Cn3ccnc3)c12		CHEMBL3927638	=	IC50	nM	17.0	CHEMBL4204	Homo sapiens	IC50	nM	17.0
328445	17707035	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OCC#N)c12		CHEMBL3963888	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328446	17707036	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OCC3CCCCO3)c12		CHEMBL3926461	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328447	17707037	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OC(C)c3cccnc3)c12		CHEMBL3971651	=	IC50	nM	9.0	CHEMBL4204	Homo sapiens	IC50	nM	9.0
328448	17707038	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OCC3CC3(F)F)c12		CHEMBL3942070	=	IC50	nM	5.0	CHEMBL4204	Homo sapiens	IC50	nM	5.0
328449	17707039	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(COc2cc(F)ccc2Nc2ncnc3cc(N=S(C)(C)=O)cc(C)c23)no1		CHEMBL3973786	=	IC50	nM	7.0	CHEMBL4204	Homo sapiens	IC50	nM	7.0
328450	17707040	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OC(C)C3CCCO3)c12		CHEMBL3940893	=	IC50	nM	23.0	CHEMBL4204	Homo sapiens	IC50	nM	23.0
328451	17707041	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	COc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC(F)(F)F)c12		CHEMBL4109958	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328452	17707042	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CCOC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCCC3)cc(C)c12		CHEMBL4112389	=	IC50	nM	23.0	CHEMBL4204	Homo sapiens	IC50	nM	23.0
328453	17707043	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OCC3CCO3)c12		CHEMBL3909270	=	IC50	nM	8.0	CHEMBL4204	Homo sapiens	IC50	nM	8.0
328454	17707044	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OCC3(C#N)CCC3)c12		CHEMBL3933675	=	IC50	nM	8.0	CHEMBL4204	Homo sapiens	IC50	nM	8.0
328455	17707045	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OC(C)Cn3ccnc3C)c12		CHEMBL3951454	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328456	17707046	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C#CC(C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(C)c12		CHEMBL3943178	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328457	17707047	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CCC(Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(C)c12)C(=O)OC		CHEMBL3956701	=	IC50	nM	138.0	CHEMBL4204	Homo sapiens	IC50	nM	138.0
328458	17707048	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)CN)c12		CHEMBL4114923	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328459	17707049	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OC(C)CC3CCOCC3)c12		CHEMBL3930273	=	IC50	nM	24.0	CHEMBL4204	Homo sapiens	IC50	nM	24.0
328460	17707050	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OC(C)c3ccccn3)c12		CHEMBL3973876	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328461	17707051	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CCOC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(C)c12		CHEMBL4108793	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328462	17707052	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OC(C)c3ccnn3C)c12		CHEMBL3912062	=	IC50	nM	42.0	CHEMBL4204	Homo sapiens	IC50	nM	42.0
328463	17707053	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@@H](C)CN)c12		CHEMBL3919311	=	IC50	nM	16.0	CHEMBL4204	Homo sapiens	IC50	nM	16.0
328464	17707054	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OCC(=O)N(C)C)c12		CHEMBL3987201	=	IC50	nM	4.0	CHEMBL4204	Homo sapiens	IC50	nM	4.0
328465	17707055	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OCC3(C(F)(F)F)CC3)c12		CHEMBL3917357	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328466	17707056	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OC(C)COC3CCOC3)c12		CHEMBL3901964	=	IC50	nM	6.0	CHEMBL4204	Homo sapiens	IC50	nM	6.0
328467	17707057	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OCC3(C)COC3)c12		CHEMBL3936564	=	IC50	nM	17.0	CHEMBL4204	Homo sapiens	IC50	nM	17.0
328468	17707058	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OCCCO)c12		CHEMBL3908621	=	IC50	nM	8.0	CHEMBL4204	Homo sapiens	IC50	nM	8.0
328469	17707059	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OCCC(F)(F)F)c12		CHEMBL3940502	=	IC50	nM	5.0	CHEMBL4204	Homo sapiens	IC50	nM	5.0
328470	17707060	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CCOC(=O)[C@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(C)c12		CHEMBL3902565	=	IC50	nM	16.0	CHEMBL4204	Homo sapiens	IC50	nM	16.0
328471	17707061	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OCC3CCNC(=O)C3)c12		CHEMBL3934970	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328472	17707062	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OC(C)Cn3cccn3)c12		CHEMBL3962466	=	IC50	nM	58.0	CHEMBL4204	Homo sapiens	IC50	nM	58.0
328473	17707063	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OC(C)c3nccs3)c12		CHEMBL3892514	=	IC50	nM	37.0	CHEMBL4204	Homo sapiens	IC50	nM	37.0
328474	17707064	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1noc(C(C)Oc2cc(F)ccc2Nc2ncnc3cc(N=S(C)(C)=O)cc(C)c23)n1		CHEMBL3917005	=	IC50	nM	9.0	CHEMBL4204	Homo sapiens	IC50	nM	9.0
328475	17707065	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OCC3CNC(=O)C3)c12		CHEMBL3978485	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328476	17707066	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OC[C@H]3CCC(=O)N3)c12		CHEMBL4109732	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328477	17707067	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OCc3ccon3)c12		CHEMBL3904562	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328478	17707068	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	COc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC(F)(F)F)c12		CHEMBL4111024	=	IC50	nM	6.0	CHEMBL4204	Homo sapiens	IC50	nM	6.0
328479	17707069	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1nnc(C(C)Oc2cc(F)ccc2Nc2ncnc3cc(N=S(C)(C)=O)cc(C)c23)o1		CHEMBL3908206	=	IC50	nM	33.0	CHEMBL4204	Homo sapiens	IC50	nM	33.0
328480	17707070	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CCC(C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(C)c12		CHEMBL3981737	=	IC50	nM	15.0	CHEMBL4204	Homo sapiens	IC50	nM	15.0
328481	17707071	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OC[C@@H]3CCC(=O)N3)c12		CHEMBL3899161	=	IC50	nM	5.0	CHEMBL4204	Homo sapiens	IC50	nM	5.0
328482	17707072	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OCC3COCCO3)c12		CHEMBL3970350	=	IC50	nM	63.0	CHEMBL4204	Homo sapiens	IC50	nM	63.0
328483	17707073	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OCC3CCOCC3)c12		CHEMBL3893800	=	IC50	nM	10.0	CHEMBL4204	Homo sapiens	IC50	nM	10.0
328484	17707074	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OC(C)c3ccncc3)c12		CHEMBL3959276	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328485	17707075	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCCC3)cc(F)c12)C(=O)NCC(F)(F)F		CHEMBL4112632	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328486	17707076	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OCC3CCOC3)c12		CHEMBL3954028	=	IC50	nM	11.0	CHEMBL4204	Homo sapiens	IC50	nM	11.0
328487	17707077	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(F)c12)C(=O)NCC(F)(F)F		CHEMBL4113312	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328488	17707078	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	COCC(C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(C)c12		CHEMBL3947558	=	IC50	nM	32.0	CHEMBL4204	Homo sapiens	IC50	nM	32.0
328489	17707079	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N[C@H](C)C(F)(F)F)c12		CHEMBL4107454	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328490	17707080	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N(CC(F)(F)F)CC(F)(F)F)c12		CHEMBL4111443	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328491	17707081	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N(CC(F)F)CC(F)F)c12		CHEMBL4110842	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328492	17707082	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NC(C(F)(F)F)C(F)(F)F)c12		CHEMBL4107951	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328493	17707083	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N(CC(F)(F)F)CC(F)(F)F)c12		CHEMBL4107921	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328494	17707084	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC3CCCO3)c12		CHEMBL4112569	=	IC50	nM	5.0	CHEMBL4204	Homo sapiens	IC50	nM	5.0
328495	17707085	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N(C)C)c12		CHEMBL4110356	=	IC50	nM	5.0	CHEMBL4204	Homo sapiens	IC50	nM	5.0
328496	17707086	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N(C)C(C)C)c12		CHEMBL4108318	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328497	17707087	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N3CC[S+]([O-])CC3)c12		CHEMBL4114913	=	IC50	nM	6.0	CHEMBL4204	Homo sapiens	IC50	nM	6.0
328498	17707088	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N3CCC(O)C3)c12		CHEMBL4110929	=	IC50	nM	28.0	CHEMBL4204	Homo sapiens	IC50	nM	28.0
328499	17707089	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N3CCCC3)c12		CHEMBL4109589	=	IC50	nM	5.0	CHEMBL4204	Homo sapiens	IC50	nM	5.0
328500	17707090	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC#N)c12		CHEMBL4113574	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328501	17707091	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC(C)O)c12		CHEMBL4113557	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328502	17707092	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NC3COC3)c12		CHEMBL4108342	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328503	17707093	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N3CCC(O)C3)c12		CHEMBL4114613	=	IC50	nM	4.0	CHEMBL4204	Homo sapiens	IC50	nM	4.0
328504	17707094	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC3CCCO3)c12		CHEMBL4114974	=	IC50	nM	24.0	CHEMBL4204	Homo sapiens	IC50	nM	24.0
328505	17707095	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N(C)Cc3ccccc3)c12		CHEMBL4113475	=	IC50	nM	34.0	CHEMBL4204	Homo sapiens	IC50	nM	34.0
328506	17707096	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N(C)CC(C)C)c12		CHEMBL4114069	=	IC50	nM	5.0	CHEMBL4204	Homo sapiens	IC50	nM	5.0
328507	17707097	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NC3CCOCC3)c12		CHEMBL4110430	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328508	17707098	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NC3CCC3)c12		CHEMBL4112581	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328509	17707099	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N3CCCC3)c12		CHEMBL4115005	=	IC50	nM	20.0	CHEMBL4204	Homo sapiens	IC50	nM	20.0
328510	17707100	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N(C)Cc3ccccc3)c12		CHEMBL4115270	=	IC50	nM	9.0	CHEMBL4204	Homo sapiens	IC50	nM	9.0
328511	17707101	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C#CCNC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(C)c12		CHEMBL4108106	=	IC50	nM	4.0	CHEMBL4204	Homo sapiens	IC50	nM	4.0
328512	17707102	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NC3CCOCC3)c12		CHEMBL4115240	=	IC50	nM	6.0	CHEMBL4204	Homo sapiens	IC50	nM	6.0
328513	17707103	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC(C)O)c12		CHEMBL4115343	=	IC50	nM	4.0	CHEMBL4204	Homo sapiens	IC50	nM	4.0
328514	17707104	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	COCC(C)NC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(C)c12		CHEMBL4106776	=	IC50	nM	12.0	CHEMBL4204	Homo sapiens	IC50	nM	12.0
328515	17707105	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N=S(C)(C)=O)c12		CHEMBL4108469	=	IC50	nM	10.0	CHEMBL4204	Homo sapiens	IC50	nM	10.0
328516	17707106	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NC3CCC3)c12		CHEMBL4115334	=	IC50	nM	5.0	CHEMBL4204	Homo sapiens	IC50	nM	5.0
328517	17707107	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CNC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCCC3)cc(C)c12		CHEMBL4108264	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328518	17707108	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CCN(CC)C(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCCC3)cc(C)c12		CHEMBL4108389	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328519	17707109	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N(C)C3CCCC3)c12		CHEMBL4111539	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328520	17707110	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C#CCNC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCCC3)cc(C)c12		CHEMBL4108049	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328521	17707111	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N(C)CCO)c12		CHEMBL4108646	=	IC50	nM	4.0	CHEMBL4204	Homo sapiens	IC50	nM	4.0
328522	17707112	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCCO)c12		CHEMBL4106820	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328523	17707113	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N3CC[S+]([O-])CC3)c12		CHEMBL4111881	=	IC50	nM	11.0	CHEMBL4204	Homo sapiens	IC50	nM	11.0
328524	17707114	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CCN(CC)C(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(C)c12		CHEMBL4114567	=	IC50	nM	8.0	CHEMBL4204	Homo sapiens	IC50	nM	8.0
328525	17707115	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N3CCOCC3)c12		CHEMBL4106549	=	IC50	nM	56.0	CHEMBL4204	Homo sapiens	IC50	nM	56.0
328526	17707116	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CCCNC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCCC3)cc(C)c12		CHEMBL4113233	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328527	17707117	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CCNC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(C)c12		CHEMBL4115253	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328528	17707118	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	COCCNC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(C)c12		CHEMBL4110873	=	IC50	nM	66.0	CHEMBL4204	Homo sapiens	IC50	nM	66.0
328529	17707119	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC(F)F)c12		CHEMBL4111906	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328530	17707120	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N(C)CCc3ccccc3)c12		CHEMBL4115049	=	IC50	nM	28.0	CHEMBL4204	Homo sapiens	IC50	nM	28.0
328531	17707121	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N[C@@H]3CCC[C@@H]3O)c12		CHEMBL4109449	=	IC50	nM	27.0	CHEMBL4204	Homo sapiens	IC50	nM	27.0
328532	17707122	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC#N)c12		CHEMBL4110019	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328533	17707123	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	COCC(C)NC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCCC3)cc(C)c12		CHEMBL4110707	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328534	17707124	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	COCCN(C)C(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCCC3)cc(C)c12		CHEMBL4109134	=	IC50	nM	7.0	CHEMBL4204	Homo sapiens	IC50	nM	7.0
328535	17707125	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NC(C)C)c12		CHEMBL4109353	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328536	17707126	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC(F)F)c12		CHEMBL4114128	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328537	17707127	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CC#CCNC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCCC3)cc(C)c12		CHEMBL4111309	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328538	17707128	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N[C@H]3CCOC3)c12		CHEMBL4112213	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328539	17707129	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N3CCC(=O)CC3)c12		CHEMBL4108141	=	IC50	nM	15.0	CHEMBL4204	Homo sapiens	IC50	nM	15.0
328540	17707130	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(N)=O)c12		CHEMBL4108717	=	IC50	nM	5.0	CHEMBL4204	Homo sapiens	IC50	nM	5.0
328541	17707131	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CCC(C)NC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(C)c12		CHEMBL4112395	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328542	17707132	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N3CCC3)c12		CHEMBL4110084	=	IC50	nM	19.0	CHEMBL4204	Homo sapiens	IC50	nM	19.0
328543	17707133	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CCC(C)NC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCCC3)cc(C)c12		CHEMBL4111615	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328544	17707134	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N(C)C)c12		CHEMBL4108125	=	IC50	nM	5.0	CHEMBL4204	Homo sapiens	IC50	nM	5.0
328545	17707135	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N(C)CC(C)C)c12		CHEMBL4112011	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328546	17707136	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N(C)C3CCCC3)c12		CHEMBL4110320	=	IC50	nM	16.0	CHEMBL4204	Homo sapiens	IC50	nM	16.0
328547	17707137	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N3CCC(=O)CC3)c12		CHEMBL4114235	=	IC50	nM	9.0	CHEMBL4204	Homo sapiens	IC50	nM	9.0
328548	17707138	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	COCCN(C)C(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(C)c12		CHEMBL4110402	=	IC50	nM	14.0	CHEMBL4204	Homo sapiens	IC50	nM	14.0
328549	17707139	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N3CCN(C)CC3)c12		CHEMBL4115554	=	IC50	nM	25.0	CHEMBL4204	Homo sapiens	IC50	nM	25.0
328550	17707140	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N[C@H]3CCOC3)c12		CHEMBL4110477	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328551	17707141	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC(C)(C)O)c12		CHEMBL4108589	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328552	17707142	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	COC1CCN(C(=O)[C@@H](C)Oc2cc(F)ccc2Nc2ncnc3cc(N=S4(=O)CCCC4)cc(C)c23)CC1		CHEMBL4114622	=	IC50	nM	4.0	CHEMBL4204	Homo sapiens	IC50	nM	4.0
328553	17707143	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NC(C)C)c12		CHEMBL4112522	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328554	17707144	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N(C)CCO)c12		CHEMBL4112710	=	IC50	nM	13.0	CHEMBL4204	Homo sapiens	IC50	nM	13.0
328555	17707145	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N3CCCCC3)c12		CHEMBL4108396	=	IC50	nM	13.0	CHEMBL4204	Homo sapiens	IC50	nM	13.0
328556	17707146	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N(C)CCc3ccccc3)c12		CHEMBL4108445	=	IC50	nM	10.0	CHEMBL4204	Homo sapiens	IC50	nM	10.0
328557	17707147	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N(C)C(C)C)c12		CHEMBL4107729	=	IC50	nM	8.0	CHEMBL4204	Homo sapiens	IC50	nM	8.0
328558	17707148	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N[C@@H]3CCC[C@H]3O)c12		CHEMBL4106486	=	IC50	nM	9.0	CHEMBL4204	Homo sapiens	IC50	nM	9.0
328559	17707149	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CC#CCNC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(C)c12		CHEMBL4107564	=	IC50	nM	9.0	CHEMBL4204	Homo sapiens	IC50	nM	9.0
328560	17707150	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N3CCCCC3)c12		CHEMBL4110518	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328561	17707151	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CCN(C)C(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(C)c12		CHEMBL4115255	=	IC50	nM	4.0	CHEMBL4204	Homo sapiens	IC50	nM	4.0
328562	17707152	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC(C)(C)O)c12		CHEMBL4110716	=	IC50	nM	6.0	CHEMBL4204	Homo sapiens	IC50	nM	6.0
328563	17707153	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N3CCC3)c12		CHEMBL4106493	=	IC50	nM	7.0	CHEMBL4204	Homo sapiens	IC50	nM	7.0
328564	17707154	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC(F)(F)F)c12		CHEMBL4115507	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328565	17707155	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCCO)c12		CHEMBL4107930	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328566	17707156	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	COC1CCN(C(=O)[C@@H](C)Oc2cc(F)ccc2Nc2ncnc3cc(N=S(C)(C)=O)cc(C)c23)CC1		CHEMBL4114099	=	IC50	nM	13.0	CHEMBL4204	Homo sapiens	IC50	nM	13.0
328567	17707157	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC(F)(F)F)c12		CHEMBL4109890	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328568	17707158	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N[C@@H]3CCC[C@@H]3O)c12		CHEMBL4107926	=	IC50	nM	9.0	CHEMBL4204	Homo sapiens	IC50	nM	9.0
328569	17707159	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CC(C)NC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(Cl)c12		CHEMBL4113568	=	IC50	nM	4.0	CHEMBL4204	Homo sapiens	IC50	nM	4.0
328570	17707160	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](C#N)NC(=O)[C@@H](C)Oc1cc(Cl)ccc1Nc1ncnc2cc(N=S3(=O)CCC3)cc(F)c12		CHEMBL3967951	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328571	17707161	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(Cl)c12)C(=O)NCCF		CHEMBL4110710	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328572	17707162	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(Cl)cc3O[C@H](C)C(=O)N[C@@H](C)C(F)(F)F)c12		CHEMBL4111236	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328573	17707163	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(Cl)c12)C(=O)NCC(F)F		CHEMBL4107688	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328574	17707164	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NC(C)C)c12		CHEMBL4111438	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328575	17707165	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NC34CC(C3)C4)c12		CHEMBL4114152	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328576	17707166	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CC(NC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(F)c12)C(F)F		CHEMBL4106778	=	IC50	nM	8.0	CHEMBL4204	Homo sapiens	IC50	nM	8.0
328577	17707167	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(C3CC3)c12)C(=O)NCC(F)(F)F		CHEMBL4113841	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328578	17707168	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(Cl)c12)C(=O)NCC#N		CHEMBL4111795	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328579	17707169	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(C(F)(F)F)c12)C(=O)NCC(F)(F)F		CHEMBL4115093	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328580	17707170	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	COc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(Cl)cc3O[C@H](C)C(=O)NCC(F)(F)F)c12		CHEMBL4107782	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328581	17707171	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(Cl)cc3O[C@H](C)C(=O)N[C@@H](C)C(F)(F)F)c12		CHEMBL4115037	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328582	17707172	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCCC(F)(F)F)c12		CHEMBL4106658	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328583	17707173	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCC3)cc(Cl)c12)C(=O)N[C@H](C)C(F)(F)F		CHEMBL4110073	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328584	17707174	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(Cl)c12)C(=O)NCC(F)(F)F		CHEMBL4115641	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328585	17707175	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(Cl)cc3O[C@H](C)C(=O)NCC(F)(F)F)c12		CHEMBL4110252	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328586	17707176	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](C#N)NC(=O)[C@@H](C)Oc1cc(Cl)ccc1Nc1ncnc2cc(N=S3(=O)CCCC3)cc(F)c12		CHEMBL3901822	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328587	17707177	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(Cl)nc3O[C@H](C)C(=O)N[C@@H](C)C(F)(F)F)c12		CHEMBL4109192	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328588	17707178	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CCOc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(Cl)cc3O[C@H](C)C(=O)N[C@@H](C)C#N)c12		CHEMBL3959814	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328589	17707179	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@H](NC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCC3)cc(Cl)c12)C(F)(F)F		CHEMBL4114373	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328590	17707180	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCC3)cc(F)c12)C(=O)NCC#N		CHEMBL4113129	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328591	17707181	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	COc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N[C@@H](C)C(F)(F)F)c12		CHEMBL4115407	=	IC50	nM	4.0	CHEMBL4204	Homo sapiens	IC50	nM	4.0
328592	17707182	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CC(C#N)NC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCC3)cc(F)c12		CHEMBL4109535	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328593	17707183	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCC3)cc(F)c12)C(=O)NCC(F)(F)F		CHEMBL4107950	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328594	17707184	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NC(CF)CF)c12		CHEMBL4109059	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328595	17707185	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](C#N)NC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCC3)cc(C(F)F)c12		CHEMBL3951911	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328596	17707186	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC#N)c12		CHEMBL4115452	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328597	17707187	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N[C@@H](C)C(F)(F)F)c12		CHEMBL4110194	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328598	17707188	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCCF)c12		CHEMBL4109489	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328599	17707189	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](C#N)NC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCC3)cc(F)c12		CHEMBL3910881	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328600	17707190	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCCF)c12		CHEMBL4108376	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328601	17707191	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCCC(F)(F)F)c12		CHEMBL4106658	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328602	17707192	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NC(C)C(F)F)c12		CHEMBL4108185	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328603	17707193	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCC3)cc(C(F)F)c12)C(=O)NCC(F)(F)F		CHEMBL4106850	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328604	17707194	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(Cl)cc3O[C@H](C)C(=O)NCC(F)F)c12		CHEMBL4109416	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328605	17707195	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@H](C#N)NC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCC3)cc(Cl)c12		CHEMBL4109879	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328606	17707196	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@H](C#N)NC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCC3)cc(F)c12		CHEMBL4113301	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328607	17707197	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CC(C)NC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCC3)cc(F)c12		CHEMBL4113595	=	IC50	nM	5.0	CHEMBL4204	Homo sapiens	IC50	nM	5.0
328608	17707198	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	COc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC#N)c12		CHEMBL4109753	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328609	17707199	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCCC(F)F)c12		CHEMBL4109513	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328610	17707200	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCC3)cc(F)c12)C(=O)NCCF		CHEMBL4114969	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328611	17707201	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@H](NC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(F)c12)C(F)(F)F		CHEMBL4110890	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328612	17707202	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC(F)(F)C(F)(F)F)c12		CHEMBL4111298	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328613	17707203	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(Cl)c12)C(=O)NC(CF)CF		CHEMBL4110031	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328614	17707204	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(F)c12)C(=O)NC(CF)CF		CHEMBL4111102	=	IC50	nM	5.0	CHEMBL4204	Homo sapiens	IC50	nM	5.0
328615	17707205	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(Cl)cc3O[C@H](C)C(=O)NCC(F)(F)F)c12		CHEMBL4113339	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328616	17707206	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCC3)cc(F)c12)C(=O)NCC(F)F		CHEMBL4115409	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328617	17707207	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(Cl)nc3O[C@H](C)C(=O)NCC(F)(F)F)c12		CHEMBL4107227	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328618	17707208	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(Cl)cc3O[C@H](C)C(=O)NC(C)C(F)F)c12		CHEMBL4113652	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328619	17707209	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CC(NC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCC3)cc(Cl)c12)C(F)F		CHEMBL4106912	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328620	17707210	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N[C@@H](C)C(F)(F)F)c12		CHEMBL4110927	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328621	17707211	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCC3)cc(F)c12)C(=O)NC(CF)CF		CHEMBL4112893	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328622	17707212	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCC3)cc(F)c12)C(=O)NCC(F)(F)C(F)(F)F		CHEMBL4111932	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328623	17707213	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CC(NC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCC3)cc(F)c12)C(F)F		CHEMBL4112102	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328624	17707214	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NC(CF)CF)c12		CHEMBL4108126	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328625	17707215	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NC(C)C#N)c12		CHEMBL4107329	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328626	17707216	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(F)c12)C(=O)NCC(F)F		CHEMBL4106616	=	IC50	nM	4.0	CHEMBL4204	Homo sapiens	IC50	nM	4.0
328627	17707217	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CC(NC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(Cl)c12)C(F)F		CHEMBL4110023	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328628	17707218	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@H](NC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(Cl)c12)C(F)(F)F		CHEMBL4113746	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328629	17707219	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@H](NC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCC3)cc(F)c12)C(F)(F)F		CHEMBL4112904	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328630	17707220	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](C#N)NC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCC3)cc(Cl)c12		CHEMBL3958645	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328631	17707221	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCC3)cc(Cl)c12)C(=O)NCC(F)(F)F		CHEMBL4115007	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328632	17707222	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC(F)(F)F)c12		CHEMBL4113440	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328633	17707223	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(Cl)nc3O[C@H](C)C(=O)N[C@@H](C)C#N)c12		CHEMBL3903763	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328634	17707224	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC(F)F)c12		CHEMBL4110107	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328635	17707225	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(Cl)cc3O[C@H](C)C(=O)NCC(F)F)c12		CHEMBL4112349	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328636	17707226	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@H](NC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCC3)cc(C(F)F)c12)C(F)(F)F		CHEMBL4109482	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328637	17707227	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCCCF)c12		CHEMBL4112873	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328638	17707228	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(Cl)cc3O[C@H](C)C(=O)N[C@H](C)C(F)(F)F)c12		CHEMBL4107518	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328639	17707229	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CC(NC(=O)[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S3(=O)CCC3)cc(C(F)F)c12)C(F)F		CHEMBL4111658	=	IC50	nM	4.0	CHEMBL4204	Homo sapiens	IC50	nM	4.0
328640	17707230	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(Cl)cc3O[C@H](C)C(=O)N[C@@H](C)C#N)c12		CHEMBL3939796	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328641	17707231	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@@H](C)CNS(C)(=O)=O)c12		CHEMBL3957458	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328642	17707232	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CC(=O)NC[C@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(C)c12		CHEMBL3945124	=	IC50	nM	7.0	CHEMBL4204	Homo sapiens	IC50	nM	7.0
328643	17707233	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)CNS(C)(=O)=O)c12		CHEMBL4113832	=	IC50	nM	83.0	CHEMBL4204	Homo sapiens	IC50	nM	83.0
328644	17707234	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@@H](C)CNC(=O)C(F)(F)F)c12		CHEMBL3953860	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328645	17707235	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CC(=O)N1CCS(=O)(=Nc2cc(C)c3c(Nc4ccc(F)cc4O[C@H](C)c4cc(C)no4)ncnc3c2)CC1		CHEMBL4107369	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328646	17707236	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CCNC(=O)NC[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(C)c12		CHEMBL4107998	=	IC50	nM	29.0	CHEMBL4204	Homo sapiens	IC50	nM	29.0
328647	17707237	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	COCC(=O)N1CCS(=O)(=Nc2cc(C)c3c(Nc4ccc(F)cc4O[C@H](C)c4cc(C)no4)ncnc3c2)CC1		CHEMBL4109457	=	IC50	nM	4.0	CHEMBL4204	Homo sapiens	IC50	nM	4.0
328648	17707238	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CCNC(=O)N1CCS(=O)(=Nc2cc(C)c3c(Nc4ccc(F)cc4O[C@H](C)c4cc(C)no4)ncnc3c2)CC1		CHEMBL4108901	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328649	17707239	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CC(=O)NC[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(C)c12		CHEMBL4106564	=	IC50	nM	35.0	CHEMBL4204	Homo sapiens	IC50	nM	35.0
328650	17707240	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)CNC(=O)C(F)(F)F)c12		CHEMBL4114116	=	IC50	nM	28.0	CHEMBL4204	Homo sapiens	IC50	nM	28.0
328651	17707241	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)CNS(=O)(=O)C(F)(F)F)c12		CHEMBL4109913	=	IC50	nM	99.0	CHEMBL4204	Homo sapiens	IC50	nM	99.0
328652	17707242	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CCC(=O)NC[C@@H](C)Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(C)c12		CHEMBL4108630	=	IC50	nM	56.0	CHEMBL4204	Homo sapiens	IC50	nM	56.0
328653	17707243	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	COC(=O)N1CCS(=O)(=Nc2cc(C)c3c(Nc4ccc(F)cc4O[C@H](C)c4cc(C)no4)ncnc3c2)CC1		CHEMBL4115668	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328654	17707244	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	COc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)N[C@@H](C)C(F)(F)F)c12		CHEMBL4115407	=	IC50	nM	5.0	CHEMBL4204	Homo sapiens	IC50	nM	5.0
328655	17707245	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	COc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC(F)F)c12		CHEMBL4113626	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328656	17707246	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	CCOc1cc(N=S2(=O)CCC2)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(=O)NCC(F)(F)F)c12		CHEMBL4111516	=	IC50	nM	4.0	CHEMBL4204	Homo sapiens	IC50	nM	4.0
328657	17707247	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	COc1cc(N=S(C)(C)=O)cc2ncnc(Nc3cccnc3O[C@H](C)C(=O)NCC(F)(F)F)c12		CHEMBL4111519	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328658	17707248	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc([C@@H](C)Oc2cc(F)ccc2Nc2ncnc3cc(N=S4(=O)CCN(C)CC4)cc(C)c23)on1		CHEMBL4108210	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
328659	17707249	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(F)(F)F)c12		CHEMBL4112179	=	IC50	nM	6.0	CHEMBL4204	Homo sapiens	IC50	nM	6.0
328660	17707250	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	COc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OC(C)c3cc(C)no3)c12		CHEMBL3967260	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328661	17707251	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C#N)c12		CHEMBL4113835	=	IC50	nM	67.0	CHEMBL4204	Homo sapiens	IC50	nM	67.0
328662	17707252	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3OC(C)C#N)c12		CHEMBL3946482	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328663	17707253	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	C[C@@H](Oc1cc(F)ccc1Nc1ncnc2cc(N=S(C)(C)=O)cc(F)c12)C(F)(F)F		CHEMBL4111983	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328664	17707254	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C#N)c12		CHEMBL4113835	=	IC50	nM	10.0	CHEMBL4204	Homo sapiens	IC50	nM	10.0
328665	17707255	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S2(=O)CCCC2)cc2ncnc(Nc3ccc(F)cc3OC(C)C#N)c12		CHEMBL3950875	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328666	17707256	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C#N)c12		CHEMBL4113835	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328667	17707257	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](C)C(F)(F)F)c12		CHEMBL4112179	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	nM	2.0
328668	17707258	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](CO)C(=O)NCC(F)(F)F)c12		CHEMBL4114025	=	IC50	nM	3.0	CHEMBL4204	Homo sapiens	IC50	nM	3.0
328669	17707259	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](CO)C(N)=O)c12		CHEMBL4114849	=	IC50	nM	46.0	CHEMBL4204	Homo sapiens	IC50	nM	46.0
328670	17707260	CHEMBL3887288	In vitro Kinase Assay: The inhibition of kinase activity of MNK2a was assessed using pre-activated GST-MNK2a. The white, 384-well OptiPlate F plates were purchased from PerkinElmer. The ADP-Glo Kinase Assay (including ultra pure ATP) was purchased from Promega (V9103). Activated MNK2a was obtained as described in WO2011/104340. The unlabeled eIF4E peptide (NH2-TATKSGSTTKNR-CONH2), differing from Seq. ID No. 5 of WO 2011/104340 by the C-terminal CONH2 group, was purchased from Thermo Fisher Scientific. All other materials were of highest grade commercially available. Compounds are tested in either serial dilutions or single dose concentrations. The compound stock solutions are 10 mM in 100% DMSO The serial compound dilutions are prepared in 100% DMSO followed by 1:27.3 intermediate dilution in assay buffer. The final DMSO concentration in assay will be <3%.	B	Cc1cc(N=S(C)(C)=O)cc2ncnc(Nc3ccc(F)cc3O[C@H](CF)C(=O)NCC(F)(F)F)c12		CHEMBL4113970	=	IC50	nM	4.0	CHEMBL4204	Homo sapiens	IC50	nM	4.0
	17964926	CHEMBL3995035	Inhibition of human MKNK2 (G63 to S388 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	95.0	CHEMBL4204	Homo sapiens	Activity	%	95.0
	17982183	CHEMBL3998816	Inhibition of human MNK2 at 1 uM using myelin basic protein as substrate in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL2012519	>	Inhibition	%	80.0	CHEMBL4204	Homo sapiens	INH	%	80.0
	18021254	CHEMBL4005957	Inhibition of recombinant full-length human N-terminal His6-tagged Mnk2 expressed in baculovirus infected Sf21 insect cells assessed as residual activity at 10 uM	B	Cc1nc(NC2CCCC2)sc1-c1ccnc(Nc2ccc(N3CCNCC3)cn2)n1		CHEMBL4071812	<	Inhibition	%	10.0	CHEMBL4204	Homo sapiens	INH	%	10.0
	18021255	CHEMBL4005957	Inhibition of recombinant full-length human N-terminal His6-tagged Mnk2 expressed in baculovirus infected Sf21 insect cells assessed as residual activity at 10 uM	B	Cc1nc(NC2CCCC2)sc1-c1nc(Nc2ccc(N3CCN(C)CC3)cn2)ncc1F		CHEMBL4072255	<	Inhibition	%	10.0	CHEMBL4204	Homo sapiens	INH	%	10.0
	18048726	CHEMBL4011073	Inhibition of human full length N-terminal GST-tagged MNK2 expressed in baculovirus expression system	B	S=C(Nc1cccc(Cl)c1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL4078182	=	IC50	nM	2700.0	CHEMBL4204	Homo sapiens	IC50	uM	2.7
	18048730	CHEMBL4011076	Inhibition of MNK2 (unknown origin) at 0.5 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Inhibition	%	46.0	CHEMBL4204	Homo sapiens	INH	%	46.0
	18048738	CHEMBL4011084	Inhibition of human full length N-terminal GST-tagged MNK2 expressed in baculovirus expression system at 5 uM	B	S=C(Nc1cccc(Cl)c1)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL4078182	=	Inhibition	%	78.0	CHEMBL4204	Homo sapiens	INH	%	78.0
	18074002	CHEMBL4015983	Inhibition of N-terminal-GST-tagged human full length MNK2 expressed in baculovirus at 200 nM	B	CC[C@H]1[C@@H](COc2nccc3cc(C(N)=O)c(OC)cc23)NC(=O)[C@H]1F		CHEMBL4081711	>	Inhibition	%	70.0	CHEMBL4204	Homo sapiens	INH	%	70.0
	18114247	CHEMBL4025247	Inhibition of wild-type human partial length MKNK2 (G63 to S388 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	89.0	CHEMBL4204	Homo sapiens	Activity	%	89.0
	18141788	CHEMBL4031403	Inhibition of human MKNK2 (G63 to S388 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-n3nc(-c4ccc(OCCN5CCOCC5)cc4)c4c(N)ncnc43)cc2)no1		CHEMBL4101411	=	Activity	%	0.75	CHEMBL4204	Homo sapiens	Activity	%	0.75
	18141809	CHEMBL4031422	Inhibition of full length recombinant human GST-tagged MKNK2 expressed in Baculovirus expression system by Z'Lyte assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-n3nc(-c4ccc(OCCN5CCOCC5)cc4)c4c(N)ncnc43)cc2)no1		CHEMBL4101411	=	IC50	nM	61.0	CHEMBL4204	Homo sapiens	IC50	nM	61.0
	18203771	CHEMBL4044058	Inhibition of wild-type human partial length MKNK2 (G63 to S388 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	86.0	CHEMBL4204	Homo sapiens	Activity	%	86.0
	18225179	CHEMBL4048640	Inhibition of full length N-terminal GST-tagged recombinant human MNK2 expressed in baculovirus expression system using Ac-TATKSGSTTKNR-NH2 as substrate preincubated for 5 mins followed by ATP addition measured after 40 mins by ADP-Glo assay	B	CC1NC(=O)c2ccc(Nc3ccncn3)cc21		CHEMBL4099497	=	IC50	nM	45.0	CHEMBL4204	Homo sapiens	IC50	nM	45.0
	18225182	CHEMBL4048640	Inhibition of full length N-terminal GST-tagged recombinant human MNK2 expressed in baculovirus expression system using Ac-TATKSGSTTKNR-NH2 as substrate preincubated for 5 mins followed by ATP addition measured after 40 mins by ADP-Glo assay	B	CC1(C)NC(=O)c2ccc(Nc3ccncn3)cc21		CHEMBL4086042	=	IC50	nM	61.0	CHEMBL4204	Homo sapiens	IC50	nM	61.0
	18225185	CHEMBL4048643	Inhibition of full length N-terminal GST-tagged recombinant human MNK2 expressed in baculovirus expression system at 1 uM using Ac-TATKSGSTTKNR-NH2 as substrate preincubated for 5 mins followed by ATP addition measured after 40 mins by ADP-Glo assay relative to control	B	CC1(C)NC(=O)c2ccc(Nc3ccncn3)cc21		CHEMBL4086042	=	Inhibition	%	66.0	CHEMBL4204	Homo sapiens	INH	%	66.0
	18225188	CHEMBL4048640	Inhibition of full length N-terminal GST-tagged recombinant human MNK2 expressed in baculovirus expression system using Ac-TATKSGSTTKNR-NH2 as substrate preincubated for 5 mins followed by ATP addition measured after 40 mins by ADP-Glo assay	B	CC1(C)NC(=O)c2ccc(Nc3ccncn3)c(=O)n21		CHEMBL4071021	=	IC50	nM	57.0	CHEMBL4204	Homo sapiens	IC50	nM	57.0
	18225191	CHEMBL4048643	Inhibition of full length N-terminal GST-tagged recombinant human MNK2 expressed in baculovirus expression system at 1 uM using Ac-TATKSGSTTKNR-NH2 as substrate preincubated for 5 mins followed by ATP addition measured after 40 mins by ADP-Glo assay relative to control	B	CC1(C)NC(=O)c2ccc(Nc3ccncn3)c(=O)n21		CHEMBL4071021	=	Inhibition	%	68.0	CHEMBL4204	Homo sapiens	INH	%	68.0
	18225193	CHEMBL4048640	Inhibition of full length N-terminal GST-tagged recombinant human MNK2 expressed in baculovirus expression system using Ac-TATKSGSTTKNR-NH2 as substrate preincubated for 5 mins followed by ATP addition measured after 40 mins by ADP-Glo assay	B	CC1(C)NC(=O)c2c(F)cc(Nc3ccncn3)c(=O)n21		CHEMBL4091862	=	IC50	nM	2.6	CHEMBL4204	Homo sapiens	IC50	nM	2.6
	18225196	CHEMBL4048640	Inhibition of full length N-terminal GST-tagged recombinant human MNK2 expressed in baculovirus expression system using Ac-TATKSGSTTKNR-NH2 as substrate preincubated for 5 mins followed by ATP addition measured after 40 mins by ADP-Glo assay	B	Cc1cc(Nc2ccncn2)c(=O)n2c1C(=O)NC2(C)C		CHEMBL4062387	=	IC50	nM	19.0	CHEMBL4204	Homo sapiens	IC50	nM	19.0
	18225199	CHEMBL4048640	Inhibition of full length N-terminal GST-tagged recombinant human MNK2 expressed in baculovirus expression system using Ac-TATKSGSTTKNR-NH2 as substrate preincubated for 5 mins followed by ATP addition measured after 40 mins by ADP-Glo assay	B	CC1(C)NC(=O)c2c(Cl)cc(Nc3ccncn3)c(=O)n21		CHEMBL4084102	=	IC50	nM	1.2	CHEMBL4204	Homo sapiens	IC50	nM	1.2
	18225208	CHEMBL4048640	Inhibition of full length N-terminal GST-tagged recombinant human MNK2 expressed in baculovirus expression system using Ac-TATKSGSTTKNR-NH2 as substrate preincubated for 5 mins followed by ATP addition measured after 40 mins by ADP-Glo assay	B	O=C1NCc2cc(Nc3cc(NC(=O)C4CC4)ncn3)ccc21		CHEMBL4100554	=	IC50	nM	5.7	CHEMBL4204	Homo sapiens	IC50	nM	5.7
	18225211	CHEMBL4048640	Inhibition of full length N-terminal GST-tagged recombinant human MNK2 expressed in baculovirus expression system using Ac-TATKSGSTTKNR-NH2 as substrate preincubated for 5 mins followed by ATP addition measured after 40 mins by ADP-Glo assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1cc(NC(=O)C3CC3)ncn1)c2=O		CHEMBL4073743	=	IC50	nM	1.8	CHEMBL4204	Homo sapiens	IC50	nM	1.8
	18225214	CHEMBL4048640	Inhibition of full length N-terminal GST-tagged recombinant human MNK2 expressed in baculovirus expression system using Ac-TATKSGSTTKNR-NH2 as substrate preincubated for 5 mins followed by ATP addition measured after 40 mins by ADP-Glo assay	B	Nc1cc(Nc2cc(Cl)c3n(c2=O)C2(CCCCC2)NC3=O)ncn1		CHEMBL4076439	=	IC50	nM	0.68	CHEMBL4204	Homo sapiens	IC50	nM	0.68
	18225236	CHEMBL4048640	Inhibition of full length N-terminal GST-tagged recombinant human MNK2 expressed in baculovirus expression system using Ac-TATKSGSTTKNR-NH2 as substrate preincubated for 5 mins followed by ATP addition measured after 40 mins by ADP-Glo assay	B	Nc1ncnc(Nc2cc(Cl)c3n(c2=O)C2(CCCCC2)NC3=O)c1Cl		CHEMBL4086747	=	IC50	nM	0.36	CHEMBL4204	Homo sapiens	IC50	nM	0.36
	18225239	CHEMBL4048640	Inhibition of full length N-terminal GST-tagged recombinant human MNK2 expressed in baculovirus expression system using Ac-TATKSGSTTKNR-NH2 as substrate preincubated for 5 mins followed by ATP addition measured after 40 mins by ADP-Glo assay	B	CC1(C)NC(=O)c2ccc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n21		CHEMBL4086319	=	IC50	nM	2.3	CHEMBL4204	Homo sapiens	IC50	nM	2.3
	18225249	CHEMBL4048640	Inhibition of full length N-terminal GST-tagged recombinant human MNK2 expressed in baculovirus expression system using Ac-TATKSGSTTKNR-NH2 as substrate preincubated for 5 mins followed by ATP addition measured after 40 mins by ADP-Glo assay	B	CC1(c2cccc(Cl)c2)NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n21		CHEMBL4064839	=	IC50	nM	1.2	CHEMBL4204	Homo sapiens	IC50	nM	1.2
	18225264	CHEMBL4048640	Inhibition of full length N-terminal GST-tagged recombinant human MNK2 expressed in baculovirus expression system using Ac-TATKSGSTTKNR-NH2 as substrate preincubated for 5 mins followed by ATP addition measured after 40 mins by ADP-Glo assay	B	N[C@H]1C[C@H](Oc2ccc3ncc(-c4ccc5cnccc5c4)n3n2)C1		CHEMBL4094080	=	IC50	nM	7.8	CHEMBL4204	Homo sapiens	IC50	nM	7.8
	18225288	CHEMBL4048640	Inhibition of full length N-terminal GST-tagged recombinant human MNK2 expressed in baculovirus expression system using Ac-TATKSGSTTKNR-NH2 as substrate preincubated for 5 mins followed by ATP addition measured after 40 mins by ADP-Glo assay	B	Cc1cc(Nc2cc(N)ncn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4073443	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
	18225338	CHEMBL4048640	Inhibition of full length N-terminal GST-tagged recombinant human MNK2 expressed in baculovirus expression system using Ac-TATKSGSTTKNR-NH2 as substrate preincubated for 5 mins followed by ATP addition measured after 40 mins by ADP-Glo assay	B	CC1(C)NC(=O)c2c(Cl)cc(Nc3cc(N)ncn3)c(=O)n21		CHEMBL4067557	=	IC50	nM	0.14	CHEMBL4204	Homo sapiens	IC50	nM	0.14
	18225355	CHEMBL4048640	Inhibition of full length N-terminal GST-tagged recombinant human MNK2 expressed in baculovirus expression system using Ac-TATKSGSTTKNR-NH2 as substrate preincubated for 5 mins followed by ATP addition measured after 40 mins by ADP-Glo assay	B	Nc1cc(Nc2cc(Cl)c3n(c2=O)C2(CCCC2)NC3=O)ncn1		CHEMBL4094975	=	IC50	nM	0.13	CHEMBL4204	Homo sapiens	IC50	nM	0.13
	18225381	CHEMBL4048640	Inhibition of full length N-terminal GST-tagged recombinant human MNK2 expressed in baculovirus expression system using Ac-TATKSGSTTKNR-NH2 as substrate preincubated for 5 mins followed by ATP addition measured after 40 mins by ADP-Glo assay	B	Cc1cc(Nc2cc(N)ncn2)c(=O)n2c1C(=O)NC21CCC(F)(F)CC1		CHEMBL4065802	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
	18232155	CHEMBL4050351	Inhibition of human MNK2 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	85.0	CHEMBL4204	Homo sapiens	Activity	%	85.0
	18248632	CHEMBL4053915	Inhibition of MKNK2 (unknown origin) at 1 uM relative to control	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4104658	=	Inhibition	%	117.0	CHEMBL4204	Homo sapiens	INH	%	117.0
	18253821	CHEMBL4055195	Inhibition of wild-type human partial length GPRK7 (G63 to S388 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL4204	Homo sapiens	Activity	%	100.0
	18253822	CHEMBL4055195	Inhibition of wild-type human partial length GPRK7 (G63 to S388 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	89.0	CHEMBL4204	Homo sapiens	Activity	%	89.0
	18253871	CHEMBL4055220	Inhibition of wild-type human partial length MNK2 (G63 to S388 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL4204	Homo sapiens	Activity	%	100.0
	18253872	CHEMBL4055220	Inhibition of wild-type human partial length MNK2 (G63 to S388 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	95.0	CHEMBL4204	Homo sapiens	Activity	%	95.0
	18265902	CHEMBL4057352	Inhibition of MNK2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	-1.0	CHEMBL4204	Homo sapiens	INH	%	-1.0
	18266096	CHEMBL4057546	Inhibition of MNK2 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	-1.7	CHEMBL4204	Homo sapiens	INH	%	-1.7
Active	18276051	CHEMBL4119011	Binding affinity to MKNK2 in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL4204	Homo sapiens	Activity		
	18282152	CHEMBL4120107	Inhibition of recombinant human N-terminal full length GST-tagged MKNK2 expressed in baculovirus at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	12.3	CHEMBL4204	Homo sapiens	INH	%	12.3
	18282471	CHEMBL4120107	Inhibition of recombinant human N-terminal full length GST-tagged MKNK2 expressed in baculovirus at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	0.9	CHEMBL4204	Homo sapiens	INH	%	0.9
	18282876	CHEMBL4120461	Inhibition of MNK2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	-1.0	CHEMBL4204	Homo sapiens	INH	%	-1.0
	18283090	CHEMBL4120675	Inhibition of MNK2 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	0.0	CHEMBL4204	Homo sapiens	INH	%	0.0
	18283305	CHEMBL4120890	Inhibition of MNK2 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	-0.7	CHEMBL4204	Homo sapiens	INH	%	-0.7
	18316813	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	COc1ccc(Nc2nccc(-c3sc(SC)nc3C)n2)c(OC)c1		CHEMBL4166548	=	Activity	%	46.0	CHEMBL4204	Homo sapiens	Activity	%	46.0
	18316814	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	CCSc1nc(C)c(-c2ccnc(Nc3ccc(OC)cc3OC)n2)s1		CHEMBL4174462	=	Activity	%	82.0	CHEMBL4204	Homo sapiens	Activity	%	82.0
	18316815	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	CCCSc1nc(C)c(-c2ccnc(Nc3ccc(OC)cc3OC)n2)s1		CHEMBL4169970	=	Activity	%	93.0	CHEMBL4204	Homo sapiens	Activity	%	93.0
	18316816	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	COc1ccc(Nc2nccc(-c3sc(SC(C)C)nc3C)n2)c(OC)c1		CHEMBL4159335	=	Activity	%	9.0	CHEMBL4204	Homo sapiens	Activity	%	9.0
	18316817	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	COCCSc1nc(C)c(-c2ccnc(Nc3ccc(OC)cc3OC)n2)s1		CHEMBL4159742	=	Activity	%	39.0	CHEMBL4204	Homo sapiens	Activity	%	39.0
	18316818	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	COc1ccc(Nc2nccc(-c3sc(SCCN(C)C)nc3C)n2)c(OC)c1		CHEMBL4167646	=	Activity	%	7.0	CHEMBL4204	Homo sapiens	Activity	%	7.0
	18316819	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	COc1ccc(Nc2nccc(-c3sc(SCCCN(C)C)nc3C)n2)c(OC)c1		CHEMBL4167329	=	Activity	%	16.0	CHEMBL4204	Homo sapiens	Activity	%	16.0
	18316820	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	COc1ccc(Nc2nccc(-c3sc(SCc4cccnc4)nc3C)n2)c(OC)c1		CHEMBL4159419	=	Activity	%	14.0	CHEMBL4204	Homo sapiens	Activity	%	14.0
	18316821	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	COc1ccc(Nc2nccc(-c3sc(SCCN4CCNCC4)nc3C)n2)c(OC)c1		CHEMBL4163881	=	Activity	%	25.0	CHEMBL4204	Homo sapiens	Activity	%	25.0
	18316822	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	COc1ccc(Nc2nccc(-c3sc(SCCN4CCOCC4)nc3C)n2)c(OC)c1		CHEMBL4174540	=	Activity	%	22.0	CHEMBL4204	Homo sapiens	Activity	%	22.0
	18316823	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	COc1ccc(Nc2nccc(-c3sc(OC)nc3C)n2)c(OC)c1		CHEMBL4174144	=	Activity	%	56.0	CHEMBL4204	Homo sapiens	Activity	%	56.0
	18316824	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	CCOc1nc(C)c(-c2ccnc(Nc3ccc(OC)cc3OC)n2)s1		CHEMBL4166229	=	Activity	%	47.0	CHEMBL4204	Homo sapiens	Activity	%	47.0
	18316825	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	CCCCOc1nc(C)c(-c2ccnc(Nc3ccc(OC)cc3OC)n2)s1		CHEMBL4170718	=	Activity	%	6.0	CHEMBL4204	Homo sapiens	Activity	%	6.0
	18316826	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	COc1ccc(Nc2nccc(-c3sc(OC(C)C)nc3C)n2)c(OC)c1		CHEMBL4162781	=	Activity	%	3.0	CHEMBL4204	Homo sapiens	Activity	%	3.0
	18316827	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	COCCOc1nc(C)c(-c2ccnc(Nc3ccc(OC)cc3OC)n2)s1		CHEMBL4172170	=	Activity	%	24.0	CHEMBL4204	Homo sapiens	Activity	%	24.0
	18316828	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	CNc1nc(C)c(-c2ccnc(Nc3ccc(OC)cc3OC)n2)s1		CHEMBL4164283	=	Activity	%	7.0	CHEMBL4204	Homo sapiens	Activity	%	7.0
	18316829	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	COc1ccc(Nc2nccc(-c3sc(N(C)C)nc3C)n2)c(OC)c1		CHEMBL4162390	=	Activity	%	16.0	CHEMBL4204	Homo sapiens	Activity	%	16.0
	18316830	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	COc1ccc(Nc2nccc(-c3c[nH]c4ccccc34)n2)c(OC)c1		CHEMBL4173067	=	Activity	%	3.0	CHEMBL4204	Homo sapiens	Activity	%	3.0
	18316831	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	COc1ccc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)c1		CHEMBL4165841	=	Activity	%	20.0	CHEMBL4204	Homo sapiens	Activity	%	20.0
	18316832	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	COc1ccc(N(C)c2nccc(-c3cn(C)c4ccccc34)n2)c(OC)c1		CHEMBL4176449	=	Activity	%	98.0	CHEMBL4204	Homo sapiens	Activity	%	98.0
	18316833	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	CCn1cc(-c2ccnc(Nc3ccc(OC)cc3OC)n2)c2ccccc21		CHEMBL4174162	=	Activity	%	19.0	CHEMBL4204	Homo sapiens	Activity	%	19.0
	18316834	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	CCCn1cc(-c2ccnc(Nc3ccc(OC)cc3OC)n2)c2ccccc21		CHEMBL4166250	=	Activity	%	19.0	CHEMBL4204	Homo sapiens	Activity	%	19.0
	18316835	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	COc1ccc(Nc2nccc(-c3cn(C(C)C)c4ccccc34)n2)c(OC)c1		CHEMBL4159011	=	Activity	%	2.0	CHEMBL4204	Homo sapiens	Activity	%	2.0
	18316836	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	COc1ccc(Nc2nccc(-c3cn(C4CCCC4)c4ccccc34)n2)c(OC)c1		CHEMBL4169662	=	Activity	%	6.0	CHEMBL4204	Homo sapiens	Activity	%	6.0
	18316837	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	COc1ccc(Nc2nccc(-c3cn(CCN4CCOCC4)c4ccccc34)n2)c(OC)c1		CHEMBL4167344	=	Activity	%	5.0	CHEMBL4204	Homo sapiens	Activity	%	5.0
	18316838	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	COCCn1cc(-c2ccnc(Nc3ccc(OC)cc3OC)n2)c2ccccc21		CHEMBL4159438	=	Activity	%	4.0	CHEMBL4204	Homo sapiens	Activity	%	4.0
	18316839	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	CCOc1ccc(Nc2nccc(-c3cn(CCOC)c4ccccc34)n2)c(OC)c1		CHEMBL4164431	=	Activity	%	77.0	CHEMBL4204	Homo sapiens	Activity	%	77.0
	18316840	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	COCCn1cc(-c2ccnc(Nc3ccc(OC)c(F)c3OC)n2)c2ccccc21		CHEMBL4172310	=	Activity	%	59.0	CHEMBL4204	Homo sapiens	Activity	%	59.0
	18316841	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	COCCn1cc(-c2ccnc(Nc3ccc(OC)cc3OC(F)(F)F)n2)c2ccccc21		CHEMBL4161023	=	Activity	%	45.0	CHEMBL4204	Homo sapiens	Activity	%	45.0
	18316842	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	COCCn1cc(-c2ccnc(Nc3ccc(OC)cc3OC(F)F)n2)c2ccccc21		CHEMBL4168949	=	Activity	%	30.0	CHEMBL4204	Homo sapiens	Activity	%	30.0
	18316843	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	COc1ccc(Nc2nccc(-c3c[nH]c4ccccc34)n2)c(OC(F)F)c1		CHEMBL4176137	=	Activity	%	96.0	CHEMBL4204	Homo sapiens	Activity	%	96.0
	18316844	CHEMBL4133272	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as residual activity at 10 uM using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay relative to control	B	Oc1ccccc1Nc1nccc(-c2c[nH]c3ccccc23)n1		CHEMBL4165526	=	Activity	%	1.0	CHEMBL4204	Homo sapiens	Activity	%	1.0
	18316866	CHEMBL4133275	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay	B	COc1ccc(Nc2nccc(-c3sc(SC(C)C)nc3C)n2)c(OC)c1		CHEMBL4159335	=	Ki	nM	1300.0	CHEMBL4204	Homo sapiens	Ki(app)	uM	1.3
	18316867	CHEMBL4133275	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay	B	COCCSc1nc(C)c(-c2ccnc(Nc3ccc(OC)cc3OC)n2)s1		CHEMBL4159742	=	Ki	nM	1700.0	CHEMBL4204	Homo sapiens	Ki(app)	uM	1.7
	18316868	CHEMBL4133275	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay	B	COc1ccc(Nc2nccc(-c3sc(SCCN(C)C)nc3C)n2)c(OC)c1		CHEMBL4167646	=	Ki	nM	230.0	CHEMBL4204	Homo sapiens	Ki(app)	uM	0.23
	18316869	CHEMBL4133275	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay	B	COc1ccc(Nc2nccc(-c3sc(SCCCN(C)C)nc3C)n2)c(OC)c1		CHEMBL4167329	=	Ki	nM	1150.0	CHEMBL4204	Homo sapiens	Ki(app)	uM	1.15
	18316870	CHEMBL4133275	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay	B	COc1ccc(Nc2nccc(-c3sc(SCc4cccnc4)nc3C)n2)c(OC)c1		CHEMBL4159419	=	Ki	nM	400.0	CHEMBL4204	Homo sapiens	Ki(app)	uM	0.4
	18316871	CHEMBL4133275	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay	B	COc1ccc(Nc2nccc(-c3sc(SCCN4CCNCC4)nc3C)n2)c(OC)c1		CHEMBL4163881	=	Ki	nM	1330.0	CHEMBL4204	Homo sapiens	Ki(app)	uM	1.33
	18316872	CHEMBL4133275	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay	B	COc1ccc(Nc2nccc(-c3sc(SCCN4CCOCC4)nc3C)n2)c(OC)c1		CHEMBL4174540	=	Ki	nM	2500.0	CHEMBL4204	Homo sapiens	Ki(app)	uM	2.5
	18316873	CHEMBL4133275	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay	B	CCCCOc1nc(C)c(-c2ccnc(Nc3ccc(OC)cc3OC)n2)s1		CHEMBL4170718	=	Ki	nM	560.0	CHEMBL4204	Homo sapiens	Ki(app)	uM	0.56
	18316874	CHEMBL4133275	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay	B	COc1ccc(Nc2nccc(-c3sc(OC(C)C)nc3C)n2)c(OC)c1		CHEMBL4162781	=	Ki	nM	980.0	CHEMBL4204	Homo sapiens	Ki(app)	uM	0.98
	18316875	CHEMBL4133275	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay	B	COCCOc1nc(C)c(-c2ccnc(Nc3ccc(OC)cc3OC)n2)s1		CHEMBL4172170	=	Ki	nM	860.0	CHEMBL4204	Homo sapiens	Ki(app)	uM	0.86
	18316876	CHEMBL4133275	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay	B	CNc1nc(C)c(-c2ccnc(Nc3ccc(OC)cc3OC)n2)s1		CHEMBL4164283	=	Ki	nM	110.0	CHEMBL4204	Homo sapiens	Ki(app)	uM	0.11
	18316877	CHEMBL4133275	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay	B	COc1ccc(Nc2nccc(-c3sc(N(C)C)nc3C)n2)c(OC)c1		CHEMBL4162390	=	Ki	nM	200.0	CHEMBL4204	Homo sapiens	Ki(app)	uM	0.2
	18316878	CHEMBL4133275	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay	B	COc1ccc(Nc2nccc(-c3c[nH]c4ccccc34)n2)c(OC)c1		CHEMBL4173067	=	Ki	nM	110.0	CHEMBL4204	Homo sapiens	Ki(app)	uM	0.11
	18316879	CHEMBL4133275	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay	B	COc1ccc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)c1		CHEMBL4165841	=	Ki	nM	610.0	CHEMBL4204	Homo sapiens	Ki(app)	uM	0.61
	18316880	CHEMBL4133275	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay	B	CCn1cc(-c2ccnc(Nc3ccc(OC)cc3OC)n2)c2ccccc21		CHEMBL4174162	=	Ki	nM	430.0	CHEMBL4204	Homo sapiens	Ki(app)	uM	0.43
	18316881	CHEMBL4133275	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay	B	CCCn1cc(-c2ccnc(Nc3ccc(OC)cc3OC)n2)c2ccccc21		CHEMBL4166250	=	Ki	nM	430.0	CHEMBL4204	Homo sapiens	Ki(app)	uM	0.43
	18316882	CHEMBL4133275	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay	B	COc1ccc(Nc2nccc(-c3cn(C(C)C)c4ccccc34)n2)c(OC)c1		CHEMBL4159011	=	Ki	nM	220.0	CHEMBL4204	Homo sapiens	Ki(app)	uM	0.22
	18316883	CHEMBL4133275	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay	B	COc1ccc(Nc2nccc(-c3cn(C4CCCC4)c4ccccc34)n2)c(OC)c1		CHEMBL4169662	=	Ki	nM	390.0	CHEMBL4204	Homo sapiens	Ki(app)	uM	0.39
	18316884	CHEMBL4133275	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay	B	COc1ccc(Nc2nccc(-c3cn(CCN4CCOCC4)c4ccccc34)n2)c(OC)c1		CHEMBL4167344	=	Ki	nM	300.0	CHEMBL4204	Homo sapiens	Ki(app)	uM	0.3
	18316885	CHEMBL4133275	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay	B	COCCn1cc(-c2ccnc(Nc3ccc(OC)cc3OC)n2)c2ccccc21		CHEMBL4159438	=	Ki	nM	180.0	CHEMBL4204	Homo sapiens	Ki(app)	uM	0.18
	18316886	CHEMBL4133275	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay	B	COCCn1cc(-c2ccnc(Nc3ccc(OC)cc3OC(F)(F)F)n2)c2ccccc21		CHEMBL4161023	=	Ki	nM	7700.0	CHEMBL4204	Homo sapiens	Ki(app)	uM	7.7
	18316887	CHEMBL4133275	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay	B	COCCn1cc(-c2ccnc(Nc3ccc(OC)cc3OC(F)F)n2)c2ccccc21		CHEMBL4168949	=	Ki	nM	1570.0	CHEMBL4204	Homo sapiens	Ki(app)	uM	1.57
	18316888	CHEMBL4133275	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system using N-terminal TAMRA-labeled eIF4E (202 to 214 residues) as substrate by IMAP TR-FRET assay	B	Oc1ccccc1Nc1nccc(-c2c[nH]c3ccccc23)n1		CHEMBL4165526	=	Ki	nM	120.0	CHEMBL4204	Homo sapiens	Ki(app)	uM	0.12
	18316938	CHEMBL4133279	ATP competitive inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as ratio of IC50 in presence of 2 mM ATP to IC50 in presence of 0.05 mM ATP using eIF4E (202 to 214 residues) as substrate by ADP-Glo assay	B	COc1ccc(Nc2nccc(-c3sc(N(C)C)nc3C)n2)c(OC)c1		CHEMBL4162390	=	Ratio IC50		614.0	CHEMBL4204	Homo sapiens	Ratio IC50		614.0
	18316939	CHEMBL4133279	ATP competitive inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as ratio of IC50 in presence of 2 mM ATP to IC50 in presence of 0.05 mM ATP using eIF4E (202 to 214 residues) as substrate by ADP-Glo assay	B	COc1ccc(Nc2nccc(-c3c[nH]c4ccccc34)n2)c(OC)c1		CHEMBL4173067	=	Ratio IC50		220.0	CHEMBL4204	Homo sapiens	Ratio IC50		220.0
	18316940	CHEMBL4133279	ATP competitive inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as ratio of IC50 in presence of 2 mM ATP to IC50 in presence of 0.05 mM ATP using eIF4E (202 to 214 residues) as substrate by ADP-Glo assay	B	COc1ccc(Nc2nccc(-c3cn(C(C)C)c4ccccc34)n2)c(OC)c1		CHEMBL4159011	=	Ratio IC50		39.0	CHEMBL4204	Homo sapiens	Ratio IC50		39.0
	18316941	CHEMBL4133279	ATP competitive inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as ratio of IC50 in presence of 2 mM ATP to IC50 in presence of 0.05 mM ATP using eIF4E (202 to 214 residues) as substrate by ADP-Glo assay	B	Oc1ccccc1Nc1nccc(-c2c[nH]c3ccccc23)n1		CHEMBL4165526	=	Ratio IC50		37.0	CHEMBL4204	Homo sapiens	Ratio IC50		37.0
	18316943	CHEMBL4133281	Competitive inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as ratio of IC50 in presence of 3 mM eIF4E substrate to IC50 in presence of 0.15 mM eIF4E substrate by ADP-Glo assay	B	COc1ccc(Nc2nccc(-c3sc(N(C)C)nc3C)n2)c(OC)c1		CHEMBL4162390	=	Ratio IC50		7.0	CHEMBL4204	Homo sapiens	Ratio IC50		7.0
	18316944	CHEMBL4133281	Competitive inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as ratio of IC50 in presence of 3 mM eIF4E substrate to IC50 in presence of 0.15 mM eIF4E substrate by ADP-Glo assay	B	COc1ccc(Nc2nccc(-c3c[nH]c4ccccc34)n2)c(OC)c1		CHEMBL4173067	=	Ratio IC50		24.0	CHEMBL4204	Homo sapiens	Ratio IC50		24.0
	18316945	CHEMBL4133281	Competitive inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as ratio of IC50 in presence of 3 mM eIF4E substrate to IC50 in presence of 0.15 mM eIF4E substrate by ADP-Glo assay	B	COCCn1cc(-c2ccnc(Nc3ccc(OC)cc3OC)n2)c2ccccc21		CHEMBL4159438	=	Ratio IC50		13.0	CHEMBL4204	Homo sapiens	Ratio IC50		13.0
	18316946	CHEMBL4133281	Competitive inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as ratio of IC50 in presence of 3 mM eIF4E substrate to IC50 in presence of 0.15 mM eIF4E substrate by ADP-Glo assay	B	Oc1ccccc1Nc1nccc(-c2c[nH]c3ccccc23)n1		CHEMBL4165526	=	Ratio IC50		8.0	CHEMBL4204	Homo sapiens	Ratio IC50		8.0
	18316950	CHEMBL4133283	Inhibition of recombinant full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system assessed as ratio of IC50 in presence of 3 mM eIF4E substrate to IC50 in presence of 0.15 mM eIF4E substrate by ADP-Glo assay	B	COc1ccc(Nc2nccc(-c3cn(C(C)C)c4ccccc34)n2)c(OC)c1		CHEMBL4159011	=	Ratio IC50		3.0	CHEMBL4204	Homo sapiens	Ratio IC50		3.0
Not Active	18317056	CHEMBL4133337	Inhibition of MNK2 in human MV4-11 cells assessed as reduction in eIF4E phosphorylation at S209 residue at 0.6 to 2.4 uM after 1 hr by Western blot method	B	COc1ccc(Nc2nccc(-c3sc(SCCN4CCOCC4)nc3C)n2)c(OC)c1		CHEMBL4174540		Inhibition	%		CHEMBL4204	Homo sapiens	INH		
Active	18317057	CHEMBL4133337	Inhibition of MNK2 in human MV4-11 cells assessed as reduction in eIF4E phosphorylation at S209 residue at 0.6 to 2.4 uM after 1 hr by Western blot method	B	COc1ccc(Nc2nccc(-c3c[nH]c4ccccc34)n2)c(OC)c1		CHEMBL4173067		Inhibition	%		CHEMBL4204	Homo sapiens	INH		
Active	18317063	CHEMBL4133341	Inhibition of MNK2 in human MV4-11 cells assessed as reduction in eIF4E phosphorylation at S209 residue at 6.5 to 26 uM after 1 hr by Western blot method	B	COc1ccc(Nc2nccc(-c3cn(CCN4CCOCC4)c4ccccc34)n2)c(OC)c1		CHEMBL4167344		Inhibition	%		CHEMBL4204	Homo sapiens	INH		
Active	18317067	CHEMBL4133344	Inhibition of MNK2 in human MV4-11 cells assessed as reduction in eIF4E phosphorylation at S209 residue at 0.6 to 2.4 uM after 24 hrs by Western blot method	B	COc1ccc(Nc2nccc(-c3c[nH]c4ccccc34)n2)c(OC)c1		CHEMBL4173067		Inhibition	%		CHEMBL4204	Homo sapiens	INH		
Active	18317070	CHEMBL4133347	Inhibition of MNK2 in human MV4-11 cells assessed as reduction in eIF4E phosphorylation at S209 residue at 6.5 to 26 uM after 24 hrs by Western blot method	B	COc1ccc(Nc2nccc(-c3cn(CCN4CCOCC4)c4ccccc34)n2)c(OC)c1		CHEMBL4167344		Inhibition	%		CHEMBL4204	Homo sapiens	INH		
	18379931	CHEMBL4145832	Inhibition of MNK2 (unknown origin) at 10 uM relative to control	B	COc1cc(NC(=O)Nc2cnc(Nc3ccc(N4CCOCC4)cc3)nc2Oc2ccc(C)cc2OC)cc(OC)c1		CHEMBL4159506	=	Inhibition	%	4.22	CHEMBL4204	Homo sapiens	INH	%	4.22
	18379983	CHEMBL4145884	Inhibition of MNK2 (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	27.12	CHEMBL4204	Homo sapiens	IC50	nM	27.12
	18440313	CHEMBL4157137	Binding affinity to wild-type human partial length MKNK2 (G63 to S388 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	99.0	CHEMBL4204	Homo sapiens	Activity	%	99.0
	18449902	CHEMBL4178136	Inhibition of human MNK2alpha (2 to 465 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	98.0	CHEMBL4204	Homo sapiens	Activity	%	98.0
	18477356	CHEMBL4183791	Inhibition of full length human N-terminal GST-tagged MNK2 expressed in baculovirus expression system at 10 nM relative to control	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(CN4CCOCC4)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL4204373	>	Inhibition	%	90.0	CHEMBL4204	Homo sapiens	INH	%	90.0
	18484269	CHEMBL4185916	Binding affinity to wild-type human partial length MKNK2 (G63 to S388 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	66.0	CHEMBL4204	Homo sapiens	Activity	%	66.0
	18484753	CHEMBL4185916	Binding affinity to wild-type human partial length MKNK2 (G63 to S388 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	84.0	CHEMBL4204	Homo sapiens	Activity	%	84.0
	18489537	CHEMBL4187278	Inhibition of wild-type human partial length MKNK2 (G63 to S388 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	90.0	CHEMBL4204	Homo sapiens	Activity	%	90.0
	18501939	CHEMBL4189528	Inhibition of wild-type human partial length MNK2 (G63 to S388 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	>	Inhibition	%	99.0	CHEMBL4204	Homo sapiens	INH	%	99.0
	18501940	CHEMBL4189528	Inhibition of wild-type human partial length MNK2 (G63 to S388 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	N#Cc1ccc(-c2cnc3ccc(-c4ccc(C(=O)N5CCOCC5)cc4)cn23)cc1		CHEMBL4211649	>	Inhibition	%	65.0	CHEMBL4204	Homo sapiens	INH	%	65.0
	18501941	CHEMBL4189528	Inhibition of wild-type human partial length MNK2 (G63 to S388 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	N#Cc1ccc(-c2cnc3ccc(-c4ccc(C(=O)N5CCOCC5)cc4)nn23)cc1		CHEMBL4203889	>	Inhibition	%	65.0	CHEMBL4204	Homo sapiens	INH	%	65.0
	18502116	CHEMBL4189497	Inhibition of GST-tagged MNK2 (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using JH3 peptide as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 60 mins	B	N#Cc1ccc(-c2cnc3ccc(-c4ccc(C(=O)N5CCOCC5)cc4)cn23)cc1		CHEMBL4211649	=	IC50	nM	86.0	CHEMBL4204	Homo sapiens	IC50	uM	0.086
	18502117	CHEMBL4189497	Inhibition of GST-tagged MNK2 (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using JH3 peptide as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 60 mins	B	CN1CCN(C(=O)c2ccc(-c3ccc4ncc(-c5ccc(C#N)cc5)n4c3)cc2)CC1		CHEMBL4204438	=	IC50	nM	72.0	CHEMBL4204	Homo sapiens	IC50	uM	0.072
	18502118	CHEMBL4189497	Inhibition of GST-tagged MNK2 (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using JH3 peptide as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 60 mins	B	CN(C)C1CCN(C(=O)c2ccc(-c3ccc4ncc(-c5ccc(C#N)cc5)n4n3)cc2)CC1		CHEMBL4216109	=	IC50	nM	11.0	CHEMBL4204	Homo sapiens	IC50	uM	0.011
	18502119	CHEMBL4189497	Inhibition of GST-tagged MNK2 (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using JH3 peptide as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 60 mins	B	N#Cc1ccc(-c2cnc3ccc(-c4ccc(C(=O)N5CCNCC5)cc4)nn23)cc1		CHEMBL4208772	=	IC50	nM	26.0	CHEMBL4204	Homo sapiens	IC50	uM	0.026
	18502120	CHEMBL4189497	Inhibition of GST-tagged MNK2 (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using JH3 peptide as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 60 mins	B	N#Cc1ccc(-c2cnc3ccc(-c4ccc(C(=O)N5CCOCC5)cc4)nn23)cc1		CHEMBL4203889	=	IC50	nM	41.0	CHEMBL4204	Homo sapiens	IC50	uM	0.041
	18502121	CHEMBL4189497	Inhibition of GST-tagged MNK2 (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using JH3 peptide as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 60 mins	B	CN1CCN(C(=O)c2ccc(-c3ccc4ncc(-c5ccc(C#N)cc5)n4n3)cc2)CC1		CHEMBL4213168	=	IC50	nM	25.0	CHEMBL4204	Homo sapiens	IC50	uM	0.025
	18502122	CHEMBL4189497	Inhibition of GST-tagged MNK2 (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using JH3 peptide as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 60 mins	B	CN(C)C1CCN(C(=O)c2ccc(-c3cn4c(-c5ccc(C#N)cc5)cnc4cn3)cc2)CC1		CHEMBL4208246	=	IC50	nM	143.0	CHEMBL4204	Homo sapiens	IC50	uM	0.143
	18502123	CHEMBL4189497	Inhibition of GST-tagged MNK2 (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using JH3 peptide as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 60 mins	B	CC(=O)N1CCN(C(=O)c2ccc(-c3cn4c(-c5ccc(O)cc5)cnc4cn3)cc2)CC1		CHEMBL4208890	=	IC50	nM	160.0	CHEMBL4204	Homo sapiens	IC50	uM	0.16
	18502124	CHEMBL4189497	Inhibition of GST-tagged MNK2 (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using JH3 peptide as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 60 mins	B	N#Cc1ccc(-c2cnc3cnc(-c4ccc(C(=O)N5CCOCC5)cc4)cn23)cc1		CHEMBL4213819	=	IC50	nM	454.0	CHEMBL4204	Homo sapiens	IC50	uM	0.454
	18502125	CHEMBL4189497	Inhibition of GST-tagged MNK2 (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using JH3 peptide as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 60 mins	B	O=C(c1ccc(-c2cn3c(-c4ccc(O)cc4)cnc3cn2)cc1)N1CCOCC1		CHEMBL4209905	=	IC50	nM	113.0	CHEMBL4204	Homo sapiens	IC50	uM	0.113
	18502126	CHEMBL4189497	Inhibition of GST-tagged MNK2 (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using JH3 peptide as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 60 mins	B	CN1CCN(C(=O)c2ccc(-c3cn4c(-c5ccc(C(N)=O)cc5)cnc4cn3)cc2)CC1		CHEMBL4204506	=	IC50	nM	187.0	CHEMBL4204	Homo sapiens	IC50	uM	0.187
	18502127	CHEMBL4189497	Inhibition of GST-tagged MNK2 (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using JH3 peptide as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 60 mins	B	CN1CCN(C(=O)c2ccc(-c3cn4c(-c5ccc(C(F)F)cc5)cnc4cn3)cc2)CC1		CHEMBL4202593	=	IC50	nM	336.0	CHEMBL4204	Homo sapiens	IC50	uM	0.336
	18502128	CHEMBL4189497	Inhibition of GST-tagged MNK2 (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using JH3 peptide as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 60 mins	B	CN1CCN(C(=O)c2ccc(-c3cn4c(-c5ccc(C(F)(F)F)cc5)cnc4cn3)cc2)CC1		CHEMBL4212200	=	IC50	nM	389.0	CHEMBL4204	Homo sapiens	IC50	uM	0.389
	18502129	CHEMBL4189497	Inhibition of GST-tagged MNK2 (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using JH3 peptide as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 60 mins	B	CN1CCN(C(=O)c2ccc(-c3cn4c(-c5ccc(Cl)cc5)cnc4cn3)cc2)CC1		CHEMBL4211757	=	IC50	nM	217.0	CHEMBL4204	Homo sapiens	IC50	uM	0.217
	18502130	CHEMBL4189497	Inhibition of GST-tagged MNK2 (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using JH3 peptide as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 60 mins	B	CN1CCN(C(=O)c2ccc(-c3cn4c(-c5ccc(C#N)cc5)cnc4cn3)cc2)CC1		CHEMBL4216991	=	IC50	nM	502.0	CHEMBL4204	Homo sapiens	IC50	uM	0.502
	18502131	CHEMBL4189497	Inhibition of GST-tagged MNK2 (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using JH3 peptide as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 60 mins	B	CN1CCN(C(=O)c2ccc(-c3cn4c(-c5ccc(C(=O)NO)cc5)cnc4cn3)cc2)CC1		CHEMBL4214092	=	IC50	nM	31.0	CHEMBL4204	Homo sapiens	IC50	uM	0.031
	18502132	CHEMBL4189497	Inhibition of GST-tagged MNK2 (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using JH3 peptide as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 60 mins	B	CN1CCN(C(=O)c2ccc(-c3cn4c(-c5ccc(C(=O)O)cc5)cnc4cn3)cc2)CC1		CHEMBL4217366	=	IC50	nM	355.0	CHEMBL4204	Homo sapiens	IC50	uM	0.355
	18502133	CHEMBL4189497	Inhibition of GST-tagged MNK2 (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using JH3 peptide as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 60 mins	B	Cc1ccc(-c2cnc3cnc(-c4ccc(C(=O)N5CCN(C)CC5)cc4)cn23)cc1		CHEMBL4212307	=	IC50	nM	410.0	CHEMBL4204	Homo sapiens	IC50	uM	0.41
	18502134	CHEMBL4189497	Inhibition of GST-tagged MNK2 (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using JH3 peptide as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 60 mins	B	CN1CCN(C(=O)c2ccc(-c3cn4c(-c5cccc(O)c5)cnc4cn3)cc2)CC1		CHEMBL4216093	=	IC50	nM	742.0	CHEMBL4204	Homo sapiens	IC50	uM	0.742
	18502135	CHEMBL4189497	Inhibition of GST-tagged MNK2 (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using JH3 peptide as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 60 mins	B	CN1CCN(C(=O)c2ccc(-c3cn4c(-c5ccccc5O)cnc4cn3)cc2)CC1		CHEMBL4202639	=	IC50	nM	5170.0	CHEMBL4204	Homo sapiens	IC50	uM	5.17
	18502136	CHEMBL4189497	Inhibition of GST-tagged MNK2 (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using JH3 peptide as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 60 mins	B	CN1CCN(C(=O)c2ccc(-c3cn4c(-c5ccccc5)cnc4cn3)cc2)CC1		CHEMBL4206349	=	IC50	nM	1430.0	CHEMBL4204	Homo sapiens	IC50	uM	1.43
	18502137	CHEMBL4189497	Inhibition of GST-tagged MNK2 (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using JH3 peptide as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 60 mins	B	CN1CCN(C(=O)c2ccc(-c3cn4c(-c5ccc(O)cc5)cnc4cn3)cc2)CC1		CHEMBL4209496	=	IC50	nM	140.0	CHEMBL4204	Homo sapiens	IC50	uM	0.14
	18502138	CHEMBL4189497	Inhibition of GST-tagged MNK2 (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using JH3 peptide as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 60 mins	B	NC(=O)c1ccc(-c2cn3c(-c4ccc(O)cc4)cnc3cn2)cc1		CHEMBL4212480	=	IC50	nM	193.0	CHEMBL4204	Homo sapiens	IC50	uM	0.193
	18502139	CHEMBL4189497	Inhibition of GST-tagged MNK2 (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using JH3 peptide as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 60 mins	B	Oc1ccc(-c2cnc3cnc(-c4ccccc4)cn23)cc1		CHEMBL4213023	=	IC50	nM	415.0	CHEMBL4204	Homo sapiens	IC50	uM	0.415
	18502140	CHEMBL4189497	Inhibition of GST-tagged MNK2 (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using JH3 peptide as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 60 mins	B	O=C(Nc1cn2c(-c3ccc(O)cc3)cnc2cn1)c1ccccc1		CHEMBL4208112	=	IC50	nM	1080.0	CHEMBL4204	Homo sapiens	IC50	uM	1.08
	18502141	CHEMBL4189497	Inhibition of GST-tagged MNK2 (72 to 385 residues) (unknown origin) expressed in Escherichia coli BL21(DE3) using JH3 peptide as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 60 mins	B	CC(=O)Nc1cn2c(-c3ccc(O)cc3)cnc2cn1		CHEMBL4208627	=	IC50	nM	515.0	CHEMBL4204	Homo sapiens	IC50	uM	0.515
	18507698	CHEMBL4191066	Inhibition of recombinant full-length human Mnk2 at 1 uM using myelin basic protein as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-6.0	CHEMBL4204	Homo sapiens	INH	%	-6.0
	18655419	CHEMBL4230816	Binding affinity to wild-type human partial length MKNK2 (G63 to S388 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL4204	Homo sapiens	Activity	%	100.0
	18663933	CHEMBL4232917	Inhibition of human MKNK2 (G63 to S388 residues) expressed in mammalian expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	92.0	CHEMBL4204	Homo sapiens	Activity	%	92.0
	18664030	CHEMBL4233014	Binding affinity to human MKNK2 (G63 to S388 residues) expressed in mammalian expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL4204	Homo sapiens	Kd	uM	5.0
	18678488	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NCCN(C)C)c(C)c12		CHEMBL4249176	=	Inhibition	%	19.0	CHEMBL4204	Homo sapiens	INH	%	19.0
	18678489	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)N(C)C)c(C)c12		CHEMBL4248703	=	Inhibition	%	24.0	CHEMBL4204	Homo sapiens	INH	%	24.0
	18678490	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	CNC(=O)c1oc2c(C(N)=O)c(O)cc(OC)c2c1C		CHEMBL4238675	=	Inhibition	%	66.0	CHEMBL4204	Homo sapiens	INH	%	66.0
	18678491	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	CCOC(=O)c1oc2c(C(N)=O)c(O)cc(OC)c2c1C		CHEMBL4237724	=	Inhibition	%	21.0	CHEMBL4204	Homo sapiens	INH	%	21.0
	18678492	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2occ(C)c12		CHEMBL4247747	=	Inhibition	%	43.0	CHEMBL4204	Homo sapiens	INH	%	43.0
	18678493	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	Cc1c(C(=O)NC2CCN(Cc3cccc(C(F)(F)F)c3)CC2)oc2ccccc12		CHEMBL4250082	=	Inhibition	%	28.0	CHEMBL4204	Homo sapiens	INH	%	28.0
	18678494	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1ccc2c(C)c(C(=O)NC3CCN(Cc4cccc(C(F)(F)F)c4)CC3)oc2c1		CHEMBL4245823	=	Inhibition	%	27.0	CHEMBL4204	Homo sapiens	INH	%	27.0
	18678495	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(OC)c2c(C)c(C(=O)NC3CCN(Cc4cccc(C(F)(F)F)c4)CC3)oc2c1		CHEMBL4239519	=	Inhibition	%	35.0	CHEMBL4204	Homo sapiens	INH	%	35.0
	18678496	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	Cc1c(C(=O)NC2CCN(Cc3cccc(C(F)(F)F)c3)CC2)oc2c(C(N)=O)c(O)cc(O)c12		CHEMBL4249621	=	Inhibition	%	34.0	CHEMBL4204	Homo sapiens	INH	%	34.0
	18678497	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(OC)c2c(C)c(C(=O)NC3CCN(Cc4cccc(C(F)(F)F)c4)CC3)oc2c1C(N)=O		CHEMBL4243303	=	Inhibition	%	29.0	CHEMBL4204	Homo sapiens	INH	%	29.0
	18678498	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NCC3CCN(Cc4ccc(Cl)c(Cl)c4)CC3)c(C)c12		CHEMBL4239077	=	Inhibition	%	38.0	CHEMBL4204	Homo sapiens	INH	%	38.0
	18678499	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCN(Cc4cccc(Cl)c4Cl)CC3)c(C)c12		CHEMBL4245844	=	Inhibition	%	21.0	CHEMBL4204	Homo sapiens	INH	%	21.0
	18678500	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCN(Cc4ccc(Cl)cc4Cl)CC3)c(C)c12		CHEMBL4242692	=	Inhibition	%	0.0	CHEMBL4204	Homo sapiens	INH	%	0.0
	18678501	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCN(Cc4c(Cl)cccc4Cl)CC3)c(C)c12		CHEMBL4239080	=	Inhibition	%	27.0	CHEMBL4204	Homo sapiens	INH	%	27.0
	18678502	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NCC3CCN(Cc4cccc(C(F)(F)F)c4)CC3)c(C)c12		CHEMBL4250161	=	Inhibition	%	49.0	CHEMBL4204	Homo sapiens	INH	%	49.0
	18678503	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCN(Cc4cccc(C(F)(F)F)c4)CC3)c(C)c12		CHEMBL4248798	=	Inhibition	%	90.0	CHEMBL4204	Homo sapiens	INH	%	90.0
	18678504	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCN(C(=O)c4ccc(C(F)(F)F)cc4)CC3)c(C)c12		CHEMBL4238758	=	Inhibition	%	29.0	CHEMBL4204	Homo sapiens	INH	%	29.0
	18678505	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCN(Cc4ccc(C(F)(F)F)cc4)CC3)c(C)c12		CHEMBL4244994	=	Inhibition	%	43.0	CHEMBL4204	Homo sapiens	INH	%	43.0
	18678506	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCN(Cc4ccc(Cl)cc4)CC3)c(C)c12		CHEMBL4249253	=	Inhibition	%	45.0	CHEMBL4204	Homo sapiens	INH	%	45.0
	18678507	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCN(Cc4ccc(C)cc4)CC3)c(C)c12		CHEMBL4242019	=	Inhibition	%	40.0	CHEMBL4204	Homo sapiens	INH	%	40.0
	18678508	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NCC3CCN(C(=O)c4ccc(F)cc4)CC3)c(C)c12		CHEMBL4246285	=	Inhibition	%	23.0	CHEMBL4204	Homo sapiens	INH	%	23.0
	18678509	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NCC3CCN(Cc4ccc(F)cc4)CC3)c(C)c12		CHEMBL4238317	=	Inhibition	%	41.0	CHEMBL4204	Homo sapiens	INH	%	41.0
	18678510	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCN(Cc4ccc(F)cc4)CC3)c(C)c12		CHEMBL4242481	=	Inhibition	%	15.0	CHEMBL4204	Homo sapiens	INH	%	15.0
	18678511	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCN(Cc4ccccc4F)CC3)c(C)c12		CHEMBL4238447	=	Inhibition	%	31.0	CHEMBL4204	Homo sapiens	INH	%	31.0
	18678512	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCN(Cc4cc(Cl)ncn4)CC3)c(C)c12		CHEMBL4248459	=	Inhibition	%	11.0	CHEMBL4204	Homo sapiens	INH	%	11.0
	18678513	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCN(Cc4ccncc4)CC3)c(C)c12		CHEMBL4250591	=	Inhibition	%	32.0	CHEMBL4204	Homo sapiens	INH	%	32.0
	18678514	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)N(C)Cc3cccc(F)c3)c(C)c12		CHEMBL4249143	=	Inhibition	%	23.0	CHEMBL4204	Homo sapiens	INH	%	23.0
	18678515	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)N(C)Cc3ccccc3)c(C)c12		CHEMBL4246777	=	Inhibition	%	0.0	CHEMBL4204	Homo sapiens	INH	%	0.0
	18678516	CHEMBL4236042	Inhibition of MNK2 (unknown origin)	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	IC50	nM	1600.0	CHEMBL4204	Homo sapiens	IC50	uM	1.6
	18678540	CHEMBL4236037	Inhibition of MNK2 (unknown origin) using S3 as substrate measured after 60 mins by HTRF assay	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	IC50	nM	1530.0	CHEMBL4204	Homo sapiens	IC50	uM	1.53
	18678541	CHEMBL4236037	Inhibition of MNK2 (unknown origin) using S3 as substrate measured after 60 mins by HTRF assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	262.0	CHEMBL4204	Homo sapiens	IC50	uM	0.262
	18678542	CHEMBL4236037	Inhibition of MNK2 (unknown origin) using S3 as substrate measured after 60 mins by HTRF assay	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCN(Cc4cccc(C(F)(F)F)c4)CC3)c(C)c12		CHEMBL4248798	=	IC50	nM	273.0	CHEMBL4204	Homo sapiens	IC50	uM	0.273
	18678543	CHEMBL4236037	Inhibition of MNK2 (unknown origin) using S3 as substrate measured after 60 mins by HTRF assay	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)Nc3ccc(C)c(C(F)(F)F)c3)c(C)c12		CHEMBL4249658	=	IC50	nM	3550.0	CHEMBL4204	Homo sapiens	IC50	uM	3.55
	18678544	CHEMBL4236037	Inhibition of MNK2 (unknown origin) using S3 as substrate measured after 60 mins by HTRF assay	B	CCN1CCN(C(=O)c2oc3c(C(N)=O)c(O)cc(OC)c3c2C)CC1		CHEMBL4237434	=	IC50	nM	1160.0	CHEMBL4204	Homo sapiens	IC50	uM	1.16
	18678545	CHEMBL4236037	Inhibition of MNK2 (unknown origin) using S3 as substrate measured after 60 mins by HTRF assay	B	CNC(=O)c1oc2c(C(N)=O)c(O)cc(OC)c2c1C		CHEMBL4238675	=	IC50	nM	1450.0	CHEMBL4204	Homo sapiens	IC50	uM	1.45
	18678546	CHEMBL4236037	Inhibition of MNK2 (unknown origin) using S3 as substrate measured after 60 mins by HTRF assay	B	COc1cc(O)c(C(N)=O)c2occ(C)c12		CHEMBL4247747	=	IC50	nM	749.0	CHEMBL4204	Homo sapiens	IC50	uM	0.749
	18678564	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	Cc1c(C(=O)NC2CCN(Cc3cccc(C(F)(F)F)c3)CC2)oc2ccccc12		CHEMBL4250082	=	Inhibition	%	0.0	CHEMBL4204	Homo sapiens	INH	%	0.0
	18678565	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1ccc2c(C)c(C(=O)NC3CCN(Cc4cccc(C(F)(F)F)c4)CC3)oc2c1		CHEMBL4245823	=	Inhibition	%	0.0	CHEMBL4204	Homo sapiens	INH	%	0.0
	18678566	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(OC)c2c(C)c(C(=O)NC3CCN(Cc4cccc(C(F)(F)F)c4)CC3)oc2c1		CHEMBL4239519	=	Inhibition	%	6.0	CHEMBL4204	Homo sapiens	INH	%	6.0
	18678567	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	Cc1c(C(=O)NC2CCN(Cc3cccc(C(F)(F)F)c3)CC2)oc2c(C(N)=O)c(O)cc(O)c12		CHEMBL4249621	=	Inhibition	%	1.0	CHEMBL4204	Homo sapiens	INH	%	1.0
	18678568	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(OC)c2c(C)c(C(=O)NC3CCN(Cc4cccc(C(F)(F)F)c4)CC3)oc2c1C(N)=O		CHEMBL4243303	=	Inhibition	%	2.0	CHEMBL4204	Homo sapiens	INH	%	2.0
	18678569	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NCC3CCN(Cc4ccc(Cl)c(Cl)c4)CC3)c(C)c12		CHEMBL4239077	=	Inhibition	%	21.0	CHEMBL4204	Homo sapiens	INH	%	21.0
	18678570	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCN(Cc4cccc(Cl)c4Cl)CC3)c(C)c12		CHEMBL4245844	=	Inhibition	%	18.0	CHEMBL4204	Homo sapiens	INH	%	18.0
	18678571	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCN(Cc4ccc(Cl)cc4Cl)CC3)c(C)c12		CHEMBL4242692	=	Inhibition	%	0.0	CHEMBL4204	Homo sapiens	INH	%	0.0
	18678572	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCN(Cc4c(Cl)cccc4Cl)CC3)c(C)c12		CHEMBL4239080	=	Inhibition	%	1.0	CHEMBL4204	Homo sapiens	INH	%	1.0
	18678573	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NCC3CCN(Cc4cccc(C(F)(F)F)c4)CC3)c(C)c12		CHEMBL4250161	=	Inhibition	%	23.0	CHEMBL4204	Homo sapiens	INH	%	23.0
	18678574	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCN(Cc4cccc(C(F)(F)F)c4)CC3)c(C)c12		CHEMBL4248798	=	Inhibition	%	85.0	CHEMBL4204	Homo sapiens	INH	%	85.0
	18678575	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCN(C(=O)c4ccc(C(F)(F)F)cc4)CC3)c(C)c12		CHEMBL4238758	=	Inhibition	%	26.0	CHEMBL4204	Homo sapiens	INH	%	26.0
	18678576	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCN(Cc4ccc(C(F)(F)F)cc4)CC3)c(C)c12		CHEMBL4244994	=	Inhibition	%	24.0	CHEMBL4204	Homo sapiens	INH	%	24.0
	18678577	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCN(Cc4ccc(Cl)cc4)CC3)c(C)c12		CHEMBL4249253	=	Inhibition	%	29.0	CHEMBL4204	Homo sapiens	INH	%	29.0
	18678578	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCN(Cc4ccc(C)cc4)CC3)c(C)c12		CHEMBL4242019	=	Inhibition	%	27.0	CHEMBL4204	Homo sapiens	INH	%	27.0
	18678579	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NCC3CCN(C(=O)c4ccc(F)cc4)CC3)c(C)c12		CHEMBL4246285	=	Inhibition	%	16.0	CHEMBL4204	Homo sapiens	INH	%	16.0
	18678580	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NCC3CCN(Cc4ccc(F)cc4)CC3)c(C)c12		CHEMBL4238317	=	Inhibition	%	32.0	CHEMBL4204	Homo sapiens	INH	%	32.0
	18678581	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCN(Cc4ccc(F)cc4)CC3)c(C)c12		CHEMBL4242481	=	Inhibition	%	8.0	CHEMBL4204	Homo sapiens	INH	%	8.0
	18678582	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCN(Cc4ccccc4F)CC3)c(C)c12		CHEMBL4238447	=	Inhibition	%	29.0	CHEMBL4204	Homo sapiens	INH	%	29.0
	18678583	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCN(Cc4cc(Cl)ncn4)CC3)c(C)c12		CHEMBL4248459	=	Inhibition	%	0.0	CHEMBL4204	Homo sapiens	INH	%	0.0
	18678584	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCN(Cc4ccncc4)CC3)c(C)c12		CHEMBL4250591	=	Inhibition	%	15.0	CHEMBL4204	Homo sapiens	INH	%	15.0
	18678585	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)N(C)Cc3cccc(F)c3)c(C)c12		CHEMBL4249143	=	Inhibition	%	11.0	CHEMBL4204	Homo sapiens	INH	%	11.0
	18678586	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)N(C)Cc3ccccc3)c(C)c12		CHEMBL4246777	=	Inhibition	%	0.0	CHEMBL4204	Homo sapiens	INH	%	0.0
	18678587	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NCc3ccccc3)c(C)c12		CHEMBL4242521	=	Inhibition	%	24.0	CHEMBL4204	Homo sapiens	INH	%	24.0
	18678588	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)Nc3ccc(C)c(C(F)(F)F)c3)c(C)c12		CHEMBL4249658	=	Inhibition	%	75.0	CHEMBL4204	Homo sapiens	INH	%	75.0
	18678589	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(C)c12		CHEMBL4246692	=	Inhibition	%	18.0	CHEMBL4204	Homo sapiens	INH	%	18.0
	18678590	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)Nc3ccccc3)c(C)c12		CHEMBL4247444	=	Inhibition	%	0.0	CHEMBL4204	Homo sapiens	INH	%	0.0
	18678591	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)N3CCN(c4cccc(C(F)(F)F)c4)CC3)c(C)c12		CHEMBL4249292	=	Inhibition	%	28.0	CHEMBL4204	Homo sapiens	INH	%	28.0
	18678592	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)N3CCN(c4ccc(F)cc4)CC3)c(C)c12		CHEMBL4249546	=	Inhibition	%	5.0	CHEMBL4204	Homo sapiens	INH	%	5.0
	18678593	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)N3CCN(c4ccccc4)CC3)c(C)c12		CHEMBL4239441	=	Inhibition	%	8.0	CHEMBL4204	Homo sapiens	INH	%	8.0
	18678594	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	CCN1CCN(C(=O)c2oc3c(C(N)=O)c(O)cc(OC)c3c2C)CC1		CHEMBL4237434	=	Inhibition	%	36.0	CHEMBL4204	Homo sapiens	INH	%	36.0
	18678595	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)N3CCCCC3)c(C)c12		CHEMBL4241586	=	Inhibition	%	19.0	CHEMBL4204	Homo sapiens	INH	%	19.0
	18678596	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)N3CCOCC3)c(C)c12		CHEMBL4241162	=	Inhibition	%	12.0	CHEMBL4204	Homo sapiens	INH	%	12.0
	18678597	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCCCC3)c(C)c12		CHEMBL4245377	=	Inhibition	%	20.0	CHEMBL4204	Homo sapiens	INH	%	20.0
	18678598	CHEMBL4236032	Inhibition of MNK2 (unknown origin) at 1 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCCC3)c(C)c12		CHEMBL4244911	=	Inhibition	%	6.0	CHEMBL4204	Homo sapiens	INH	%	6.0
	18678599	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)N3CCCCC3)c(C)c12		CHEMBL4241586	=	Inhibition	%	23.0	CHEMBL4204	Homo sapiens	INH	%	23.0
	18678600	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	CCN1CCN(C(=O)c2oc3c(C(N)=O)c(O)cc(OC)c3c2C)CC1		CHEMBL4237434	=	Inhibition	%	79.0	CHEMBL4204	Homo sapiens	INH	%	79.0
	18678601	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)N3CCN(c4ccccc4)CC3)c(C)c12		CHEMBL4239441	=	Inhibition	%	15.0	CHEMBL4204	Homo sapiens	INH	%	15.0
	18678602	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)N3CCN(c4ccc(F)cc4)CC3)c(C)c12		CHEMBL4249546	=	Inhibition	%	10.0	CHEMBL4204	Homo sapiens	INH	%	10.0
	18678603	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NCc3ccccc3)c(C)c12		CHEMBL4242521	=	Inhibition	%	28.0	CHEMBL4204	Homo sapiens	INH	%	28.0
	18678604	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)Nc3ccc(C)c(C(F)(F)F)c3)c(C)c12		CHEMBL4249658	=	Inhibition	%	57.0	CHEMBL4204	Homo sapiens	INH	%	57.0
	18678605	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(C)c12		CHEMBL4246692	=	Inhibition	%	35.0	CHEMBL4204	Homo sapiens	INH	%	35.0
	18678606	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)Nc3ccccc3)c(C)c12		CHEMBL4247444	=	Inhibition	%	0.0	CHEMBL4204	Homo sapiens	INH	%	0.0
	18678607	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)N3CCN(c4cccc(C(F)(F)F)c4)CC3)c(C)c12		CHEMBL4249292	=	Inhibition	%	61.0	CHEMBL4204	Homo sapiens	INH	%	61.0
	18678608	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2occ(C)c12		CHEMBL4247747	=	Inhibition	%	77.0	CHEMBL4204	Homo sapiens	INH	%	77.0
	18678609	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	CCOC(=O)c1oc2c(C(N)=O)c(O)cc(OC)c2c1C		CHEMBL4237724	=	Inhibition	%	41.0	CHEMBL4204	Homo sapiens	INH	%	41.0
	18678610	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	CNC(=O)c1oc2c(C(N)=O)c(O)cc(OC)c2c1C		CHEMBL4238675	=	Inhibition	%	73.0	CHEMBL4204	Homo sapiens	INH	%	73.0
	18678611	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)N(C)C)c(C)c12		CHEMBL4248703	=	Inhibition	%	45.0	CHEMBL4204	Homo sapiens	INH	%	45.0
	18678612	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NCCN(C)C)c(C)c12		CHEMBL4249176	=	Inhibition	%	24.0	CHEMBL4204	Homo sapiens	INH	%	24.0
	18678613	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCCC3)c(C)c12		CHEMBL4244911	=	Inhibition	%	22.0	CHEMBL4204	Homo sapiens	INH	%	22.0
	18678614	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)NC3CCCCC3)c(C)c12		CHEMBL4245377	=	Inhibition	%	28.0	CHEMBL4204	Homo sapiens	INH	%	28.0
	18678615	CHEMBL4236031	Inhibition of MNK2 (unknown origin) at 10 uM using S3 as substrate measured after 60 mins by HTRF assay relative to control	B	COc1cc(O)c(C(N)=O)c2oc(C(=O)N3CCOCC3)c(C)c12		CHEMBL4241162	=	Inhibition	%	24.0	CHEMBL4204	Homo sapiens	INH	%	24.0
	18697662	CHEMBL4254335	Inhibition of wild-type human partial length MKNK2 (G63 to S388 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	73.0	CHEMBL4204	Homo sapiens	Activity	%	73.0
	18751992	CHEMBL4264405	Binding affinity to wild-type human partial length MKNK2 (G63 to S388 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	97.0	CHEMBL4204	Homo sapiens	Activity	%	97.0
	18761541	CHEMBL4266520	Inhibition of recombinant human full length N-terminal His6-tagged MNK2 expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	33.0	CHEMBL4204	Homo sapiens	INH	%	33.0
	18761812	CHEMBL4266520	Inhibition of recombinant human full length N-terminal His6-tagged MNK2 expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	1.0	CHEMBL4204	Homo sapiens	INH	%	1.0
	18761975	CHEMBL4266520	Inhibition of recombinant human full length N-terminal His6-tagged MNK2 expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	1.0	CHEMBL4204	Homo sapiens	INH	%	1.0
	18764494	CHEMBL4267067	Inhibition of human MNK2 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4288103	<	Inhibition	%	70.0	CHEMBL4204	Homo sapiens	INH	%	70.0
	18764495	CHEMBL4267067	Inhibition of human MNK2 at 100 nM	B	CN1CCC(c2nc(-c3cccc(S(C)(=O)=O)c3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4286880	<	Inhibition	%	70.0	CHEMBL4204	Homo sapiens	INH	%	70.0
	18764496	CHEMBL4267067	Inhibition of human MNK2 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)c(NS(C)(=O)=O)c3)c(-c3ccnc(NCC4CC4)n3)s2)CC1		CHEMBL4286841	<	Inhibition	%	70.0	CHEMBL4204	Homo sapiens	INH	%	70.0
Not Active	18847294	CHEMBL4304926	Inhibition of wild-type human partial length MKNK2 (G63 to S388 residues) expressed in mammalian expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL4204	Homo sapiens	INH		
	18858069	CHEMBL4307915	Binding affinity to wild-type human partial length MKNK2 (G63 to S388 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	87.0	CHEMBL4204	Homo sapiens	Activity	%	87.0
	18892915	CHEMBL4314881	Inhibition of recombinant full-length human Mnk2 assessed as residual activity at 10 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	88.0	CHEMBL4204	Homo sapiens	Activity	%	88.0
	18919450	CHEMBL4322807	Binding affinity to recombinant human full-length N-terminal GST-tagged MKNK2 expressed in baculovirus expression system using RS peptide as substrate incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	162.0	CHEMBL4204	Homo sapiens	Kd	nM	162.0
	18919638	CHEMBL4322807	Binding affinity to recombinant human full-length N-terminal GST-tagged MKNK2 expressed in baculovirus expression system using RS peptide as substrate incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	205.0	CHEMBL4204	Homo sapiens	Kd	nM	205.0
	18938105	CHEMBL4327779	Inhibition of human MNK2 assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	91.19	CHEMBL4204	Homo sapiens	Activity	%	91.19
	18938106	CHEMBL4327779	Inhibition of human MNK2 assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	93.04	CHEMBL4204	Homo sapiens	Activity	%	93.04
	18938624	CHEMBL4328143	Inhibition of human MNK2 assessed as residual activity at 100 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL4204	Homo sapiens	Activity	%	65.0
	18939004	CHEMBL4328507	Inhibition of human MNK2 using MBP as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	20.3	CHEMBL4204	Homo sapiens	IC50	10'-8M	2.03
	18952558	CHEMBL4331737	Inhibition of MNK2 (unknown origin) expressed in HEK293 cells assessed as decrease in eIF4E phosphorylation at Ser209 residues by Western blot analysis	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	IC50	nM	1600.0	CHEMBL4204	Homo sapiens	IC50	nM	1600.0
	18952559	CHEMBL4331737	Inhibition of MNK2 (unknown origin) expressed in HEK293 cells assessed as decrease in eIF4E phosphorylation at Ser209 residues by Western blot analysis	B	Cc1cc(Nc2cc(N)ncn2)c(=O)n2c1C(=O)NC21CCCCC1.Cl		CHEMBL4298140	=	IC50	nM	1.0	CHEMBL4204	Homo sapiens	IC50	nM	1.0
	18952560	CHEMBL4331737	Inhibition of MNK2 (unknown origin) expressed in HEK293 cells assessed as decrease in eIF4E phosphorylation at Ser209 residues by Western blot analysis	B	N#Cc1ccc(-c2cnc3ccc(-c4ccc(C(=O)N5CCOCC5)cc4)cn23)cc1		CHEMBL4211649	=	IC50	nM	86.0	CHEMBL4204	Homo sapiens	IC50	nM	86.0
	18953683	CHEMBL4331934	Inhibition of MNK2 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(NC3CCCCC3)c12		CHEMBL4440433	=	Inhibition	%	8.0	CHEMBL4204	Homo sapiens	INH	%	8.0
	18953749	CHEMBL4331934	Inhibition of MNK2 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccccc3F)c12		CHEMBL4449552	=	Inhibition	%	24.0	CHEMBL4204	Homo sapiens	INH	%	24.0
	18953848	CHEMBL4331934	Inhibition of MNK2 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(OC3CCCCC3)c12		CHEMBL4524629	=	Inhibition	%	37.0	CHEMBL4204	Homo sapiens	INH	%	37.0
	18953940	CHEMBL4331993	Inhibition of MNK2 (unknown origin) at 1 uM relative to control	B	CC(C)n1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cn1		CHEMBL4589022	=	Inhibition	%	5.0	CHEMBL4204	Homo sapiens	INH	%	5.0
	18954004	CHEMBL4331993	Inhibition of MNK2 (unknown origin) at 1 uM relative to control	B	c1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cc(N2CCOCC2)n1		CHEMBL4460272	=	Inhibition	%	13.0	CHEMBL4204	Homo sapiens	INH	%	13.0
	18954071	CHEMBL4331934	Inhibition of MNK2 (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccc4ncsc4c3)c12		CHEMBL4588446	=	Inhibition	%	22.0	CHEMBL4204	Homo sapiens	INH	%	22.0
	18958757	CHEMBL4333502	Binding affinity to wild-type human partial length MKNK2 (G63 to S388 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	100.0	CHEMBL4204	Homo sapiens	Activity	%	100.0
	18964479	CHEMBL4335179	Inhibition of recombinant full-length human Mnk2 assessed as residual activity at 1 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	77.0	CHEMBL4204	Homo sapiens	Activity	%	77.0
	18964480	CHEMBL4335179	Inhibition of recombinant full-length human Mnk2 assessed as residual activity at 1 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	84.0	CHEMBL4204	Homo sapiens	Activity	%	84.0
	18971994	CHEMBL4337004	Inhibition of recombinant human MNK2 assessed as residual activity at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma-33ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	84.0	CHEMBL4204	Homo sapiens	Activity	%	84.0
	19035213	CHEMBL4350377	Inhibition of recombinant His-tagged MNK2 (unknown origin) assessed as residual activity at 10 uM by IMAP TR-FRET assay relative to control	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccccn1)c2=O		CHEMBL4544955	=	Activity	%	92.0	CHEMBL4204	Homo sapiens	Activity	%	92.0
	19035214	CHEMBL4350377	Inhibition of recombinant His-tagged MNK2 (unknown origin) assessed as residual activity at 10 uM by IMAP TR-FRET assay relative to control	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1cccnc1)c2=O		CHEMBL4450493	=	Activity	%	72.0	CHEMBL4204	Homo sapiens	Activity	%	72.0
	19035215	CHEMBL4350377	Inhibition of recombinant His-tagged MNK2 (unknown origin) assessed as residual activity at 10 uM by IMAP TR-FRET assay relative to control	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncc1)c2=O		CHEMBL4449736	=	Activity	%	4.0	CHEMBL4204	Homo sapiens	Activity	%	4.0
	19035216	CHEMBL4350377	Inhibition of recombinant His-tagged MNK2 (unknown origin) assessed as residual activity at 10 uM by IMAP TR-FRET assay relative to control	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(NCc1ccccn1)c2=O		CHEMBL4514592	=	Activity	%	76.0	CHEMBL4204	Homo sapiens	Activity	%	76.0
	19035217	CHEMBL4350377	Inhibition of recombinant His-tagged MNK2 (unknown origin) assessed as residual activity at 10 uM by IMAP TR-FRET assay relative to control	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(NCc1cccnc1)c2=O		CHEMBL4449353	=	Activity	%	97.0	CHEMBL4204	Homo sapiens	Activity	%	97.0
	19035218	CHEMBL4350377	Inhibition of recombinant His-tagged MNK2 (unknown origin) assessed as residual activity at 10 uM by IMAP TR-FRET assay relative to control	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(NCc1ccncc1)c2=O		CHEMBL4439683	=	Activity	%	101.0	CHEMBL4204	Homo sapiens	Activity	%	101.0
	19035219	CHEMBL4350377	Inhibition of recombinant His-tagged MNK2 (unknown origin) assessed as residual activity at 10 uM by IMAP TR-FRET assay relative to control	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(NCCc1ccccn1)c2=O		CHEMBL4588740	=	Activity	%	101.0	CHEMBL4204	Homo sapiens	Activity	%	101.0
	19035220	CHEMBL4350377	Inhibition of recombinant His-tagged MNK2 (unknown origin) assessed as residual activity at 10 uM by IMAP TR-FRET assay relative to control	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(NCCc1cccnc1)c2=O		CHEMBL4592711	=	Activity	%	100.0	CHEMBL4204	Homo sapiens	Activity	%	100.0
	19035221	CHEMBL4350377	Inhibition of recombinant His-tagged MNK2 (unknown origin) assessed as residual activity at 10 uM by IMAP TR-FRET assay relative to control	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(NCCc1ccncc1)c2=O		CHEMBL4554804	=	Activity	%	59.0	CHEMBL4204	Homo sapiens	Activity	%	59.0
	19035222	CHEMBL4350377	Inhibition of recombinant His-tagged MNK2 (unknown origin) assessed as residual activity at 10 uM by IMAP TR-FRET assay relative to control	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ncccc1F)c2=O		CHEMBL4472319	=	Activity	%	108.0	CHEMBL4204	Homo sapiens	Activity	%	108.0
	19035223	CHEMBL4350377	Inhibition of recombinant His-tagged MNK2 (unknown origin) assessed as residual activity at 10 uM by IMAP TR-FRET assay relative to control	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1cncc(F)c1)c2=O		CHEMBL4593338	=	Activity	%	101.0	CHEMBL4204	Homo sapiens	Activity	%	101.0
	19035224	CHEMBL4350377	Inhibition of recombinant His-tagged MNK2 (unknown origin) assessed as residual activity at 10 uM by IMAP TR-FRET assay relative to control	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncc1F)c2=O		CHEMBL4535537	=	Activity	%	24.0	CHEMBL4204	Homo sapiens	Activity	%	24.0
	19035225	CHEMBL4350377	Inhibition of recombinant His-tagged MNK2 (unknown origin) assessed as residual activity at 10 uM by IMAP TR-FRET assay relative to control	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccc(F)cn1)c2=O		CHEMBL4443000	=	Activity	%	98.0	CHEMBL4204	Homo sapiens	Activity	%	98.0
	19035226	CHEMBL4350377	Inhibition of recombinant His-tagged MNK2 (unknown origin) assessed as residual activity at 10 uM by IMAP TR-FRET assay relative to control	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccc(C(F)(F)F)cn1)c2=O		CHEMBL4517229	=	Activity	%	98.0	CHEMBL4204	Homo sapiens	Activity	%	98.0
	19035227	CHEMBL4350377	Inhibition of recombinant His-tagged MNK2 (unknown origin) assessed as residual activity at 10 uM by IMAP TR-FRET assay relative to control	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccnc(O)c1)c2=O		CHEMBL4454334	=	Activity	%	57.0	CHEMBL4204	Homo sapiens	Activity	%	57.0
	19035228	CHEMBL4350377	Inhibition of recombinant His-tagged MNK2 (unknown origin) assessed as residual activity at 10 uM by IMAP TR-FRET assay relative to control	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1cccnn1)c2=O		CHEMBL4461330	=	Activity	%	70.0	CHEMBL4204	Homo sapiens	Activity	%	70.0
	19035229	CHEMBL4350377	Inhibition of recombinant His-tagged MNK2 (unknown origin) assessed as residual activity at 10 uM by IMAP TR-FRET assay relative to control	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccnnc1)c2=O		CHEMBL4444914	=	Activity	%	77.0	CHEMBL4204	Homo sapiens	Activity	%	77.0
	19035230	CHEMBL4350377	Inhibition of recombinant His-tagged MNK2 (unknown origin) assessed as residual activity at 10 uM by IMAP TR-FRET assay relative to control	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1cnccn1)c2=O		CHEMBL4445628	=	Activity	%	84.0	CHEMBL4204	Homo sapiens	Activity	%	84.0
	19035231	CHEMBL4350377	Inhibition of recombinant His-tagged MNK2 (unknown origin) assessed as residual activity at 10 uM by IMAP TR-FRET assay relative to control	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ncccn1)c2=O		CHEMBL4450850	=	Activity	%	91.0	CHEMBL4204	Homo sapiens	Activity	%	91.0
	19035232	CHEMBL4350377	Inhibition of recombinant His-tagged MNK2 (unknown origin) assessed as residual activity at 10 uM by IMAP TR-FRET assay relative to control	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncn1)c2=O		CHEMBL4439094	=	Activity	%	2.0	CHEMBL4204	Homo sapiens	Activity	%	2.0
	19035233	CHEMBL4350377	Inhibition of recombinant His-tagged MNK2 (unknown origin) assessed as residual activity at 10 uM by IMAP TR-FRET assay relative to control	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1nccs1)c2=O		CHEMBL4435731	=	Activity	%	45.0	CHEMBL4204	Homo sapiens	Activity	%	45.0
	19035234	CHEMBL4350377	Inhibition of recombinant His-tagged MNK2 (unknown origin) assessed as residual activity at 10 uM by IMAP TR-FRET assay relative to control	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ncco1)c2=O		CHEMBL4444417	=	Activity	%	42.0	CHEMBL4204	Homo sapiens	Activity	%	42.0
	19035235	CHEMBL4350377	Inhibition of recombinant His-tagged MNK2 (unknown origin) assessed as residual activity at 10 uM by IMAP TR-FRET assay relative to control	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccon1)c2=O		CHEMBL4466664	=	Activity	%	11.0	CHEMBL4204	Homo sapiens	Activity	%	11.0
	19035236	CHEMBL4350377	Inhibition of recombinant His-tagged MNK2 (unknown origin) assessed as residual activity at 10 uM by IMAP TR-FRET assay relative to control	B	Cc1cc(Nc2cc(N)ncn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4073443	=	Activity	%	-0.2	CHEMBL4204	Homo sapiens	Activity	%	-0.2
	19035243	CHEMBL4350374	Inhibition of recombinant His-tagged MNK2 (unknown origin) using eIF4E-derived peptide as substrate in presence of ATP at Km concentration by ADP-Glo assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncc1)c2=O		CHEMBL4449736	=	Ki	nM	82.0	CHEMBL4204	Homo sapiens	Ki	uM	0.082
	19035244	CHEMBL4350374	Inhibition of recombinant His-tagged MNK2 (unknown origin) using eIF4E-derived peptide as substrate in presence of ATP at Km concentration by ADP-Glo assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncc1F)c2=O		CHEMBL4535537	=	Ki	nM	438.0	CHEMBL4204	Homo sapiens	Ki	uM	0.438
	19035245	CHEMBL4350374	Inhibition of recombinant His-tagged MNK2 (unknown origin) using eIF4E-derived peptide as substrate in presence of ATP at Km concentration by ADP-Glo assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccnc(O)c1)c2=O		CHEMBL4454334	=	Ki	nM	1277.0	CHEMBL4204	Homo sapiens	Ki	uM	1.277
	19035246	CHEMBL4350374	Inhibition of recombinant His-tagged MNK2 (unknown origin) using eIF4E-derived peptide as substrate in presence of ATP at Km concentration by ADP-Glo assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncn1)c2=O		CHEMBL4439094	=	Ki	nM	3.0	CHEMBL4204	Homo sapiens	Ki	uM	0.003
	19035247	CHEMBL4350374	Inhibition of recombinant His-tagged MNK2 (unknown origin) using eIF4E-derived peptide as substrate in presence of ATP at Km concentration by ADP-Glo assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccon1)c2=O		CHEMBL4466664	=	Ki	nM	43.0	CHEMBL4204	Homo sapiens	Ki	uM	0.043
	19035248	CHEMBL4350374	Inhibition of recombinant His-tagged MNK2 (unknown origin) using eIF4E-derived peptide as substrate in presence of ATP at Km concentration by ADP-Glo assay	B	Cc1cc(Nc2cc(N)ncn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4073443	=	Ki	nM	3.0	CHEMBL4204	Homo sapiens	Ki	uM	0.003
	19035317	CHEMBL4350413	Inhibition of human MNK2 assessed as residual activity at 10 uM using MBP as substrate by [gamma-33P]-ATP assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncn1)c2=O		CHEMBL4439094	=	Activity	%	2.0	CHEMBL4204	Homo sapiens	Activity	%	2.0
	19035330	CHEMBL4350434	Competitive inhibition of recombinant His-tagged MNK2 (unknown origin) using eIF4E derived peptide as substrate in presence of ATP at concentration of 10XKm by ADP-Glo assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncn1)c2=O		CHEMBL4439094	=	IC50	nM	4.0	CHEMBL4204	Homo sapiens	IC50	uM	0.004
	19035331	CHEMBL4350435	Competitive inhibition of recombinant His-tagged MNK2 (unknown origin) using eIF4E derived peptide as substrate at concentration of Km/10 in presence of ATP by ADP-Glo assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncc1)c2=O		CHEMBL4449736	=	IC50	nM	190.0	CHEMBL4204	Homo sapiens	IC50	uM	0.19
	19035332	CHEMBL4350434	Competitive inhibition of recombinant His-tagged MNK2 (unknown origin) using eIF4E derived peptide as substrate in presence of ATP at concentration of 10XKm by ADP-Glo assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncc1)c2=O		CHEMBL4449736	=	IC50	nM	209.0	CHEMBL4204	Homo sapiens	IC50	uM	0.209
	19035333	CHEMBL4350433	Competitive inhibition of recombinant His-tagged MNK2 (unknown origin) using eIF4E derived peptide as substrate in presence of ATP at Km concentration by ADP-Glo assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncc1)c2=O		CHEMBL4449736	=	IC50	nM	159.0	CHEMBL4204	Homo sapiens	IC50	uM	0.159
	19035334	CHEMBL4350433	Competitive inhibition of recombinant His-tagged MNK2 (unknown origin) using eIF4E derived peptide as substrate in presence of ATP at Km concentration by ADP-Glo assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncn1)c2=O		CHEMBL4439094	=	IC50	nM	5.0	CHEMBL4204	Homo sapiens	IC50	uM	0.005
	19035335	CHEMBL4350432	Competitive inhibition of recombinant His-tagged MNK2 (unknown origin) using eIF4E derived peptide as substrate in presence of ATP at concentration of Km/5 by ADP-Glo assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncn1)c2=O		CHEMBL4439094	=	IC50	nM	5.0	CHEMBL4204	Homo sapiens	IC50	uM	0.005
	19035337	CHEMBL4350432	Competitive inhibition of recombinant His-tagged MNK2 (unknown origin) using eIF4E derived peptide as substrate in presence of ATP at concentration of Km/5 by ADP-Glo assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncc1)c2=O		CHEMBL4449736	=	IC50	nM	169.0	CHEMBL4204	Homo sapiens	IC50	uM	0.169
	19035394	CHEMBL4350435	Competitive inhibition of recombinant His-tagged MNK2 (unknown origin) using eIF4E derived peptide as substrate at concentration of Km/10 in presence of ATP by ADP-Glo assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncn1)c2=O		CHEMBL4439094	=	IC50	nM	1.5	CHEMBL4204	Homo sapiens	IC50	uM	0.0015
	19035395	CHEMBL4350436	Competitive inhibition of recombinant His-tagged MNK2 (unknown origin) using eIF4E derived peptide as substrate at Km concentration in presence of ATP by ADP-Glo assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncc1)c2=O		CHEMBL4449736	=	IC50	nM	182.0	CHEMBL4204	Homo sapiens	IC50	uM	0.182
	19035396	CHEMBL4350436	Competitive inhibition of recombinant His-tagged MNK2 (unknown origin) using eIF4E derived peptide as substrate at Km concentration in presence of ATP by ADP-Glo assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncn1)c2=O		CHEMBL4439094	=	IC50	nM	1.5	CHEMBL4204	Homo sapiens	IC50	uM	0.0015
	19035397	CHEMBL4350437	Competitive inhibition of recombinant His-tagged MNK2 (unknown origin) using eIF4E derived peptide as substrate at concentration of 10XKm in presence of ATP by ADP-Glo assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncc1)c2=O		CHEMBL4449736	=	IC50	nM	163.0	CHEMBL4204	Homo sapiens	IC50	uM	0.163
	19035398	CHEMBL4350437	Competitive inhibition of recombinant His-tagged MNK2 (unknown origin) using eIF4E derived peptide as substrate at concentration of 10XKm in presence of ATP by ADP-Glo assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncn1)c2=O		CHEMBL4439094	=	IC50	nM	2.0	CHEMBL4204	Homo sapiens	IC50	uM	0.002
Not Active	19039686	CHEMBL4351956	Inhibition of recombinant full-length human Mnk2 at 10 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4204	Homo sapiens	INH		
Active	19041190	CHEMBL4352451	Inhibition of human MNK2 at 10 uM using MBP as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL4204	Homo sapiens	INH		
	19059693	CHEMBL4357994	Binding affinity to wild-type human partial length MKNK2 (G63 to S388 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	97.0	CHEMBL4204	Homo sapiens	Activity	%	97.0
	19063673	CHEMBL4359460	Binding affinity to wild-type human partial length MKNK2 (G63 to S388 residues) expressed in mammalian expression system at 100 nM by Kinomescan method relative to control	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213	>	Activity	%	90.0	CHEMBL4204	Homo sapiens	Activity	%	90.0
	19090258	CHEMBL4365832	Inhibition of wild-type human partial length MKNK2 (G63 to S388 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	41.0	CHEMBL4204	Homo sapiens	Activity	%	41.0
	19092017	CHEMBL4366491	Inhibition of human MNK2 at 100 nM using MBP as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	21.07	CHEMBL4204	Homo sapiens	INH	%	21.07
	19144656	CHEMBL4377672	Inhibition of recombinant full-length human Mnk2 at 1 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	68.0	CHEMBL4204	Homo sapiens	INH	%	68.0
	19146851	CHEMBL4378941	Inhibition of recombinant full-length human MNK2 at 10 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting analysis relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	7.0	CHEMBL4204	Homo sapiens	INH	%	7.0
	19147941	CHEMBL4379259	Inhibition of recombinant full length human MNK2 using myelin basic protein as substrate incubated for 40 mins in presence of [gamma-33ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	19155048	CHEMBL4380977	Inhibition of MNK2 (unknown origin) using Km ATP by radiometric assay	B	COc1ccc(Nc2nccc(-c3sc(=O)n(C)c3C)n2)c(OC)c1		CHEMBL4444307	=	IC50	nM	370.0	CHEMBL4204	Homo sapiens	IC50	nM	370.0
	19155056	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	Clc1ncnc2ccsc12		CHEMBL2113964	=	IC50	nM	5200.0	CHEMBL4204	Homo sapiens	IC50	uM	5.2
	19155057	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	Nc1cc(-c2ccc(Cl)cc2)n[nH]1		CHEMBL1778132	=	IC50	nM	20000.0	CHEMBL4204	Homo sapiens	IC50	uM	20.0
	19155058	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	Oc1ccc(-n2ccnc2)cc1		CHEMBL275339	=	IC50	nM	3700.0	CHEMBL4204	Homo sapiens	IC50	uM	3.7
	19155059	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	O=C(O)c1ccc(-c2cccnc2)s1		CHEMBL4449392	=	IC50	nM	2900.0	CHEMBL4204	Homo sapiens	IC50	uM	2.9
	19155060	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	Nc1cccc(-c2cccnc2)c1		CHEMBL1778131	=	IC50	nM	17000.0	CHEMBL4204	Homo sapiens	IC50	uM	17.0
	19155061	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	OCc1ccc(-c2cccnc2)cc1		CHEMBL4527170	=	IC50	nM	12000.0	CHEMBL4204	Homo sapiens	IC50	uM	12.0
	19155062	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	Nc1ccc(-n2cnc(Cl)c2Cl)cc1		CHEMBL4452239	=	IC50	nM	11000.0	CHEMBL4204	Homo sapiens	IC50	uM	11.0
	19155063	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	Nc1nc(-c2ccc(O)cc2)cs1		CHEMBL483790	=	IC50	nM	60000.0	CHEMBL4204	Homo sapiens	IC50	uM	60.0
	19155064	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	c1cncc(-c2csc(-c3cccnc3)n2)c1		CHEMBL118266	=	IC50	nM	20000.0	CHEMBL4204	Homo sapiens	IC50	uM	20.0
	19155065	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	Nc1snnc1-c1ccc(C(F)(F)F)cc1		CHEMBL4570088	=	IC50	nM	36000.0	CHEMBL4204	Homo sapiens	IC50	uM	36.0
	19155066	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	Cc1ccc2nc(C(F)(F)F)cc(N3CCNCC3)c2c1		CHEMBL2441619	=	IC50	nM	7100.0	CHEMBL4204	Homo sapiens	IC50	uM	7.1
	19155067	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	NC(=O)c1ccc(-c2cccnc2)cc1		CHEMBL4522631	=	IC50	nM	3600.0	CHEMBL4204	Homo sapiens	IC50	uM	3.6
	19155068	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	NC(=O)c1ccc(-c2cccnc2)cc1O		CHEMBL4529617	=	IC50	nM	3000.0	CHEMBL4204	Homo sapiens	IC50	uM	3.0
	19155069	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	NC(=O)c1ccc(-c2cccnc2)cc1Cl		CHEMBL4457016	=	IC50	nM	6900.0	CHEMBL4204	Homo sapiens	IC50	uM	6.9
	19155070	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	Cc1cc(-c2cccnc2)ccc1C(N)=O		CHEMBL4593941	=	IC50	nM	13000.0	CHEMBL4204	Homo sapiens	IC50	uM	13.0
	19155071	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	COc1cc(-c2cccnc2)ccc1C(N)=O		CHEMBL4563423	=	IC50	nM	1000.0	CHEMBL4204	Homo sapiens	IC50	uM	1.0
	19155072	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	COc1cc(C(N)=O)ccc1-c1cccnc1		CHEMBL4531667	=	IC50	nM	7200.0	CHEMBL4204	Homo sapiens	IC50	uM	7.2
	19155073	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	CCOc1cc(-c2cccnc2)ccc1C(N)=O		CHEMBL4590023	=	IC50	nM	800.0	CHEMBL4204	Homo sapiens	IC50	uM	0.8
	19155074	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	CCNc1cc(-c2cccnc2)ccc1C(N)=O		CHEMBL4474769	=	IC50	nM	5100.0	CHEMBL4204	Homo sapiens	IC50	uM	5.1
	19155075	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	CC(C)Oc1cc(-c2cccnc2)ccc1C(N)=O		CHEMBL4450463	=	IC50	nM	340.0	CHEMBL4204	Homo sapiens	IC50	uM	0.34
	19155076	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	NC(=O)c1ccc(-c2cccnc2)cc1OC1CCC1		CHEMBL4473517	=	IC50	nM	730.0	CHEMBL4204	Homo sapiens	IC50	uM	0.73
	19155077	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	NC(=O)c1ccc(-c2cccnc2)cc1OC1CCCCC1		CHEMBL4456135	=	IC50	nM	300.0	CHEMBL4204	Homo sapiens	IC50	uM	0.3
	19155078	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	NCCOc1cc(-c2cccnc2)ccc1C(N)=O		CHEMBL4537933	=	IC50	nM	460.0	CHEMBL4204	Homo sapiens	IC50	uM	0.46
	19155079	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	NC(=O)c1ccc(-c2cccnc2)cc1OC1CCNC1		CHEMBL4583708	=	IC50	nM	1800.0	CHEMBL4204	Homo sapiens	IC50	uM	1.8
	19155080	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	NC(=O)c1ccc(-c2cccnc2)cc1OC1CCNCC1		CHEMBL4518152	=	IC50	nM	1200.0	CHEMBL4204	Homo sapiens	IC50	uM	1.2
	19155081	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	COc1cncc(-c2ccc(C(N)=O)cc2)c1		CHEMBL4457163	=	IC50	nM	1500.0	CHEMBL4204	Homo sapiens	IC50	uM	1.5
	19155082	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	CC(=O)c1cncc(-c2ccc(C(N)=O)cc2)c1		CHEMBL4551912	=	IC50	nM	6400.0	CHEMBL4204	Homo sapiens	IC50	uM	6.4
	19155083	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	NC(=O)c1ccc(-c2cncc(C(=O)O)c2)cc1		CHEMBL4474546	=	IC50	nM	1400.0	CHEMBL4204	Homo sapiens	IC50	uM	1.4
	19155084	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	COc1ccc(-c2ccc(C(N)=O)cc2)cn1		CHEMBL4462666	=	IC50	nM	108000.0	CHEMBL4204	Homo sapiens	IC50	uM	108.0
	19155085	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	Cc1ncccc1-c1ccc(C(N)=O)cc1		CHEMBL4483063	=	IC50	nM	43000.0	CHEMBL4204	Homo sapiens	IC50	uM	43.0
	19155086	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	NC(=O)c1ccc(-c2cncc(Cl)c2)cc1		CHEMBL4530427	=	IC50	nM	3300.0	CHEMBL4204	Homo sapiens	IC50	uM	3.3
	19155087	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	NC(=O)c1ccc(-c2cncc(-c3ccccc3)c2)cc1		CHEMBL4453446	=	IC50	nM	410.0	CHEMBL4204	Homo sapiens	IC50	uM	0.41
	19155088	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	NC(=O)c1ccc(-c2cncc(-c3cccnc3)c2)cc1		CHEMBL4574792	=	IC50	nM	970.0	CHEMBL4204	Homo sapiens	IC50	uM	0.97
	19155089	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	Cn1ccc(-c2cncc(-c3ccc(C(N)=O)cc3)c2)n1		CHEMBL4558635	=	IC50	nM	310.0	CHEMBL4204	Homo sapiens	IC50	uM	0.31
	19155090	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	Cn1cc(-c2cncc(-c3ccc(C(N)=O)cc3)c2)cn1		CHEMBL4457368	=	IC50	nM	350.0	CHEMBL4204	Homo sapiens	IC50	uM	0.35
	19155091	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	CC(C)Oc1cc(-c2cncc(-c3cnn(C)c3)c2)ccc1C(N)=O		CHEMBL4457274	=	IC50	nM	160.0	CHEMBL4204	Homo sapiens	IC50	uM	0.16
	19155092	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	CC(C)Oc1cc(-c2cncc(-c3nn[nH]n3)c2)ccc1C(N)=O		CHEMBL4587472	=	IC50	nM	80.0	CHEMBL4204	Homo sapiens	IC50	uM	0.08
	19155093	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	CC(C)Oc1cc(-c2cncc(N3CCCC3)c2)ccc1C(N)=O		CHEMBL4441602	=	IC50	nM	500.0	CHEMBL4204	Homo sapiens	IC50	uM	0.5
	19155094	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	CC(C)Oc1cc(-c2cncc(N3CCOCC3)c2)ccc1C(N)=O		CHEMBL4465294	=	IC50	nM	390.0	CHEMBL4204	Homo sapiens	IC50	uM	0.39
	19155095	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	CNC(=O)c1cncc(-c2ccc(C(N)=O)c(OC(C)C)c2)c1		CHEMBL4586717	=	IC50	nM	630.0	CHEMBL4204	Homo sapiens	IC50	uM	0.63
	19155096	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	CC(C)Oc1cc(-c2cncc(-c3cnn(C(C)C)c3)c2)ccc1C(N)=O		CHEMBL4588193	=	IC50	nM	42.0	CHEMBL4204	Homo sapiens	IC50	uM	0.042
	19155097	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	CC(C)Oc1cc(-c2cncc(-c3cnn(C4COC4)c3)c2)ccc1C(N)=O		CHEMBL4587832	=	IC50	nM	89.0	CHEMBL4204	Homo sapiens	IC50	uM	0.089
	19155098	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	CC(C)Oc1cc(-c2cncc(-c3cnn(C4CCOC4)c3)c2)ccc1C(N)=O		CHEMBL4443472	=	IC50	nM	44.0	CHEMBL4204	Homo sapiens	IC50	uM	0.044
	19155099	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	CC(C)Oc1cc(-c2cncc(-c3c[nH]nc3C3CC3)c2)ccc1C(N)=O		CHEMBL4462099	=	IC50	nM	54.0	CHEMBL4204	Homo sapiens	IC50	uM	0.054
	19155100	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	Cc1[nH]ncc1-c1cncc(-c2ccc(C(N)=O)c(OC(C)C)c2)c1		CHEMBL4569209	=	IC50	nM	16.0	CHEMBL4204	Homo sapiens	IC50	uM	0.016
	19155101	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	Cc1n[nH]c(C)c1-c1cncc(-c2ccc(C(N)=O)c(OC(C)C)c2)c1		CHEMBL4442209	=	IC50	nM	14.0	CHEMBL4204	Homo sapiens	IC50	uM	0.014
	19155102	CHEMBL4380979	Inhibition of MNK2 (unknown origin)	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	=	IC50	nM	109.0	CHEMBL4204	Homo sapiens	IC50	nM	109.0
	19155103	CHEMBL4380979	Inhibition of MNK2 (unknown origin)	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	IC50	nM	20.0	CHEMBL4204	Homo sapiens	IC50	nM	20.0
	19155105	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	O=C(O)c1ccc(-c2cccnc2)cc1		CHEMBL4539725	=	IC50	nM	6000.0	CHEMBL4204	Homo sapiens	IC50	uM	6.0
	19155106	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	CNC(=O)c1ccc(-c2cccnc2)cc1		CHEMBL4518443	=	IC50	nM	184000.0	CHEMBL4204	Homo sapiens	IC50	uM	184.0
	19155107	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	O=C(c1ccc(-c2cccnc2)cc1)N1CCNCC1		CHEMBL4444560	=	IC50	nM	171000.0	CHEMBL4204	Homo sapiens	IC50	uM	171.0
	19155108	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	NC(=O)c1ccc(-c2ccnc(N)c2)cc1		CHEMBL4452380	=	IC50	nM	45000.0	CHEMBL4204	Homo sapiens	IC50	uM	45.0
	19155109	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	NC(=O)c1ccc(-c2ccc(N)nc2)cc1		CHEMBL4446188	=	IC50	nM	13000.0	CHEMBL4204	Homo sapiens	IC50	uM	13.0
	19155110	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	NC(=O)c1ccc(-c2cccnc2N)cc1		CHEMBL4570689	=	IC50	nM	1900.0	CHEMBL4204	Homo sapiens	IC50	uM	1.9
	19155194	CHEMBL4380947	Inhibition of N-terminal GST-tagged MNK2 (unknown origin) (72 to 385 residues) expressed in Escherichia coli BL21 (DE3) cells using 5-FAM-TATKSGSTTKNRFVV-NH2 peptide as substrate preincubated with enzyme for 10 mins followed by substrate addition after 60 mins in presence of ATP by caliper mobility shift assay	B	Cc1c(-c2cncc(-c3ccc(C(N)=O)c(OC(C)C)c3)c2)cnn1C		CHEMBL4440223	=	IC50	nM	120.0	CHEMBL4204	Homo sapiens	IC50	uM	0.12
	19159521	CHEMBL4382625	Binding affinity to wild-type human partial length MKNK2 (G63 to S388 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	26.0	CHEMBL4204	Homo sapiens	Activity	%	26.0
Active	19170016	CHEMBL4384671	Inhibition of GST-fused MNK2a (unknown origin) expressed in HEK293 cells using eIF4E as substrate after 30 mins by Western blot analysis	B	Cc1c(C(=O)NCCCN(C)C)sc2ncnc(Nc3ccc(F)cc3OC(C)CF)c12		CHEMBL3702341		Inhibition	%		CHEMBL4204	Homo sapiens	INH		
Active	19170017	CHEMBL4384671	Inhibition of GST-fused MNK2a (unknown origin) expressed in HEK293 cells using eIF4E as substrate after 30 mins by Western blot analysis	B	Cc1c(C(=O)NCCCN2CCCC2)sc2ncnc(Nc3ccc(F)cc3OC(C)C)c12		CHEMBL4456938		Inhibition	%		CHEMBL4204	Homo sapiens	INH		
	19181083	CHEMBL4387294	Inhibition of tracer 236 binding to full length human GST-tagged MKNK2 expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	18.3	CHEMBL4204	Homo sapiens	INH	%	18.3
	19181308	CHEMBL4387294	Inhibition of tracer 236 binding to full length human GST-tagged MKNK2 expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	75.0	CHEMBL4204	Homo sapiens	INH	%	75.0
	19191486	CHEMBL4389344	Inhibition of wild-type human partial length MKNK2 (G63 to S388 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	34.0	CHEMBL4204	Homo sapiens	INH	%	34.0
	19192007	CHEMBL4389821	Inhibition of wild-type human partial length MKNK2 (G63 to S388 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	64.0	CHEMBL4204	Homo sapiens	INH	%	64.0
	19200263	CHEMBL4391447	Binding affinity to wild-type human partial length MKNK2 (G63 to S388 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	72.0	CHEMBL4204	Homo sapiens	Activity	%	72.0
	19225478	CHEMBL4395898	Inhibition of human recombinant MNK2 at 1 uM using CREBtide as substrate measured after 90 mins in presence of ATP by LANCE assay relative to control	B	CCc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4536012	=	Inhibition	%	1.16	CHEMBL4204	Homo sapiens	INH	%	1.16
	19242734	CHEMBL4400069	Inhibition of full length recombinant human MNK2 assessed as residual activity at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma-33P]ATP at Km concentration by radiometric assay relative to control	B	COc1ccc2c(CCNc3nc(NCc4ccc(=O)[nH]c4)c4nc[nH]c4n3)c[nH]c2c1		CHEMBL4555782	=	Activity	%	76.0	CHEMBL4204	Homo sapiens	Activity	%	76.0
	19266513	CHEMBL4405463	Inhibition of wild-type human partial length MKNK2 (G63 to S388 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	19276092	CHEMBL4408095	Inhibition of recombinant human full length MNK2 at 1 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	10.0	CHEMBL4204	Homo sapiens	INH	%	10.0
	19292310	CHEMBL4411561	Inhibition of N-terminal GST tagged full length human MNK2 (1 to 465 end residues) expressed in baculovirus expression system at 1 uM in presence of ATP at its Km level relative to control	B	Cn1cc(Nc2nccc(N3C[C@H]4CC[C@H](C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1		CHEMBL4458435	=	Inhibition	%	68.0	CHEMBL4204	Homo sapiens	INH	%	68.0
	22388103	CHEMBL4666415	Inhibition of MNK2 (unknown origin) at 500 nM relative to control	B	Cc1cc(Nc2cc(N3CCN(CCCN(C)C)CC3)ncn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4757546	=	Inhibition	%	103.0	CHEMBL4204	Homo sapiens	INH	%	103.0
	22388202	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	Cc1cc(Nc2ccncn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4780209	=	Inhibition	%	97.3	CHEMBL4204	Homo sapiens	INH	%	97.3
	22388203	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	Cc1cc(Nc2ccncc2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4751127	=	Inhibition	%	88.3	CHEMBL4204	Homo sapiens	INH	%	88.3
	22388204	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	Cc1cc(Nc2ccccn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4747129	=	Inhibition	%	16.2	CHEMBL4204	Homo sapiens	INH	%	16.2
	22388205	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	Cc1cc(Nc2cccnc2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4791161	=	Inhibition	%	13.3	CHEMBL4204	Homo sapiens	INH	%	13.3
	22388206	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	Cc1cc(Nc2ncccn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4776154	=	Inhibition	%	18.9	CHEMBL4204	Homo sapiens	INH	%	18.9
	22388207	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	Cc1cc(Nc2cnccn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4757777	=	Inhibition	%	36.8	CHEMBL4204	Homo sapiens	INH	%	36.8
	22388208	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	Cc1cc(Nc2ccnnc2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4760245	=	Inhibition	%	70.3	CHEMBL4204	Homo sapiens	INH	%	70.3
	22388209	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	Cc1cc(Nc2cccnn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4746641	=	Inhibition	%	23.9	CHEMBL4204	Homo sapiens	INH	%	23.9
	22388210	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	Cc1cccc(Nc2cc(C)c3n(c2=O)C2(CCCCC2)NC3=O)n1		CHEMBL4792146	=	Inhibition	%	13.4	CHEMBL4204	Homo sapiens	INH	%	13.4
	22388211	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	Cc1cc(Nc2cc(C)c3n(c2=O)C2(CCCCC2)NC3=O)ccn1		CHEMBL4741111	=	Inhibition	%	45.2	CHEMBL4204	Homo sapiens	INH	%	45.2
	22388212	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	Cc1cccnc1Nc1cc(C)c2n(c1=O)C1(CCCCC1)NC2=O		CHEMBL4752964	=	Inhibition	%	23.0	CHEMBL4204	Homo sapiens	INH	%	23.0
	22388213	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	Cc1cc(Nc2ccnc(N)c2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4740694	=	Inhibition	%	70.5	CHEMBL4204	Homo sapiens	INH	%	70.5
	22388214	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	Cc1cc(Nc2cc(N)ccn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4791921	=	Inhibition	%	30.8	CHEMBL4204	Homo sapiens	INH	%	30.8
	22388215	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	Cc1cc(Nc2ccnc(N)n2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4784364	=	Inhibition	%	66.3	CHEMBL4204	Homo sapiens	INH	%	66.3
	22388216	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	Cc1cc(Nc2nccc(N)n2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4754789	=	Inhibition	%	30.2	CHEMBL4204	Homo sapiens	INH	%	30.2
	22388217	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	Cc1cc(Nc2cncc(N)n2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4757325	=	Inhibition	%	33.2	CHEMBL4204	Homo sapiens	INH	%	33.2
	22388218	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	Cc1cc(Nc2cn(C)nc2C#N)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4747663	=	Inhibition	%	11.9	CHEMBL4204	Homo sapiens	INH	%	11.9
	22388219	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	Cc1cc(Nc2cn(C)nc2C(F)F)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4747093	=	Inhibition	%	14.6	CHEMBL4204	Homo sapiens	INH	%	14.6
	22388220	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	Cc1cc(Nc2cn(C)nc2N)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4743829	=	Inhibition	%	55.4	CHEMBL4204	Homo sapiens	INH	%	55.4
	22388221	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	Cc1cc(Nc2cc(N)ncn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4073443	=	Inhibition	%	98.8	CHEMBL4204	Homo sapiens	INH	%	98.8
	22388222	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	Cc1cc(Nc2cc(N3CCOCC3)ncn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4797682	=	Inhibition	%	35.5	CHEMBL4204	Homo sapiens	INH	%	35.5
	22388223	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	Cc1cc(Nc2cc(N3CCCCC3)ncn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4752750	=	Inhibition	%	50.3	CHEMBL4204	Homo sapiens	INH	%	50.3
	22388224	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	Cc1cc(Nc2cc(NC3CCNCC3)ncn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4793971	=	Inhibition	%	75.8	CHEMBL4204	Homo sapiens	INH	%	75.8
	22388225	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	Cc1cc(Nc2cc(N3CCC(N)CC3)ncn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4797669	=	Inhibition	%	64.3	CHEMBL4204	Homo sapiens	INH	%	64.3
	22388226	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	Cc1cc(Nc2cc(N3CCNCC3)ncn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4754824	=	Inhibition	%	87.7	CHEMBL4204	Homo sapiens	INH	%	87.7
	22388227	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)ncn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4787265	=	Inhibition	%	66.8	CHEMBL4204	Homo sapiens	INH	%	66.8
	22388228	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	CC(=O)N1CCN(c2cc(Nc3cc(C)c4n(c3=O)C3(CCCCC3)NC4=O)ncn2)CC1		CHEMBL4741081	=	Inhibition	%	86.9	CHEMBL4204	Homo sapiens	INH	%	86.9
	22388229	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	Cc1cc(Nc2cc(N3CCN(CCN(C)C)CC3)ncn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4796087	=	Inhibition	%	89.0	CHEMBL4204	Homo sapiens	INH	%	89.0
	22388230	CHEMBL4666429	Inhibition of MNK2 (unknown origin) at 100 nM incubated for 60 mins by HTRF assay	B	Cc1cc(Nc2cc(N3CCN(CCCN(C)C)CC3)ncn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4757546	=	Inhibition	%	91.2	CHEMBL4204	Homo sapiens	INH	%	91.2
	22388231	CHEMBL4666430	Potency index, ratio of IC50 of eFT508 to IC50 of compound for inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cc(Nc2cc(N3CCN(CCN(C)C)CC3)ncn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4796087	=	Ratio IC50		2.0	CHEMBL4204	Homo sapiens	Ratio IC50		2.0
	22388232	CHEMBL4666430	Potency index, ratio of IC50 of eFT508 to IC50 of compound for inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cc(Nc2cc(N3CCN(CCCN(C)C)CC3)ncn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4757546	=	Ratio IC50		2.0	CHEMBL4204	Homo sapiens	Ratio IC50		2.0
	22388262	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cc(Nc2ccncn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4780209	=	IC50	nM	8.3	CHEMBL4204	Homo sapiens	IC50	nM	8.3
	22388263	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cc(Nc2ccncc2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4751127	=	IC50	nM	137.7	CHEMBL4204	Homo sapiens	IC50	nM	137.7
	22388264	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cc(Nc2ccccn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4747129	>	IC50	nM	500.0	CHEMBL4204	Homo sapiens	IC50	nM	500.0
	22388265	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cc(Nc2cccnc2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4791161	>	IC50	nM	500.0	CHEMBL4204	Homo sapiens	IC50	nM	500.0
	22388266	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cc(Nc2ncccn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4776154	>	IC50	nM	500.0	CHEMBL4204	Homo sapiens	IC50	nM	500.0
	22388267	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cc(Nc2cnccn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4757777	>	IC50	nM	500.0	CHEMBL4204	Homo sapiens	IC50	nM	500.0
	22388268	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cc(Nc2ccnnc2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4760245	=	IC50	nM	162.3	CHEMBL4204	Homo sapiens	IC50	nM	162.3
	22388269	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cc(Nc2cccnn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4746641	>	IC50	nM	500.0	CHEMBL4204	Homo sapiens	IC50	nM	500.0
	22388270	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cccc(Nc2cc(C)c3n(c2=O)C2(CCCCC2)NC3=O)n1		CHEMBL4792146	>	IC50	nM	500.0	CHEMBL4204	Homo sapiens	IC50	nM	500.0
	22388271	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cc(Nc2cc(C)c3n(c2=O)C2(CCCCC2)NC3=O)ccn1		CHEMBL4741111	=	IC50	nM	398.0	CHEMBL4204	Homo sapiens	IC50	nM	398.0
	22388272	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cccnc1Nc1cc(C)c2n(c1=O)C1(CCCCC1)NC2=O		CHEMBL4752964	>	IC50	nM	500.0	CHEMBL4204	Homo sapiens	IC50	nM	500.0
	22388273	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cc(Nc2ccnc(N)c2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4740694	=	IC50	nM	48.2	CHEMBL4204	Homo sapiens	IC50	nM	48.2
	22388274	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cc(Nc2cc(N)ccn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4791921	>	IC50	nM	500.0	CHEMBL4204	Homo sapiens	IC50	nM	500.0
	22388275	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cc(Nc2ccnc(N)n2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4784364	=	IC50	nM	228.0	CHEMBL4204	Homo sapiens	IC50	nM	228.0
	22388276	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cc(Nc2nccc(N)n2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4754789	>	IC50	nM	500.0	CHEMBL4204	Homo sapiens	IC50	nM	500.0
	22388277	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cc(Nc2cncc(N)n2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4757325	>	IC50	nM	500.0	CHEMBL4204	Homo sapiens	IC50	nM	500.0
	22388278	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cc(Nc2cn(C)nc2C#N)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4747663	>	IC50	nM	500.0	CHEMBL4204	Homo sapiens	IC50	nM	500.0
	22388279	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cc(Nc2cn(C)nc2C(F)F)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4747093	>	IC50	nM	500.0	CHEMBL4204	Homo sapiens	IC50	nM	500.0
	22388280	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cc(Nc2cn(C)nc2N)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4743829	=	IC50	nM	389.0	CHEMBL4204	Homo sapiens	IC50	nM	389.0
	22388281	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cc(Nc2cc(N)ncn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4073443	=	IC50	nM	2.1	CHEMBL4204	Homo sapiens	IC50	nM	2.1
	22388282	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cc(Nc2cc(N3CCOCC3)ncn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4797682	=	IC50	nM	454.0	CHEMBL4204	Homo sapiens	IC50	nM	454.0
	22388283	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cc(Nc2cc(N3CCCCC3)ncn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4752750	=	IC50	nM	452.0	CHEMBL4204	Homo sapiens	IC50	nM	452.0
	22388284	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cc(Nc2cc(NC3CCNCC3)ncn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4793971	=	IC50	nM	49.8	CHEMBL4204	Homo sapiens	IC50	nM	49.8
	22388285	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cc(Nc2cc(N3CCC(N)CC3)ncn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4797669	=	IC50	nM	82.0	CHEMBL4204	Homo sapiens	IC50	nM	82.0
	22388286	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cc(Nc2cc(N3CCNCC3)ncn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4754824	=	IC50	nM	18.3	CHEMBL4204	Homo sapiens	IC50	nM	18.3
	22388287	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)ncn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4787265	=	IC50	nM	42.1	CHEMBL4204	Homo sapiens	IC50	nM	42.1
	22388288	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	CC(=O)N1CCN(c2cc(Nc3cc(C)c4n(c3=O)C3(CCCCC3)NC4=O)ncn2)CC1		CHEMBL4741081	=	IC50	nM	63.8	CHEMBL4204	Homo sapiens	IC50	nM	63.8
	22388289	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cc(Nc2cc(N3CCN(CCN(C)C)CC3)ncn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4796087	=	IC50	nM	7.5	CHEMBL4204	Homo sapiens	IC50	nM	7.5
	22388290	CHEMBL4666432	Inhibition of recombinant human N-terminal GST-tagged MNK2 (1 to 465 residues) expressed in baculovirus expression system using TATKSGSTTKNR as substrate preincubated for 10 mins followed by ATP addition and measured after 40 mins by luminescence based assay	B	Cc1cc(Nc2cc(N3CCN(CCCN(C)C)CC3)ncn2)c(=O)n2c1C(=O)NC21CCCCC1		CHEMBL4757546	=	IC50	nM	6.1	CHEMBL4204	Homo sapiens	IC50	nM	6.1
	22392102	CHEMBL4667197	Inhibition of tracer 236 binding to recombinant human N-terminal GST-tagged full length MKNK2 expressed in baculovirus expression system at 10 uM incubated for 60 mins by Lanthascreen assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	1.0	CHEMBL4204	Homo sapiens	INH	%	1.0
	22423439	CHEMBL4674295	Inhibition of human MNK2 using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	96.03	CHEMBL4204	Homo sapiens	Activity	%	96.03
	22423440	CHEMBL4674295	Inhibition of human MNK2 using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	24.28	CHEMBL4204	Homo sapiens	Activity	%	24.28
	22766906	CHEMBL4703323	Inhibition of N-terminal GST-tagged recombinant human full length MNK2 expressed in baculovirus expression system at 10 uM incubated for 1 hr by Kinase Tracer 236 based LanthaScreen Eu kinase binding assay relative to control	B	COc1c(O)cc2oc(-c3ccc(O)cc3)cc(=O)c2c1O		CHEMBL293776	=	Inhibition	%	93.0	CHEMBL4204	Homo sapiens	INH	%	93.0
	22766907	CHEMBL4703323	Inhibition of N-terminal GST-tagged recombinant human full length MNK2 expressed in baculovirus expression system at 10 uM incubated for 1 hr by Kinase Tracer 236 based LanthaScreen Eu kinase binding assay relative to control	B	COc1ccc(-c2oc3cc(OC)c(OC)c(O)c3c(=O)c2O)cc1O		CHEMBL77588	>	Inhibition	%	70.0	CHEMBL4204	Homo sapiens	INH	%	70.0
	22766908	CHEMBL4703323	Inhibition of N-terminal GST-tagged recombinant human full length MNK2 expressed in baculovirus expression system at 10 uM incubated for 1 hr by Kinase Tracer 236 based LanthaScreen Eu kinase binding assay relative to control	B	COc1cc2c(c(OC)c1CC=C(C)C)C(=O)CC(c1ccc(OC)c(OC)c1C/C=C(\C)CCC=C(C)C)O2		CHEMBL4755408	>	Inhibition	%	70.0	CHEMBL4204	Homo sapiens	INH	%	70.0
	22766909	CHEMBL4703323	Inhibition of N-terminal GST-tagged recombinant human full length MNK2 expressed in baculovirus expression system at 10 uM incubated for 1 hr by Kinase Tracer 236 based LanthaScreen Eu kinase binding assay relative to control	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	>	Inhibition	%	70.0	CHEMBL4204	Homo sapiens	INH	%	70.0
	22766910	CHEMBL4703323	Inhibition of N-terminal GST-tagged recombinant human full length MNK2 expressed in baculovirus expression system at 10 uM incubated for 1 hr by Kinase Tracer 236 based LanthaScreen Eu kinase binding assay relative to control	B	COc1cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc2c1		CHEMBL210635	>	Inhibition	%	70.0	CHEMBL4204	Homo sapiens	INH	%	70.0
	22766911	CHEMBL4703323	Inhibition of N-terminal GST-tagged recombinant human full length MNK2 expressed in baculovirus expression system at 10 uM incubated for 1 hr by Kinase Tracer 236 based LanthaScreen Eu kinase binding assay relative to control	B	O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL151	>	Inhibition	%	70.0	CHEMBL4204	Homo sapiens	INH	%	70.0
	22766912	CHEMBL4703323	Inhibition of N-terminal GST-tagged recombinant human full length MNK2 expressed in baculovirus expression system at 10 uM incubated for 1 hr by Kinase Tracer 236 based LanthaScreen Eu kinase binding assay relative to control	B	O=c1c(O)c(-c2ccncc2)oc2ccc(Cl)cc12		CHEMBL4740978	>	Inhibition	%	70.0	CHEMBL4204	Homo sapiens	INH	%	70.0
	22766913	CHEMBL4703323	Inhibition of N-terminal GST-tagged recombinant human full length MNK2 expressed in baculovirus expression system at 10 uM incubated for 1 hr by Kinase Tracer 236 based LanthaScreen Eu kinase binding assay relative to control	B	COc1ccc(C(=O)/C=C/c2ccc(O)c(Br)c2)cc1		CHEMBL4747606	>	Inhibition	%	70.0	CHEMBL4204	Homo sapiens	INH	%	70.0
	22766914	CHEMBL4703323	Inhibition of N-terminal GST-tagged recombinant human full length MNK2 expressed in baculovirus expression system at 10 uM incubated for 1 hr by Kinase Tracer 236 based LanthaScreen Eu kinase binding assay relative to control	B	COc1cc(O)c(C(=O)/C=C/c2ccc(C(=O)O)cc2)c(OC)c1		CHEMBL4097277	>	Inhibition	%	70.0	CHEMBL4204	Homo sapiens	INH	%	70.0
	22766915	CHEMBL4703323	Inhibition of N-terminal GST-tagged recombinant human full length MNK2 expressed in baculovirus expression system at 10 uM incubated for 1 hr by Kinase Tracer 236 based LanthaScreen Eu kinase binding assay relative to control	B	O=C(/C=C/c1cccc(O)c1)c1ccccc1O		CHEMBL3823220	>	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	22766916	CHEMBL4703323	Inhibition of N-terminal GST-tagged recombinant human full length MNK2 expressed in baculovirus expression system at 10 uM incubated for 1 hr by Kinase Tracer 236 based LanthaScreen Eu kinase binding assay relative to control	B	COc1cc(O)c(C(=O)/C=C/c2ccccc2)c(OC)c1		CHEMBL104255	>	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	22766917	CHEMBL4703323	Inhibition of N-terminal GST-tagged recombinant human full length MNK2 expressed in baculovirus expression system at 10 uM incubated for 1 hr by Kinase Tracer 236 based LanthaScreen Eu kinase binding assay relative to control	B	COc1ccc(-c2cc(=O)c3ccc(O)cc3o2)cc1OC		CHEMBL345778	>	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	22766918	CHEMBL4703323	Inhibition of N-terminal GST-tagged recombinant human full length MNK2 expressed in baculovirus expression system at 10 uM incubated for 1 hr by Kinase Tracer 236 based LanthaScreen Eu kinase binding assay relative to control	B	O=c1cc(-c2ccccc2)oc2cc(O)ccc12		CHEMBL276915	>	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	22766919	CHEMBL4703323	Inhibition of N-terminal GST-tagged recombinant human full length MNK2 expressed in baculovirus expression system at 10 uM incubated for 1 hr by Kinase Tracer 236 based LanthaScreen Eu kinase binding assay relative to control	B	COc1ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1		CHEMBL243664	>	Inhibition	%	50.0	CHEMBL4204	Homo sapiens	INH	%	50.0
	22766920	CHEMBL4703324	Inhibition of N-terminal GST-tagged recombinant human full length MNK2 expressed in baculovirus expression system incubated for 1 hr by Kinase Tracer 236 based LanthaScreen Eu kinase binding assay relative to control	B	COc1c(O)cc2oc(-c3ccc(O)cc3)cc(=O)c2c1O		CHEMBL293776	=	IC50	nM	252.0	CHEMBL4204	Homo sapiens	IC50	nM	252.0
	22766921	CHEMBL4703324	Inhibition of N-terminal GST-tagged recombinant human full length MNK2 expressed in baculovirus expression system incubated for 1 hr by Kinase Tracer 236 based LanthaScreen Eu kinase binding assay relative to control	B	COc1ccc(-c2oc3cc(OC)c(OC)c(O)c3c(=O)c2O)cc1O		CHEMBL77588	=	IC50	nM	1703.0	CHEMBL4204	Homo sapiens	IC50	nM	1703.0
	22766922	CHEMBL4703324	Inhibition of N-terminal GST-tagged recombinant human full length MNK2 expressed in baculovirus expression system incubated for 1 hr by Kinase Tracer 236 based LanthaScreen Eu kinase binding assay relative to control	B	COc1cc2c(c(OC)c1CC=C(C)C)C(=O)CC(c1ccc(OC)c(OC)c1C/C=C(\C)CCC=C(C)C)O2		CHEMBL4755408	=	IC50	nM	8262.0	CHEMBL4204	Homo sapiens	IC50	nM	8262.0
	22766923	CHEMBL4703324	Inhibition of N-terminal GST-tagged recombinant human full length MNK2 expressed in baculovirus expression system incubated for 1 hr by Kinase Tracer 236 based LanthaScreen Eu kinase binding assay relative to control	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	IC50	nM	308.0	CHEMBL4204	Homo sapiens	IC50	nM	308.0
	22766924	CHEMBL4703324	Inhibition of N-terminal GST-tagged recombinant human full length MNK2 expressed in baculovirus expression system incubated for 1 hr by Kinase Tracer 236 based LanthaScreen Eu kinase binding assay relative to control	B	COc1cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc2c1		CHEMBL210635	=	IC50	nM	979.0	CHEMBL4204	Homo sapiens	IC50	nM	979.0
	22766925	CHEMBL4703324	Inhibition of N-terminal GST-tagged recombinant human full length MNK2 expressed in baculovirus expression system incubated for 1 hr by Kinase Tracer 236 based LanthaScreen Eu kinase binding assay relative to control	B	O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL151	=	IC50	nM	579.0	CHEMBL4204	Homo sapiens	IC50	nM	579.0
	22766926	CHEMBL4703324	Inhibition of N-terminal GST-tagged recombinant human full length MNK2 expressed in baculovirus expression system incubated for 1 hr by Kinase Tracer 236 based LanthaScreen Eu kinase binding assay relative to control	B	O=c1c(O)c(-c2ccncc2)oc2ccc(Cl)cc12		CHEMBL4740978	=	IC50	nM	6486.0	CHEMBL4204	Homo sapiens	IC50	nM	6486.0
	22766927	CHEMBL4703324	Inhibition of N-terminal GST-tagged recombinant human full length MNK2 expressed in baculovirus expression system incubated for 1 hr by Kinase Tracer 236 based LanthaScreen Eu kinase binding assay relative to control	B	COc1ccc(C(=O)/C=C/c2ccc(O)c(Br)c2)cc1		CHEMBL4747606	=	IC50	nM	4672.0	CHEMBL4204	Homo sapiens	IC50	nM	4672.0
	22766928	CHEMBL4703324	Inhibition of N-terminal GST-tagged recombinant human full length MNK2 expressed in baculovirus expression system incubated for 1 hr by Kinase Tracer 236 based LanthaScreen Eu kinase binding assay relative to control	B	COc1cc(O)c(C(=O)/C=C/c2ccc(C(=O)O)cc2)c(OC)c1		CHEMBL4097277	=	IC50	nM	3697.0	CHEMBL4204	Homo sapiens	IC50	nM	3697.0
	22809790	CHEMBL4713325	Inhibition of recombinant full length human Mnk2 assessed as residual activity at 1 uM using myelin basic protein as substrate incubated for 40 mins in presence of Km ATP by radiometric scintillation counting analysis relative to control	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	Activity	%	88.0	CHEMBL4204	Homo sapiens	Activity	%	88.0
	22843660	CHEMBL4720646	Inhibition of human MNK2 using MBP as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	19.0	CHEMBL4204	Homo sapiens	IC50	10^-8M	1.9
	22844009	CHEMBL4720995	Inhibition of human MNK2 assessed as residual activity using MBP as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	51.32	CHEMBL4204	Homo sapiens	Activity	%	51.32
	22844761	CHEMBL4721436	Inhibition of MNK2 (unknown origin) assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	101.64	CHEMBL4204	Homo sapiens	Activity	%	101.64
	22874838	CHEMBL4725529	Inhibition of human MNK2 assessed as remaining enzyme activity at 1 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Activity	%	34.0	CHEMBL4204	Homo sapiens	Activity	%	34.0
Not Active	22889534	CHEMBL4729053	Inhibition of wild-type human partial length MKNK2 (G63 to S388 residues) expressed in mammalian expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL4204	Homo sapiens	INH		
	22915545	CHEMBL4735374	Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate measured after 2 hrs by ADP-glo luminescence assay	B	CC(=O)Nc1cccc(Cn2cc(-c3ccc4c(N)n[nH]c4c3)ccc2=O)c1		CHEMBL4785028	=	IC50	nM	8.0	CHEMBL4204	Homo sapiens	IC50	nM	8.0
	22915546	CHEMBL4735374	Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate measured after 2 hrs by ADP-glo luminescence assay	B	Nc1n[nH]c2cc(-c3ccc(=O)n(Cc4cccc(C(F)(F)F)c4)c3)ccc12		CHEMBL4757431	=	IC50	nM	21.0	CHEMBL4204	Homo sapiens	IC50	nM	21.0
	22915547	CHEMBL4735374	Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate measured after 2 hrs by ADP-glo luminescence assay	B	Nc1n[nH]c2cc(-c3ccc(=O)n(Cc4cccc(Cl)c4)c3)ccc12		CHEMBL4764756	=	IC50	nM	6.0	CHEMBL4204	Homo sapiens	IC50	nM	6.0
	22915548	CHEMBL4735374	Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate measured after 2 hrs by ADP-glo luminescence assay	B	Nc1n[nH]c2cc(-c3ccc(=O)n(Cc4cccc(F)c4)c3)ccc12		CHEMBL4787269	=	IC50	nM	5.0	CHEMBL4204	Homo sapiens	IC50	nM	5.0
	22915549	CHEMBL4735374	Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate measured after 2 hrs by ADP-glo luminescence assay	B	Nc1n[nH]c2cc(-c3ccc(=O)n(Cc4ccccc4F)c3)ccc12		CHEMBL4752141	=	IC50	nM	4.0	CHEMBL4204	Homo sapiens	IC50	nM	4.0
	22915550	CHEMBL4735374	Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate measured after 2 hrs by ADP-glo luminescence assay	B	Nc1n[nH]c2cc(-c3ccc(=O)n(Cc4ccccc4)c3)ccc12		CHEMBL4755524	=	IC50	nM	32.0	CHEMBL4204	Homo sapiens	IC50	nM	32.0
	22915551	CHEMBL4735374	Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate measured after 2 hrs by ADP-glo luminescence assay	B	CC(=O)Nc1cccc(Cn2cc(-c3ccc4cn[nH]c4c3)ccc2=O)c1		CHEMBL4750622	=	IC50	nM	43.0	CHEMBL4204	Homo sapiens	IC50	nM	43.0
	22915552	CHEMBL4735374	Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate measured after 2 hrs by ADP-glo luminescence assay	B	Nc1cccc(Cn2cc(-c3ccc4cn[nH]c4c3)ccc2=O)c1		CHEMBL4759018	=	IC50	nM	84.0	CHEMBL4204	Homo sapiens	IC50	nM	84.0
	22915553	CHEMBL4735374	Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate measured after 2 hrs by ADP-glo luminescence assay	B	NC(=O)c1ccc(Cn2cc(-c3ccc4cn[nH]c4c3)ccc2=O)cc1		CHEMBL4763764	>	IC50	nM	2000.0	CHEMBL4204	Homo sapiens	IC50	nM	2000.0
	22915554	CHEMBL4735374	Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate measured after 2 hrs by ADP-glo luminescence assay	B	NC(=O)c1cccc(Cn2cc(-c3ccc4cn[nH]c4c3)ccc2=O)c1		CHEMBL4790632	=	IC50	nM	106.0	CHEMBL4204	Homo sapiens	IC50	nM	106.0
	22915555	CHEMBL4735374	Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate measured after 2 hrs by ADP-glo luminescence assay	B	NC(=O)c1ccccc1Cn1cc(-c2ccc3cn[nH]c3c2)ccc1=O		CHEMBL4763087	=	IC50	nM	340.0	CHEMBL4204	Homo sapiens	IC50	nM	340.0
	22915556	CHEMBL4735374	Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate measured after 2 hrs by ADP-glo luminescence assay	B	O=c1ccc(-c2ccc3cn[nH]c3c2)cn1Cc1ccc(C(F)(F)F)cc1		CHEMBL4776712	=	IC50	nM	1112.0	CHEMBL4204	Homo sapiens	IC50	nM	1112.0
	22915557	CHEMBL4735374	Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate measured after 2 hrs by ADP-glo luminescence assay	B	O=c1ccc(-c2ccc3cn[nH]c3c2)cn1Cc1cccc(C(F)(F)F)c1		CHEMBL4746396	=	IC50	nM	32.0	CHEMBL4204	Homo sapiens	IC50	nM	32.0
	22915558	CHEMBL4735374	Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate measured after 2 hrs by ADP-glo luminescence assay	B	O=c1ccc(-c2ccc3cn[nH]c3c2)cn1Cc1ccccc1C(F)(F)F		CHEMBL4752471	=	IC50	nM	100.0	CHEMBL4204	Homo sapiens	IC50	nM	100.0
	22915559	CHEMBL4735374	Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate measured after 2 hrs by ADP-glo luminescence assay	B	O=c1ccc(-c2ccc3cn[nH]c3c2)cn1Cc1ccc(Cl)c(Cl)c1		CHEMBL4762761	=	IC50	nM	97.0	CHEMBL4204	Homo sapiens	IC50	nM	97.0
	22915560	CHEMBL4735374	Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate measured after 2 hrs by ADP-glo luminescence assay	B	O=c1ccc(-c2ccc3cn[nH]c3c2)cn1Cc1cccc(Cl)c1		CHEMBL4749973	=	IC50	nM	40.0	CHEMBL4204	Homo sapiens	IC50	nM	40.0
	22915561	CHEMBL4735374	Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate measured after 2 hrs by ADP-glo luminescence assay	B	O=c1ccc(-c2ccc3cn[nH]c3c2)cn1Cc1ccccc1Cl		CHEMBL4752921	=	IC50	nM	78.0	CHEMBL4204	Homo sapiens	IC50	nM	78.0
	22915562	CHEMBL4735374	Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate measured after 2 hrs by ADP-glo luminescence assay	B	O=c1ccc(-c2ccc3cn[nH]c3c2)cn1Cc1cccc(F)c1		CHEMBL4791136	=	IC50	nM	38.0	CHEMBL4204	Homo sapiens	IC50	nM	38.0
	22915563	CHEMBL4735374	Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate measured after 2 hrs by ADP-glo luminescence assay	B	O=c1ccc(-c2ccc3cn[nH]c3c2)cn1Cc1ccccc1F		CHEMBL4795993	=	IC50	nM	37.0	CHEMBL4204	Homo sapiens	IC50	nM	37.0
	22915564	CHEMBL4735374	Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate measured after 2 hrs by ADP-glo luminescence assay	B	Cn1cc(-c2ccc3cn[nH]c3c2)ccc1=O		CHEMBL4757267	>	IC50	nM	2000.0	CHEMBL4204	Homo sapiens	IC50	nM	2000.0
	22915565	CHEMBL4735374	Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate measured after 2 hrs by ADP-glo luminescence assay	B	O=C(N1CCOCC1)n1cc(-c2ccc3cn[nH]c3c2)ccc1=O		CHEMBL4793538	>	IC50	nM	2000.0	CHEMBL4204	Homo sapiens	IC50	nM	2000.0
	22915566	CHEMBL4735374	Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate measured after 2 hrs by ADP-glo luminescence assay	B	O=C(Cn1cc(-c2ccc3cn[nH]c3c2)ccc1=O)c1ccccc1		CHEMBL4793486	=	IC50	nM	1073.0	CHEMBL4204	Homo sapiens	IC50	nM	1073.0
	22915567	CHEMBL4735374	Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate measured after 2 hrs by ADP-glo luminescence assay	B	O=c1ccc(-c2ccc3cn[nH]c3c2)cn1CCc1ccccc1		CHEMBL4746326	>	IC50	nM	2000.0	CHEMBL4204	Homo sapiens	IC50	nM	2000.0
	22915568	CHEMBL4735374	Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate measured after 2 hrs by ADP-glo luminescence assay	B	Cn1cc2ccc(-c3ccc(=O)n(Cc4ccccc4)c3)cc2n1		CHEMBL4752505	>	IC50	nM	2000.0	CHEMBL4204	Homo sapiens	IC50	nM	2000.0
	22915569	CHEMBL4735374	Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate measured after 2 hrs by ADP-glo luminescence assay	B	Cn1ncc2ccc(-c3ccc(=O)n(Cc4ccccc4)c3)cc21		CHEMBL4765071	>	IC50	nM	2000.0	CHEMBL4204	Homo sapiens	IC50	nM	2000.0
	22915570	CHEMBL4735374	Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate measured after 2 hrs by ADP-glo luminescence assay	B	O=c1ccc(-c2ccc3cc[nH]c3c2)cn1Cc1ccccc1		CHEMBL4758288	>	IC50	nM	2000.0	CHEMBL4204	Homo sapiens	IC50	nM	2000.0
	22915571	CHEMBL4735374	Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate measured after 2 hrs by ADP-glo luminescence assay	B	O=c1ccc(-c2ccc3cn[nH]c3c2)cn1Cc1ccccc1		CHEMBL4789590	=	IC50	nM	75.0	CHEMBL4204	Homo sapiens	IC50	nM	75.0
	22915572	CHEMBL4735374	Inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate measured after 2 hrs by ADP-glo luminescence assay	B	O=c1ccc(-c2n[nH]c3ncc(Br)cc23)cn1Cc1ccccc1		CHEMBL4743561	=	IC50	nM	12.0	CHEMBL4204	Homo sapiens	IC50	nM	12.0
	22915635	CHEMBL4735410	ATP-competitive inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate and varying levels of ATP by ADP-glo luminescence assay	B	Nc1n[nH]c2cc(-c3ccc(=O)n(Cc4ccccc4F)c3)ccc12		CHEMBL4752141	=	Ki	nM	11.1	CHEMBL4204	Homo sapiens	Ki	nM	11.1
	22915636	CHEMBL4735410	ATP-competitive inhibition of recombinant human full-length N-terminal GST-fused MNK2 (1 to 465 residues) expressed in baculovirus expression system using GRSRSRSRSR as substrate and varying levels of ATP by ADP-glo luminescence assay	B	Nc1n[nH]c2cc(-c3ccc(=O)n(Cc4cccc(Cl)c4)c3)ccc12		CHEMBL4764756	=	Ki	nM	5.5	CHEMBL4204	Homo sapiens	Ki	nM	5.5
	22922026	CHEMBL4736833	Inhibition of wild-type human partial length MKNK2 (G63 to S388 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	COc1cc(-c2cnc3c(N4CCC[C@H](CNC(=O)C5CC5)C4)snc3c2)ccc1N		CHEMBL4745028	<	Activity	%	10.0	CHEMBL4204	Homo sapiens	Activity	%	10.0
	22952909	CHEMBL4766846	Inhibition of recombinant human MNK2 assessed as residual activity at 10 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma-33ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	6.0	CHEMBL4204	Homo sapiens	Activity	%	6.0
	22953096	CHEMBL4767033	Inhibition of recombinant human MNK2 using myelin basic protein as substrate incubated for 40 mins in presence of [gamma-33ATP by scintillation counting based radiometry assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	IC50	nM	136.0	CHEMBL4204	Homo sapiens	IC50	uM	0.136
	23122679	CHEMBL4805030	Inhibition of human MKNK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	71.0	CHEMBL4204	Homo sapiens	Activity	%	71.0
	23123374	CHEMBL4805618	Inhibition of human MKNK2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	82.0	CHEMBL4204	Homo sapiens	Activity	%	82.0
	23123833	CHEMBL4806077	Inhibition of DNA-tagged human MKNK2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	68.0	CHEMBL4204	Homo sapiens	Activity	%	68.0
	23124838	CHEMBL4806635	Inhibition of human MKNK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	83.0	CHEMBL4204	Homo sapiens	Activity	%	83.0
	23124839	CHEMBL4806635	Inhibition of human MKNK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	69.0	CHEMBL4204	Homo sapiens	Activity	%	69.0
	23128326	CHEMBL4807917	Inhibition of MKNK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL4204	Homo sapiens	Activity	%	75.0
	23128327	CHEMBL4807917	Inhibition of MKNK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL4204	Homo sapiens	Activity	%	75.0
	23128328	CHEMBL4807917	Inhibition of MKNK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL4204	Homo sapiens	Activity	%	75.0
	23128816	CHEMBL4808067	Inhibition of MNK2 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)[nH]c3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4874174	=	Inhibition	%	90.0	CHEMBL4204	Homo sapiens	INH	%	90.0
	23128817	CHEMBL4808067	Inhibition of MNK2 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3n[nH]nc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4853006	=	Inhibition	%	32.0	CHEMBL4204	Homo sapiens	INH	%	32.0
	23152087	CHEMBL4810649	Binding affinity to wild-type human partial length MKNK2 (G63 to S388 residues) expressed in mammalian expression system measured after 1 hr by competitive binding assay	B	CN(C)c1nccc(-c2cnn3ncccc23)n1		CHEMBL4848254	=	Kd	nM	1800.0	CHEMBL4204	Homo sapiens	Kd	nM	1800.0
	23212889	CHEMBL4822877	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate at 500 nM preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	O=C(c1ccc(-c2ccc3ncc(-c4ccc5cnccc5c4)n3c2)cc1)N1CCOCC1		CHEMBL4869957	=	Inhibition	%	106.0	CHEMBL4204	Homo sapiens	INH	%	106.0
	23212890	CHEMBL4822877	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate at 500 nM preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	O=C(c1ccc(-c2ccc3ncc(-c4cnc5ccccc5c4)n3c2)cc1)N1CCOCC1		CHEMBL4862514	=	Inhibition	%	21.0	CHEMBL4204	Homo sapiens	INH	%	21.0
	23212891	CHEMBL4822877	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate at 500 nM preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	O=C(c1ccc(-c2ccc3ncc(-c4ccc5ncccc5c4)n3c2)cc1)N1CCOCC1		CHEMBL4848427	=	Inhibition	%	64.0	CHEMBL4204	Homo sapiens	INH	%	64.0
	23212892	CHEMBL4822877	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate at 500 nM preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	O=C(c1ccc(-c2ccc3ncc(-c4ccc5cnccc5c4)n3c2)cc1)N1CCC(N2CCOCC2)CC1		CHEMBL4864827	=	Inhibition	%	77.71	CHEMBL4204	Homo sapiens	INH	%	77.71
	23212893	CHEMBL4822877	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate at 500 nM preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	O=C(c1ccc(-c2ccc3ncc(-c4cnc5ccccc5c4)n3c2)cc1)N1CCC(N2CCOCC2)CC1		CHEMBL4848805	=	Inhibition	%	18.67	CHEMBL4204	Homo sapiens	INH	%	18.67
	23212894	CHEMBL4822877	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate at 500 nM preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	O=C(c1ccc(-c2ccc3ncc(-c4ccc5ncccc5c4)n3c2)cc1)N1CCC(N2CCOCC2)CC1		CHEMBL4876117	=	Inhibition	%	34.94	CHEMBL4204	Homo sapiens	INH	%	34.94
	23212895	CHEMBL4822877	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate at 500 nM preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	O=C(c1ccc(-c2ccc3ncc(-c4ccc5cnccc5c4)n3c2)cc1)N1CCC(N2CCCCC2)CC1		CHEMBL4858035	=	Inhibition	%	74.7	CHEMBL4204	Homo sapiens	INH	%	74.7
	23212896	CHEMBL4822877	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate at 500 nM preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	O=C(c1ccc(-c2ccc3ncc(-c4cnc5ccccc5c4)n3c2)cc1)N1CCC(N2CCCCC2)CC1		CHEMBL4851380	=	Inhibition	%	48.8	CHEMBL4204	Homo sapiens	INH	%	48.8
	23212897	CHEMBL4822877	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate at 500 nM preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	O=C(c1ccc(-c2ccc3ncc(-c4ccc5ncccc5c4)n3c2)cc1)N1CCC(N2CCCCC2)CC1		CHEMBL4853176	=	Inhibition	%	2.41	CHEMBL4204	Homo sapiens	INH	%	2.41
	23212898	CHEMBL4822877	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate at 500 nM preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	O=C(c1ccc(-c2ccc3ncc(-c4ccc5cnccc5c4)n3c2)cc1)N1CCNCC1		CHEMBL4865340	=	Inhibition	%	77.71	CHEMBL4204	Homo sapiens	INH	%	77.71
	23212899	CHEMBL4822877	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate at 500 nM preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	O=C(c1ccc(-c2ccc3ncc(-c4cnc5ccccc5c4)n3c2)cc1)N1CCNCC1		CHEMBL4869672	=	Inhibition	%	68.07	CHEMBL4204	Homo sapiens	INH	%	68.07
	23212900	CHEMBL4822877	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate at 500 nM preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	O=C(c1ccc(-c2ccc3ncc(-c4ccc5ncccc5c4)n3c2)cc1)N1CCNCC1		CHEMBL4878777	=	Inhibition	%	49.89	CHEMBL4204	Homo sapiens	INH	%	49.89
	23212901	CHEMBL4822877	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate at 500 nM preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	N[C@H]1CCCN(C(=O)c2ccc(-c3ccc4ncc(-c5ccc6cnccc6c5)n4n3)cc2)C1		CHEMBL4878199	=	Inhibition	%	97.31	CHEMBL4204	Homo sapiens	INH	%	97.31
	23212919	CHEMBL4822879	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	O=C(c1ccc(-c2ccc3ncc(-c4ccc5cnccc5c4)n3c2)cc1)N1CCOCC1		CHEMBL4869957	=	IC50	nM	25.7	CHEMBL4204	Homo sapiens	IC50	nM	25.7
	23212920	CHEMBL4822879	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	O=C(c1ccc(-c2ccc3ncc(-c4cnc5ccccc5c4)n3c2)cc1)N1CCOCC1		CHEMBL4862514	=	IC50	nM	635.7	CHEMBL4204	Homo sapiens	IC50	nM	635.7
	23212921	CHEMBL4822879	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	O=C(c1ccc(-c2ccc3ncc(-c4ccc5ncccc5c4)n3c2)cc1)N1CCOCC1		CHEMBL4848427	=	IC50	nM	215.8	CHEMBL4204	Homo sapiens	IC50	nM	215.8
	23212922	CHEMBL4822879	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	O=C(c1ccc(-c2ccc3ncc(-c4ccc5cnccc5c4)n3c2)cc1)N1CCC(N2CCOCC2)CC1		CHEMBL4864827	=	IC50	nM	3.2	CHEMBL4204	Homo sapiens	IC50	nM	3.2
	23212923	CHEMBL4822879	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	O=C(c1ccc(-c2ccc3ncc(-c4ccc5cnccc5c4)n3c2)cc1)N1CCC(N2CCCCC2)CC1		CHEMBL4858035	=	IC50	nM	1.5	CHEMBL4204	Homo sapiens	IC50	nM	1.5
	23212924	CHEMBL4822879	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	O=C(c1ccc(-c2ccc3ncc(-c4ccc5cnccc5c4)n3c2)cc1)N1CCNCC1		CHEMBL4865340	=	IC50	nM	2.9	CHEMBL4204	Homo sapiens	IC50	nM	2.9
	23212925	CHEMBL4822879	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	O=C(c1ccc(-c2ccc3ncc(-c4cnc5ccccc5c4)n3c2)cc1)N1CCNCC1		CHEMBL4869672	=	IC50	nM	51.2	CHEMBL4204	Homo sapiens	IC50	nM	51.2
	23212926	CHEMBL4822879	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	NC1CCN(C(=O)c2ccc(-c3ccc4ncc(-c5ccc6cnccc6c5)n4c3)cc2)CC1		CHEMBL4872637	=	IC50	nM	5.2	CHEMBL4204	Homo sapiens	IC50	nM	5.2
	23212927	CHEMBL4822879	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	N[C@H]1CCCN(C(=O)c2ccc(-c3ccc4ncc(-c5ccc6cnccc6c5)n4c3)cc2)C1		CHEMBL4857770	=	IC50	nM	2.5	CHEMBL4204	Homo sapiens	IC50	nM	2.5
	23212928	CHEMBL4822879	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	N[C@@H]1CCCN(C(=O)c2ccc(-c3ccc4ncc(-c5ccc6cnccc6c5)n4c3)cc2)C1		CHEMBL4852274	=	IC50	nM	8.9	CHEMBL4204	Homo sapiens	IC50	nM	8.9
	23212929	CHEMBL4822879	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	NC1CCN(C(=O)c2ccc(-c3ccc4ncc(-c5ccc6cnccc6c5)n4n3)cc2)CC1		CHEMBL4862651	=	IC50	nM	15.7	CHEMBL4204	Homo sapiens	IC50	nM	15.7
	23212930	CHEMBL4822879	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	N[C@H]1CCCN(C(=O)c2ccc(-c3ccc4ncc(-c5ccc6cnccc6c5)n4n3)cc2)C1		CHEMBL4878199	=	IC50	nM	3.4	CHEMBL4204	Homo sapiens	IC50	nM	3.4
	23212931	CHEMBL4822879	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	N[C@@H]1CCCN(C(=O)c2ccc(-c3ccc4ncc(-c5ccc6cnccc6c5)n4n3)cc2)C1		CHEMBL4862069	=	IC50	nM	6.6	CHEMBL4204	Homo sapiens	IC50	nM	6.6
	23212932	CHEMBL4822879	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	NC1CCN(C(=O)c2ccc(-c3cn4c(-c5ccc6cnccc6c5)cnc4cn3)cc2)CC1		CHEMBL4857509	=	IC50	nM	18.5	CHEMBL4204	Homo sapiens	IC50	nM	18.5
	23212933	CHEMBL4822879	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	N[C@H]1CCCN(C(=O)c2ccc(-c3cn4c(-c5ccc6cnccc6c5)cnc4cn3)cc2)C1		CHEMBL4865426	=	IC50	nM	19.4	CHEMBL4204	Homo sapiens	IC50	nM	19.4
	23212934	CHEMBL4822879	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	N[C@@H]1CCCN(C(=O)c2ccc(-c3cn4c(-c5ccc6cnccc6c5)cnc4cn3)cc2)C1		CHEMBL4879113	=	IC50	nM	26.7	CHEMBL4204	Homo sapiens	IC50	nM	26.7
	23212935	CHEMBL4822879	Inhibition of N-terminal GST-fused human full length recombinant MNK2 (1 to 465 residues) expressed in baculovirus-infected Sf21 cells using TATKSGSTTKNR as substrate preincubated with enzyme and substrate for 10 mins followed by ATP addition and measured after 40 mins by ADP-glo luminescence assay	B	N#Cc1ccc(-c2cnc3ccc(-c4ccc(C(=O)N5CCOCC5)cc4)cn23)cc1		CHEMBL4211649	=	IC50	nM	9.4	CHEMBL4204	Homo sapiens	IC50	nM	9.4
	23213435	CHEMBL4822969	Inhibition of human recombinant MNK2 by Lanthascreen assay	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930	=	Inhibition	%	1.0	CHEMBL4204	Homo sapiens	INH	%	1.0
	23236742	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	IC50	nM	1600.0	CHEMBL4204	Homo sapiens	IC50	nM	1600.0
	23236743	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	CNC(=O)c1cccc(C#Cc2ccccc2Nc2ncnc3ccc(Cl)nc23)c1		CHEMBL4848439	=	IC50	nM	4900.0	CHEMBL4204	Homo sapiens	IC50	uM	4.9
	23236744	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	CN(C)C(=O)c1cccc(C#Cc2ccccc2Nc2ncnc3ccc(Cl)nc23)c1		CHEMBL4872456	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	23236745	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	CCCNC(=O)c1cccc(C#Cc2ccccc2Nc2ncnc3ccc(Cl)nc23)c1		CHEMBL4872712	=	IC50	nM	3900.0	CHEMBL4204	Homo sapiens	IC50	uM	3.9
	23236746	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	O=C(c1cccc(C#Cc2ccccc2Nc2ncnc3ccc(Cl)nc23)c1)N1CCNCC1		CHEMBL4867333	=	IC50	nM	5000.0	CHEMBL4204	Homo sapiens	IC50	uM	5.0
	23236747	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	O=C(c1cccc(C#Cc2ccccc2Nc2ncnc3ccc(Cl)nc23)c1)N1CCOCC1		CHEMBL4873909	>	IC50	nM	10000.0	CHEMBL4204	Homo sapiens	IC50	uM	10.0
	23236748	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	COC(=O)c1cccc(C#Cc2ccccc2Nc2ncnc3ccc(Cl)nc23)c1		CHEMBL4875475	=	IC50	nM	4200.0	CHEMBL4204	Homo sapiens	IC50	uM	4.2
	23236749	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	CNC(=O)c1oc2ccc(Nc3ncnc4ccc(Cl)nc34)cc2c1C		CHEMBL4856576	=	IC50	nM	2500.0	CHEMBL4204	Homo sapiens	IC50	uM	2.5
	23236750	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	Cc1c(C(=O)N(C)C)oc2ccc(Nc3ncnc4ccc(Cl)nc34)cc12		CHEMBL4874353	=	IC50	nM	2200.0	CHEMBL4204	Homo sapiens	IC50	uM	2.2
	23236751	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	CCCNC(=O)c1oc2ccc(Nc3ncnc4ccc(Cl)nc34)cc2c1C		CHEMBL4866279	=	IC50	nM	1900.0	CHEMBL4204	Homo sapiens	IC50	uM	1.9
	23236752	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	Cc1c(C(=O)N2CCNCC2)oc2ccc(Nc3ncnc4ccc(Cl)nc34)cc12		CHEMBL4855483	=	IC50	nM	1900.0	CHEMBL4204	Homo sapiens	IC50	uM	1.9
	23236753	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	Cc1c(C(=O)N2CCOCC2)oc2ccc(Nc3ncnc4ccc(Cl)nc34)cc12		CHEMBL4850233	=	IC50	nM	1800.0	CHEMBL4204	Homo sapiens	IC50	uM	1.8
	23236754	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	COC(=O)c1oc2ccc(Nc3ncnc4ccc(Cl)nc34)cc2c1C		CHEMBL4860143	=	IC50	nM	4800.0	CHEMBL4204	Homo sapiens	IC50	uM	4.8
	23236755	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	c1ccc(Nc2ncnc3ccc(-c4ccccc4)nc23)cc1		CHEMBL4866350	=	IC50	nM	612.0	CHEMBL4204	Homo sapiens	IC50	nM	612.0
	23236756	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	CNC(=O)c1ccc(-c2ccc3ncnc(Nc4ccccc4)c3n2)cc1		CHEMBL4861078	=	IC50	nM	58.0	CHEMBL4204	Homo sapiens	IC50	nM	58.0
	23236757	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	O=C(c1ccc(-c2ccc3ncnc(Nc4ccccc4)c3n2)cc1)N1CCNCC1		CHEMBL4853562	=	IC50	nM	36.0	CHEMBL4204	Homo sapiens	IC50	nM	36.0
	23236758	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	O=C(c1cccc(-c2ccc3ncnc(Nc4ccccc4)c3n2)c1)N1CCNCC1		CHEMBL4846164	=	IC50	nM	624.0	CHEMBL4204	Homo sapiens	IC50	nM	624.0
	23236759	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	O=C(c1ccc(-c2ccc3ncnc(Nc4ccccc4F)c3n2)cc1)N1CCNCC1		CHEMBL4872538	=	IC50	nM	10.0	CHEMBL4204	Homo sapiens	IC50	nM	10.0
	23236760	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	O=C(c1ccc(-c2ccc3ncnc(Nc4cccc(F)c4)c3n2)cc1)N1CCNCC1		CHEMBL4859617	=	IC50	nM	33.0	CHEMBL4204	Homo sapiens	IC50	nM	33.0
	23236761	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	O=C(c1ccc(-c2ccc3ncnc(Nc4ccc(F)cc4)c3n2)cc1)N1CCNCC1		CHEMBL4876307	=	IC50	nM	26.0	CHEMBL4204	Homo sapiens	IC50	nM	26.0
	23236762	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	O=C(c1cccc(-c2ccc3ncnc(Nc4ccc(F)cc4)c3n2)c1)N1CCNCC1		CHEMBL4858115	=	IC50	nM	52.0	CHEMBL4204	Homo sapiens	IC50	nM	52.0
	23236763	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	Cc1ccc(Nc2ncnc3ccc(-c4ccc(C(=O)N5CCNCC5)cc4)nc23)cc1		CHEMBL4849911	=	IC50	nM	62.0	CHEMBL4204	Homo sapiens	IC50	nM	62.0
	23236764	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	O=C(c1ccc(-c2ccc3ncnc(Nc4ccc(C(F)(F)F)cc4)c3n2)cc1)N1CCNCC1		CHEMBL4848753	=	IC50	nM	41.0	CHEMBL4204	Homo sapiens	IC50	nM	41.0
	23236765	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	COc1ccc(Nc2ncnc3ccc(-c4ccc(C(=O)N5CCNCC5)cc4)nc23)cc1		CHEMBL4864209	=	IC50	nM	111.0	CHEMBL4204	Homo sapiens	IC50	nM	111.0
	23236766	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	O=C(c1ccc(-c2ccc3ncnc(Nc4ccc(O)cc4)c3n2)cc1)N1CCNCC1		CHEMBL4861251	=	IC50	nM	41.0	CHEMBL4204	Homo sapiens	IC50	nM	41.0
	23236767	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	N#Cc1ccc(Nc2ncnc3ccc(-c4ccc(C(=O)N5CCNCC5)cc4)nc23)cc1		CHEMBL4879010	=	IC50	nM	43.0	CHEMBL4204	Homo sapiens	IC50	nM	43.0
	23236768	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	COc1cc(F)ccc1Nc1ncnc2ccc(-c3ccc(C(=O)N4CCNCC4)cc3)nc12		CHEMBL4857156	=	IC50	nM	29.0	CHEMBL4204	Homo sapiens	IC50	nM	29.0
	23236769	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	COc1cc(Nc2ncnc3ccc(-c4ccc(C(=O)N5CCNCC5)cc4)nc23)ccc1F		CHEMBL4859971	=	IC50	nM	25.0	CHEMBL4204	Homo sapiens	IC50	nM	25.0
	23236770	CHEMBL4828252	Inhibition of MKN2 (unknown origin) in presence of ATP by HTRF assay	B	CC(C)Oc1cc(F)ccc1Nc1ncnc2ccc(-c3ccc(C(=O)N4CCNCC4)cc3)nc12		CHEMBL4869634	=	IC50	nM	7.0	CHEMBL4204	Homo sapiens	IC50	nM	7.0
	23236805	CHEMBL4828256	Inhibition of wild type human partial length MKN2 (G63 to S388 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	CC(C)Oc1cc(F)ccc1Nc1ncnc2ccc(-c3ccc(C(=O)N4CCNCC4)cc3)nc12		CHEMBL4869634	=	Inhibition	%	100.0	CHEMBL4204	Homo sapiens	INH	%	100.0
	23236812	CHEMBL4828263	Inhibition of wild type human partial length MKN2 (G63 to S388 residues) expressed in mammalian expression system by HTRF method	B	CC(C)Oc1cc(F)ccc1Nc1ncnc2ccc(-c3ccc(C(=O)N4CCNCC4)cc3)nc12		CHEMBL4869634	=	IC50	nM	7.0	CHEMBL4204	Homo sapiens	IC50	nM	7.0
	23240828	CHEMBL4829153	Inhibition of wild-type human partial length MKNK2 (G63 to S388 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)C[C@@H](N)C(=O)Nc1ccc(-c2cnco2)c(OC(F)F)c1		CHEMBL4872886	=	Activity	%	1.4	CHEMBL4204	Homo sapiens	Activity	%	1.4
	23240842	CHEMBL4829167	Inhibition of wild-type human partial length MKNK2 (G63 to S388 residues) expressed in mammalian expression system by Kinomescan method	B	CC(C)C[C@@H](N)C(=O)Nc1ccc(-c2cnco2)c(OC(F)F)c1		CHEMBL4872886	=	IC50	nM	428.0	CHEMBL4204	Homo sapiens	IC50	uM	0.428
	23279631	CHEMBL4836793	Inhibition of MNK2 (unknown origin) assessed as residual activity at 500 nM	B	FC(F)(F)c1n[nH]cc1-c1nc2ccc3[nH]ncc3c2c2c1CCCC2		CHEMBL4593398	<	Activity	%	25.0	CHEMBL4204	Homo sapiens	Activity	%	25.0
Active	23298303	CHEMBL4841510	Inhibition of MKNK2 (unknown origin)	B	COc1ccc(-n2cc(-c3n[nH]c4cc(Cl)c(N[C@@H]5CCN(C6COC6)C5)cc34)cn2)cc1		CHEMBL4847487		Inhibition	%		CHEMBL4204	Homo sapiens	INH		
Not Active	23317514	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23317982	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23318649	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	85.0	CHEMBL4204	Homo sapiens	% Control	%	85.0
Not Active	23319132	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	74.0	CHEMBL4204	Homo sapiens	% Control	%	74.0
Not Active	23319769	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	83.0	CHEMBL4204	Homo sapiens	% Control	%	83.0
Not Active	23320244	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	96.5	CHEMBL4204	Homo sapiens	% Control	%	96.5
Not Active	23320922	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23321390	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	75.0	CHEMBL4204	Homo sapiens	% Control	%	75.0
Not Active	23322020	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	74.0	CHEMBL4204	Homo sapiens	% Control	%	74.0
Not Active	23322488	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	87.0	CHEMBL4204	Homo sapiens	% Control	%	87.0
Not Active	23323177	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	93.0	CHEMBL4204	Homo sapiens	% Control	%	93.0
Not Active	23323645	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23324064	CHEMBL4880683	Mnk2 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1	Outside typical range	CHEMBL4593677		Inhibition	%	-13.0	CHEMBL4204	Homo sapiens	% inhibition	%	-13.0
Not Active	23324499	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	90.6	CHEMBL4204	Homo sapiens	% Control	%	90.6
Not Active	23325134	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	83.0	CHEMBL4204	Homo sapiens	% Control	%	83.0
Not Active	23325602	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	99.0	CHEMBL4204	Homo sapiens	% Control	%	99.0
Not Active	23326249	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	86.0	CHEMBL4204	Homo sapiens	% Control	%	86.0
Not Active	23326717	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23327417	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	83.0	CHEMBL4204	Homo sapiens	% Control	%	83.0
Not Active	23327885	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	76.0	CHEMBL4204	Homo sapiens	% Control	%	76.0
Not Active	23328472	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	92.0	CHEMBL4204	Homo sapiens	% Control	%	92.0
Not Active	23328940	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23329427	CHEMBL4881134	Mnk2(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	99.0	CHEMBL4204	Homo sapiens	% residual kinase activity	%	99.0
Not Active	23329886	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23330354	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23331110	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	94.0	CHEMBL4204	Homo sapiens	% Control	%	94.0
Not Active	23331578	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23332165	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	95.0	CHEMBL4204	Homo sapiens	% Control	%	95.0
Not Active	23332631	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	85.2	CHEMBL4204	Homo sapiens	% Control	%	85.2
Not Active	23333349	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	84.8	CHEMBL4204	Homo sapiens	% Control	%	84.8
Not Active	23333988	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	63.0	CHEMBL4204	Homo sapiens	% Control	%	63.0
Not Active	23334456	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	71.0	CHEMBL4204	Homo sapiens	% Control	%	71.0
Not Active	23335435	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	90.0	CHEMBL4204	Homo sapiens	% Control	%	90.0
Not Active	23335903	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	90.0	CHEMBL4204	Homo sapiens	% Control	%	90.0
Not Active	23336530	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	90.0	CHEMBL4204	Homo sapiens	% Control	%	90.0
Not Active	23336998	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	90.0	CHEMBL4204	Homo sapiens	% Control	%	90.0
Not Active	23337685	CHEMBL4882056	MKNK2 (MNK2) Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	99.0	CHEMBL4204	Homo sapiens	% Ctrl	%	99.0
Not Active	23338079	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	88.0	CHEMBL4204	Homo sapiens	% Control	%	88.0
Not Active	23338547	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	94.0	CHEMBL4204	Homo sapiens	% Control	%	94.0
Not Active	23339159	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23339627	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	87.0	CHEMBL4204	Homo sapiens	% Control	%	87.0
Not Active	23340264	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23340732	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23341389	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23341857	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23342473	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23342941	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23343571	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	92.0	CHEMBL4204	Homo sapiens	% Control	%	92.0
Not Active	23344039	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	96.0	CHEMBL4204	Homo sapiens	% Control	%	96.0
Not Active	23344677	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23345250	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	70.0	CHEMBL4204	Homo sapiens	% Control	%	70.0
Not Active	23345718	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	75.0	CHEMBL4204	Homo sapiens	% Control	%	75.0
Not Active	23346295	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	74.7	CHEMBL4204	Homo sapiens	% Control	%	74.7
Not Active	23346763	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23347365	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	90.6	CHEMBL4204	Homo sapiens	% Control	%	90.6
Not Active	23347855	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	82.6	CHEMBL4204	Homo sapiens	% Control	%	82.6
Not Active	23348434	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23348902	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	75.0	CHEMBL4204	Homo sapiens	% Control	%	75.0
Not Active	23349489	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	57.0	CHEMBL4204	Homo sapiens	% Control	%	57.0
Not Active	23350107	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	76.0	CHEMBL4204	Homo sapiens	% Control	%	76.0
Not Active	23350575	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	66.0	CHEMBL4204	Homo sapiens	% Control	%	66.0
Not Active	23351180	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23351648	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23352138	CHEMBL4882827	MKNK2 (MNK2) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	9.348	CHEMBL4204	Homo sapiens	% Inhibition	%	9.3478
Not Active	23352672	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	74.0	CHEMBL4204	Homo sapiens	% Control	%	74.0
Not Active	23353140	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	67.0	CHEMBL4204	Homo sapiens	% Control	%	67.0
Not Active	23354022	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23354490	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23355222	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23355690	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	73.0	CHEMBL4204	Homo sapiens	% Control	%	73.0
Not Active	23356326	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23356794	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23357403	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	74.0	CHEMBL4204	Homo sapiens	% Control	%	74.0
Not Active	23358050	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23358518	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	77.0	CHEMBL4204	Homo sapiens	% Control	%	77.0
Not Active	23359104	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	73.2	CHEMBL4204	Homo sapiens	% Control	%	73.2
Not Active	23359702	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23360170	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23360755	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	94.0	CHEMBL4204	Homo sapiens	% Control	%	94.0
Not Active	23361223	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23361796	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	76.0	CHEMBL4204	Homo sapiens	% Control	%	76.0
Not Active	23362332	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23362800	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23364442	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	73.0	CHEMBL4204	Homo sapiens	% Control	%	73.0
Not Active	23364910	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	83.0	CHEMBL4204	Homo sapiens	% Control	%	83.0
Not Active	23365649	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	75.0	CHEMBL4204	Homo sapiens	% Control	%	75.0
Not Active	23366192	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	94.0	CHEMBL4204	Homo sapiens	% Control	%	94.0
Not Active	23366782	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23367250	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23367657	CHEMBL4884010	MKNK2 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	96.0	CHEMBL4204	Homo sapiens	% Residual activity with Skepinone-L	%	96.0
Not Active	23368128	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	94.0	CHEMBL4204	Homo sapiens	% Control	%	94.0
Not Active	23368596	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	91.0	CHEMBL4204	Homo sapiens	% Control	%	91.0
Not Active	23369195	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	86.0	CHEMBL4204	Homo sapiens	% Control	%	86.0
Slightly Active	23369663	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	37.0	CHEMBL4204	Homo sapiens	% Control	%	37.0
Not Active	23370145	CHEMBL4884389	Mnk2(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	110.0	CHEMBL4204	Homo sapiens	% residual kinase activity	%	110.0
Not Active	23370631	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	98.0	CHEMBL4204	Homo sapiens	% Control	%	98.0
Not Active	23371099	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23371908	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	84.0	CHEMBL4204	Homo sapiens	% Control	%	84.0
Not Active	23372376	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23375036	CHEMBL4886025	MKNK2 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	6.5	CHEMBL4204	Homo sapiens	% Inhibition	%	6.5
Not Active	23375286	CHEMBL4886268	MAP kinase interacting serine/threonine kinase 2 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	10.0	CHEMBL4204	Homo sapiens	% inhibition	%	10.0
Not Active	23375803	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	98.0	CHEMBL4204	Homo sapiens	% Control	%	98.0
Not Active	23376271	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23376848	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23377316	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23378176	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	82.0	CHEMBL4204	Homo sapiens	% Control	%	82.0
Not Active	23378644	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	76.0	CHEMBL4204	Homo sapiens	% Control	%	76.0
Not Active	23379811	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	85.0	CHEMBL4204	Homo sapiens	% Control	%	85.0
Not Active	23380279	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	96.0	CHEMBL4204	Homo sapiens	% Control	%	96.0
Not Active	23380973	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	96.0	CHEMBL4204	Homo sapiens	% Control	%	96.0
Not Active	23381621	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23382089	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23382713	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23383181	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	91.0	CHEMBL4204	Homo sapiens	% Control	%	91.0
Not Active	23383892	CHEMBL4887509	MKNK2 (MNK2) Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	68.0	CHEMBL4204	Homo sapiens	% Ctrl	%	68.0
Not Active	23384050	CHEMBL4887648	MNK2 ALPHA DUNDEE kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	67.2	CHEMBL4204	Homo sapiens	% Ctrl	%	67.2
Not Active	23384356	CHEMBL4887951	Mnk2(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	3.39	CHEMBL4204	Homo sapiens	% inhibition	%	3.39
Not Active	23385096	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL4204	Homo sapiens	% Control	%	100.0
Not Active	23385563	CHEMBL4879820	KinomeScan assay: inhibition of MKNK2	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	85.0	CHEMBL4204	Homo sapiens	% Control	%	85.0
